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Membrane fusion, the merging of two initially distinct membranes to form one
common lipid bilayer, is a fundamental mechanism of life. It occurs many times each
day within every eukaryotic cell as part of essential daily homeostatic processes, as
well as between individual cells, such as sperm and egg during fertilisation. The fusion
mechanism is, however, also crucial to the development ofmany diseases. All
enveloped viruses, and indeed many other obligate intracellular parasites, must fuse
their own surrounding lipid bilayer with the membrane of their host's target cell in
order to gain cell entry and thus the ability to replicate. These infections produce
disease states, and possibly even death, in the host species.
Despite the clear importance of fusion, the precise molecular events that
occur during this process are still not known. Fusion proteins of viruses have
recently become popular tools for use in fusion studies. More specifically, several
viruses have known fusion peptides, the sections of these proteins which confer their
fusogenic activity. This thesis examines the structure and function of the putative
fusion peptide of the retrovirus Feline leukaemia virus, (FeLV), using a variety of
mainly biophysical techniques.
The structural effects of the FeLV fusion peptide on lipid polymorphism
were studied. Using differential scanning calorimetry, 3IP nuclear magnetic
resonance and time-resolved X-ray diffraction this peptide was found to induce
changes in lipid conformation and motion similar to those of known fusogens: it
favoured the formation ofnon-bilayer lipid conformations which have a relatively
large negative curvature, namely the inverted hexagonal phase and isotropic lipid
states. Moreover, using X-ray diffraction, a new lipid phase was observed in the
presence of the FeLV peptide.
Neutron diffraction studies revealed a change in the packing of lipid
molecules within a bilayer and also possible thinning of the bilayer, both ofwhich
were induced by interaction with the FeLV fusion peptide.
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Fusogenic activity for this putative viral fusion peptide was demonstrated,
using fusion assays, which measured the merging of lipid membranes in the presence
of the FeLV fusion peptide.
These findings are discussed in the light of the current concepts of the fusion
mechanism. They add support to two currently favoured theories of fusion:
precession by a fusion peptide as a means of inducing the initial destabilisation of a
bilayer, and the formation ofhighly bent, high energy lipid intermediates, such as the
'modified stalk', in the multistep fusion pathway.
Circular dichroism was employed to determine the secondary structure of the
FeLV fusion peptide under a variety of experimental conditions. This peptide was
observed to flip readily between a-helical and p sheet conformations. This suggests
that structural plasticity may be an important dynamic property of fusion peptides.
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Chapter 1: Introduction to Fusion
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1. Introduction
1.1 The Importance of Fusion
Membrane fusion is an essential, ubiquitous life process. It occurs many times
each day within every animal cell, where it plays a vital role in endocytosis, organelle
formation, interorganelle trafficking, and constitutive and regulated exocytosis. Fusion
between individual cells is also important as, for example, between sperm and egg
during fertilisation. Flowever, fusion is also associated with many disease processes:
the entry into host cells of all enveloped viruses and many other intracellular parasites
utilises this mechanism.
It is now widely recognised that the essential structural element of a biological
membrane is the lipid bilayer. This stable configuration, described in the 'fluid mosaic'
model of Singer and Nicolson (1972), is formed spontaneously by the assembly of
amphipathic membrane lipids. The resulting structure is normally largely impermeable,
and so the cell membrane controls the entry and exit of substances into and out of the
cell. Cell fusion, the merging of the lipid bilayers of two distinct cells to form one
common bilayer, and the mixing of the two cells' contents (Figure 1.1), is a means of
overcoming these imposed restrictions. Membrane fusion is thought to be the central
process in cell fusion, with the mixing of cell contents following passively thereafter.
Despite the clear importance of fusion, the precise events which occur during
this process are still not fully understood. Diverse fusion reactions are known to differ
in their biochemical control, location and required speed. The essence ofany
biological reaction is controlled change. Thus different biological fusion systems are
thought to be catalysed by their own specific 'fusion' proteins, which initiate the
multistep fusion pathway. An understanding of the mechanism of fusion requires that
key structural fusion intermediates be identified and characterised. Since fusion is a
very rapid and localised event, and as the dimensions of individual lipid molecules are
below the resolution of the electron microscope, this has proved to be very difficult.
Consequently, many of the current ideas on fusion have developed from theoretical
calculations of the energetics involved in this process. These models of fusion have
then been used in attempts to explain past and present experimental findings. The
21
Figure 1.1. A general overview of the fusion process, as illustrated
by fusion between a vesicle and a planar bilayer. Prior to fusion, the
lipid molecules comprise two distinct bilayers. They then move
through several unknown, intermediate conformations, to end as one
common, stable bilayer conformation. Mixing of the aqueous
contents of the two cells follows the initial steps in membrane fusion.
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historical experimental and theoretical backgrounds are essential to an understanding
of the current concepts of fusion.
1.2 The Role of Lipids in Fusion
1.2a. Non-bilayer Lipid Phases
Lipid-water systems are classed as lyotropic liquid crystals. 'Lyotropic' means
that the systems have more than one component, for example lipid and water, while
'liquid crystalline' infers that they show crystalline periodicity in one, two or three
dimensions, but that the lipid molecules are not locked in a rigid lattice and can diffuse
freely. Thus these lipid arrangements are more ordered than a liquid but less ordered
than a crystalline solid, hence their name. A phospholipid molecule has a polar
headgroup, which prefers a polar water environment, and nonpolar hydrocarbon
chains which, in contrast, aggregate to minimise contact with the polar solvent. This
results in the spontaneous assembly of structures in which the lipid headgroups form a
continuous interface between the hydrocarbon chains and the water. A lipid phase is
such a macroscopically homogeneous arrangement at thermodynamic equilibrium.
The bilayer, or lamellar, phase describes the stable and relatively planar configuration
of biological membranes. A subdivision of the lamellar phase, La, represents lipid
molecules at a temperature above that at which their chains 'melt' and the lipids gain
an increase in mobility compared to that seen in the more rigid gel phase. In vivo
biological membranes are in the La phase.
The ability ofhydrated lipids to adopt a variety of different phases in addition
to the bilayer phase is now well documented. It has long been known, since the
pioneering work ofLuzzati (Luzzati and Husson, 1962), that some phospholipids
which are major components ofbiological membranes do not form lamellar phases in
the purified form. Roughly 10-50% ofmembrane lipids will form non-bilayer phases in
isolation (Cullis et al, 1985). These lipids assemble into a variety of different
structures, or phases (see Figure 1.2).
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Figure 1.2. Important lipid phases: HI5 H„, bicontinuous cubic phases
Q229 and Q224, and discontinuous cubic phase Q227. In Q229 and Q224 two
interpenetrating but unconnected water regions are separated by a single
continuous lipid layer. In Q227 two discontinuous lipid micellar
populations (shown as differently shaded micelles) are embedded in a
matrix ofwater.
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The inverted hexagonal phase
The inverted hexagonal (Hn) phase comprises lipid tubes which stack like
pipes in storage (Turner and Gruner, 1992). In this arrangement, the lipid headgroups
are directed towards the interior of the tubes and the hydrocarbon chains extend
towards the outer surface. By convention, this lipid surface is defined as having a net
negative radius of curvature (Tate et al, 1991) (see Figure 1.3). Positive curvature
describes headgroup surfaces which curve towards the hydrocarbon region. In Hn the
lipid headgroups are less exposed to the aqueous phase than in La: there is only a
limited amount ofwater in the tubes. The La-Hn phase transition is thought to be
important in fusion.
Cubic phases
Cubic (Q) phases are nonlamellar structures that some phospholipids form as a
sidepath during the transition from La to Hn (Lindblom and Rilfors, 1989) (see Figure
1.4). This is consistent with the curvature sequence ofphases, since the mean
curvature of the headgroup surface in Q phase lies between those of the La and Hn
phases (Gruner et al, 1988). Electron microscopic evidence suggests that some
biological specimens contain extensive domains of cubic structures (Landh, 1995). In
some lipid systems, cubic phases can be induced by repeated cycling of the system
above and below the La-Hn phase transition temperature, TH. Q phases represent
three-dimensional structures, the exact symmetry ofwhich depends upon the
components present and the conditions of the system. Bicontinuous cubic phases
contain a pair of three-dimensional labyrinths of the same polarity, apolar for type I
and polar for type II, which are mutually intertwined and unconnected, being
separated from each other by a continuous, fluid self-intersecting septum of the
opposite polarity (Vargas et al, 1992). Thus, although named bicontinuous, these
phases are really 'quadricontinuous', since the monolayers on each side of the minimal
surface and the two labyrinths are distinct (Tate et al, 1991). In the inverted versions,
Qn, the labyrinth interiors are coated by the polar lipid headgroups, and the lipid
surfaces are saddle-like in shape, having a negative interfacial curvature. These
25
mm
Figure 1.3 . Monolayer curvature, a: positive, b: zero and c: negative.




















Figure 1.4. The relationship between cubic phases and the inverted
hexagonal phase. Current theories suggest that the two pathways share
common lipid intermediates early on in their formation. These early non-
bilayer intermediates may also be involved in the fusion process (see text
for details).
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structures are like three-dimensional sponges, being highly permeable to both water-
and hydrocarbon-soluble substances. Two important bicontinuous cubic phases are
224 229 •
Q (spacegroup Pn3m), and Q , nicknamed 'Plumber's nightmare' (spacegroup
Im3m) The other main group of cubic phases, discontinuous cubic phases, represents
various complex packings of discrete micellar or inverse micellar aggregates, which
are embedded in a continuous hydrocarbon matrix. These discontinuous phases are
thus water impermeable. One such example is Q227 (spacegroup Fd3m).
Cubic phase structures were used by Luzzati et al (1993) to develop the
'patch the puncture' theory for repair of enzymatic attack on membranes. In this
224 • • 227model, Q represents a lipid intermediate in the repair pathway, and Q a water¬
tight, end stage lipid conformation. Nieva et al (1995) have since successfully related
this model to intermediate and end stages ofmembrane fusion.
Kinetically, cubic phases can be extremely stable, so that reversion to the La
phase can be very slow. All cubic phases are seen to be highly viscous when compared
to La or to Hn. This is probably due to the three-dimensional periodic structure: flow
requires some elements to leave their energy troughs in the lattice.
Other lipidphases
Alternative lipid configurations include the Hi phase and rhombic phases.
These are not currently implicated in the fusion process. The Hi phase consists of lipid
molecules arranged in stacked rods like Ho, but in Hi the lipid headgroups face
outwards and the acyl chains lie on the insides of the tubes. Hi is not normally
observed for diacylphospholipids, but it is formed by lysolipids, which are known
inhibitors of fusion.
1.2b. Factors Affecting Lipid Phase Formation
Force and energy calculations to fit Luzatti's data led to the realisation that
Van der Waals forces were not sufficient to account for phase determination or lipid
hydration (Parsegian and Ninham, 1971). Lipid phase formation is due to the balance
of lateral forces that exist across a lipid bilayer. These consist of steric repulsions
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between the lipid chains and the lipid headgroups, tension acting at the lipid-water
interface, and additional attractive and repulsive headgroup-headgroup interactions
from components such as hydration, charge and residual hydrogen-bonding (Seddon,
1992).
The molecular 'shape' concept
Israelachvili et al (1980) suggested that these various effects give rise to a
preferred 'molecular shape' for a lipid molecule, which explains phase preference (see
Figure 1.5). In greatly simplified terms, 'cylindrically shaped' lipids, such as diacyl
phosphatidylcholines (PCs), whose headgroups and acyl chains are usually of
approximately the same diameter, would prefer the bilayer phase, whilst 'cone-
shaped' lipids such as diacyl phosphatidylethanolamines (PEs), which often have
headgroups of smaller diameter than their acyl chains, would favour the Hn phase.
Similarly, an increase in the unsaturation of the fatty acid chains, which increases the
volume of the chain region, would promote Hn formation. It has been shown that PEs
and unsaturated fatty acids do indeed promote the formation ofHh (Cullis et al, 1991;
Epand et al, 1991).
This molecular 'shape' affects the lipid's critical packing parameter (CPP),
which is described by the equation:
CPP = — 1.1
al
where v is the hydrocarbon volume, a is the optimal surface area at the hydrocarbon-
water interface, and 1 is the critical chain length, or the maximum length a molecule
can extend in a direction perpendicular to the plane of the bilayer. Under a given set
of thermodynamic conditions (temperature, hydration etc.) a specific lipid molecule
will generally have a preferred interfacial area per molecule, a preferred interfacial
monolayer mean curvature, and a preferred interfacial Gaussian curvature. (The
Gaussian curvature is the product of the two principle curvatures at a common point
on a lipid surface). These effects compete with geometric packing constraints and
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interactions transverse to the lipid bilayers (for example, hydration, electrostatic, van
der Waals and fluctuation forces) to determine which phase is the thermodynamically
stable one. Thus, for example, an increase in the water content (increased hydration
force), or in the length of the acyl chains present (increased hydrophobic forces), or in
the headgroup ionisation (increased electrostatic repulsion) will act to stabilise La.
Conversely, an increase in the temperature of the system, and thus in lipid chain
motion (increased monolayer negative curvature), will favour Ho. This is shown by
the conversion ofmany phospholipid systems from La to Hn as the temperature of the
system increases. A summary of these different effects is shown in Figure 1.6. The
combination of all these individual factors produces characteristic phase transition
temperatures for a given lipid system under a standard set of thermodynamic
conditions.
Lipid monolayer intrinsic curvature
A more quantitative formulation of the 'shape' concept involves a
determination of the free energy per molecule when it occupies a given molecular
volume of a given shape.
Helfrich (1973) introduced the concept of intrinsic, or spontaneous, curvature
of a lipid monolayer. This describes the monolayer's shape in a stress-free state, and
thus relates the stress profiles of the monolayers to elastic moduli. Thus the free
energy depends not only upon what shape the monolayer is in, but also upon the
shape that represents its minimum energy state. For a lipid monolayer, this can be
thought of as the shape it would assume if the headgroups were hydrated with water
and the terminal methyl groups were surrounded by a nonpolar solvent (Epand el al,
1995). Deviations away from the preferred values of area or curvature will have
associated elastic energy costs. Kirk et al (1984) successfully formulated the La-Hn
transition by dividing the free energy mto components arising from the elastic bending
of the lipid monolayers and the hydrocarbon packing energies. Similarly, Gruner
(1985) developed a more accurate and quantitative description ofphase equilibrium,
describing it as a competition between the elastic free energy of a lipid monolayer and














Figure 1.6. Factors that influence the La to Hn phase transition.
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of the monolayer to bend to form a curved surface with an equilibrium radius of
curvature, called the intrinsic radius of curvature, Ro. The smaller Ro is, the greater is
the instability of the bilayer structure, and also the tendency to form phases such as
Ho. Generally the preferred phase adopted is a compromise, and some degree of
physical 'frustration' remains (Anderson et al, 1988).
It is not possible to calculate Ro; it must be determined empirically. However,
Marsh (1996) has recently suggested a new expression for the intrinsic curvature of a
lipid monolayer in terms of a novel lipid packing parameter: V/Al, where V is the
volume of the entire lipid molecule, 1 is its length and A is the area of the lipid
headgroup at the lipid-water interface. It remains to be seen if this new parameter
stands up to rigorous testing.
There is much experimental support for the overall concepts just described. As
an example, Kozlov and co-workers (1994) used well-defined osmotic stresses to
control the La-Hn phase transition, and to measure how much work this flat-to-
negative curvature transition takes. They found that the required bending energy
dramatically depended upon the type of lipids present in the monolayer, with
increasing amounts ofPE reducing this considerably.
1.2c. Non-bilayer Lipid Phases in Fusion
It was quickly realised that non-bilayer phases might have important biological
structural and functional roles. Cells carefully control the ratio of'bilayer' to 'non-
bilayer' lipids present in their membranes. A number ofprokaryotes alter the lipid
compositions of their membranes depending upon their growth conditions. This
alteration results in the membrane adjusting its properties so that it remains as a
bilayer, but it lies close to the La to Hn phase boundary, suggesting that this
composition is important. Wieslander (1996) proposed this for Acholeplasma
laidlawii and it has also been found for other prokaryotes. Non-bilayer phases have
now been implicated in a variety of biological processes.
Lucy (1970) first suggested that the fusion mechanism might involve a lipid
phase change. Indeed, the structural analysis of fusion between liposomes began with
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studies of lipid phase behaviour (Papahadjopoulos et al, 1977). Fusion ofpure lipid
bilayers is sensitive to the presence ofnon-bilayer lipids, and a variety of nonlamellar
assemblies have been proposed as fusion intermediates. During fusion there must be a
transient disruption in bilayer structure to permit lipid mixing, and to allow the fusing
monolayers to bend.
Phases such as Hn are unlikely to participate directly in fusion. Early
suggestions were made that the Hn phase might be involved (Cullis and Hope, 1978),
but Hij is a thermodynamically stable and relatively long-lived phase, and fusion is an
extremely rapid process, which may occur within a few microseconds (Aimers and
Tse, 1990). Potential candidates for intermediate structures in the fusion pathway
must, therefore, be short-lived. Since the La and H0 phases are of very different
topologies, the phase transition between the two must involve tearing and
reorganisation within the lipid bilayer. Theoretically, the cost in free energy must be
high, imposing a large kinetic barrier. The kinetics of the La-Hn phase transition are
indeed very slow close to the phase boundary (Tate et al, 1992): time-resolved X-ray
data that were collected for several PE-water systems showed the coexistence ofLa
and Hn phases that exhibited well-ordered lattices throughout the transition period,
under slow transition conditions. This indicated that the sample material could reorder
itself in a shorter time than the transition time, and suggested that it is indeed a large
kinetic activation energy barrier that limits the transition in this regime. Finally, there
cannot be extensive formation ofH0 in biological membranes, since this would result
in a breakdown of the cell's permeability barrier.
It is probable that it is the tendency towards inverse phase formation that is the
important factor in the fusion process, rather than the actual formation of these
phases. Epand et al (1987) correlated the inhibition ofmembrane fusion by some
compounds with their ability to increase TH. Similarly, several known fusogens have
been shown to lower TH (Epand and Epand, 1994; van Gorkom et al, 1992; Siegel et
al, 1989a). The tendency towards Hn phase formation will result in a less stable
bilayer structure with a more hydrophobic surface, which can more readily attach to
another hydrophobic membrane surface.
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Work on fusion of large unilamellar vesicles (LUVs) composed ofN-
monomethyldioleoylphosphatidylethanolamine (MeDOPE) and PE/PC mixtures
directly correlated the appearance ofnonlamellar structures with initial fusion rates
(Ellens et al, 1989). This suggested that the nonlamellar structures might be
intermediates in the fusion pathway, or that they might be formed from an
intermediate shared with the fusion pathway. Since the detected nonlamellar
structures were not transient, and the kinetics of formation of the nonlamellar
structure in MeDOPE have been shown to be slow relative to the initial rates of fusion
(van Gorkom et al, 1992), it is more likely that these observed structures utilised a
common intermediate with the fusion pathway.
As mentioned earlier, cubic phases can form as a sidepath in the La-Hn phase
transition. It has been suggested that cubic phases, or cubic-like structures, are
intermediates in membrane fusion. Thus diacylglycerol (DAG) promotes both fusion
between LUVs and also the formation of cubic phases (Basanez et al, 1996). The
cubic phase is an extremely stable thermodynamic phase, so its direct participation as
a fusion intermediate seems very unlikely. However, the fusion pore, the end stage of
fusion, bears a remarkable similarity to the local structure of the inverse Im3m
bicontinuous cubic phase Q229 (Ellens et al, 1989).
If these ideas are correct, it should be possible to inhibit fusion with agents
which spontaneously partition into a membrane and which contain polar groups that
will make the membrane surface more hydrophilic, and thus stabilise the bilayer phase.
Thus cholesterol sulphate inhibits model membrane fusion, fusion of Sendai virus to
ganglioside-containing liposomes, and Sendai-induced haemolysis (Cheetham et al,
1990). Moreover, sperm have high concentrations of cholesterol sulphate, and its
hydrolysis is thought to play an important role in the capacitation reaction that is
required for mammalian sperm-egg fusion (Langlais et al, 1981).
Further support comes from the observation that lysophosphatidylcholine
(LPC), whose headgroup has a very large diameter in comparison to that of its single
lipid tail, is a bilayer-stabilising lipid. Addition of exogenous LPC to a wide variety of
fusion systems causes fast, dose-dependent and potent inhibition of fusion, which is
reversible upon withdrawal of the lipid. Fusion reactions affected include:
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1. syncitium formation caused by low pH and either Influenza haemagglutinin (HA) or
baculovirus gp64 (Zimmerberg et al, 1995) ;
2. fusion between Sendai virus and liposomes (Yeagle et al, 1994);
3. myoblast fusion (Schudt and Pette, 1976);
4. calcium-triggered exocytosis of either sea urchin egg cortical granules or digitonin-
permealised bovine chromaffin cells (Zimmerberg et al, 1995);
5. mast cell degranulation triggered by GTPyS (Zimmerberg et al, 1995);
6. protein trafficking between successive cisternae of the Golgi stack (Glick and
Rothman, 1987);
7. rat endoplasmic reticulum fusion mediated by GTP (Zimmerberg et al, 1995);
LPC also inhibits the redistribution of fluorescent membrane dye between fusing
membranes. This inhibition of fusion cannot be ascribed to any specific chemical
group; zwitterionic LPC, lysoPE, negatively charged lysophosphatidylserine and
lysophosphatidylinositol and a set ofLPCs of varying length of chain and degree of
unsaturation all had similar effects on fusion (Chernomordik et al, 1993). However,
caution should be used in ascribing all of the effects of LPC to membrane changes;
recent work by Gunther-Ausborn and co-workers (1995) suggests that LPC inhibits
the binding of Influenza virus to liposomal membranes, and that this effect is due to
non-membrane-bound LPC. Thus free LPC must be washed away before starting
experiments, and this factor must be considered when looking at results obtained in
some of the previous LPC studies.
Obversely, cA-unsaturated fatty acids, such as arachidonic acid or oleic acid,
which have previously been shown to act as Hn promoters, do enhance fusion. This
effect has been found in a number of situations, for example low pH syncitia
formation by baculovirus (Chernomordik et al, 1995a), fusion between endosomes
(Mayorga et al, 1993), Ca2+-triggered fusion of chromaffin granules (Creutz, 1981)
and GTP-dependent fusion ofmicrosomes (Paiement et al, 1994). Furthermore,
Bailey and Cullis (1997) have correlated liposome fusion rates with an increase in the
unsaturation of the PE acyl chain, and thus the tendency towards inverted phase
formation. The replacement of PC, a bilayer stabiliser, with PE, an Hn promoter, also
promotes virus-liposome fusion (Hoekstra and Kok, 1989). Although the precise
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monolayer composition ofmyoblast membranes is not known, lipid changes do occur
just before fusion (Santini et al, 1990; Santini et al, 1991). The amounts ofPC and
phosphatidylinositol (PI) decrease, whereas PE, cholesterol and phosphatidic acid
levels all increase. Agents that delay fusion delay these changes in lipid composition.
Finally, DAG promotes both Hn phase formation and fusion (Siegel et al, 1989a,
1989b; Basanez et al, 1996).
These findings suggest that the tendency to form non-bilayer lipid phases is
important in a very diverse range of fusion reactions. Phase transitions between La, Q
and Hn appear to occur by the formation of discrete intermediate structures. Verkleij
et al (1979) first observed such intermediates near the La-Hn boundary using freeze-
fracture electron microscopy (FFEM). These were called 'lipidic particles', and
thereafter have been observed frequently (eg. Hui et al, 1981; Hui et al 1983; Gagne
et al, 1985). Several different structures have been suggested for lipidic particles, but,
to date, their structure has not been established unequivocally. Cryo-electron
microscopy also revealed the interlamellar attachment (ILA) (Siegel et al, 1989c),
which is a semi-toroidal (tyre rim-shaped) attachment between flat bilayer sheets.
Thus ILAs have been directly imaged, but once again, the precise molecular structure
is unknown. The first step of the La-Q phase transition may be the formation of an
ordered array of ILAs: Siegel (1989c) found, using time-resolved cryo transmission
electron microscopy (TRC-TEM), that ILAs appear to mediate both fusion and the
La-Q phase transition. This supports Ellens and co-workers findings that membrane
fusion and inverted cubic (Qn) phase formation occur via the same structure (Ellens et
al, 1986; Ellens et al, 1989). Their results also show that, for MeDOPE, lipidic
particles are ILAs, and suggest that, in the temperature range where ILAs are formed,
fusion is an obligatory step in the La-Qn phase transition for this lipid system. It has
also been suggested that ILAs may correspond to the 'stalks' mentioned below.
Siegel and Epand (1997) have very recently studied the La-Hn transition. They
found evidence that this transition occurs in at least three steps:
1. Many small connections form between apposed membranes.
2. The connections aggregate within the planes of the bilayers to form arrays with
hexagonal order in some projections.
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3. These quasi-hexagonal structures elongate into small domains ofHn, acquiring
molecules by diffusion from contiguous bilayers.
The non-lamellar morphology they observed by cryo-TEM was transient, with a
lifetime ofminutes or less.
Theoretical models (e.g. Siegel, 1993) also show successive formation of
transient and local non-bilayer intermediates along the fusion pathway, the energetics
of these intermediates depending upon the bending elastic energy of the lipid
monolayers. Siegel and Epand (1997) suggest that the lipid intermediates observed in
the L„-Hn transition agree well with the putative fusion intermediates ofSiegel
(1993).
Liposome fusion kinetics have also been correlated with lateral phase
segregation of the different lipid constituents present (Bentz et al, 1987). This allows
for the possibility ofproduction of local domains of inverted-phase promoting, and
thus fusion enhancing, lipid molecules.
A putative model of the overall relationship between fusion and lipid phase
changes is shown in Figure 1.7. Certainly experimental work on lamellar/inverted
phase transitions has greatly improved our understanding of the relative stability of
lipid structures ofdifferent geometrical structure.
1.2d. Lipid Fusion Mechanisms
It will not be possible to determine logically the mode of action of fusion
proteins until we understand the energetic and conformational changes of the lipid
molecules present in the two apposed and fusing bilayers. Ifwe appreciate the fusion
mechanisms of pure lipid systems we may then identify methods by which proteins can
catalyse similar processes under different conditions, and also what type ofprotein
structures would be the most effective catalysts.
Biological fusion is driven mainly by proteins, but there is a fundamental stage
of actual membrane merging which may be regulated by the properties of the lipid
bilayers. Thus, exogenously added lipids do not need to be present during the

















Figure 1.7. The relationship between fusion and non-bilayer phases.
Fusion and cubic phase formation are thought to share common early lipid
intermediate structures. The precise pathway followed will depend upon
the constituents and the thermodynamic conditions present.
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respectively inhibit and promote baculovirus-mediated fusion even when added
immediately after application of a low pH pulse (Chernomordik. 1996). Lipids
therefore appear to affect fusion downstream of the triggering process, which explains
why, at this particular stage, different biological and model fusion reactions may
converge to common lipid structural intermediates, driven by similar forces. Lipid
composition can thus determine whether or not an activated complex proceeds to
complete fusion. Fusion ofpure lipid bilayers can model biological fusion in lipid
sensitivity and, hopefully, in the intermediates involved. The use of such model
systems allows control of the total lipid composition of the component membranes,
and also independent alteration of this in the different monolayers of the fusing
membranes. Thus many theoretical calculations and much experimental proof for the
various fusion hypotheses have come from the use of such systems, which may be
based on fusing planar lipid bilayers and/or liposomes. Liposomes are lipid bilayers
enclosing an aqueous compartment, so they are good models of simple cells. They
allow manipulation not only of the lipids present, but also of the aqueous contents.
Thus by labelling membrane lipids with fluorescent dye, and by enclosing aqueous
fluorescent dyes, or polymers such as dextran, or ions such as PL. within the
liposome, it is possible to follow the mixing of lipids and the mixing of contents as
separate processes, any leakage that occurs, and also the formation of intercellular
pores. This helps to reveal the sequence of individual steps in the fusion process. The
kinetic analysis of fusion, based mainly on the use of these fluorescent markers, is now
well developed (Nir et al, 1980; Bentz et al, 1983, 1985, 1988; Ellens et al, 1984).
The findings from these experiments can then be compared with results obtained by
electron microscopy and with biophysical data for the same lipid systems, in an
attempt to relate observed lipid structures and changes in lipid conformation and
motion to individual, kinetically-discernible steps in the fusion process.
Many fusion mechanisms have been proposed. Bentz and Ellens (1988)
suggested that the overall process ofmembrane fusion required at least three steps:
1. The close approach of the fusing membranes.
2. The formation, at least transiently, ofhigher energy, highly bent lipid structures that
involve non-bilayer assemblies.
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3. The mixing ofmembrane components to fuse into one common membrane.
Close membrane approach
Close approach requires membrane dehydration (Rand, 1981).
Phosphatidylserine (PS) bilayers are known to form dehydrated contacts in the
presence of Ca2T ions, which are proven fusogenic agents for liposomes composed of
this lipid (Bentz et al, 1985). Thus it seems that, for some systems at least, the first
step in fusion is governed by hydration forces (Rand and Parsegian, 1989), more
specifically by the need to remove tightly bound water molecules from the lipid
headgroups. An estimation of the work required to bring two 300A unilamellar
vesicles to within a separation of 13A yields a figure of the order of 1 OCT, which
corresponds to a statistical weighting of 104 against this mutual approach (Lis et al,
1982; Parsegian et al, 1979). This will be affected by the lipids present. Cholesterol
can facilitate, or may even be essential, for liposome/viral fusion processes (Asano and
Asano, 1988; Gollins and Porterfield, 1986; Hoekstra and Kok, 1989; White and
Helenius, 1980). Cholesterol also promotes fusion of secretory granules with
liposomes (Vogel et al, 1992). Furthermore, the lipid envelopes of viruses, which one
might expect to be specialised for fusion, are known to be rich in cholesterol (Klenk,
1973). Cholesterol may modify repulsions between adjacent membranes by interfering
with the organisation of interfacial water, since it decreases the depth to which water
penetrates into a lipid bilayer (Simon et al, 1982). It may also reduce steric repulsions
between membranes due to its ability to spread the lipid headgroups further apart in
the bilayer (Mcintosh et al, 1989).
PE can hydrogen bond to adjacent lipids through its amino and phosphoryl
groups, whilst the PC headgroup lacks a group that can act as a hydrogen bond
donor, and so it is expected to interact more strongly with water than does PE. Thus
bilayers that are rich in PE can dehydrate and aggregate more readily than can bilayers
rich in PC (Seddon et al, 1983; Chang and Epand, 1983). Partial phase separation,
with the accumulation ofmore weakly hydrated lipids, like PE, in the fusion region
might reduce the hydration barrier. A large body of evidence indicates that biological
membranes are indeed laterally structured. Recently, Lehtonin (1996) found domain
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formation in certain lipid mixtures. He suggested that hydrophobic mismatch is the
cause of this microdomain formation for lipids in fluid, liquid crystalline bilayers.
Thus, in membranes containing lipids with large variations in hydrophobic thickness
(such as biological membranes), the minimum energy state of the system is
represented by enrichment of its short chain and long chain constituents into
microdomains, to avoid exposure ofhydrocarbons to water, and to minimise the
length of domain boundaries. Close approach may also require local defects in lipid
packing, which will result in some exposure of hydrophobic surfaces in the membrane
(Bentz and Ellens, 1988; Rand, 1981).
Clearly the large hydration barrier will prevent mutual close approach of
membranes in any significantly large area, since the energy necessary to overcome
repulsion is proportional to the area of close contact. Local bending of the membranes
will decrease this mutual repulsion. It has been suggested that membrane bending may
be produced by out-of-plane thermal fluctuations of the apposed bilayers (Leikin et al,
1987). Certainly, the diameter of the membrane contact region prior to fusion has
been shown to be small: approximately lOnm (Chandler, 1984; Siegel and Epand,
1997).
The definitive answer to the question of the mechanism by which the hydration
barrier is overcome is still elusive. It seems likely that it will vary amongst different
fusion systems, depending upon the specific components present in each individual
process.
Formation of lipidfusion intermediates
It is unlikely that a fusion pore, the end stage ofmembrane fusion, would be
formed by a single catastrophic rearrangement, involving energy-intensive
rearrangements of a large number ofmolecules, since the activation energy required
would be prohibitively large. Much more likely is the concept of fusion occurring
through the formation of one or more discrete intermediate structures, which would
have continuous lipid-water interfaces with no free monolayer or bilayer edges. Thus
each intermediate could preserve some of the equilibrium structure of the original
bilayers, and hence reduce the number ofmolecules that need to be perturbed in order
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to be converted to the next step in the fusion pathway. Fusion could then occur at an
overall faster rate by means of successive stages that required lower activation
energies. Intermediate formation is likely to be co-operative, since large perturbations
made to one lipid molecule will substantially change the energy required to perturb its
neighbour. It is logical to assume that the structures which require the least activation
energy would be the most likely to occur.
The difficulties involved in the direct visualisation, in any great detail, of the
tiny, localised and extremely transient fusion intermediates has led to the proposal of a
variety of possible structures. Two main fusion pathways have been proposed as a
result of these ideas, one involving micellar intermediates, and the other utilising a
stalk-like structure. Lucy (1970) envisaged the formation ofnormal micelles at fusion
sites. Siegel (Siegel, 1984) then modelled the fusion pathway using inverted micellar
intermediates (IMIs) (see Figure 1.8). IMIs had, theoretically, the required short
lifetimes and the structural ability to mix the lipid components of the two opposing
bilayers. However, IMI formation seems to be very unlikely for a wide range of
membrane compositions. Siegel (1993) subsequently showed, using calculations of
free energy, that IMIs are unlikely to take part in most fusion mechanisms, even in the
vicinity of the La-Hn phase transition, where IMI formation would be easiest.
Hemifusion, the merging of the two outer membrane leaflets only, has long
been suggested as an intermediate in the fusion pathway (Palade, 1975; Pinto da Silva
and Nogueira, 1977). Theoretical calculations led to the proposal of'stalks' as
achievable fusion intermediates (Markin et al, 1984; Chernomordik et al, 1987) (see
Figure 1.9). Very little activation energy was thought to be required to achieve this
state, and the IMI free energy was shown to be higher than that of the stalk, for all
values ofmarginal radius (Siegel, 1993). Also the stalk's lifetime could be sufficiently
short for it to act as a candidate for a fusion intermediate. Stalks could form a
subsequent fusion intermediate much faster than IMIs (Siegel, 1994).
A stalk is a neck-like, or semi-toroidal, local connection between the outer,
contacting monolayers of two fusing membranes, which thus become continuous. The
best analogy for its shape is the waist of an hourglass, and its radius is comparable to









Figure 1.8. Inverted micellar intermediate (IMI) formation as a
fusion mechanism. IMIs are cylindrically symmetrical about the
vertical midline axis, and are composed of cylindrical micelles
inside a semitoroidal outer monolayer. For certain values ofR0,
IMIs can transform into interlamellar attachments (ILAs), or
fusion pores, thus fusing the two monolayers.
Figure 1.9. The basic stalk model for a fusion intermediate.
The upper and lower stalk surfaces are formed from the
original inner monolayer leaflets of the two apposing
membranes, whilst the stalk sides comprise the original
outer or contacting monolayers. The stalk is cylindrically
symmetrical about the midline vertical axis.
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following transient point contact between the two apposed membranes. Monolayer
rupture is related to the competition between the hydration forces and the
hydrophobic energy of contact between the monolayer interior and water. At small
distances between membranes the energy of hydration repulsion becomes so large that
it is energetically more favourable to replace it by the hydrophobic energy required to
rupture the contacting monolayers. Thus stalk formation leads to a hemifusion stage,
in which fusion of contacting monolayers occurs without merger of inner, or distal,
monolayers.
Stalks are hard to visualise due to their low image contrast; they are calculated
to have a diameter ofonly ~4nm at their narrowest point, which is the minimum
possible diameter, being the thickness of a bilayer. Most of the total free energy of the
stalk is associated with this waist. In general terms, the larger the spatial extent of a
structural change the more slowly it occurs. We know that fusion is a very rapid
process, so the rate-limiting step(s) should logically involve as small a structure as
possible.
The original stalk theory calculated its free energy by assuming that the main
contribution came from the elastic bending of the contacting monolayers of the two
membranes. Stalks have a net negative curvature, and the spontaneous curvature of
the contacting monolayers should determine the energy of the stalk, its formation and
expansion. Certainly, the effects ofmembrane composition on lipid bilayer fusion are
consistent with the hypothesis that the rate-limiting intermediates ofmembrane fusion
have net negative curvature. The stalk hypothesis was based on morphological studies
(e.g. Hui et al, 1981; Markin et al, 1984) and theoretical analysis (e.g. Kozlov and
Markin, 1983; Chernomordik et al, 1987).
The original stalk model has recently been modified by Siegel (1993). This
modification includes the possible contributions of hydrophobic void spaces within the
intermediate (Figure 1.10). Formation ofany intermediate structure between two
membranes has to be accompanied by the peeling apart of the hydrophobic sides of
lipid monolayers, thus creating hydrophobic voids within the intermediate. This
creation of voids is similar to the packing problem seen for Hn, in which voids are
created between the individual lipid cylinders. These must be filled by the intercalation
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Figure 1.10. Modified stalk mechanism of fusion. This takes into
account the energy contributions caused by the formation of
hydrophobic voids, shown as filled black areas in a, stalk b and
TMC c. The effect of dimpling of the inner, or distal, monolayers
during stalk formation, as shown in a, is also considered in this
model, a is an early, stalk-like conformation. The marginal radius,
r, of the stalk is shown in b.
45
of the lipid acyl chains. The larger the Hn tube diameter, the larger are the voids that
must be filled. Seddon (1990) and Tate el al (1991) successfully rationalised the
relative stabilities of the La, Q and Hn phases in excess water by purely considering Ro
of the constituent monolayers and the free energy associated with the hydrophobic
packing voids present. Moreover, the void energy contributions may explain the
observed effects of traces ofhexadecane on fusion rates of anionic lipid systems
(Walter and Siegel, 1993): hexadecane is a fusion promoter, and it can partition to fill,
and thus reduce in size, these voids. These findings led Siegel (1993) to suggest that a
similar approach would be valid for continuous-monolayer intermediates in general,
and thus for fusion intermediates.
Void energy may dramatically increase stalk energy, both directly and
indirectly, by requiring the inner, or distal, monolayers to bend and dimple in order to
reduce the void volume. Void energy may be very large if all of the lipid molecules in
the bilayer are identical, but it will significantly decrease for model bilayers formed
from lipid mixtures, and also in the presence of small amounts of impurities, such as
neutral lipids or any lipids with longer hydrocarbon chains, which may fill the voids.
Biological membranes surpass simple lipid membranes in their complexity. Thus the
energy balance for a stalk connecting two biological membranes should differ from
that of a stalk intermediate of lipid bilayer fusion. The energy ofhydrophobic voids
ought to be much less significant for biological membranes known to consist of
complex mixtures of lipids, including apolar ones.
Another important modification of the original stalk model is the consideration
of the effects of the geometry of the fusion site: as two membranes pucker towards
each other, the contribution of the negative meridional curvature will decrease and the
contribution of the positive parallel curvature will increase. Thus, deformation of the
original membranes at the contact site not only affects the elastic energy of a stalk but
may even change the sign of its net curvature from negative to positive.
Helm el al (1989) have developed a different model which suggests that the
energy for lipid bilayer hemifiision comes solely from the long range attractive forces
of the hydrophobic interiors of the membranes. However, they used supported planar
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lipid bilayers which cannot undergo elastic deformation as easily as, for example, free
liposomal lipids. No further evidence to support this theory has so far come to light.
The 'stalk-pore' model is based on minimising the free energy of the two
highest-energy, non-bilayer intermediates, the stalk and the pore. Two mechanisms
have been suggested to describe the conversion of the hemifusion intermediate into
the complete fusion product. In the first, a slight radial expansion of the stalk results
in the formation of a transmonolayer contact (TMC), so named because as the stalk
radius increases, the distal, or trans, monolayers, which form the upper and lower
stalk surfaces, dimple inwards and meet in the centre of the structure. Siegel (1993)
showed that the amount of free energy required for this stalk-TMC conversion
depends upon the marginal radius of the stalk, and Ro of the system. For a certain
range of values for these, the TMC will have a lower energy than the stalk, and TMC
formation will be spontaneous. TMC formation is produced by continuous, slight
deformations of continuous monolayers, so no great energy barriers exist between the
stalk and the TMC. Once formed, the expansion of this TMC is constrained by the
lipid comprising the outer membrane leaflets, which must have somewhere to go
(Chernomordik et al, 1987). Since monolayers in the same membrane cannot lose
contact with each other, stalk expansion results in the compression of the original
contacting monolayers and the extension of the distal ones. This brings the contact
bilayer under mechanical tension which in some cases may superimpose with pre¬
existing membrane tension. An additional constraint that may limit TMC expansion is
the energy contribution of the hydrophobic void spaces within the intermediate
(Siegel, 1993). If the void energy of the hydrophobic spaces in the TMC intermediate
is very high, then it is quickly released by the spontaneous and direct formation of a
fusion pore. Rupture of the dimpled monolayers to form a pore releases some of the
curvature energy and all of the interstice energy. Alternatively, for certain values of
Ro, and if the void energy is lower, the TMC will expand radially to produce an
extended bilayer diaphragm (e.g. Chernomordik et al, 1995d). This then ruptures to
form a fusion pore. In both lipid models, the walls of the pore are formed by the
merger of the original distal monolayers of the membranes.
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These postulated intermediates are consistent with models for the relative
chemical potentials of the inverted phases (Kirk et al, 1984; Gruner, 1985; Gruner et
al, 1986), and also with X-ray diffraction results (Tate and Gruner, 1987; Gruner et
al, 1988), and they can explain most of the 3IP nuclear magnetic resonance (31P-
NMR), differential scanning calorimetry (DSC) and morphological data concerning
these transitions (Siegel, 1993; Siegel and Epand, 1997).
Two successive bending deformations ofmembrane monolayers in opposite
directions are required by this model: stalk energy will decrease with an increase in
the negative spontaneous curvature of the outer membrane monolayer, whilst pore
edge energy will decrease with a positive increase in spontaneous curvature for the
inner membrane monolayer. Chernomordik et al (1985) studied hemifusion and pore
formation in parallel for planar lipid bilayers ofPE in the presence of different
concentrations of LPC. The exponential increase in the waiting time ofhemifusion,
and the linear decrease in the linear tension of pores with LPC concentration, and
even the actual ratio between the slopes of these dependencies were in quantitative
agreement with the theoretical stalk model. Siegel (1993) has rationalised the
mechanism of fusion catalysed by the Influenza virus fusion protein using the modified
stalk model.
Biological membranes are dynamic structures with a lipid composition known
to be very asymmetric and heterogeneous. If the 'stalk-pore' model is true, then to be
ideally suited for fusion, membranes should be asymmetrical, with the contacting
monolayers containing Hn phase-promoting lipids and distal monolayers containing
micelle-forming lipids. PE is located predominantly in the outer monolayer of the
secretory chromaffin granules (Zachowski et al, 1989), whilst the inner monolayer of
these granules has a very significant amount of lysolipids in it; up to 17% of the total
phospholipid (Voyta et al, 1978). The Golgi apparatus membranes contain 10% of
lyso lipids in their inner monolayers (Mutz and Helfrich, 1990). Thus the lipid
asymmetry in these membranes, which are presumably specialised for fusion, is
consistent with the predictions of the 'stalk-pore' model for 'ideally fusible'
membranes.
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In the final stage ofmembrane fusion the initially narrow pore subsequently
widens to achieve complete fusion, when an aqueous pathway develops between the
two initially distinct aqueous volumes. The pore tends to grow slowly, followed by a
final fast expansion. The most sensitive assays for pore formation,
electrophysiological recordings, allow the detection of a pore as soon as ions can pass
through.
In the 'stalk-pore' theory the fusion pore is lined by lipid molecules. An
alternative hypothesis for biological fusion is that the pore is lined by fusion protein
molecules, which line up around the pore and present hydrophilic surfaces to the
aqueous pore channel and hydrophobic surfaces to the nearby lipid molecules in the
pore vicinity. Electrophysiological recordings performed simultaneously with
measurements of the mixing of lipids and aqueous contents, and of the surface area of
one of a pair of fusing cells showed that HA-mediated fusion was first detected by the
formation of the fusion pore, which occured prior to lipid dye or aqueous dye
spreading (Zimmerberg et al, 1995). This HA-mediated fusion pore is reversible and
small, and its growth is characterised by semi-stable stages (Spruce et al, 1991), as is
the growth of the exocytotic fusion pore (Curran et al, 1993). Thus there is still some
controversy over the structure of this fusion end product. It is most probable that the
structure of the fusion pore varies between individual fusion systems.
Recent experimental evidence to support the 'stalk-pore 'fusion mechanism
There is now good evidence that an altered form of the fusogen Influenza
virus haemagglutinin (HA) leads to hemifusion in unfixed, unglycerinated samples of
cells (Kemble et al, 1994; Melikyan et al, 1995). Kemble et al engineered HA to be
anchored in the outer leaflet of cell membranes by a glycosylphosphatidylinositol
(GPI) tail, rather than by its normal transmembrane domain. For low pH-triggered
fusion of the HA-expressing cells with erythrocytes, GPI-HA, like wild type HA (wt-
HA), promoted rapid mixing of lipids. In contrast to wt-HA, GPI-HA did not
promote mixing of any water-soluble probes. These results strongly suggest that GPI-
HA mediates hemifusion. Melikyan et al, using video fluorescence microscopy and
time-resolved electrical admittance measurements, demonstrated that the
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establishment of lipid continuity during fusion ofGPI-HA expressing cells to planar
lipid bilayers is not accompanied by fusion pore formation. They suggest that
hemifusion may also be an intermediate in the wild-type viral fusion reactions. If this is
so, merging of contacting monolayers should precede fusion pore formation.
Hemifusion is also documented in phospholipid model membrane fusion
(Chernomordik et al, 1995b, 1995c).
For polymer-mediated fusion, very recent work by Lee and Lentz (1997) has
identified distinct kinetic steps in poly(ethylene glycol)(PEG)-mediated fusion of small
unilamellar vesicles (SUVs), which support the 'stalk-pore' hypothesis. (PEG is a
dehydrating agent). Their results separate fusion into several distinct kinetic stages:
1. outer leaflet mixing accompanied by
2. transient pore formation, both occurring on a time scale of approximately 10
seconds, and leading to an initial reversible intermediate. This was measured by H+
transfer and appears to be a flickering pore. (It is possible that the first intermediate
formed is a dynamic mixture of a stalk structure and a transient pore).
3. a 1-3 minute delay leading to formation of a fusion-committed second intermediate.
4. inner leaflet mixing on a time scale of about 150 seconds.
5. contents mixing on a time scale of 150-300 seconds.
Inner leaflet mixing, which had never before been shown to be distinct from outer
leaflet mixing, began simultaneously with, but was completed before, contents mixing.
The fusion intermediates were shown to have merged outer leaflets and distinct inner
leaflets prior to pore formation. Removal ofPEG allowed the first intermediate to
revert to SUVs, but the second intermediate irreversibly continued to form a fusion
pore. Pore dilation appeared to be slow, as noted by the slower mixing of large
molecular contents compared to H+ transfer and inner leaflet lipid mixing. This
sequence shows remarkable homology to protein-mediated fusion events.
Very recent work by Siegel and Epand (1997) suggests that the first step in
the fusion ofpure DiPoPE LUVs is the formation of stalks, which in this system
almost immediately expand slightly to form TMCs.
The formation of fusion pores from either TMCs or extended hemifusion
diaphragms will depend upon the lipid system involved. Thus it is also likely that the
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intermediates formed may vary between different biological fusion systems, and it is
also very possible that each step that we have discussed in the fusion process may well
have several different structural components.
The modified stalk mechanism of Siegel (1993) predicts that formation ofboth
stalks and TMCs requires least energy when the spontaneous curvature of the system
has values corresponding to proximity to La-Hn phase transitions. This has led to the
study of fusion intermediates near the La-Hn or La-Q phase boundaries.
l.2e. Other Possible Effects ofLipids on Fusion
Lipids influence some important biological reactions by direct interactions
with proteins. It is possible that they may regulate some fusion processes by acting as
specific receptors, or even as cofactors, to produce a change in the conformation and
activity of the proteins involved. Specific requirements for small amounts ofparticular
lipids might be expected for this type of effect. This is seen for Semliki Forest virus-
mediated fusion, which depends upon the presence of cholesterol (White and
Helenius, 1980) and sphingolipids (Nieva et al, 1994a) in the target membrane.
Lipids could also affect the lateral association of fusion proteins into
multimolecular complexes. Alternatively they could alter the mode of insertion of the
fusogenic peptide into the target membrane.
1.3 The Role of Fusion Proteins
1.3a. General overview
Initially proteins were considered to be a barrier to fusion. Early electron
microscopy studies showed the production of areas devoid ofprotein, called 'bare
Hpid patches', during the fusion process. The subsequent realisation that proteins
could indeed act as fusogens followed the discovery by virologists and cell biologists
that animal viruses could induce fusion between cells, and moreover, that this process
depended upon the presence of certain virus-specific proteins (Poste and Pasternak,
1978; White et al, 1983). The ensuing use of ultrafast freezing techniques combined
with electron microscopy also showed that proteins were not in fact cleared from the
fusion site, as had been previously thought (Schmidt et al, 1983; Plattner et al, 1988).
Since enveloped viruses employ specific proteins to fuse with host cells, it was
thought likely that cellular fusion reactions were also protein mediated. Currently
there is a large number of known and putative fusion proteins, ofwhich the viral ones,
which tend to be the simplest, are by far the best characterised. Many processes, such
as intra-Golgi fusion, require a 'fusion machine', a complex of integral and peripheral
proteins that is necessary and sufficient to promote fusion (White, 1992). Thus the
simpler viral fusion proteins are useful tools with which to study the fusion process. It
must be realised, however, that they serve only as a limited prototype for cellular
fusion, particularly for fusion events that initiate between cytoplasmic leaflets.
A fusion protein is an integral membrane protein which, upon triggering,
changes conformation to expose a hydrophobic domain that promotes the mixing of
the lipid components of the two apposed bilayers (White, 1992). Proofof fusion
activity can be obtained either by reconstitution of the purified candidate fusion
protein in vitro, often in lipid vesicles, followed by demonstration of fusogenic
capacity for this system (e.g. Stegmann et al, 1987), or by expression of fusion
activity following transfection of the cloned gene that encodes the candidate fusion
protein (e.g. White et al, 1983). The abolition of fusion activity by site-directed
mutagenesis of a fusion protein also provides strong evidence for its role in fusion
(e.g. Gething et al, 1986), and suggestive evidence has come from the application of
antibodies that inhibit fusion without inhibiting viral binding (e.g Fuller and Spear,
1987).
We still do not understand the energetic driving force for the molecular
mechanisms by which fusion proteins cause separate bilayers to merge. 'Even a
thorough knowledge of each player's personality does not yield an understanding of
the rules of the game.' (Chernomordik et al, 1995)! Is fusion driven by
conformational changes of fusion proteins, with lipids acting as a passive matrix, or
do lipids fuse directly, without guidance from proteins, when it is energetically
favourable for them to do so? Individual fusion proteins may merge lipid bilayers
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differently, with fusion depending upon specific protein-lipid interactions. Proteins
may aid in overcoming the repulsive hydration forces that discourage fusion, or in
promoting the hydrophobic attractive forces that favour the process. Fusion proteins
may determine the geometry of the fusion site, and act to lower the free energy of a
lipid intermediate so that lipids spontaneously rearrange. Proteins would substantially
lower the curvature energy of catenoidal or semitoroidal structures if they locally
deformed the two original bilayers towards each other at the fusion site. This type of
deformation has been observed in a prefusion step in Influenza virus-mediated fusion
(Ruigrok et al, 1992). It has been suggested for Influenza virus-mediated fusion that a
hemifusion intermediate might resemble the 'stalk', but the precise nature of such
intermediates has not yet been definitively established for any protein-mediated
reaction. Recent experiments indicate that viral proteins are perfectly capable of
mediating fusion of lipid bilayers that do not contain Hn phase-competent lipids
(Alford et al, 1994; Stegmann, 1993). Thus, at least for viral protein-mediated fusion,
it seems probable that the critical decrease in the energy of the bent intermediates is
caused by the effects of these proteins on the spontaneous curvature ofmembrane
monolayers and the geometry of the fusion sites. Fusion proteins might also serve to
limit potentially catastrophic side reactions, such as the lysis of one or more
interacting membranes.
1.3b. Viral Fusion Proteins
Fusion proteins have now been identified for most enveloped viruses of
animals. They can be broadly divided into two classes, according to the dependence of
their fusogenic activity on pH. There are two distinct pathways by which enveloped
viruses enter cells (see Figure 1.11). They may bind to receptors on the target cell's
plasma membrane and then fuse their lipid envelope with this lipid bilayer at pH 7.4.
Alternatively, receptor binding by a virus may cause viral internalisation by
endocytosis, and thus exposure to acidic pH within the endosome. At a pH that is
specific for each individual viral strain, triggering will occur, and thus fusion between
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release of the viral nucleocapsid into the cell cytoplasm. pH dependence tends to be a
property of the virus family: as examples, all orthomyxoviruses and rhabdoviruses
require low pH to fuse (Marsh and Helenius, 1989; Ohnishi, 1988), whilst all
coronaviruses and herpesviruses are pH-independent (Sturman et al, 1985; Spear et
al, 1989). The retroviruses, however, appear to be an exception: Mouse mammary
tumour virus requires a low pH to fuse (Redmond et al, 1984), whilst Human
immunodeficiency virus (HIV) can fuse at pH 7.4 (McClure et al, 1988; Stein et al,
1987). This pH dependence is a property of the viral fusion protein. Viruses which
fuse with the plasma membrane have a pH-independent fusion protein (these can also
fuse with acidic endosomes), whilst those which require endocytosis to gain cell entry
have low-pH dependent fusion proteins. Experimental proof for this has come from
cellular expression of viral fusion proteins: thus cells expressing these proteins from
Influenza virus. Vesicular stomatitis virus (VSV) or Semliki forest virus (SFV) only
fuse if exposed to low pH, whilst expression of Simian virus 5, Respiratory syncitial
virus (RSV) or HIV fusion proteins allow cell fusion at neutral pH (Kowalski et al,
1987; Lifson et al, 1986; Paterson et al, 1985; Stegmann et al, 1989; White et al,
1983). Low pH-dependent fusion proteins require acidic conditions to achieve their
fusion-active molecular conformations, whilst those which are pH-independent are
thought to be directly triggered to change conformation by receptor binding, although
this is less clear. Other host cell factors are often required for optimal fusion,
particularly for pH-independent viruses.
Different viral fusion proteins possess distinct native structures and the
dynamics of their fusion-inducing conformational changes differ markedly.
Nonetheless, most share many common properties. They are all class 1 integral
membrane proteins, with at least 85% of their mass lying external to the viral
membrane, and they are present at high surface density (there are about 500 fusion
protein molecules on the surface of an Influenza virion). They have characteristic
shapes, which consist of a long fibrous stem topped by a globular domain, and are
commonly referred to as 'spike' proteins (see Figure 1.12). Most contain N-linked
oligosaccharides, and many are fatty acylated. They all form higher order oligomers.
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(Wiley and Skehel, 1987), in which all three subunits are involved in fusion (Boulay et
al, 1988). The fusion protein usually forms a single active oligomeric spike;
Herpesvirus is unusual in requiring the cooperation of several distinct spike proteins
to form a fusion-active complex.
Many fusion proteins are synthesised as large, inactive precursors. Proteolytic
cleavage of a single peptide bond produces two polypeptide chains, which remain
associated through disulphide bonds or through noncovalent interactions (see Figure
1.12 inset). The C-terminal polypeptide product anchors the protein to the viral
membrane, and normally contains three distinct regions: extracellular, membrane
spanning and cytoplasmic. The extracellular region contains a short, apolar sequence
called the fusion peptide. The N-terminal product contains the receptor binding site
and most of the antigenic determinants. This proteolytic processing is required to
activate the fusion ability of the protein.
Fusion peptides are highly conserved within viral families. The fusion peptides
of various Retroviridae are shown in Table 1.1, where they can be seen to display
extreme similarity. It was this homology of the amino acid sequences of the amino
(N)-termini of viral fusion proteins that led to the proposal that this region was
intimately involved in the fusion process (Gething et al, 1978). Viral fusion peptides
lie either at the proteolytically generated new N-terminus of the membrane anchored
polypeptide fragment or internally within this fragment. HA and the Env glycoproteins
ofHIV, Simian immunodeficiency virus (SIV) and probably also Feline leukaemia
virus (FeLV) have amino terminal fusion peptides (McCune et al, 1988; Ohnishi,
1988; Stegmann et al, 1989; White et al, 1983). There is no relationship between the
pH dependence of fusion and the fusion peptide's location. Hydrophobic affinity
labelling experiments (Harter et al, 1989) and site-directed mutagenesis studies
(Gething et al, 1986; Bosch et al, 1989) have established the active participation of
the fusion peptides of Influenza HA and SIV Env in mediating fusion. Work with
synthetic peptides corresponding to these two fusion peptide sequences has also
demonstrated their active roles in fusion, and mutations of these synthetic peptides
have been shown to alter, reduce or abolish fusion (e.g. Lear and Degrado, 1986;
Rafalski et al. 1990; Diizgunes and Shavnin, 1992; Nieva et al, 1994b; Delahunty et
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Retrovirus Sequence ofFusion peptide
Feline leukaemia virus FeLV (strain
Garner-Arnstein)
FeLV (strain Snyder-Theilen)
Moloney murine leukaemia virus
(MoMLV)
Kirsten murine leukaemia virus
AKV murine leukaemia virus
Simian immunodeficiency virus (SIV)








Tablel.l Sequences of the fusion peptides of two strains of FeLV and
of several other Retroviridae. Homologous residues are shown in red.
58
al, 1996; Gray et al, 1996). Furthermore, site-directed mutations in the fusion peptide
of Influenza virus that abolish fusion activity do not compromise haemagglutinin
biosynthesis, surface expression, post-translational cleavage or the low-pH induced
conformational change (Gething et al, 1986). All viral fusion peptides tend to be rich
in glycine and alanine residues, and are either exclusively apolar, as are most
retroviruses, or contain a few negatively charged residues, as in Influenza HA. Thus it
has been postulated that the presence of two relatively apolar sequences (the fusion
peptide and the transmembrane region) within a single polypeptide chain may allow
the fusion protein to interact simultaneously and hydrophobically with both the viral
and target membranes, and hence to promote rapid and efficient fusion (e.g. Stegmann
et al, 1989). Further support for this comes from the finding that non-membrane
anchored HA can affect fusion between SUVs, but the rate of fusion is much less than
that seen with intact FIA (Wharton et al, 1986).
Individual viruses tend to require specific conditions to be activated for fusion.
Thus SFV requires the presence of cholesterol (e.g. Phalen and Kielian, 1991) and
sphingolipids (e.g. Corver et al. 1995) in the target membrane for fusion to occur.
More specifically, the results ofCorver and co-workers suggest that sphingolipids
may act as a cofactor in SFV fusion. HIV has a very strong affinity for cardiolipin
such that its absence in LUV membranes decreases the fusion rate by at least two
orders ofmagnitude (Tarsen et al, 1993). HIV fusion is also promoted by
physiological levels of calcium, and the presence ofCD4 receptors also enhances the
overall rate of fusion. PS is thought to be the cellular receptor for VSV (Marsh and
Helenius, 1989). Influenza virus (Stegmann et al, 1985), SIV (Larsen et al, 1990) and
Sendai virus (Nir et al, 1986) all fuse preferentially with negatively charged
liposomes. These are but a few specific examples of important factors for individual
fusion processes cited in the literature to date. Other common features include
temperature dependence of viral fusion reactions (the rate of Sendai-induced fusion is
zero at 22°C and increases about 25 times between 25°C and 37°C; White, 1990),
and a lack of requirement for ionic gradients or osmotic pressure.
Efforts to understand how viral fusion proteins work have been aided in recent
years by the crystallographic determination of the structures of several fusion proteins.
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The current understanding of the Influenza virus fusion process is described in detail,
as HA is, at present, the best characterised fusion protein. HIV-mediated fusion is also
then discussed, since HIV has the best characterised retroviral fusion protein.
Influenza virus undergoes low pH-induced fusion, whilst HIV shows pH
independence. Thus these serve as specific examples of the two classes of viral fusion
protein.
Influenza virus HA-mediatedfusion
The biosynthesis, folding, oligomerisation and native structure ofHA have all
been described in detail (Wiley and Skehel, 1987; Doms et al, 1993). HAO, the initial
fusion-incompetent precursor protein, is cleaved proteolytically to form two
disulphide-bonded units. These are HA1. a 328 amino acid residue globular unit
which houses the sialic acid receptor-binding domain in its uppermost region (Weis et
al, 1988). and HA2, a 221 residue fibrous stem-like subunit. which forms the centre
of the molecule and which has an amino-terminal fusion peptide and a transmembrane
segment. Between the globular domain and the fibrous stem there is a hinge region.
These dipeptide monomers associate to form trimers that project about 135 A from
the viral membrane. This would seem likely to prevent the virus from closely
approaching the target membrane.
The neutral pH structure ofBHA has been determined by X-ray
crystallography to a 3 A resolution (Wilson et al, 1981) (see Figure 1.13). BHA
represents a fragment ofHA. in which each HA2 chain has been cleaved once, after
residue 175, by the protease bromelain (Brand and Skehel, 1972). Bromelain thus
produces a soluble trimer without the membrane anchoring segment ofHA2. In the
neutral pH conformation, the three fusion peptides, one from each monomer, are
located about 100 A from the target membrane, and are tucked into the trimer
interface by a network of hydrogen bonds, lying roughly parallel to the plane of the
viral membrane. They are thus not readily accessible for participation in any
membrane interactions.
It is known that low pH, between pH 4.9 and pH 5.2 for different strains of
Influenza virus, is required to elicit a fusion-inducing conformational change in HA.
60
BHA TBHA2
Figure 1.13. Comparison of the structure of an intact BHA monomer
(left) to that of a TBHA2 monomer (right). Corresponding regions are
coloured identically. BHA regions which are proteolytically cleaved to
form TBHA2 or which are apparently disordered in TBHA2 are shown
in black. The HA1 (3 strand, which is disulphide linked to HA2, is blue
(reproduced from Bullough et al, 1994).
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This has been most convincingly demonstrated by the use ofmonoclonal antibodies
that are specific for either the acid or neutral HA conformation (Daniels et al, 1983;
Webster et al, 1983; Copeland et al, 1986; Kielian et al, 1990). This low-pH induced
conformational change is a regulated process: it is not denaturation since the acidic
form maintains a definite structure (Wharton et al, 1988), whilst denaturation has
been shown to abolish recognition of the acidic form (Kielian et al, 1990).
The release of the fusion peptide from the molecular interior ofHA is a key
feature of the low-pH conformational change. HA simultaneously acquires
hydrophobic properties (e.g. Stegmann et al, 1989), and can thus bind to target
membranes (e.g. Stegmann et al, 1991), which is an obvious requirement for
fusogenic activity. It would thus appear likely that the fusion peptide is responsible for
most of the concomitantly observed increase in hydrophobicity. This is supported by
several studies. Firstly, Gething and co-workers (1986) found that a mutant HA,
which had the fusion peptide's Glycine at position 1 replaced by Glutamate, had a
greatly reduced ability to interact with membranes. Secondly, HAO does not acquire
amphipathic properties on exposure to low pH (Doms and Helenius, 1988). Thirdly,
the fusion peptide is the only sequence to be labelled with hydrophobic photoaffinity
labels when BHA is added to preformed liposomes at low pH (Harter et al, 1989).
Fourthly, BHA is seen to aggregate at low pH, but thermolysin, which digests the
fusion peptide, can resolubilise these aggregates (Ruigrok et al, 1988), and finally,
drugs that prevent the the extrusion of the fusion peptide from its pH 7.4 location
inhibit fusion (Bodian et al, 1993).
Exposure of the fusion peptides was described by Doms et al (1993) and also
dissociation of the globular head domains ofHA, such that the heads bend outwards
radially (similar to a tulip opening). Carr and Kim (1993) used circular dichroism
(CD) and modelling studies to propose a model for the low-pH induced
conformational change in the HA stem domain. HA2 contains a long region ofheptad
repeats, that is hydrophobic amino acids that are spaced every four and then every
three residues. Hydrophobic amino acids that recur with this periodicity often stabilise
the cores of a-helical coiled coils. There are 88 residues in this heptad repeat region,
yet only 34 were seen to form a coiled coil in BHA (Wilson et al, 1981). The first 54
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residues form a buttressing helix and an extended loop. Thus Carr and Kim suggested
that these flanking regions might be recruited into the central coiled coil at low pH.
This would be made possible by the fusion peptide's release from its buried location,
where it appears to serve as a linchpin and stabilise the initial, hairpin-like stem
arrangement.
HA is the only fusion protein for which atomic resolution structures are
available for both its pH forms. The strain X:31 has been studied in the main, and it
should be remembered that there are important differences in the conformational
changes ofHA for different viral strains (Tsurudome et al, 1992). It is thought that
the distinctions in pH threshold which occur for different strains and subtypes are due
to the relative displacement of structural domains (e.g. the elimination of electrostatic
and hydrophobic interactions) that occur during the conformational change (Wharton
et al, 1988).
Influenza virus enters the cell by receptor-mediated endocytosis. Both
attachment of the viral envelope to cell surface receptors and fusion with the
endosomal membrane after acidification of the endosomal lumen are mediated by HA
(Gething and Sambrook, 1981). Influenza virus fusion exhibits a lag phase between
binding and the onset of detectable fusion (this lag phase is seen even if the virus is
pre-bound to the target membranes). Thus it is likely that fusion is a multistep
process. Exposure of the HA fusion peptide and its insertion into LUVs occurs early
during the lag phase, preceding the onset of fusion (Stegmann et al, 1990). This
indicates that the fusion peptide exposure is not a rate-limiting step. Moreover, the
duration of the lag phase varies non-linearly with HA surface density suggesting that
more than one HA trimer participates in the initiation of fusion (Danieli et al, 1996).
A Hill plot of these data suggested that a minimum of three or four HA trimers is
required to intitiate fusion. Thus cooperativity at the level of the HA trimers appears
to required.
Ideally, one would like to reconstruct the three dimensional structure of intact
HA in its low pH form, since it is possible that proteolytic cleavage leads to
stabilisation of a different structure, or generation of additional degrees of freedom
that are unavailable in the resulting fragments. However, even whole BHA aggregates
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at low pH through exposure of its fusion peptides, which makes it unsuitable for
crystallographic studies. One fragment, comprising most ofHA1, showed no
significant change on lowering of the pH (Bizebard el al, 1995). Bullough et al (1994)
determined the crystal structure ofTBHA2, which has been a major step forward in
our knowledge of the HA low pH conformation. TBHA2 is formed by exposing BHA
to a pH of 5, and then treating it with trypsin to cleave off the globular domain, and
finally with thermolysin to digest the exposed fusion peptide (see Figure 1.13). Thus
each monomer includes residues 38-175 ofHA2 disulphide bonded to residues 1-27
ofHA1. Their results show that several changes have occurred in the HA2 stem at
acidic pH.
Three major changes take place on lowering the pH, as shown in Figure 1.14.
Firstly, a prominent loop, B in Figure 1.14, transforms into an a helix, as had been
previously proposed by Carr and Kim, and thus connects the existing helical regions A
and C. This elongation of the helical region would propel the fusion peptide upwards
towards a target membrane. Secondly, residues 106-112 convert from a helix to a
loop. In the neutral structure the fusion peptide and a loop comprising HA1 residues
14-52 cross this region of the native long a helix. Thus the fusion peptide becomes
exposed in the pH change. This would also flip the rest ofhelix D through 180° so
that it runs antiparallel to the C helix, and is stabilised by an extensive hydrophobic
interface between these two helices. This docking ofhelix D against helix C would be
blocked by the fusion peptide and adjacent sequences in their original positions, and
thus it seems likely that the two changes described occur sequentially. Thirdly, about
20 C-terminal amino acids become undetectable by X-ray techniques, suggesting that
they are in a disordered, and possibly even extended, conformation, which could be as
long as 100 A. Thus only 30 residues of each HA2 subunit, which comprise the
invariant triple-stranded coiled coil at the stem centre, retain their neutral pH
conformation. Regions of disorder are also seen in HA1 at low pH, suggesting that
the head domains may be attached to the stems by a flexible tether, which could
extend as far as 100 A.
Support for these crystallographic results comes from work by Daniels et al
(1987,1985). The fusion protein mutants that were studied changed their
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Figure 1.14. Model comparing the structures of TBHA2 (right) with the
corresponding regions ofBHA (left). One monomer is shown for clarity.
The black arrow represents the HA1 chain which is disulphide bonded
to HA2. Regions ofHA2 are labelled A to H (see text for details). Helix
H is not seen in TBHA2, and may be disordered (reproduced from
Hughson, 1995).
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conformation, and hence mediated fusion, at elevated pH. Thus interactions which are
modified in the transition to the fusion-active structure were identified by the
distribution of these mutations. One mutation group stabilised the buried location of
the fusion peptide. Another stabilised the short helix A and the loop B against the long
CD helix, whilst a third group stabilised contacts between HA1 and B and CD of
HA2. A fourth group ofmutations altered the interface between the HA1 subunits
which suggested that the globular domains do dissociate at fusogenic pH. Their
dissociation is probably accompanied by the refolding of loop B since HA1 is docked
against this loop in BHA. The dimensions and shape ofTBHA2 revealed by X-ray
structure also agree well with electron micrographs of the molecule.
These structural data ofBullough and co-workers (1994), combined with
results from other experimental techniques, have led to the proposal of a model ofHA
mediated fusion (White, 1995). The basic principle is that conformational changes in
HA drive the transitions that are required to fuse two membranes, that is to bring
them close together and to induce the bending required to produce hemifusion and the
opening and subsequent dilation of a fusion pore. Thus several different HA
conformational states participate in fusion at different stages in the process. Figure
1.15 shows the different putative HA conformations for each step of the fusion model.
It is likely that there are more HA conformations between these different forms.
In this model, step 1 of fusion involves the 'spring-loaded' conformational
change of the B loop to produce an extended coiled coil which drives the initial
interaction of the fusion peptides with the target membrane. This corresponds to 'low-
pH 1' HA in Figure 1.15. Separation of the globular heads is essential for this step:
proof for this comes from the non-fusogenic phenotype of a mutant HA in which
Kemble et al (1992) linked these domains by chemically manufactured disulphide
bonds. The neutral pH structure presumably keeps the viral and target membranes too
far apart to be capable ofmediating further steps in fusion.
Step 2 includes the observed lag phase and is suggested to involve clustering,
orientation and binding to the target membrane of at least 3 or 4 HA trimers. The
higher order assembly of trimers may be facilitated by the increased flexibility ofHA
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changes (Stegmann et al, 1990) as well as rotational and lateral mobility (Junankar
and Cherry, 1986) for HA may be required to establish a fusion site.
In step 3 the HA trimers encircling the nascent fusion site bend, thus forming
the 'low-pH 2' structure (Figure 1.15). This may require the helix-to-loop transition
ofHA2 residues 106-112. If the HA trimers remain firmly anchored to the target
membrane via the fusion peptides, and also firmly tethered to the viral membrane by
their transmembrane domains, then if several trimers simultaneously bend radially
outwards from the fusion site, they will force the interacting bilayers to bend with
them, thus producing a hemifiision intermediate. This bending of the trimers may be
facilitated by the increased flexibility of the 20 carboxy-terminal residues, which lie
nearest to the transmembrane anchor. Wharton et al (1995) performed electron
microscopy studies which showed that the HA trimer can bend asymmetrically. The
results of Tatulian et al (1995) suggest that HA trimers do indeed tilt at the fusion
site: at fusogenic pH HA trimers tilted 55-70° from the membrane normal. However,
a recent study ofHA-induced fusion using quick freezing electron microscopy did not
observe any tilting ofHA trimers (Kanaseki et al, 1997). At this stage the fusion
peptides could also insert into the target membranes at an oblique angle, as has been
suggested by Brasseur et al (1990), to produce destabilisation of these lipid
membranes.
Step 4 involves HA imposing tension on the hemifusion diaphragm so that it
eventually breaks. This rupture may require a transmembrane anchor that spans the
viral membrane, as suggested by the results ofKemble et al (1994) and Melikyan et al
(1995) (see earlier). In this elastic coupling model, bending of the HA ectodomain
pulls on the transmembrane domain and cytoplasmic regions ofHA, thus forcing the
transmembrane domain to orientate more parallel to the membrane plane. This would
generate stresses on the diaphragm and disturb the configuration of the component
lipids.
Step 4 is probably reversible, since the early HA fusion pores 'flicker', that is
they repeatedly open and close (Spruce et al, 1991). The dimensions of the initial
aqueous connection inferred from electrophysiological studies (1-2 nm) are consistent
with a structure involving a small number of trimers (Spruce et al, 1989). Lipid flow
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is known to be restricted in the initial fusion pore (Zimmerberg et al, 1994;
Blumenthal et al, 1995). This may be due to the formation of a barrier by the clusters
ofHA transmembrane domains in the early and narrow fusion pore (Kemble et al,
1994; Zimmerberg et al, 1994). If this is so, the HA trimers would have to move apart
to allow unimpeded lipid flow. It is known that small aqueous contents can move
through the fusion pore before larger ones (Zimmerberg et al, 1994). This could be
due to progressive widening ofone pore, or alternatively to the coalescence of several
smaller pores. There is still controversy over the precise molecular nature of the HA-
mediated fusion pore.
Finally, in step 5, the fusion pore opens irreversibly and dilates. For fusion
between HA-expressing fibroblasts and red blood cells, this occurs over tens of
milliseconds (Spruce et al, 1989). This may be driven by the conversion ofHA into its
final low pH form, as seen for TBHA2. If so, the proposed extension of the 20 C-
terminal residues might allow HA to continue to bend, and thus to sweep through the
toroid of the membrane comprising the initial fusion pore. This would relax the
tension and the high bilayer curvature of the lipid-protein fusion intermediate
conformations. In this step, the fusion peptides would finally embed in an antiparallel
orientation in the same membrane as their transmembrane domains. This represents
the 'final low-pH' HA form (Figure 1.15 and Figure 1.16c).
Various experimental results add support to this theory. Possible orientations
of the low pH form ofHA are shown in Figure 1.16. It is known that most Influenza
strains undergo irreversible inactivation in the absence of a target membrane (Skehel
et al, 1982; White and Wilson, 1987). This appears to correlate with gross
morphological changes in the viral coat, as seen using electron microscopy (e.g. Doms
et al, 1985): Influenza virions display distinct, closely packed HA spikes at neutral
pH, but after brief incubation at low pH, the viral coat seems much more
disorganised, with the individual HA trimers no longer being distinguishable.
Moreover, electron microscopy of inactivated virus digested by trypsin allows
visualisation of individual trimers. These studies suggest that the trimer stems are
indeed inverted with respect to the viral membrane (see Figure 1.16b). Hydrophobic











Figure 1.16. Possible orientations of low-pH treated HA relative to viral
and cellular membranes (adapted from Hughson, 1995). The TM unit is
pink. The fusion peptide is black. Regions A to D are colour coded as in
the previous diagram. Only one monomer is shown. TBHA2 a: in a
putative initial stage ofmembrane fusion, b: in inactivated virus, in the
absence of a target membrane c:in 'final low pH' form The fusion
peptide and TM unit are inserted into the same, fused membrane.
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the viral membrane (Weber et al, 1994), but not the coiled coil region (Durrer et al,
1996), as had been previously suggested (Yu et al, 1994). Yu and co-workers had
proposed that the inserted coiled coil might drag the two fusing membranes closer
together, with HA maintaining its upright position. Further support for the inversion
ofHA comes from Wharton et al (1995), who found that an antibody, which
recognises the HA region that undergoes the helix-to-loop transition, is bound to the
membrane-distal region of inactivated HA, 110A from the viral membrane.
Interestingly, a role for the fusion peptide in pore dilation has also been suggested.
Schoch and Blumenthal (1993) found that non-lethal mutations in the fusion peptide
affected the transfer of large molecules between fusing partners. They suggested that
the fusion peptide may be important in holding together the HA trimers to form a
fusion pore.
If, at the end of fusion HA is in an inactive form, then we know the structure
and orientation of segments ofHA in its pre- and post-fusogenic forms. This model is
highly speculative, but it does allow for the logical coordination of the dynamic
rearrangements of both lipids and HA that must occur during membrane fusion.
Other hydrophobic sequences of the HA ectodomain also become accessible
to a fluorophore at low pH (Korte and Herrmann, 1994). A Scatchard plot of their
results for the binding to HA of a fluorescent probe indicated that the ectodomain had
at least two types ofbinding site, which differed in their affinity for this probe.
Modelling studies have shown the existence of several hydrophobic sequences in the
ectodomain at pH 5.0, which are comparable in length and hydrophobicity to the
fusion peptide (Korte et al, 1992). It is therefore possible that interactions between
regions of the globular domains ofHA1 and HA2 or the target membrane may also
play a role in fusion.
There is still much controversy over the precise events in HA-mediated fusion.
Kanaseki et al (1997) have recently published a study of Influenza virus fusion with
LUVs, using quick freezing electron microscopy. They observed 10-20 nm diameter
outward bendings of the LUV bilayer, where the LUV and viral membranes had made
contact. These protrusions were arranged polygonally to reflect the array ofHA
spikes on the virus, and sometimes had a tiny hole, of diameter about 4 nm in their
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centre. The pits had particles in them, which they suggested were the fusion peptides,
but no bending ofHA trimers was observed. Thus they surmised that penetration of
the fusion peptide may occur in upright HA, and that these straight spikes ofHA tug
and deform the apposing membranes into closer contact.
The current, widely held hypothesis is that viral-mediated fusion utilises
common lipid intermediates with pure lipid fusion systems. However, Shangguan et al
(1996) studied fusion between Influenza virus and LUV of varying lipid composition.
They found that LPC and arachidonic acid (AA) at physiologically relevant
concentrations, and also hexadecane, had no effect on the fusion kinetics. Thus they
concluded that monolayer curvature and void stabilisation do not seem to affect the
rate-limiting step in HA-mediated fusion, and thus it may not proceed through
common intermediates with liposome-liposome fusion.
Kim et al (1996) studied various mutants of the peripheral part of the HA2, in
particular the region that is proposed to undergo the loop-to-helical coiled coil. They
found good flexibility for this region, and thus concluded that it was unlikely to form a
well defined coiled coil as suggested by Bullough and co-workers. Finally, a very
recent paper by Shangguan and co-workers (1998), which correlated the kinetics of
low pH-induced fusion of Influenza virus with liposomes and the conformational
changes that occurred in HA, suggests that the crystallographically determined low-
pH form ofHA is not a precursor ofviral fusion, but an end product of this process.
Influenza virus-mediated fusion is seen as the general prototype for fusion
processes, since it by far the most thoroughly studied mechanism. The amount of
conflicting experimental evidence indicates how much is still unknown about fusion in
general.
HIV-mediatedfusion
Less is known about the activation of fusion proteins that function at neutral
pH. Their requirement for host cell receptors led to the belief that it was the
interaction between the viral fusion protein and its host cell receptor which triggered
the fusion-activating conformational change. The mechanism of retrovirus-mediated
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membrane fusion has, until very recently, remained elusive due to the lack of detailed
structural information about Env proteins. The low virus titre in natural systems, the
large size of the envelope complexes, and the labile association between SU and TM
have all hindered structural studies. However, a recent study by Hernandez et al
(1997) on an avian retroviral fusion protein has demonstrated that receptor binding
does indeed appear to activate this fusion protein in much the same manner as low pH
activates the low pH-dependent viral fusion proteins. HIV is currently the best studied
of the neutral pH viruses, due to its extreme medical importance.
The Env proteins of retroviruses bind to cell receptors and promote fusion
(Hunter and Swanstrom, 1990). Env proteins are synthesised as polyprotein
precursors and, like Influenza HA, they require proteolytic cleavage into a large
surface (SU) and a smaller transmembrane (TM) subunit to become fusogenic. SU
contains the receptor binding site, whereas TM houses the transmembrane anchoring
domain and the fusion peptide. In HIV this cleavage has also been shown to be
important for efficient incorporation into virus particles (Dubay et al, 1995). Unlike
Influenza HA1 and HA2, SU (gpl20) and TM (gp41) ofHIV remain associated only
through noncovalent bonds on the external surface of the virus. gpl20 binds to CD4,
the primary HIV receptor (Weiss, 1992), and subsequently to a 7-span transmembrane
chemokine receptor (D'Souza and Harden, 1997). gp41 is responsible for fusion
activity, with both the amino terminal fusion peptide and the transmembrane domain
playing important roles (Freed et al, 1990; Owens et al, 1994). The HIV Env is
almost certainly a tetramer (Pinter et al, 1989; Weiss et al, 1990; Schawaller et al,
1989; Thomas et al, 1991).
The binding ofHIV Env to CD4 induces a number of conformational changes.
These have been detected by antibody and protease probes (Moore et al, 1990;
Clements et al, 1991; Hart et al, 1991). Some of these are temperature dependent, as
indeed is HIV fusion (Frey et al, 1995). Dissociation ofgpl20 is instigated by CD4
binding (Moore et al, 1990). This shedding of gpl20 may parallel the displacement of
HA1 which occurs during the low-pH conformational change.
The presence ofCD4 alone was discovered to be insufficient to allow HIV
entry into primate cells. Thus cofactors must exist to support fusion. Fusin, a new
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member of the G-protein-coupled transmembrane receptors, has been shown to fulfil
this role for T lymphocytes (Feng et al, 1996). HIV isolates that differ in their cellular
tropism use different subsets of chemokine receptors as entry cofactors. Thus
macrophage-tropic HIV strains primarily use CCR5, whereas T-cell tropic and dual-
tropic isolates use CXCR4 receptors (D'Souza and Harden, 1997). HIV (and SIV)
forms a complex between the Env protein and the two appropriate cell-surface
membrane receptors. Very recent work by Weissman et al (1997) has shown that
macrophagotropic strains ofHIV (and SIV) induce a signal through CCR5 on CD4"
T cells, which induces chemotaxis ofT cells. Whilst this signal is not required for
efficient fusion and viral entry (Oravecz et al, 1996), it may contribute to the
pathogenesis ofHIV by attracting CD4+ cells to sites of viral replication, by
promoting viral replication by increasing the activation of target cells, and/or by
altering viral-associated cytopathicity or apoptosis (Weissman et al, 1997).
HIV is also able to infect human cells that have no detectable CD4, which
suggests that there must be another HIV receptor. A glycosphingolipid,
galactosylceramide, will bind gpl20 (Long et al, 1994). The level of expression of this
lipid on colonic epithelium is associated with permissiveness to HIV-1 infection
(Fantini et al, 1993). Several other putative HIV receptors have also been reported.
Two sequences containing heptad hydrophobic repeats follow the fusion
peptide in gp41. These are predicted to form a coiled coil (Delwart et al, 1990). This
coiled coil is critical for fusion, but it not known at which stage it is required. Lu et al
(1995) studied a bacterially-expressed gp41, which they suggested formed a stable a-
helical trimer of heterodimers. In this model, the first predicted coiled coil region
forms an interior and parallel homotrimer, and the second coiled coil packs around the
exterior in an antiparallel manner. This is very like the C and D helices of TBHA2. A
recent study of the predicted coiled coil region of the retrovirus Molony murine
leukaemia virus (MoMLV) also suggests that this region does indeed form a stable
and trimeric coiled coil, adjacent to the fusion peptide, in the absence of the SU
subunit (Fass and Kim, 1995) (see Figure 1.17b). Other evidence of the importance
this region comes from proline substitutions in the heptad repeat region which lies
nearest to the fusion peptide. These abolished fusion (Dubay et al, 1992; Chen et al,
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1993). Synthetic peptides corresponding to the coiled coil region also inhibited fusion
(Wild et al, 1994). However, the most recent evidence for structural similarity of this
predicted coiled coil region of gp41 to TBHA2 comes from crystallographic studies
by Weissenhorn et al (1997) (see Figure 1.17a). They replaced the HIV fusion peptide
with a trimeric GCN4 coiled coil, and performed X-ray crystallography on the
resulting solubilised, protease-resistant fragment of the gp41 ectodomain, which
represents about 10% of the original gpl20/gp41 complex. The core of this molecule
was found to be an extended, triple stranded a helical coiled coil with the amino
terminus at its tip. Furthermore, a carboxy-terminal a helix packed against the outside
of the coiled coil in an antiparallel fashion, thus placing the amino and carboxy termini
near each other at one end of the long rod. This study was performed in the absence
ofgpl20, and since the dissociation ofgpl20 is required for fusion activity, the
assumption is that the gp41 structure formed in the absence ofgpl20 may well be the
final fusogenic form, as was assumed for HA2. The extreme thermostability of the
observed structure adds support to this view: triggering of viral fusion proteins would
be expected to produce a stable conformation, probably from an initially trapped,
metastable form. Chan and co-workers (1997) have also very recently determined the
crystal structure of a smaller fragment of gp41, and their results agree very closely
with those ofWeissenhorn et al, as described here.
All Antiviruses have long cytoplasmic tails: 150 to 200 amino acids in length.
Mutations in the tail region can affect both the Env ectodomain conformation
(Mulligan et al, 1992) and the kinetics ofHIV infection (LaBranche et al, 1994). Rein
et al (1994) generated a mutant ofMoMLV in which the cytoplasmic tail was absent.
Cells which expressed this truncated pl5E form induced rapid cell-cell fusion. Similar
findings have also occurred for SIV (Zingler and Littman, 1993).
It is clear that, despite the lack of any obvious evolutionary relationship
between the orthomyxovirus and retrovirus families, there are many similarities
between HA and gpl60, and indeed TM ofMoMLV (see Figure 17.a to c). Thus,
although individual viral fusion proteins differ in their native structures and triggers
required for fusion, the end results of their conformational changes may be the same.
Firstly, all three viruses shown here expose and reposition their fusion peptides to
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achieve closer approach to their target membranes. Secondly, their polypeptide chains
reverse their direction at the far end of the coiled coil from the fusion peptide and
proceed back towards the N-terminal tip. This turn occurs at the same place in HIV-1
and MoMLV, residue 78, and the following 15 amino acid residues are also very
similar. Thirdly, like the B loop in HA2, which undergoes a loop-to-helix transition at
the pH of fusion, gp41 is particularly rich in polar and charged side chains between
residues 39 and 53. Thus this region may not be a helical in the native gpl20/gp41.
Fourthly, the C-terminal link which connects to the transmembrane anchor is probably
flexible in all three viruses. The structure ofGCN4/gp41 adds more support to the
hypothesis that the fusion peptide and transmembrane anchor are indeed likely to be
juxtaposed at one end of the coiled coil once the outer layer of helices have assembled
onto the core, or in other words, once the protein has turned back on itself. It is not,
however, known whether the central coiled coil of gp41 is extended by the
conformational change, or whether it exists in this elongated configuration throughout
the lifetime of the molecule, with the gpl20 subunit protecting it from premature
exposure. If the folding ofbuttressing helices to form a six-helix bundle is indeed a
common feature of viral fusion protein activation, then it may provide a new target for
the development of antiviral drugs.
More generally, subsequent steps may also involve similar principles: lateral
association of oligomers to form fusion active complexes, possible induction of
hemifusion, and finally reversible opening ofnarrow fusion pores, which subsequently
and irreversibly dilate (see Figure 1.18). The exact extents to which the same basic
mechanisms apply to cellular fusion events remain to be seen.
1.3c Viral Fusion Peptides
The destabilisation of the target cell and viral membranes within the virus-cell
adhesion area is a critical step in membrane fusion. The observation that
conformational changes of viral fusion proteins led to the uncovering of their fusion
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probably by inserting into the target membrane. Thus the ability of synthetic peptides
corresponding to these sequences to penetrate into membranes and cause their
destabilisation can reveal some of the molecular mechanisms of viral-mediated
membrane fusion. The discovery of specific requirements for particular amino acid
sequences and peptide structures for fusogenic activity can also aid our understanding
of the fusion process. By studying synthetic fusion peptides, it is therefore possible to
determine the minimum molecular requirements for protein-mediated fusion. These
are usually studied in model membrane systems, which allow complete control of the
lipid composition present in the fusing bilayers.
It is clear that many of the features of the intact virus are not present in the
simple system of a peptide segment of a viral fusion protein. Receptor binding does
not occur, and insertion of a fusion peptide does not cross link two membranes. The
viral and target cell membranes are likely to have different physical properties from
those of two identical liposomes present in a model system. Oligomerisation is less
likely to occur in simple peptide systems, and the conformation adopted by an isolated
fusion peptide may be different from that present in the whole fusion protein. On the
other hand, the molecular nature of the early steps in fusion may be much harder to
unravel in the more complex system of an intact virus. Other parts of the fusion
protein, and indeed other members of the oligomeric protein structure, are also
involved in fusion. Thus studies on the membrane-destabilising effects of fusion
peptides, and the molecular and structural requirements for this process, appear to be
more relevant than investigations of the induction ofmembrane fusion by these
peptides.
A number of viruses now have fusion peptides with proven fusogenic capacity,
for example Influenza virus, HIV and SIV (e.g. Influenza virus: Lear and Degrado,
1987; HIV: Freed et al, 1990; SIV: Bosch et al, 1989). Moreover, the specific
requirement for the precise amino acid sequence of certain fusion peptides has been
demonstrated by mutagenesis. Work by Martin and colleagues (1994) showed that
synthetic peptides, which had the same hydrophobicity as the fusion peptide from SIV
but an altered amino acid composition, were non-fusogenic. Similarly, Duzgiines and
Shavnin (1992) found that the fusion peptides ofVSV and the 17 residue fusion
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peptide fragment from Influenza virus have the same hydrophobicities per unit but
they have different effects upon membranes of the same composition. Thus, whilst the
hydrophobicity of these peptides is clearly important if they are to interact with
hydrophobic lipid membranes, it alone is not sufficient to provide the ability to
promote fusion.
There are still many viruses for whom the fusion peptide is inferred from
homology with other known fusion peptides, and for whom the precise length of this
fusogenic region is uncertain. This includes the fusion peptide ofFeLV.
The mode of action of viral fusion peptides is still not clear. There is, however,
much evidence that fusion peptides do not merely act as aggregation agents for
neighbouring bilayers. A number of studies have been performed on the effects of
specific viral fusion peptides on lipid polymorphism and bilayer stability (e.g. Epand et
al, 1994; Epand and Epand, 1994; Colotto et al, 1996). These have attempted to
correlate fusion activity with the induction of bilayer destabilisation, and with the
promotion of the formation of non-bilayer phases of negative curvature. The studies
involve a very small sample of viral fusion peptides, but they do appear to
demonstrate a relationship between these two processes. Fusion peptides may act, at
least in part, by increasing the negative curvature of lipid systems. It is unlikely that
fusion peptides would significantly reduce the hydrophobic packing voids that are
present in inverted phases, since these peptides are not sufficiently hydrophobic to
pack into these defects.
Siegel and Epand (1997) have very recently suggested that fusion peptides
might also act by lowering the tension required for rupture of the TMC lipid
intermediate, thus resulting in more rapid ILA, or fusion pore, formation. IfTMCs are
common intermediates in two competing pathways, namely the La-Hn and La-Qn
transitions, then the stability of the TMC may be central to the differential rate of
formation of these two lipid phases. The longer-lived are TMCs, the more likely they
are to aggregate and form quasihexagonal arrays ofHu precursors. However, if the
TMCs are less stable, they are more likely to rupture and form ILAs, or fusion pores.
The lowering of the rupture tension of the TMC diaphragm may occur through an
effect of the fusion peptide on the cohesion of the lipid membrane, for example,
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through a local change in bilayer thickness around the adsorbed peptide (He et al,
1996).
It was suggested by White (1992) that fusion peptides do not actually embed
in either the target membrane or the viral membrane, but that they provide a
hydrophobic surface along which the lipid molecules could flow between fusing
membranes. However, a large body of experimental evidence now exists to suggest
that fusion peptides do indeed insert into the target membrane, and, as previously
mentioned for HA, possibly also into the viral membrane in the final stages of fusion.
Brasseur et al (1990) used modelling studies to examine a range ofviral fusion
peptides. It was assumed that the peptides adopted a purely a-helical conformation,
and this study concluded that the oblique insertion of these peptides into the target
membrane disrupted lipid packing and thus produced bilayer destabilisation. Epand et
al (1992) then suggested that longitudinal precession of the obliquely oriented peptide
would lead to greater disruption of the bilayer centre than of its surface, thereby
increasing the negative curvature pressure, and hence favouring both the formation of
inverted lipid phases and fusion.
The secondary structures of individual fusion peptides have been studied (e.g.
Diizgunes and Shavnin, 1992; Nieva et al, 1994b; Gray et al, 1996; Ishiguro et al,
1996). This has led to conflicting evidence on their active conformations, with
different experiments supporting either the a helix or a P structure for this role.
Attempts have been made to elucidate the angles and depths ofmembrane
insertion of viral fusion peptides (e.g. Martin et al, 1993; Martin et al, 1994; Macosko
et al, 1997), once more endeavouring to correlate these factors with fusogenic
activity.
The different experimental protocols ofprevious relevant work on fusion
peptides will be considered in each of the related chapters of this thesis, since this
prior knowledge provided the foundation from which this project was derived. Thus
Chapters 2, 3, 4 and 5 of this thesis are concerned with the structural effects of the
fusion peptide ofFeLV on lipid polymorphism. Chapter 6 examines the different
secondary structures adopted by this peptide under various experimental conditions,
and Chapter 7 provides experimental evidence for the fusogenic capacity of this
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putative viral fusion peptide. The results obtained from the experiments in this thesis
will also be discussed in detail in the light of the previous findings of other research
groups.
1.4 Feline Leukaemia Virus (FeLV)
The cat has the widest spectrum ofnaturally occurring retrovirus-induced
diseases of any nonlaboratory animal (Rojko and Hardy, 1994). Of these feline
retroviruses, FeLV is the best characterised. FeLV is now recognised as the most
common single, non-traumatic cause of death in adult cats worldwide (Rojko and
Hardy, 1994). Due to its extremely immunosuppressive nature, it is also responsible
for more feline diseases than any other single agent. Clinical symptoms and disease
conditions caused by FeLV include lymphosarcomas, leukaemias and anaemias,
marrow aplasia, membranous glomerulonephritis, fibrosarcoma, gastroenteritis,
polyarthritis, infertility and many more! At present, there is no truly effective vaccine
for FeLV; there are 11 different vaccines available in the USA, and the claims by their
manufacturers of the efficacies of the individual vaccines may be extremely
overinflated. Novel alternative treatments or preventive measures would, therefore, be
of great benefit.
FeLV and its related diseases have now been studied for a more than a quarter
of a century, partly because of their importance to the cat population, but also as a
retroviral animal model (Cotter and Essex, 1977) for human immunosuppressive and
neoplastic disorders, such as HIV. The early observations on feline retroviruses were
crucial to our current understanding and management of retroviral diseases, both in
veterinary and human medicine. Even now, FeLV is still used as a valuable model for
the mechanisms ofhuman diseases such as cancer and immunodeficiency. This is
partly due to the fact that FeLV is a natural pathogen, which is endemic in an outbred
mammalian population, and thus it may parallel human retroviral diseases more
closely than than those produced by retroviruses that occur almost exclusively in
inbred laboratory animals. As a recent example, Rohn and co-workers (1996) have
used experimental infection with molecularly cloned FeLV strains to isolate and
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characterise different novel FeLV variants that evolve in vivo. They have found that
different variants are associated with different pathogenic aspects of the development
of thymic lymphoma.
On the public health front, the possible zoonotic potential ofFeLV is still
unresolved. Oncogenic retroviruses have jumped species barriers in the past to cause
lymphomas (Rojko and Flardy, 1994). These have been identified, in the main, by
molecular hybridisation techniques or observations of shared DNA sequences.
Experimental innoculation ofneonatal puppies with FeLV has been shown to cause
lymphomas (Rickard et al, 1969). Since domestic cats and humans live in close
proximity there is great potential for FeLV transmission to humans via cat saliva. In
vitro experiments have shown that FeLV subgroups B and C can readily replicate in
human cells (Jarrett et al, 1969; Jarrett, 1971). An American study established that the
risk of leukaemia in children was doubled by exposure to sick cats (Bross and Gibson,
1970), whilst a British study found that this increased the risk of childhood lymphoid
cancer, but not of other forms of cancer (Penrose, 1970). In the case ofadults, no link
has been found for the general public, but veterinarians were found to have an almost
twofold increase in lymphomas compared to the general adult population (Gutensohn
et al, 1980). The investigators could neither prove nor disprove FeLV as a possible
aetiological factor. Human serum complement does destroy FeLV rapidly and
completely, but since this defence system is not fully developed in children, possibly
until the age of 6 years, and as it may be impaired in immunosuppressed adults, there
exists a possibility of zoonotic infection in these individuals. Thus FeLV possibly has
direct importance as a human pathogen. It should be noted, however, that human
retroviruses are considered to be very different from all known feline retroviruses.
Jarrett et al (1964) first discovered FeLV in 1964. It is a pathogenic,
exogenous retrovirus of cats, originally of rodent origin: its nucleic acids are closely
related to chromosomal DNA of the modern rat (Benveniste et al, 1975). The belief is
that, one to ten million years ago, in a northern African desert, an ancestral cat ate an
ancestral rat, which had harboured and replicated its own endogenous retrovirus.
Thus the cat became infected with the rat virus! In 1973 it was shown that FeLV is
transmitted contagiously (Jarrett et al, 1973; Hardy et al, 1973), thus dispelling the
83
belief that cancer-causing retroviruses were laboratory artefacts. This also led to the
eventual realisation that contagious transmission is far more frequent than genetic
transmission for most retroviruses. The commonest route ofFeLV horizontal
transmission is by excretion in infected cat saliva.
FeLV belongs to the Family Retroviridae, Subfamily Oncovirinae, and has
three subtypes A, B and C, each ofwhich has several different strains. It is an
enveloped RNA virus, of diameter 1 lOnm. Its structure is shown in Figure 1.12.
Surrounding the genome is a hexagonal core protein coat, containing the p27 protein,
then an acidic coat ofprotein pi 2, and finally an envelope containing viral gp85
glycoprotein spikes. gp85 is the fusion protein ofFeLV, and comprises two
polypeptide subunits, generated by proteolytic cleavage. The SU subunit is called
gp70 and is linked by disulphide bridges to the TM subunit, pl5E (Schafer and
Bolognesi, 1977; Bolognesi et al, 1978). gp70 contains the receptor binding site
(Laird et al, 1973) and has an FeLV subgroup-specific antigenic domain (Jarrett and
Russell, 1978). FeLV-B infects many non-feline cell lines in vitro and recognises the
human Pitl receptor, a sodium-dependent phosphate symporter, although certain
strains ofFeLV-B can also use the human Pit2 receptor (Boomer et al, 1997). FeLV-
A primarily infects feline cells; the receptor for FeLV-A is not as yet known. pl5E
houses the transmembrane-anchoring region, an extremely immunosuppressive amino
acid sequence, and the putative amino-terminal fusion peptide. This extremely
hydrophobic putative fusion peptide is 27 amino acids in length and shows a large
degree ofhomology to other known retroviral fusion peptides (see Table 1.1). It is
also completely conserved between all known strains of FeLV. FeLV fuses directly
with the target cell's plasma membrane (Laird et al, 1973), and thus shows pH-
independent fusion.
1.5 The Aims of This Project
The main objective of this research project was to characterise the fusion
peptide ofFeLV, using a variety of complementary biophysical and biochemical
techniques. The FeLV fusion peptide sequence is listed in the Swiss Protein Data
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Base, and has also been quoted in several scientific papers. However, to my
knowledge, there is currently no published experimental work on the molecular
mechanisms ofFeLV-induced fusion that follow receptor binding, and more
especially, on the fusion peptide ofFeLV. Thus, on commencing this research, the
aims were to ascertain the membrane-destabilising effect of this peptide sequence, and
to identify the secondary structures of the peptide in its active and inactive forms. A
variety of complementary biophysical techniques have been employed to obtain this
information. Biochemical fluorescent fusion assays were also performed, in an attempt
to induce fusion by this peptide, and to determine the conditions required for this to
occur.
By studying one specific fusion peptide in detail, it is hoped that one may gain
a wider understanding of the principles of viral fusion in general, and possibly even
some insights into certain aspects of cellular fusion processes. It is only by fully
understanding basic life processes such as fusion that we can logically design
therapeutic agents to alter these processes when required. Even at present it is
possible to use the correlations between observations in model systems and in
biological membranes to predict the effect ofmembrane additives, and to design new
therapeutic agents on this basis. Thus several antiviral drugs are bilayer stabilisers, for
example carbobenzoxy-D-Phe-L-Phe-Gly (Epand, 1986), and tromantidine (Cheetham
and Epand, 1987). Cyclosporin also stabilises bilayers, and it inhibits membrane fusion
in model systems at low concentration (Epand et al, 1987). Furthermore, this agent
specifically inhibits herpes simplex virus induced cell-cell fusion (McKenzie et al,
1987). Tromantidine, an inhibitor of herpes penetration, inhibits the increased cell
membrane protein diffusion caused by this virus (Epand, 1990). In view of the
extremely limited range of clinically useful antiviral agents available at the current
time, and the particular difficulties associated with the treatment, and indeed
prophylaxis, of retroviral infections, an increase in our understanding of the infective
mechanisms of these obligate intracellular parasites, and the design of novel antiviral
therapeutic agents can only be advantageous.
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Chapter 2: The use of Differential Scanning Calorimetry to
determine the effects of the Feline Leukaemia Virus Fusion Peptide
on a Lipid Bilayer to Inverted Hexagonal Phase Transition
Temperature
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2. Differential Scanning Calorimetry
2.1. Theoretical Background to Thermal Analysis
Thermal analysis can be used to measure certain aspects of phase transitions of
lipids. A substance, such as a lipid, that is heated will maintain a constant temperature
during a phase transition despite continued heat input, since energy is required to
separate the component lipid molecules. The heat energy supplied during a phase
transition thus enables the molecules to overcome the forces between them, causing
their regular molecular packing to break down and giving them a greater degree of
freedom and disorder, or entropy. This heat energy, which the sample absorbs in an
endothermic transition and releases in an exothermic transition, is called the latent, or
hidden, heat, since it does not produce a change of temperature in the sample. Thus a
plot of sample temperature against time as a lipid is heated will show an inflection
which gives an indication of the lipid's phase transition temperature. 'Thermal
analysis' originally referred to such simple heating experiments, which date from the
middle of the 18th century. Thermal analysis methods use calorimeters, which are
measuring devices in which a precisely determined amount ofheat is supplied to a
sample, or abstracted from a sample, and the resultant temperature change in the
sample is measured.
In 1899 Roberts-Austen found that a more accurate measure of transition
temperatures could be obtained by plotting the difference in temperature between the
sample and its surroundings. This then led to the development ofDifferential Thermal
Analysis (DTA), notably by Le Chatelier. Present day DTA compares the sample with
an inert reference under carefully controlled conditions of heating or cooling. Thus the
sample and a similar mass of reference material are placed in separate holders and
inserted into a heating block. The reference material is a substance which does not
undergo a phase transition in the temperature range of interest, for example a quantity
of the pure solvent that was used in the sample preparation. The temperatures of both
sample and reference are measured electrically using thermocouples or platinum
resistance thermometers. The same heat flow is supplied to the two materials, and
thus their temperatures rise at approximately the same rate until a phase change
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occurs. The sample will then maintain a constant temperature until it has changed
phase, whilst the temperature of the reference material will continue to rise. When the
phase transition is complete, the sample then increases in temperature once more until
it equilibrates with the heating block, and the temperatures of the sample and
reference will thus reconverge. A plot of the sample temperature (Ts) minus the
reference temperature (Tr) will show a negative asymmetric peak, the position of
which gives an accurate measure of the phase transition temperature (see Figure 2.1).
Moreover, the area under the peak is related to the amount of heat absorbed during
the transition. However, quantitative measurements are obtained more accurately
using the related technique ofDifferential Scanning Calorimetry (DSC).
In DSC experiments the sample and reference materials are heated individually
so that a constant temperature difference is maintained between them, even during
phase transitions. This is accomplished by a feedback mechanism which alters the rate
ofheat flow to the sample. Thus when the sample reaches its phase transition
temperature, the required constant temperature difference between sample and
reference can only be achieved by a large increase in the rate of heat flow to the
sample. The measured signal in DSC is proportional to the rate ofheat flow to the
sample, and a plot of this quantity against the sample temperature will show a positive
peak during endothermic transitions (see Figure 2.2). (Endothermic processes have
positive peaks by definition in thermodynamics). The total area under a DSC peak can
also be measured, and, providing that the sample is totally enclosed within the heating
block, this area is directly related to the heat of transition with an accuracy of about
2% (Warren, 1987).
DSC has several advantages over DTA: disturbances such as temperature
variations in the environment of the measuring system affect the sample and reference
materials similarly in DSC studies and, moreover, compensation is made for these
disturbances when the difference between the two individual systems is determined.
There are still some problems and limitations associated with DSC ofwhich
one should be aware. Firstly, there is no theoretically well-founded, complete
understanding ofDSC, nor is there, as yet, an international agreement on procedures




Figure 2.1. Ideal DTA heating curve of a pure substance undergoing a
phase transition at a temperature TH. The sample is heated at a constant
rate, and the difference between the sample temperature, Ts and the
reference temperature, Tr, is plotted against the sample temperature.
Th
Sample temperature, Ts
Figure 2.2. Ideal DSC heating curve of a pure substance undergoing a
phase transition at temperature TH. The required rate of heat flow to
sustain a constant temperature difference between the sample and
reference is plotted against the sample temperature.
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definitely backed up both theoretically and experimentally. Secondly, the basic
information regarding the behaviour of two substances when they are mixed together
is contained in the binary phase diagram for the system. This phase diagram relates to
the behaviour under equilibrium conditions, and the validity of phase boundaries
determined by DSC will depend upon the rate at which equilibrium conditions are
obtained. Thus differential thermal methods are most suitable for the study of systems
in which equilibrium conditions are attained rapidly. Nonetheless, DSC is a recognised
technique for the study of the effect of fusogens on TH of lipid systems, since it is
perfectly accurate for relative measurements, even if it may be slightly inaccurate for
some absolute measurements. Thus whilst the recorded values of TH for these systems
may not be precisely the same as the true thermodynamic values, the effect of an
added impurity, such as a fusion peptide, on TH will be valid.
2.2 Practical considerations for DSC
The development ofhighly sensitive calorimeters, which require only milligram
quantities of sample, has increased the resolution ofDSC, and has also extended its
application to materials that are only available in small amounts. The best results are
obtained using the minimum size of sample, and also the minimum heating rate which
will provide a satisfactory signal. It is essential for DSC measurements that the
measuring system is composed of solid parts, and has defined heat conduction paths.
This allows the sample reaction to be regarded as a small disturbance of the steady-
state temperature field that is produced by the heating protocol. The noise of the
system must be low to enable sensitive measurement ofheat flow rates. Good thermal
contact between the sample capsule and holder, and an even distribution of sample
within the capsule, are essential to allow satisfactory interpretation of the baseline.
This can be difficult with multi-component systems, since it may be hard to obtain a
small sample that is homogeneous, and thus truly representative. The shape of the
DSC peak is also affected by these factors, as well as the thermal resistance between
the sample and its holder, and the thermal conductivity within the sample. Thus a
granular sample may produce an irregular peak, and sample purity is ofutmost
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importance. A minimum of deadspace within the sample capsule is also essential in
order to prevent separation of a free water layer by evaporation and recondensation of
water within the capsule.
2.2a Power Compensation DSC
The DSC calorimeter consists of two identical microfurnaces of the same type
(usually made of a platinum-iridium alloy), each ofwhich contains a temperature
sensor (platinum resisitance thermometer) and a heating resistor (platinum wire). The
microfurnaces, which are thermally decoupled, are positioned in an aluminium block
of constant temperature. A purge gas ofnitrogen or helium flows through the
chambers continuously. (Helium is preferred to nitrogen due to its higher thermal
conductivity). During heating scans, the same heating power is supplied to both
microfurnaces, using a control circuit to change their mean temperatures at a preset
scanning rate. If there is ideal symmetry, the temperature ofboth microfurnaces will
be identical. However, when an asymmetry occurs, a temperature difference between
the two microfurnaces results, which generates an input signal, in the form of a
voltage, to a second control circuit. This control circuit then tries to compensate for
the temperature difference by changing an additional heating power. The
compensating power is proportional to the temperature difference, and the total
compensating energy, the integral ofpower against time, is equal to the reaction heat,
or the heat of the phase transition. A heat flow rate is internally assigned to the real
measured signal using factory-installed calibration. The output signal is also given as a
heat flow rate signal, and is related to the true heat flow rate by a constant value,
which must be determined by caloric calibration. Calibration at several different
temperatures is required, since the response of the system is non-linear. This is
achieved using substances of known melting point.
There is no ideal power compensation DSC. In real machines the sample is
always put into a container which is then placed into a heater, so that at least one heat
conduction path and thus at least one time constant exists between the heating control
and the sample location. Moreover, the proportional controller can never completely
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compensate for the measured temperature difference, so that a slight temperature
difference remains between the sample and the reference. Thus the calibration factors
depend upon the temperature and thermal conductivity of the sample, the heating rate
and on the magnitude of the heat of the phase transition. The temperature difference
between the two microfurnaces is also not totally compensated for in commercial
DSC machines. During a phase transition peak there is still, therefore, a temperature
difference between sample and reference, which is proportional to the reaction heat
flow rate. Hence the measured signal is 'smeared' in comparison with the processes
inside the sample, and the measured curve put out by the DSC machine is only a
'smeared' representation of the function searched for. In many cases however, this
measured curve is sufficiently accurate for the desired evaluations to be made. This is
true for the determination of the temperatures of lipid phase changes.
2.3 Application of DSC to Fusion Studies: Aims of these DSC Experiments
Correlations have been found between the promotion ofmembrane fusion by
certain compounds and their ability to lower the lipid bilayer to inverted hexagonal
phase transition temperature, TH, as measured by high sensitivity DSC (e.g. Siegel et
al, 1989b; Epand et al, 1994; Epand and Epand, 1994). Similarly, fusion inhibitors
have been shown to raise TH (Epand, 1986). Whilst kinetically-stable lipid phases,
such as the Hn phase, may not be involved in biological fusion, the first steps in their
transition pathways from the lamellar phase may be very important, in particular the
bilayer destabilisation thus produced. Fusion catalysts are thought to affect the
kinetics of the phase transitions, and not the thermodynamic stability of the individual
lipid phases themselves. Moreover, a favouring of the conversion of the lipid bilayer
to non-lamellar phases, such as the Hn phase, should enhance the rate of formation of
fusion intermediates, such as the 'modified stalk' (Siegel and Epand, 1997).
In the light of these previous experimental findings for known fusogens, a
DSC study of the FeLV fusion peptide was performed. The aims were to ascertain the
effect of a range of peptide concentrations on TH, and thus determine any effects of
the FeLV fusion peptide on the conversion of the lipid bilayer to the Hu phase. This,
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in turn, might identify certain membrane destabilising properties of the FeLV fusion
peptide, and might also provide some support for the link between the bilayer-inverted
hexagonal phase transition and membrane fusion.
2.4 Materials and Methods
2.4a FeLV Fusion Peptide
The 27 amino acid sequence of the amino-terminal fusion peptide, which is
common to all documented strains ofFeLV, was ascertained to be EPISLTVALML-
GGLTVGGIAAGVGTGT (Swiss Protein Data Bank, 1996; release number 34.0).
This peptide has proved to be extremely difficult to work with, due to its high
hydrophobicity, and its total lack of solubility in almost all common solvent systems.
Initially, two batches ofpeptide were synthesised, using the Merrifield solid-phase
principle, by two different commercial companies. Neither of these companies could
purify the resulting crude peptides due to the aforementioned lack ofpeptide
solubility. Consequently, several attempts were made to purify these crude peptides,
using reverse-phase high performance liquid chromatography (HPLC). A Phenomenex
C8 Primesphere column (250 x 4.6mm) was used, which is a preparative column, with
a C8 guard column in place. The peptides were partially dissolved in
dimethylformamide (DMF) with prolonged sonication, and aliquots of this solution
were applied to the column, and eluted using the solvent gradient method of:







where solvent A was water/0.1% trifluoroacetic acid (TFA) and solvent B was
acetonitrile (ACN)/0.1% TFA. Both solutions were filtered before use.
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A Pharmacia LKB HPLC machine with low pressure mixing system was
employed. Identical aliquots of the peptide did not elute from the column at a constant
time, nor were the peptide peaks of constant size and shape. This was most probably
due to the difficulties in obtaining a true solution of the peptide in DMF. However,
the peptide also appeared to stick on the column during some runs, so that no peaks
other than those of the solvents were obtained. The peptide chemical research group,
which is headed by Professor Ramage in the Chemistry Department at Edinburgh
University were then contacted, and asked for advice on purifying these crude
peptides. Initial Mass Spectrometry runs confirmed speculation that there was indeed
very little of the desired peptide present in these samples, and that it would be
uneconomical and extremely difficult to attempt any purification processes. However,
Professor Ramage's group, which now works commercially under the name of
Albachem Ltd, 26 Craigleith View, Edinburgh, EH4 3JZ, Scotland, UK, are very
experienced in the handling ofhighly hydrophobic peptides and they offered to
attempt the synthesis and purification of this peptide, partly in the interests of their
research on this topic. A lysine (which is the next naturally occurring carboxy terminal
residue in the fusion protein) was included on the carboxy terminus to increase
peptide solubility. The peptide was synthesised on an Applied Biosystems 430A
instrument, using Fmoc chemistry with the side chain protecting groups selected as
tBu (Ser, Thr) and OtBu (Glu). The completed peptide was cleaved with a solution of
TFA/H20 (95%:5%) plus scavengers (ethanedithiol/thioanisole/triisopropanesilicane)
and the solvent was evaporated under vacuum. The crude peptide was then dissolved
in 50% TFA/H2O and successfully purified by reverse-phase HPLC, using a RPC4 (10
x 100mm) column, eluting with a linear gradient from 10% acetonitrile in water (0.1%
TFA) to 60% acetonitrile in water (0.1% TFA) over 30 minutes. The peptide was
characterised by mass spectroscopy (MALDI, PerSeptive Biosystem laserTec) (see
Figure 2.3), amino acid analysis (LKB 4150 alpha amino acid analyser) (see Table
2.1) and analytical HPLC using PRC4 (4.6 x 100mm), RPC8 (4.6 x 220mm) and
Vydac C8 (4.6 x 250mm) columns, runnirig a linear gradient of 10% acetonitrile in
water (0.1% TFA) to 90% acetonitrile in water (0.1% TFA) over 30 minutes (see
Figure 2.4). The assembly of the peptide was reasonably efficient, but the purification
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Mass (m/z)
Figure 2.3. Mass spectrometry analysis of the purified FeLV fusion peptide.
The low molecular weight peaks represent components of the matrix used to
support the sample. The main peak of high molecular weight represents the
purified FeLV peptide. The predicted mass is 2583.57.
Time (Minutes)
Figure 2.4. Analytical HPLC trace for the purified FeLV peptide. The
peaks at 3 mins and at 31 mins are solvent peaks. The diagonal line
represents the percentage mobile phase present at any specific time.
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Amino Acid FeLV Peptide:
Composition of Stoichiometric %s expected



















Table 2.1. Comparison of the stoichiometric percentages of individual
amino acids present in the synthesised FeLV fusion peptide, as
determined by amino acid analysis, with the expected stoichiometric
percentages for each individual amino acid, calculated from the peptide
sequence.
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process was found to be very difficult. The peptide was found to be very insoluble;
accordingly, 50% TFA was added to take it into solution. However, a very broad
peak without any resolution was obtained under normal eluting conditions, unless a
very dilute solution was applied. Thus the purification could only be carried out
batchwise on a small analytical-sized scale (0.5 to 1.0 mg per run). Even so, some
runs yielded no peaks due to the peptide remaining stuck on the column.
2.4b Preparation ofLipid and Lipid/Peptidefilms
Pure PE is readily able to adopt the Hn phase structure. The transition from
the lamellar to the Hn phase is induced by an increase in temperature. PEs have
several advantages for use in DSC studies on fusion peptides. They do not form well
sealed vesicles, which increases the likelihood of the peptide having access to all of
the lipid present in the sample. Also, PEs are lipids which enhance the rate ofvirus-
induced fusion (White et al, 1982; Stegmann et al, 1985). Dipalmitoleoylphos-
phatidylethanolamine (DiPoPE) was chosen for this study as it had been used
previously for DSC studies on other known viral fusion peptides, and as it was known
to have a relatively low TH of 43.2°C (Epand, 1990). Thus studies of this lipid can be
performed at temperatures that are at, or close to, biologically relevant temperatures,
which are unlikely to cause significant thermal denaturation of any folded form of the
fusion peptide and which are sufficiently close to the ambient temperature that heat
losses due to exchanges with the environment are small. (DSC experiments performed
at high temperatures have the added problem that the heat flows exchanged with the
surroundings, by conduction, convection and radiation, will be relatively large
compared to the quantity of heat to be measured.) The disadvantage ofPEs is that
they do not form well-dispersed aqueous suspensions, and thus great care is required
to produce homogeneous samples.
DiPoPE was purchased from Avanti Polar Lipids (Alabaster, AL, USA).
Purity was confirmed by Thin Layer Chromatography, which showed a single spot for
this lipid.
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Weighed amounts of the lipid, or lipid plus peptide, were vortexed thoroughly
in chloroform. The peptide-containing samples were then sonicated until the peptide
dissolved. The chloroform was evaporated using a stream of dry nitrogen gas,
depositing each lipid or lipid/peptide sample as a film on the walls of a 13 x 100mm
Pyrex test tube. The surface area of the film should be as large as possible so that the
lipid film produced is very thin (New, 1990), and nitrogen is used in order to try to
prevent peroxidation and oxidation of the lipids. These samples were then placed
under vacuum for four hours, followed by lyophilisation overnight to remove any
residual solvent molecules. The resulting films were then suspended in buffer, and
vortexed vigorously at room temperature for 10 minutes. The buffers used were
20mM PIPES, ImM EDTA, 150mM NaCl and 0.002% sodium azide for the
experiments conducted at pH 7.4, and lOmM citrate, 0.15M NaCl for the pH 5.0
samples. All samples were made to a final DiPoPE concentration of 10mg/ml,
including varying peptide concentrations as required, and they and the reference
buffers were degassed under vacuum just prior to use. Thorough mixing was applied
to ensure as uniform a sample suspension as possible for injection into the sample
chamber.
2.4c Differential Scanning Calorimetry
An MC-2 high sensitivity scanning calorimeter (Microcal Co., Amherst, MA,
USA) was employed, which is a power compensation DSC machine. This is calibrated
by an electrical pulse which travels through a heating element ofknown resistance in
the reference cell. This calibration was also verified by measuring the enthalpy ofwell
established phospholipid phase transitions, such as that ofDipalmitoylphosphatidyl-
choline (DPPC). The sample chamber held 1.4ml, and nitrogen gas purged the system.
A scan rate of45K/h was used. Continous heating scans were run from 25°C through
to 60°C.
Using the MC2, the raw data curve is the difference in power supplied to the
two cells to maintain their temperatures identical to within 0.0001°C. Thus raw data
are in units ofmCalories(mCal)/min. The computer software was then used to divide
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these figures by the scan rate, so that the data were now in units ofmCal/°C. Next the
data were divided by the number ofmillimoles of lipid present in the sample, having
taken into account the cell volume. Thus the results were now in units of Cal/°C/Mole
lipid. A baseline was then drawn to connect the parts of the curve before and after the
phase transition. At least two points before and after the peak were selected. This
yielded a curve which showed the excess enthalpy of the phase transition compared to
the baseline values. A 'Deconvolute' programme was then used to determine the
enthalpy and phase transition temperature for this curve. This recorded bilayer to
hexagonal phase transition was fitted to one ideal two state process, as described by a
single van't Hofif component, using the DA2 software pakage from Microcal, and the
reported transition temperature is that for the fitted curve.
The van't Hoff equation relates the decrease in the phase transition
temperature of the lipid/peptide mixture to the amount ofpeptide present. This is
based on the simplest theory, which treats the sample as a eutectic mixture (a eutectic
mixture has the lowest freezing point ofany possible proportions of its constituents).
In principle, any phase transition of a eutectic mixture starts at the eutectic




where xin,p is the mole fraction of the eutectic impurity, in this case peptide; Ttrs is the
phase transition temperature of the completely pure component, which is DiPoPE
here; AH is the phase transition enthalpy of the pure component, or lipid, at the
resulting temperature, and R is the gas constant, 8.31441 J mol"1 K'. Thus if the
amount of impurity, or peptide, present is known, the transition temperature can be
calculated more accurately than that which is measured directly.
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2.5 DSC Results and Discussion
Figure 2.5 shows three representative thermograms, at pH 7.4, from which
values for TH were obtained. The curves are displaced vertically from one another for
convenience of display. It can be seen that TH is lowered in the presence ofboth of the
concentrations ofFeLV fusion peptide shown. At very high peptide concentrations,
such as are seen in Figure 2.5(c), the baselines were in some instances slightly
irregular. This reflects the difficulties that were encountered in maintaining samples
with large amounts of the FeLV peptide present in a completely homogeneous state
for the entire duration of experiment. Plots of the change in TH with increasing
peptide mole fraction, at pH 7.4 and pH 5.0, are shown in Figures 2.6a and 2.6b
respectively. The resultant curves show an initial decrease in TH, followed by an
increase in TH with consecutive rises in the peptide:lipid molar ratio. At peptide mole
fractions of>1.5 x 10~3, a broadening of the enthalpy peaks was observed, which
indicates a decrease in cooperativity for this transition. A broadening of endotherms
has been seen previously in the presence of the fusogen DAG (Siegel et al, 1989b).
The two pH curves are at least biphasic: obviously the possibility exists that these
curves are described by more complex functions.
Th is the temperature at which the free energies of the La and Hn lipid phases
are equal. Thus TH is a measure of the relative stability of the Lu and Hn lipid phases,
and the effect of a peptide on TH is a measure of how the peptide affects the relative
stability of these two phases. The reduction in TH that was observed initially with
increasing peptide concentration suggests that, at peptide mole fractions less than or
equal to 1.5 x 10"3, the FeLV fusion peptide favours the formation of the Hn phase
over the La phase at both pH 5.0 and pH 7.4. The FeLV virus fuses with biological
cells at pH 7.4 (Laird et al, 1973), so a decrease in TH at both pH values is to be
expected with this fusion peptide. DSC experiments performed at pH 7.4 using a
synthetic dodecapeptide corresponding to the amino-terminal SIV fusion peptide also
showed a decrease in TH with the wild type fusion peptide, while little change in TH
was seen with a non-fusogenic mutant (Epand et al, 1994). Experiments which
studied the effect of the Influenza virus fusion peptide on TH found a difference with
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Figure 2.5. Some representative thermograms, obtained at pH 7.4.
Pure DiPoPE (a); DiPoPE with FeLV peptide, at a peptide mole
fraction of 0.5 x 10~3 (b) and 0.65 x 10"3 (c). TH is lowered in the
presence of the FeLV peptide. DSC heating scan rate 45K/hr.
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Figure 2.6. Change in the lamellar to inverted hexagonal phase
transition temperature as a function of the mole fraction of Feline
leukaemia virus fusion peptide present at pH 7.4 (■) (a) and
pH 5.0 (•) (b).
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pH (Epand & Epand, 1994): this fusion peptide lowered TH at pH 5.0, but increased
Th at pH 7.4. These findings correlate with the Influenza virus peptide's pH-
dependent fusogenic ability. In the same study two non-fusogenic Influenza virus
mutants, which had a glutamate substituted for the glycine at position 1 or 4 of the
fusion peptide, were found to raise TH, at both pH 5.0 and pH 7.4. This suggests that,
at low peptide concentrations, a lowering of TH is a fundamental property of viral
fusion peptides. Table 2.2 shows the values of the slopes for the dependence of TH on
the mole fraction of fusion peptide for these three peptides, which provide a measure
of the effect of the peptides on bilayer stability. It should be noted that the range of
peptide concentrations included here is not the same for FeLV as for the other two
peptides studied, since only the FeLV data which show a reduction in TH are
considered, that is the first halfof the plotted results. This may explain, in part, why
the FeLV gradients are so much steeper. However, some of the quantitative
differences between these values may be due to the difference in the structures of the
fusion peptides. The FeLV peptide has an acidic residue on its amino terminus, the
Influenza peptide has several acidic residues along its length, and the SIV peptide has
no polar residues. These factors will affect the depth and angle of peptide penetration
into the lipid bilayer: alteration of the amino acid sequences of fusion peptides
changes the membrane orientation of these peptides (Brasseur et al, 1990).
Other known fusogens have also been shown to stabilise the Hn phase relative
to La. Thus 2 mol% DAG, which is produced in vivo by the phosphotidylinositol
cycle, can lower TH (Siegel et al, 1989a) for some lipid systems by as much as 20°C.
Moreover, TH decreases in an approximately linear fashion with increasing DAG in
the concentration range of 0-3mol% (Siegel et al, 1989b). CHEMS (cholesterol
hemisuccinate) promotes Hn phase formation at acidic pH, and significantly enhances
the rate of Sendai virus fusion at pH 5.0 (Cheetham and Epand, 1987).
The reduction in TH is less at FeLV peptide mole fractions above
1.5 x 10"3, at both pH 5.0 and pH 7.4. This may be due to increased self-aggregation
of the extremely hydrophobic FeLV peptide molecules at these higher concentrations,
thus preventing them, in part, from inserting into the lipid bilayers. Grossly, the
peptide does appear to self-aggregate in these concentration ranges, as seen by the
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Viral Fusion Slope of line (°C/molar Slope of line (°C/molar
Peptide fraction peptide) at pH 5.0. fraction peptide) at pH 7.4.
Influenza HA2 -453 ± 112 a 301 ±49 a
SIV not studied -360 ±100b
FeLV -2128 ±233 -1116 ±444
a: from Epand,R.M., & Epand, R.F. (1994).
b: from Epand, R.F. et al (1994).
Table 2.2. Comparison of the effect of viral fusion peptides on Th of
DiPoPE.
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formation of gel-like masses in these samples by the end of the heating scans. It has
been observed previously that fusion peptide analogues aggregate in solution (e.g.
Wharton et al, 1988; Takahashi, 1990). A similar phenomenon has also been observed
with Amphotericin B, which is extremely hydrophobic in nature (Epand, R.M.,
personal communication). A synthetic 19 amino acid peptide corresponding to the
amino terminus of the F1 subunit of the Measles virus fusion protein lowered TH of
Dielaidoylphosphatidylethanolamine (DEPE), but only by a maximum of 1.5°C
(Epand et al, 1992). However, this peptide is also extremely difficult to solvate, and
thus it is probable that it is not uniformly distributed in the samples, which may reduce
its effect on lipid phase behaviour.
The FeLV pH 5.0 results show a more marked decrease in the lowering of TH
compared to the pH 7.4 data. Presumably there is more self-aggregation of the
peptide at this pH, possibly due to a decrease in negative charge of the glutamate
residues at acidic pH. The portion of the FeLV peptide which is aggregated may lie
along the bilayer surface, rather than insert into the membrane, and actually stabilise
the La phase, possibly by reducing its negative curvature strain.
Further support for the link between bilayer destabilisation and the
enhancement of fusion comes from the effects of fusion inhibitors on the La-Hn phase
transition. Some examples are cholesterol sulphate (Cheetham et al, 1990) and
cholesterol phosphorylcholine (Cheetham et al, 1994), which are potent inhibitors of
Sendai virus fusion with both human red blood cells and liposomal membranes, and
which raise the TH ofDEPE. Similarly, LPC inhibits a number ofmembrane fusion
processes (Chernomordik et al, 1993), and it also can raise TH (Epand, 1985). Finally,
Tromantidine, which is a therapeutic agent used against Influenza and Herpes virus
infections, raises the TH of a variety of synthetic PEs.
Enhancement ofHn formation may be due to disruption of lipid packing and/or
effects on lipid hydration, producing an increase in monolayer negative curvature
strain (Gruner, 1985). X-ray studies of the Hn phase lattice constant at constant
temperature can determine whether alteration of the spontaneous radius of curvature
of the lipid/water interface, Ro, occurs, and thus a change in monolayer negative
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curvature strain. This is indeed seen for DiPoPE samples containing the FeLV peptide
(see Chapter 4).
An increase in the negative curvature strain of bilayers is believed to result in
increased rates of viral fusion (Siegel, 1993). The first structures to form in the La-Hn
phase transition may be similar to those that mediate membrane fusion in many lipid
systems. This may explain the relationship between an increase in membrane fusion
rates and the effect of a fusion promoter on lipid polymorphism. Central to the
currently favoured theory on this link is the formation of the 'modified stalk'
intermediate, which has overall negative curvature (Siegel, 1993). Thus the formation
of this intermediate would be accelerated by agents or conditions which favour the
formation of inverted phases. Very recent work by Siegel and Epand (1997) suggests
that both the La-Hn phase transition and membrane fusion do indeed proceed via the
formation ofmodified stalks. These then almost immediately expand to form
transmonolayer contacts (TMCs), which were seen using TRC-TEM in this study as
small connections between apposed membranes. The TMCs were then observed to
aggregate side-to-side, forming arrays with hexagonal order in some directions.
Aggregation would reduce some of the free energy of the system. Thus at
temperatures below TH, although the lipid in each individual TMC still has a higher
free energy than bilayer lipid, the activation energy required to revert this process is
higher in a TMC aggregate than for isolated TMCs. Elence kinetically metastable
TMC arrays are formed, which can then elongate directly into Hh domains. These
findings support previous theoretical predictions that local defects in membranes are
likely to arise or accumulate near phase boundaries. The subsequent formation of
fusion pores from the TMCs will depend upon the individual lipid system involved.
Although Hn itself is not seen in biological membranes, related non-bilayer
structures such as Tin precursors could well form and could be involved in membrane
fusion processes. In support of this, Zellmer and co-workers (1994) found that vesicle
fusion could be catalysed by lipid chain melting alone, provided that the temperature
of the system was not far below TH. Thus the whole lipid system does not have to go
through a non-bilayer phase transition to promote fusion.
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In this present work it is demonstrated using DSC that the putative fusion
peptide ofFeLV can lower TH ofDiPoPE, particularly at low mole fractions of
peptide. Thus this peptide appears to be a bilayer destabiliser. This agrees with
previous findings for known fiisogens, and hence adds support to the link between the
bilayer-inverted hexagonal phase transition and membrane fusion.
Since the 1960s thermal analysis methods have frequently been used in studies
ofmembranes. However, to understand fully the phase transitions of lipids in
biological membranes it is not sufficient to consider the behaviour ofpure isolated
lipid species alone, since biological membranes are highly heterogeneous in their
phospholipid content and since they also contain a variety of non-phospholipid
components, which can interact with the phospholipids and influence their behaviour.
Nonetheless, studies of the effects of viral fusion peptides on the thermotropic
properties ofpure lipid species aim to provide a basic insight into the mode of action
of these fusogens, in particular their modulation of lipid polymorphism. Moreover,
whilst biological membranes are indeed heterogeneous, the existence ofmicrodomains
of individual lipid species may be important for fusion. Webb and co-workers (1993)
studied mixtures ofDOPC and dioleoylphosphatidylethanolamine (DOPE), and found
that, by decreasing the water content, these lipids demixed prior to undergoing a
phase change to Hn. Thus they concluded that the differential hydration characteristics
of various membrane components may induce lateral fluid lipid demixing during
dehydration. Since dehydration has been identified as an early step in fusion, the study
of one individual lipid species may thus be quite relevant to biological fusion events.
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Chapter 3:31Phosphorus Nuclear Magnetic Resonance Spectroscopy
studies on the effect of the Feline Leukaemia Virus Fusion Peptide on
Lipid Polymorphism
"What an enormous revolution would be made in biology, if physics or chemistry
could supply the physiologist with a means ofmaking out the molecular structure of





3. Phosphorus Nuclear Magnetic Resonance Spectroscopy
3.1 General Introduction
Spectroscopy measures the absorption of electromagnetic radiation by
substances, and can be used to determine the structure of organic compounds.
Nuclear Magnetic Resonance Spectroscopy (NMR) measures the change of
the spin state of a nuclear magnetic moment when the nucleus absorbs electro¬
magnetic radiation in a strong magnetic field.jlPhosphorus NMR (31P NMR) can be
used to study the structure and dynamics ofmodel and biological membranes. Since
the 31P nucleus is the only isotope ofphosphorus that is found in natural biological
structures, and since each phospholipid molecule within a membrane contains at least
one phosphate radical in its headgroup, 31P NMR studies can be performed without
the addition of any probes to the membrane under study. 31P NMR is thus a non¬
invasive technique, and it is also extremely sensitive.
31P NMR primarily senses the behaviour and the environment of the
phosphorus atom in the phospholipid headgroup, and so this technique measures the
properties of the membrane surface; other properties are sensed indirectly. 3IP NMR
is also 'blind' to any materials in the sample that do not contain phosphorus.
3.2 Theoretical Background to NMR Spectroscopy
When a compound absorbs energy, it undergoes transitions to different energy
states. Since these energy states are 'quantised', a particular atomic nucleus will only
absorb the precise amount of energy required to change state. Thus one can correlate
the frequency of electromagnetic radiation absorbed by a compound with its structure.
The frequency of absorbed radiation is measured by a spectrometer.
Certain elements have isotopes the nuclei ofwhich are intrinsically magnetic.
These include the 3IP nucleus, but not those of the common natural isotopes of
carbon, nitrogen or oxygen. An intrinsically magnetic nucleus spins about an axis, in a
similar manner to that in which the Earth spins around the sun. This intrinsic spin is
called the spin angular momentum of the nucleus, and it is quantised. The spin
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quantum number of a nucleus is largely determined by the number of unpaired protons
and neutrons. Protons and neutrons each have a spin quantum number of V2. Thus a
3IP nucleus, which has one unpaired neutron, also has a spin quantum number of/2. It
is the spinning of the 31P nucleus, which acts like a single charged particle, that creates
the small intrinsic magnetic field. The magnitude and direction of this field are
described by a vector called the magnetic moment.
When a compound containing 3IP is placed in a strong magnetic field, the
magnetic moments of the spinning jlP nuclei can align in only two directions: with the
direction of the applied field (parallel), or opposed to the direction of the applied field
(antiparallel) (see Figure 3.1a). The nuclei which have magnetic moments that adopt a
parallel alignment have slightly lower energy than those with magnetic moments
showing antiparallel alignment. Thus slightly more than half of the nuclei will have
their magnetic moments in the parallel state. It is only the magnetic moments of the
nuclei, and not the molecule as a whole, that become aligned with the field. The two
states are separated by an amount ofenergy AE, as shown in Figure 3.1b, which
depends upon the strength of the magnetic field and the size of the nuclear magnetic
moment.
The spin properties of the nucleus, however, slightly complicate this situation.
Thus, instead of aligning directly with or against the direction of the field, the
magnetic moment vector precesses, that is it rotates about the external field direction
whilst tracing out the shape of the surface of a cone (see Figure 3.2). The frequency
of this precessional rotation of the magnetic moment is called the Larmor frequency,
and the magnetic moment vector can adopt either a low energy, 'spin-up' state, or a
high energy, 'spin-down' state.
The magnetic moment of a particle, p, is related to its angular momentum, J,
by a fixed constant called the gyromagnetic ratio, y:
p = yj 3.1












Figure 3.1. a: The two pennitted alignments for spin states of spin 1/2 nuclei
within a strong applied magnetic field, b: Energy levels of a spin 1/2 nucleus
in a magnetic field. The two permitted orientations of the nuclear magnetic




Figure 3.2. Precession of the magnetic moment vector, p, of a
particle or nucleus with spin quantum number 1/2 about a magnetic
field, B0. p traces out the surface of a cone, with a half-angle, 9, of
55°. (a) Low-energy configuration, the 'spin-up' state; (b) High-
energy configuration, the 'spin-down' state.
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When a particle is placed in a magnetic field, the Larmor precessional
frequency of the magnetic moment vector, v0, varies with the external field strength,
B0, according to the following equation:
An electromagnetic wave may be regarded as a varying electric field coupled
with a varying magnetic field that are at right angles to each other and to the direction
of travel (see Figure 3.3). If electromagnetic radiation is directed towards a particle
that is in a strong magnetic field, the magnetic component of this radiation will affect
the motion of the particle. Thus the magnetic moment of the particle will now attempt
to precess about both external magnetic fields, and the second magnetic vector will
induce a wobbling in the original direction of precession. Moreover, if the magnetic
vector of the electromagnetic radiation is linearly polarised and is perpendicular in
direction to the original magnetic field, and if its frequency is equal to the Larmor
frequency of the particle's magnetic moment, then the magnetic moment of the
particle will attempt to rotate in phase with a circular component of this wave (see
Figure 3.4). (Linearly polarised electromagnetic waves may be perceived as being
composed of two circularly polarised components, which are described by a helical
wave which rotates clockwise and an identical wave rotating anticlockwise). Quantum
mechanics, however, will allow only two orientations of the particle's magnetic
moment with respect to either magnetic field. Thus the particle's magnetic moment
cannot precess about either magnetic field; instead, when the frequency of the
electromagnetic radiation equals the Larmor frequency, a few of the lower-energy,
parallel 'spin-up' nuclei absorb energy and switch their spin states from the lower-
energy, parallel state to the higher-energy, antiparallel "spin-down' state (see Figure
3.2). This conversion is called a 'flip'. The higher-energy, antiparallel nuclei can also
lose energy to their surroundings and return to the parallel state. At the frequency that
causes 'flips', the nuclei are said to be in resonance with the radiation, hence the
origin of the term 'Nuclear Magnetic Resonance'.
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Figure 3.3. A linearly polarised electromagnetic wave with direction of
propagation z. M represents the magnetic component, and oscillates in
the zy plane; E represents the electric component, and oscillates in the zx
plane. M and E are at right angles to each other, and the energies associated
with M and E are equal.
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Figure 3.4. Relationship between the magnetic moment vector, p., of
a particle and the magnetic vector of a linearly polarised
electromagnetic wave, Bj. At the Larmor frequency, p and a circular
component ofBj rotate in phase.
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The exact frequency of electromagnetic energy that is required to produce
resonance depends mainly upon the strength of the applied field and the isotope being
studied (see Equation 3.2). For a given field strength, the resonance frequency is
determined principally by the type of nuclide under observation, since every nucleus
has a characteristic magnetic moment. In addition, the resonance frequency also
depends to a slight extent upon the chemical environment of a nucleus in a molecule.
31P nuclei in an organic molecule are surrounded by electrons. Under the
influence of a strong external magnetic field these electrons circulate within their
orbitals, leading to the creation of tiny magnetic fields, called molecular fields. The
molecular fields oppose the externally applied field. This means that the actual
magnetic field strength at the location of a 31P nucleus in a compound will be slightly
less than the applied field strength. The 31P nucleus is thus said to be 'chemically
shielded' from the applied field by the local molecular field of the molecule, and the
resultant change in the resonance frequency of the nucleus is called the 'chemical
shift'.
The molecular magnetic field of a compound will vary within its structure,
since the electron density varies from one part of the molecule to another, depending
upon the chemical bonding present. The molecular axis which has the lowest electron
density will, for example, produce the least chemical shielding, and will result in the
smallest chemical shift.
Other factors affect the amount of shielding that a 3IP nucleus experiences.
The electron density of the bonds near a jlP nucleus can be altered by the presence of
other atoms within the molecular structure. Thus a nearby electronegative atom will
withdraw electrons from the vicinity of the 31P, which will cause a decrease in the size
of the induced molecular magnetic field. Consequently the size of the applied
magnetic field that is required to induce flip in the spin state of that 31P nucleus is
reduced, and that 31P nucleus is 'deshielded' to some extent. This will cause a
'chemical shift' in the opposite direction to that produced by chemical shielding.
The particular arrangement of bonds and other atoms around a 31P nucleus
will thus produce an overall combined effect upon the resonance frequency of this
nucleus. Different31P nuclei will therefore experience slightly different magnetic fields
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depending upon their location within the molecule, and will come into resonance at
slightly different combinations ofapplied magnetic field strength and radio frequency.
The resulting signals are plotted to produce a spectrum. Since, in practice, it is
impossible to obtain a spectrum from an isolated nucleus, the resulting chemical shifts
are expressed in fractional units (parts per million, ppm) relative to a standard
compound, which is normally the methyl resonance of tetramethylsilane (since proton
NMR was the first type ofNMR performed, most spectrometers are calibrated for
•H).
A phosphorus atom that exists as part of a phosphate diester, for example the
phosphorus within a phospholipid molecule, has an anisotropic electron distribution
(see Figure 3.5). This will lead to anisotropic chemical shielding, and thus an
anisotropic chemical shift. By defining three principle axes, 011,022 and 033, it is
possible to calculate the chemical shift for any orientation of a phosphate diester
within a magnetic field (see Figure 3.5a). However, in order to perform this
calculation, a knowledge of the chemical shift values for all three reference axes
would be required. This three-dimensional character of the chemical shift is called the
'chemical shift tensor'. The recorded lineshape, or 'powder pattern', for a rigid solid
represents the superposition of all possible orientations for a phosphate diester within
a sample, with a 1 iand 033 defining the extreme edges of the spectrum, and ct22 a single
intermediate peak. Measurements of these principle elements of the chemical shift
tensor have been made for phospholipids in dry powders. Such a powder pattern is
shown in Figure 3.6a. Moreover, the relationship between the three principle elements
of the chemical shift tensor and the molecular coordinates of the phosphate has been
determined in crystals oforganic phosphodiesters (Kohler and Klein, 1977).
The first 31P NMR studies ofmembranes were performed in 1972 (e.g. Barker
et al, 1972; Horwitz and Klein, 1972). As in the rigid phosphate diester, there is
anisotropic shielding of the phosphorus nuclei from the applied magnetic field due to
the anisotropy in the local electron distribution around the phosphorus nucleus. This
results in chemical shift anisotropy. Thus the resonance frequency of a phosphorus
atom will depend upon the angle between the phosphate region of the lipid headgroup
and the magnetic field. However, biological membranes are not rigid structures: they
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Figure 3.5. The principle axis system for phosphate diesters, as found
in lipid systems, a) a rigid phosphate diester and b) a phosphate diester,
such as is found in a phospholipid, undergoing rapid rotation about the
long axis of the molecule, whilst the rotational axis simultaneously
wobbles with restricted amplitude. The expected corresponding 31P NMR
spectra are shown.
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are sufficiently fluid to allow considerable translational, rotational and flexing
movements of the constituent phospholipid molecules. This will alter the chemical
shielding in comparison to the shielding under static conditions, and hence the
chemical shift. Rapid motion will average some of the chemical shift tensors. As an
example, if rotation occurred about the <733 axis, then the cii 1 and cr22 axes would be
averaged; this would produce the lineshape shown in Figure 3.5b. The resulting
powder spectrum will display a maximum intensity for the axis of rotation that is
perpendicular to the magnetic field (o±) whilst the least intense end of the spectrum,
or shoulder, represents the chemical shift when the axis of rotation is parallel to the
magnetic field (a//) (Tilcock et al, 1986). A reduction in the chemical shift anisotropy
occurs when the rotational axis itself undergoes a wobbling motion, resulting in partial
averaging of 0|_ and <7// (Seelig et al, 1977). The extent of the reduction is a direct
measure of the amplitude ofmotion. Thus it can be seen that the resultant 3IP NMR
lineshapes are determined by the extent ofmotional averaging, on the 31P NMR time
scale, of the chemical shift anisotropy of the 31P atom present in the phospholipid
headgroup. This, in turn, is directly influenced by the amount ofmotion possible
within the phospholipid dispersions: the greater the motion, the narrower will be the
NMR lines. Moreover, the characteristic lineshapes which are observed for the
different lipid phases can be readily predicted from the motional averaging that exists
in that particular structure (Yeagle, 1989).
Within a given lipid phase, the phospholipid molecules diffuse about rapidly,
subject to the constraint that the headgroups move within the lipid-water interface.
Thus in a lamellar phase, the constituent phospholipids can diffuse laterally within the
plane of the membrane. If the lamellar systems are large enough, the lateral diffusion
will not produce significant motional averaging. However, the molecules can also
rotate and flex, and these movements are characterised, on average, by cylindrical
symmetry, with the bilayer normal as the axis ofmotional averaging. This rapid
rotational motion along the long axis of the phospholipid molecule averages two of
the chemical shift tensors. This motion is believed to originate from motion around
the P/ODAG bond (see Figure 3.5b). Translational diffusion perpendicular to the
membrane surface is severely restricted by the hydrophobic effect. The hindered
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movements of the phospholipid molecules are therefore 'anisotropic': correlations
exist between the initial and final orientations of the phospholipid molecules over the
10 5s time scale of an NMR measurement. This anisotropy ofmovement is reflected in
the resultant chemical shielding anisotropy, such that the static chemical shielding
anisotropy is partially averaged out. Thus the observed maximum resonance for the La
phase in a spectrum is asymmetric (see Figure 3.6), and occurs about 12-15ppm from
zero. The width of the recorded powder pattern, which is the spectrum obtained for a
random dispersion ofmembranes, and which represents the weighted sum ofmany
spectra for all possible molecular orientations, represents the degree of chemical
shielding anisotropy present. Thus an increase in the width of a powder pattern
represents an increased restriction ofmotion of the phospholipid headgroups. Often
there is a gradual decrease in the chemical shift anisotropy with temperature. Thus the
axis of rotation wobbles more at higher temperatures, as expected.
The Hn phase has cylindrical symmetry, and these cylinders tend to be small in
diameter. As an example, if the diameter of the Hn aqueous pores is about 2nm, and
the diffusion coefficient for lateral diffusion is assumed to be about 10"8cm2s~ , then a
phospholipid molecule can circumnavigate an Hn cylinder in about 10"6 seconds
(Yeagle, 1989). This is rapid when compared to the width in Hz of the 31P powder
pattern in the lamellar phase. Thus an additional motional averaging occurs for the
chemical shift tensor compared to that of the lamellar phase, and if all other factors
remain constant, the transition from La to Hn reduces the width of the powder pattern
by half (see Figure 3.6). The shape of the powder pattern is also reversed. Thus the
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maximum resonance for Hn occurs about 6ppm from zero on the spectrum. P NMR
lineshapes for hexagonal phases do not distinguish between the Hi and the Hn phases.
However, since the Hi phase occurs only when lysolipids are present at high lipid
concentrations, this does not present a real problem.
Finally, if phospholipid motion through all orientations with a short correlation
time (~10~5 sec; Gruner el al, 1985) is possible, in other words in a structure where
the molecules can tumble rapidly through all angles of space, then an isotropic narrow
31P NMR resonance is obtained, which is centred on zero in the spectrum, (see Figure
3.6), and no powder pattern is seen. Structures giving rise to isotropic 31P NMR
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Figure 3.6.31P NMR spectra for various aqueous dispersions of
phospholipids: bilayer, hexagonal and isotropic.
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resonances are themselves termed 'isotropic', but this term encompasses several
different structures. There are at least five different possibilities:
1. a solution phase, with the phospholipid dissolved in organic solvent.
2. a micellar phase; micelles are small enough to have a rotational correlation time that
is shorter than 10"6 sec (Yeagle,1989).
3. SUV; their rotation is fast enough to satisfy the requirement.
4. a cubic phase; cubic phases consist of a series of short rods connected at right
angles which resemble the Hn phase. Thus phospholipids diffusing from one segment
to another will experience 90° of rotational freedom. Moreover, since the lengths of
the segments are similar to their diameters, normal lateral diffusion rates of
phospholipids are adequate to provide sufficiently rapid movement through the 90° of
rotational freedom to produce isotropic resonance.
5. An inverted micellar phase; this was postulated to coexist within the phospholipid
bilayer, and has been described as an IMI in fusion (e.g. Siegel, 1984). The structure
offers rapid rotational freedom through lateral diffusion around the inverted micelle.
The details of this structure have still not been adequately demonstrated experiment¬
ally.
It can be seen, from the explanations above, that the averaged lineshape for
the 31P resonance is indirectly related to the phospholipid phase present; it is
dependent upon the local environments of the phosphorus atoms within the lipid, and
the motion available to them in a given lipid phase. Thus the observed 3IP lineshapes
do not have unique relationships with particular phase structures. For example, the
inability of 31P NMR to distinguish between the various possible sources of isotropic
resonances does represent a weakness. Low angle X-ray and neutron diffraction
studies are the definitive techniques for identification of lipid phase structure.
However, these techniques require a regular lattice that exhibits long-range order if
one is to obtain the higher order reflections that are required for unambiguous phase
assignment. One advantage of 31P NMR is that it does not require a regular lattice
exhibiting long-range order. The question of the 'phase' of nonperiodic structures has
been addressed by applying 31P NMR to periodic structures for which X-ray
diffraction has been performed and the identity of the physical phase present is thus
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clear. Extrapolation is then carried out, by asserting that, since 31P NMR is sensitive
to the microscopic constraints of the structures, and not to the lattice on which these
structures are placed, these characteristic 31P NMR lineshapes may be used to indicate
the presence of the microscopic structures even when no lattice is present. This
procedure is valid, as long as tests for self-consistency are continually applied.
An extensive study performed by Tilcock and co-workers (1986) to determine
the extent of the correlation between determinations of lipid phase by 3IP NMR and
small-angle X-ray diffraction techniques showed that this correlation is in fact
excellent. Thus their results strongly support the use of J,P NMR as a convenient
diagnostic technique for detecting phospholipid phase structures in model and
biological membranes.
3.3 Practical Considerations for 31P NMR
There are three essential requirements for an NMR experiment: a strong static
magnetic field, a source of radiofrequency radiation to excite the nuclei in the sample
and a method for detecting the NMR signal.
The magnetic field used should be as strong as possible. This will optimise
sensitivity, maximise the separation of chemical shift differences and minimise strong
coupling effects. A superconducting solenoid, which is a coil of resistance-free alloy
that supports a persistent current, is often used, since it can produce a strong,
homogeneous and stable magnetic field. Spinning the sample, at rates ofup to 50Elz,
helps to average any non-uniformities in the magnetic field and yields sharper
resonances.
The electromagnetic radiation is usually generated by passing a sinusoidally
oscillating current through a coil arranged around the sample, which sits inside the
magnet. The electrons circulating in the coil generate an oscillating electromagnetic
field whose magnetic component excites the sample, provided its frequency equals the
Larmor frequency of the 3,P atoms present in the sample. Radio frequency waves are
used for 3IP NMR, since they are the correct frequency to induce 3IP nuclear magnetic
resonance. During resonance the 31P nuclei flip to the spin-down state. Thermal
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fluctuations within the sample and random magnetic interactions result in the
continual return to the spin-up state. Thus the sample continually absorbs and re-emits
radiofrequency radiation, and the re-emitted radiation induces an alternating current in
a suitably placed receiver coil. This current is then amplified to produce the NMR
signal.
The most common type of 31P NMR performed nowadays is the pulse NMR
technique, or Fourier transformNMR spectroscopy (FT-NMR). In this method, a
short, intense burst of radiofrequency radiation is applied to the sample to induce
resonance. The resulting oscillating magnetisation is detected as a function of time
after the end of the pulse, and is processed in a computer to produce the final
spectrum. The NMR probe holds and spins the sample, couples the radiofrequency
field to the spins, and picks up the ensuing NMR signal. After amplification, the NMR
signal from the probe is mixed with a reference voltage, which is of the same radio
frequency as the pulse that was used to excite the spins. This results in subtraction of
the reference frequency from the NMR signal to produce an audiofrequency voltage
which is further amplified, digitised and processed in the computer. Fourier transform
is used to analyse the signal, or free induction decay. The signal is the sum of the
individual oscillating voltages from the various nuclei in the sample. Thus the
individual components that make up the spectrum are determined. FT-NMR is much
more rapid and sensitive than the older, continuous sweep NMR methods, and the
signal-to-noise ratio is greatly improved.
One problem that exists for 31P NMR experiments on lipid membranes is that
'H, which is intrinsically magnetic, accounts for 99.98% ofnaturally occurring
hydrogen atoms (Fessenden and Fessenden, 1990). This nucleus can affect the
response of the 31P nucleus to the external magnetic field, and thus result in spectral
distortion. One way ofovercoming this problem is to employ spin decoupling. Spin
decoupling uses the technique of simultaneously transmitting an intense beam of radio
frequency radiation which has a frequency equal to the Larmor frequency of the
unwanted 'id nuclei. These nuclei then flip at too fast a rate for the 31P nuclei to detect
their orientation, and thus the resulting spectrum will not be distorted by the presence
of the 'H nuclei. This means that the signals for each group ofmagnetically-equivalent
124
phosphorus nuclei will appear as singlets, unsplit by any protons that are directly
bonded to these nuclei.
A spectrum is a graph of the intensity of the absorption (in practice usually re-
emission) of radio waves versus the delta values, where 1 delta value is one part per
million of the instrument's radio frequency. Thus for an instrument operating at
60MHz, 1 delta is equal to 60Hz. A standard sample is used to set delta to zero: this is
usually tetramethylsilane (TMS). This allows the comparison ofNMR spectra, which
have been obtained using different instruments. The difference in delta values from
zero to each signal represents the chemical shift.
Since it is the shape of the powder pattern which is sensitive to the
morphology of the phospholipid molecules within the sample, it is very important to
obtain undistorted spectra in order to interpret results correctly. The commonest
problem in 31P NMR studies ofmembranes is indeed spectral distortion, which makes
lineshape interpretation both difficult and uncertain. The study ofphospholipids in the
liquid crystalline state and the use ofhigh magnetic fields mean that obtaining
conditions for adequate 'H decoupling is generally not too difficult. However, lipid
membranes produce broad powder patterns: as wide as 200ppm for an amorphous
phospholipid sample, which means that the decay of the signal in the time domain is
rapid. Single-pulse acquisition experiments can lead to a loss and/or distortion in the
first portion of the time domain, which is where the majority of the information on the
lineshape usually resides. As a rule these distortions cannot be removed by further
processing of the data. However it has been shown that, by using a simple Hahn echo
pulse sequence, along with extensive phase cycling, spectral artefacts can be avoided
(Ranee and Byrd, 1983).
The initial part of the spectrum is usually missed; this is because of receiver
dead time. A two pulse system can be used to overcome this problem. The second
pulse causes a complete refocusing of the nuclear magnetisation (providing that there
are no irreversible effects from application of the first pulse). Thus the signal starting
at the peak of the echo is identical to the signal following a single pulse, and by having
the echo form beyond the receiver dead time following the second pulse, it is possible
to avoid distortions due to finite recovery time. This principle is used to generate a
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'Hahn echo', and Fourier transforming the signal starting at the peak of the echo will
provide an undistorted spectrum (see Figure 3.7). The echo time must be short
relative to the spin lattice relaxation times of the resonances being measured. The
pulse widths should also be adequate to excite the full extent of the expected powder
pattern. In practice, data acquisition should start prior to the echo maximum, and then
after signal averaging is complete, a point is chosen which should represent the start
of the Fourier transform. Usually the software performs this task.
3.4 Application of 3IP NMR to Fusion Studies: Aims of these 3IP NMR
Experiments
Many lipid systems that exhibit the classical thermodynamic La and Hn phases
also exhibit other distinct morphological states between these two phases. These have
• • • 31been correlated with cubic phase X-ray diffraction patterns, isotropic P NMR
signals, and/or lipidic particles/interbilayer attachment sites using FFEM (e.g. Luzzati
and Reiss-Husson,1966; Cullis and de Kruijff, 1978; Verkleijj et al, 1979; Larsson et
al, 1980; Tilcock et al, 1982; Verkleijj, 1984; Gagne et al, 1985). Since biomembrane
lipid compositions are not far from the La/inverted cubic(Qn)/Hn phase boundaries
under physiological conditions, intermediates that form in these phase transitions may
be relevant to biological membrane fusion.
In view of these findings, experimental evidence was sought to link the fusion
pathway to the production of isotropic lipid states. Gagne et al (1985) showed that
the phospholipid N-Monomethyldioleoylphosphatidylethanolamine (MeDOPE)
existed in the La phase below 20°C, in the Hn phase above 70°C, and showed
isotropic NMR resonances at intermediate temperatures. Ellens et al (1986)
correlated the initial kinetics of fusion between pure MeDOPE lipid vesicles with the
development of isotropic states by this lipid. They found that, at temperatures where
MeDOPE produces isotropic 31P NMk resonances, the initial rates of fusion between
MeDOPE LUVs increase. Thus at 20°C the initial rate of fusion between MeDOPE
vesicles was very slow: ~l%/min, whereas at 60°C, the temperature at which first
isotropic structures were first observed, the initial fusion rate abruptly increased to a
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Figure 3.7. Schematic diagram to show the principle behind the
two-pulse Hahn echo sequence. The dashed lines following the
pulses represent receiver dead time. The start of the echo is marked,
and can be seen to be identical to the original signal produced by
the first pulse.
127
much higher value: ~5%/sec. Furthermore, the amount of isotropic 31P NMR
resonance present in the 31P NMR spectrum has been directly correlated with the rate
ofmembrane fusion between MeDOPE vesicles (Yeagle et al, 1992). Other
experimental work with pure lipid systems has also suggested that isotropic structures
may be intermediates in lipid membrane fusion (e.g. Ellens et al, 1984; Ellens et al,
1989; Siegel et al, 1989a).
As regards viral fusion mechanisms, Kelsey et al (1990) found that Sendai
virus could fuse with pure MeDOPE vesicles, but not with pure egg PC LUVs (in the
absence of receptors for HN, the Sendai virus fusion protein); egg PC is not capable
of forming isotropic lipid structures. Work with the fusion peptides from SIV (Epand
et al, 1994) and Influenza virus (Epand and Epand, 1994) has showed a large increase
in the amount of isotropic resonance ofMeDOPE in their presence.
3IP NMR is particularly useful for the detection ofnon-bilayer structures that
might be important to the fusion event. Because of the narrowness of the 3IP NMR
resonances, it is possible to observe such components when they arise from as little as
a few percent of the total phospholipid. 3IP NMR does not depend upon ordered
arrays of lipid molecules, so it can detect some isotropic structures which are not
readily apparent by X-ray diffraction. This is important, as a complete model of fusion
requires as much knowledge of transient fluctuations as of the equilibrium
configurations of the constituent phospholipid molecules. It also does not depend
upon representative sampling, as does electron microscopy for example, since it is
sensitive to all the phospholipids in the sample. Since DSC rarely shows evidence of
cubic phases, because of the long incubation periods necessary for the appearance of
macroscopic amounts of this phase and the small enthalpies involved, 31P NMR is
much more suitable for examination of the cubic phase pathway. This is illustrated by
the results of van Gorkom et al (1992), who showed that DSC studies with MeDOPE
and the fusion promotor DAG, which together produce 3IP NMR isotropic
resonances, could not detect the formation of isotropic lipid states unless a very slow
scan rate was used.
The aims of the experiments described in this chapter were, first, to determine
the effects of the FeLV fusion peptide on lipid polymorphism, as observed by 3IP
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NMR, in particular any changes in the formation of the isotropic state, and therefore,
second, to provide support for a link between the pathways for the formation of cubic
phases and the fusion mechanism.
3.5 Materials and Methods
3.5a Sample Preparation
MeDOPE and DiPoPE were purchased from Avanti Polar Lipids (Alabaster,
AL, USA). Purity was confirmed by Thin Layer Chromatography, which showed a
single spot for each. MeDOPE forms irregular, nonlamellar structures, which produce
an isotropic resonance over a wide range of temperatures using 31P NMR (e.g. Gagne
et al, 1985; Ellens et al, 1986), so it is a good choice for jlP NMR studies of the
effects of fusion peptides on lipid polymorphism. Previous X-ray studies have shown
that DiPoPE does not form detectable amounts of inverted cubic phases when heated
through Th (Colotto et al, 1996; Colotto and Epand, 1997), and thus the pure lipid is
not as well suited to NMR studies of isotropic signals as MeDOPE (see Discussion
section on cubic phase formation). However, the effect of the FeLV fusion peptide on
the polymorphism ofDiPoPE is of interest, particularly for comparison with the
results obtained in the DSC and X-ray diffraction experiments, in which DiPoPE was
studied (see Chapters 2 and 4).
Preparation of lipid and lipid/peptide films was as described in Chapter 2,
except that the lipid concentration was 50mg/ml. One disadvantage of 31P NMR is
that it does require quite large amounts of lipid: the sample must be large enough to
provide an adequate signal-to-noise ratio in the time allotted for acquisition of data.
Dispersions ofMLVs were thus formed, as described in Chapter 2. These are much
more suited to NMR experiments than biological membranes, since the
multimolecular structures can pack much more closely. The high lipid concentration
also aids the formation ofnon-bilayer phases. The lipid/peptide molar ratios were
100:1 or 200:1 for the peptide-containing samples.
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Care must be taken as the lamellar to Hn phase transition exhibits considerable
thermal hysteresis. The starting point for a thermal study must, therefore, be carefully
established. This necessitates several ffeeze-thaw cycles of the lipid sample, in order
to produce a reproducible starting lamellar phase structure, before commencing the
study at the temperature of interest. Thus, prior to commencing the measurements,
the samples were subjected to three ffeeze-thaw cycles. This was achieved by
immersing them in liquid nitrogen for two minutes, and then holding them under a
running cold water tap until they thawed. This also ensured that that full hydration of
the dry MeDOPE and DiPoPE had occurred.
Finally, the suspensions were vortexed vigorously to produce a thick lipid
paste, and loaded into 5mm diameter thin-walled NMR tubes.
3.5b 31PNuclearMagnetic Resonance Spectroscopy
A Bruker drx500 spectrometer, operating at a frequency of 202.45 MHz with
broad band proton decoupling, was used to obtain the spectra. Gated proton
decoupling was employed during data acquisition only, to eliminate sample heating.
Other spectral parameters were: sweep width (the range of frequency values over
which the spectra are measured), 48.5 KHz; time domain, 32,768 data points, and
acquisition time (the measuring time of the signal), 0.34s.
Samples were heated in 5°C steps in the temperature regions near to TH, and
in 10°C steps elsewhere. After raising the sample temperature an equilibration time of
approximately 15 minutes was used before starting measurements. Fast temperature
equilibration was obtained by using small volumes. The temperature was then
maintained to within ± 0.1 °C by a Bruker B-VT 1000 variable temperature unit,
which uses liquid nitrogen for lower temperatures and nitrogen gas flow for
temperatures above 45°C. It is very important when conducting heating experiments
that samples are kept below each temperature of interest prior to measurement. If the
lipids are heated above the required temperature and then recooled lipid can become
trapped in a cubic phase, and this phase may persist even after lowering the
temperature to well below that at which cubic phase appears on sample heating.
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100 scans were collected for each measurement. A relaxation delay of 3
seconds was used between scans. This is long enough to ensure that there is no
attenuation of some of the resonances present. The spin lattice relaxation time for
phospholipids is fairly similar, regardless of the headgroup structure or the lipid
morphology present, so a constant delay time can be used throughout the experiment.
Prior to Fourier transformation of the signal, exponential line-broadening of 100Hz
was applied. The standard substance used to calibrate the spectrometer was
phosphoric acid, and thus the resonance from this compound represented Oppm on the
spectra obtained for the samples.
3.6 3IP NMR Results and Discussion
Figure 3.8 shows the 31P NMR powder patterns obtained for pure MeDOPE,
and MeDOPE plus FeLV fusion peptide over a range of increasing temperatures. The
lipid dispersion ofpure MeDOPE at 40°C shows a 31P NMR powder pattern that is
indicative of a liquid-crystalline bilayer arrangement with axially symmetric motions.
In the pure lipid, the formation of an isotropic signal was not observed until 50°C.
(The lamellar, isotropic and hexagonal spectral components overlap if they appear
concurrently). The amount of isotropic phase increases with increasing temperatures.
At 55°C and above, a powder pattern indicative of a hexagonal phase is also seen.
The temperature at which isotropic resonances are first seen, Ti, depends upon
the history and age of the sample and the purity of the synthetic lipid. Hydrophobic
impurities, lipid degradation products and incomplete hydration lower Ti significantly.
Data reported here were obtained with fresh lipid suspensions which were fully
hydrated by freeze-thaw cycling and by an equilibration period after each temperature
increment. In the literature, there is a large discrepancy with regard to Ti. However,
the 31P NMR spectra obtained depend upon the experimental conditions present, and
especially upon the temperature equilibration around the La-Hn phase transition. Thus
some of the differences in the reported results are likely to arise from systematic






























Figure 3.8.31P NMR spectra ofpure MeDOPE, and samples
containing different molar fractions of the FeLV fusion peptide, as a
function of temperature. Only the pH 7.4 data are shown, but the pH
5.0 results were qualitatively similar.
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experiments described here, and thus any differences in lipid polymorphism should be
attributable to the effect of the fusion peptide.
In the presence of the FeLV fusion peptide, Ti is lowered. There is also a
direct correlation between the molar fraction ofpeptide present and the amount of
isotropic signal seen at 40°C. It can also be seen that, with FeLV fusion peptide
present, a larger percentage of the lipid remains in the isotropic state over the full
range of recorded temperatures. At 82°C, a small amount ofMeDOPE with FeLV
peptide has converted to the Hn phase, whereas by 75 °C, the pure lipid already has a
larger Hu signal. No significant differences were found between the pH 7.4 and the pH
5.0 data.
Figure 3.9 shows the 31P NMR powder patterns obtained for pure DiPoPE,
and DiPoPE plus FeLV fusion peptide as a function of temperature. The pure DiPoPE
samples show a direct transition from the lamellar to the hexagonal phase; there is no
significant isotropic peak at any of the recorded temperatures. In the presence of the
FeLV peptide, however, a substantial isotropic component is seen throughout the
entire recorded temperature range. Only pH 5.0 data are shown, but the pH 7.4
results were qualitatively similar.
These results clearly demonstrate the promotion of the formation of lipid
isotropic states by the FeLV fusion peptide, in two different lipid systems and at pH
5.0 and pH 7.4. These findings agree with previous work using known viral fusion
peptides. Epand and co-workers (1994) showed that the wild type fusion peptide
from SIV enhanced the production of isotropic signals by MeDOPE, whereas these
structures were formed much less readily in the presence of a non-fusogenic peptide
mutant, SIVmutV. Similar work with the Influenza virus fusion peptide (Epand and
Epand, 1994) showed that the wild type fusion peptide promoted the formation of
isotropic lipid structures by MeDOPE at pH 5.0, the fusogenic pH for this virus. Two
mutant fusion peptides, with Glu for Gly substitutions in position 1 or position 4 of
the peptide, induced much less isotropic signal in MeDOPE at pH 5.0 than that
obtained in the presence of the wild type fusion peptide. Moreover, the El mutant,
which is known to induce the least membrane destabilisation of the two mutants, as




















Figure 3.9. P NMR spectra ofDiPoPE alone, and in the presence of a
100:1 molar ratio of lipid:FeLV peptide. Only pH 5.0 data are shown but
the pH 7.4 results were qualitatively similar.
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contents (Rafalski et al, 1991), was also found to induce the smallest amount of
isotropic resonance at pH 5.0. Yeagle et al (1991) showed that the presence of the
Measles virus fusion peptide at a lipid:peptide molar ratio of200:1, or 0.5mol%
peptide, significantly facilitated the formation of isotropic J,P resonances by
MeDOPE. Furthermore, at a lipidrpeptide molar ratio of 100:1, the effect was even
greater: Ti dropped by about 30°C. In this same study, the Measles virus fusion
peptide was also shown to enhance the initial rates of fusion between Sendai virus and
MeDOPE LUVs by about 30%, at the lower peptide concentration of 0.5mol%.
Comparable findings have occurred for studies of other known fusogens. Thus
the addition ofDAG to PC bilayers (Dawson et al, 1984) or to PC:PE: cholesterol
mixtures (Basanez et al, 1996) was seen to induce isotropic 31P NMR signals. Siegel
et al (1989a) studied the effect ofDAG on MeDOPE polymorphism and fusion
between MeDOPE LUVs, and found that 2mol% DAG could lower both Ti and the
temperature for the onset of fast membrane fusion by 15-20°C. Similar results were
obtained by van Gorkom et al (1992). Epand and co-workers (1993) studied the
peptide fFGOBz, which promotes fusion between MeDOPE vesicles. This peptide
was, in addition, found to promote the formation of isotropic states in MeDOPE, both
by lowering Ti and by increasing the relative intensity of the isotropic signal at
temperatures of 45°C and higher.
The relationship between the fusion pathway and the formation of isotropic
lipid states has been further endorsed by work with known fusion inhibitors. Thus a
jlP NMR study of LPC, which inhibits fusion between MeDOPE LUVs and between
Sendai virus and MeDOPE LUVs, showed that it also stabilised the lamellar lipid
phase and reduced the formation ofnon-lamellar structures throughout the entire
studied temperature range (Yeagle et al, 1994). Furthermore, LPC was seen to
suppress the increased formation of isotropic resonances induced in MeDOPE by the
SIVwt fusion peptide (Epand et al, 1994), and to counteract the promotion of the
isotropic state in PC:PE:cholesterol by DAG (Basanez et al, 1996). As another
example, the peptide ZfFG is a potent anti-Measles agent (Richardson et al, 1980),
which inhibits fusion between MeDOPE vesicles, and also Sendai virus fusion with
human red blood cells (Kelsey et al, 1991). Kelsey and co-workers (1990, 1991)
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correlated this inhibition of fusion with the inhibition ofnon-bilayer phase formation:
ZfFG was seen to decrease the relative intensity of the isotropic 31P NMR resonances
ofMeDOPE by broadening the resonance, over a wide range of temperatures.
It is, therefore, clear that some connection exists between the formation of
isotropic lipid states and the fusion pathway, at least in certain lipid systems. The
studies described above use lipids that have a nearby Hn boundary, and the connection
between fusion and isotropic structure formation is also only valid for systems which
show jlP isotropic resonances on the first heating scan.
Factors that determine the relative stability of bilayer and non-bilayer phases
are the intrinsic radius of curvature of each monolayer of a bilayer, and the
hydrocarbon packing constraints (Gruner, 1985; Siegel et al, 1989a) and energy
contributions of the hydrophobic void spaces (Siegel, 1993) for the different
structures present. An increase in the isotropic resonance of a lipid may represent a
decrease in the effective radius of curvature of the existing lipid structures, since a
reduction in 31P NMR linewidth is due to an increase in the motional averaging of the
chemical shift anisotropy. Support for this change in monolayer curvature comes from
work by Kelsey et al (1991), who found that the fusion inhibitor ZfFG hindered the
formation ofSUV, which are structures of small radius of curvature. Similarly, Yeagle
and co-workers (1992) also found that ZfFG appeared to destabilise lipids in
structures with a negative radius of curvature. Yeagle et al (1994) also showed that
LPC, which inhibited Sendai virus fusion, also stabilised the bilayer phase and reduced
the formation of all non-lamellar structures. Thus they, too, concluded that at least
some of the intermediates in Sendai virus fusion must contain lipid surfaces with a
small radius of curvature. Finally, DAG, which promotes membrane fusion and
isotropic state formation, is thought to increase the relative volume of the
hydrocarbon region of phospholipid molecules, since unsubstituted glycerol
headgroups are known to partition preferentially into the hydrocarbon region (Gulik
et al, 1988), with their hydroxyl groups positioned at the membrane surface
(Hamilton et al, 1991a, 1991b). Thus DAG should increase the monolayer negative
curvature, as discussed in Chapter 1. It should be noted that it is theoretically possible
that the decrease in the observed NMR linewidth could result from either a decreased
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diffusion rate between the isotropic structures and the bilayer, or an increased
diffusion rate within the isotropic structures. It is hard, however, to envisage how
such dynamic alterations would cause a decrease in the observed rate ofmembrane
fusion.
The isotropic state may represent a kinetically hindered transition to the Hn
phase (Ellens et al, 1986). It is also thought to represent the first step in the formation
of inverted cubic phases (Ellens et al, 1989). Lipids with 'intermediate' values of
spontaneous radius of curvature, such as MeDOPE, can form cubic phases, which
have space groups of Im3m and Pn3m, as seen by X-ray diffraction (Gruner et al,
1988; Siegel and Banschbach, 1990). It is unlikely that ordered cubic phases are
intermediates in the fusion pathway, since fusion intermediates are isolated structures,
not phases (Yeagle, 1994), and cubic phases have extreme kinetic stability (Gruner et
al, 1988). It has, however, been suggested that fusion intermediates may resemble
intermediates formed on the pathway to cubic phase formation (Siegel & Epand,
1997). Thus the observed 3IP NMR isotropic states may represent disordered bilayer
intermediates or regions of cubic phases that lack long range order, and the
metastability of these molecular intermediates may cause fusion.
Theoretical predictions suggest that all lipid intermediates form between
apposed bilayers in the La phase. It has been suggested that the formation of cubic
phases may occur via high-curvature intermediates such as ILAs (Siegel 1986a;
1986b), which are catenoidal bilayer connections between apposed La lamellae (see
Figure 3.10). ILAs should yield isotropic 3IP NMR resonances and 'lipidic particle'
morphology in FFEM micrographs. Inverted cubic phase formation can occur then
once a large number of ILAs are present within a bilayer. As the ILAs increase in
number they automatically form a lattice with the same periodicity as one of the
infinite periodic surface-based Qn phases. Formation of Im3m symmetry from the ILA
lattice is easy, as it involves no further change of connectivity between the bilayers.
The other observed Qn geometries are nearly isoenergetic, and have the same genus,
so interconversion between these phases should be relatively easy.
ILA formation should also result in membrane fusion, since an ILA resembles












Figure 3.10. Proposed mechanism for the La/Qn phase transition, a)
ILAs form between apposed La bilayers. ILAs resemble fusion pores,
b) many ILAs form, so the La lattice disorders, c) Eventually an ILA
array forms with a primitve tetragonal unit cell. This has the same
connectivity as Q229, which is shown in d). Conversion into Q229
requires only bilayer bending, as does the inter-conversion between
the different inverted, bicontinuous cubic phases shown in d). The
driving forces for the conversion between c) and d), and within d) are
the different thermodynamic stabilities of the Qn phases (Anderson et
al, 1988) and constraints imposed by the water content of the sample
(Siegel, 1986c).
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may be an obligatory step in the transition to the cubic phase. Fusion may result from
the gradual accumulation of isolated intermembrane intermediates, which can then
transform into fusion structures. Siegel et al (1989c) used TRC-TEM to image the
intermediates in bilayer to non-bilayer transitions. They visualised ILAs, and showed
that ILAs did assemble into a lattice. Moreover, ILAs appeared to mediate both
membrane fusion and the La/Qn phase transition. Siegel (1986b, 1986c) also explained
the hysteresis seen for the La/Qn phase transition on the basis of the formation of
numerous ILAs, which rearrange into isotropic states that are metastable over a broad
temperature range. The type of phase transition that occurs in a lipid system will thus
be determined by the tendency of the system to form ILAs.
Fusion promoters, such as viral fusion peptides, could increase the formation
of isotropic lipid states, and thus favour the fusion process in several possible ways.
Firstly, they could act by reducing the intrinsic radius of curvature of the lipid
monolayers present, thus destabilising the bilayer phase relative to more negatively
curved, non-bilayer structures. Evidence to support this mechanism is seen in the
experiments using the FeLV fusion peptide, namely its effect on the FIn phase lattice
constant ofDiPoPE (see Chapter 4). Secondly, fusion promoters might either relieve
the packing constraints or reduce the void energies present in these curved lipid
arrangements. This may also be relevant to the mode of action of the FeLV fusion
peptide, as shown by its effect on lipid packing arrangements in the stacked bilayers
which were used for neutron diffraction experiments (see Chapter 5). According to
the 'modified stalk' theory ofmembrane fusion, ILAs are formed from TMCs
(transmonolayer contacts) (see Chapter 1). Thus a third possible mode of action for
fusion peptides is that they might lower the rupture tension of the TMC diaphragm,
thus increasing the formation of ILAs and fusion pores. Siegel and Epand (1997)
suggest that TMC diaphragm rupture tension may be a crucial factor in determining
how much Qn forms, and therefore also the fusogenic capacity of lipid and lipid-
protein systems where the lipid present is a PE. Thinning of the lipid bilayer will
reduce this rupture tension, and this is seen in the presence of the FeLV fusion
peptide, using neutron diffraction (see Chapter 5).
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In conclusion, my results presented here for the putative fusion peptide from
FeLV suggest that it is indeed favouring the production of lipid structures, which are
likely to be involved both in the formation of cubic phases, and in the rate-limiting
intermediate stages of the fusion pathway.
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Chapter 4: The use of Time-Resolved X-ray Diffraction to observe
the effects on Lipid Phase Transitions and Lipid Structural




X-ray diffraction is the most important and least ambiguous method of
structural determination of lipid phases (Luzzati, 1968). It is directly sensitive to the
relative positions of the component atoms that are present in a lipid sample, and so it
can identity the structural rearrangements that distinguish different lipid phases. The
relatively recent development ofpowerful synchotron X-ray sources has greatly
reduced the sample exposure times that are required to obtain good diffraction data.
This has led to the evolution of time-resolved X-ray diffraction (TRXRD). Direct and
quantitative measurements can be made of phase transitions in bulk lipid samples
using TRXRD. This approach allows a more dynamic examination of lipid phase
changes compared to traditional X-ray diffraction methods. TRXRD enables both the
kinetics of the transitions and the formation of intermediate structures to be studied,
which, in turn, hopefully provide some understanding of the mechanisms of the lipid
phase transitions.
4.2 Theoretical Background
Diffraction is defined as the deviation of a wave from its natural direction of
propagation when it encounters an object or a medium with spatially varying
transmittance (Warren, 1987). Diffraction at single or multiple slits is due to the
superposition of secondary wavelets that are produced by different parts of the same
wavefront. The diffraction pattern produced by a single bilayer is similar to that seen
for Young's double slits, since the bilayer contains two parallel polar headgroup
regions, which diffract X-rays strongly. Thus diffraction from a single lipid bilayer
results in the production ofalternating regions of constructive and destructive
interference. A pattern similar to Young's fringes is produced by this interference,
which is called the diffraction pattern, or diffractogram.
If a multiple slit arrangement, such as a diffraction grating, which has identical,
equally spaced diffracting elements, is used to produce diffraction, each narrow slit in
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the grating will act as a source of secondary wavelets (see Figure 4.1). These wavelets
superpose beyond the slits, resulting in constructive interference in certain directions
and destructive interference in others. Furthermore, different secondary wavelets from
the same slit also interfere with each other. This combined effect results in the
production of a diffraction pattern, with maxima corresponding to the regions of
constructive interference, and minima to those of destructive interference. Moreover,
a grating which has a large number of slits produces completely destructive
interference in all directions other than those which are described by the equation:
sinG = nk 4.1
d
where 0 is the diffraction angle relative to the normal, X is the wavelength of the
incident radiation, d is the distance between adjacent lines of the grating, and n is an
integer, or order ofdiffraction (see Figure 4.2).
It is not practical to record the diffraction pattern from one molecule as its
interaction with radiation is very weak, and hence it would take an extremely long
time to obtain a sufficiently strong diffraction pattern. In order to study the structure
of lipid bilayers, a regular stack or a random dispersion of bilayers are thus normally
used. Regular stacks ofbiological membranes or artificial lipid bilayers form a similar
type of structure to a diffraction grating. This stacked bilayer arrangement produces a
relatively large distance between adjacent slits, and thus it gives rise to a small angle,
or Tow angle', diffraction pattern. (It can be seen from Equation 4.1 that there is an
inverse relationship between the distance between the individual slits and the resultant
angle of diffraction. The reciprocal of d is also known as the 'spatial frequency' of the
diffraction grating).
The analogy with a diffraction grating only describes the two-dimensional
effects of diffraction by lipid bilayers. The situation is further complicated by the
three-dimensional arrangement ofatoms and molecules within the bilayer structure. If
one regards the arrangement of these bilayer constituents, and also of the individual
bilayers, as comprising layers or planes (see Figure 4.3), then, in addition, each
individual plane will reflect radiation. Constructive interference will only occur
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Figure 4.2. a) Diffraction at a multiple slit grating. Wavelets can arise
from points A and B on two successive slits and travel at an angle 0 to
the direction of the incident wave. The path difference AC between the
wavelets is dsin0. If <isin0 = rik, then reinforcement of the diffracted
wavelets will occur, b) Diffraction orders produced by such diffracted
wavelets.
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between waves reflected from parallel planes when the angle of reflection is given by
the Bragg equation, namely:
sin0 = nX 4.2
2d
where d is the perpendicular spacing between the molecular planes, and 0 is the angle
between the incident beam and the molecular planes, X is the wavelength of the
incident radiation and n is an integer, or order of diffraction. W.L. Bragg (1913) was
the first person to realise that diffraction from a regularly repeating structure could be
described in terms of 'reflections' from planes of equal scattering density. This greatly
simplified the analysis of three-dimensional X-ray data, since now diffraction in only
one plane needs to be considered.
There are only certain angles for the incident radiation beam which fulfill the
Bragg equation when considering the three-dimensional diffraction produced by
planes ofmolecules. This is because, in order for constructive interference to occur
between radiation reflected from points in adjacent planes, the difference in the path
length travelled by these waves must be an integral number ofwavelengths, which will
cause these waves to be in phase. At all other angles, there is destructive interference
and so no observable diffraction. Thus the sample must either contain a totally random
dispersion of lipid bilayers, which will clearly satisfy every possible angular
requirement, or else the sample must be moved around a static beam direction until
the required Bragg angle is achieved. From Equation 4.2 it can be seen that:
2sin0 = nX 4.3
d
The angle of the diffracted beam is called the 'scattering angle' and is the angle
between the main beam and the diffracted beam. Its size is twice that of the incident
beam (see Figure 4.3). Moreover, at small angles, such as are used for low orders of
low angle diffraction experiments, sin0 « 0. Thus the scattering angle, 0S, can be
approximated by the equation:
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In 1923 de Broglie suggested that matter might exhibit wave-particle duality
and thus have wave properties, an idea that had already been accepted for
electromagnetic radiation. This is now an accepted concept for matter, and beams of
X-rays or electrons or neutrons are currently used for diffraction experiments on
biological membranes. These are particularly suited for use in these experiments
because of the size of lipid bilayers: a typical membrane is less than lOnm in
diammeter, and therefore radiation of lnm or less is required in order to produce a
useful, detailed diffraction pattern.
X-rays are scattered by the electrons present in the sample; this occurs as a
result of the interaction of the incident electromagnetic radiation with the charged
electron clouds. Both coherent and incoherent scattered radiation are produced. The
diffraction pattern is due to the interference of the coherent scattered radiation, whilst
the incoherent scattering is responsible for the background radiation that is produced
during a diffraction experiment. Subtraction of this background component is a
prerequisite step in the determination of the intensity values for the diffraction peaks.
In a typical X-ray diffraction experiment, a narrow, well-defined beam ofX-
rays is directed through the specimen, and the distribution and intensity of the X-rays
that are scattered are recorded as a function of angle. Most of the X-ray beam will
pass straight through the sample, and this radiation is not recorded. Since X-ray
diffraction is directly sensitive to geometrical structure, it is an excellent technique
with which to study lipid phase transitions; indeed, different lipid phases are often
determined by the symmetry of the small angle X-ray diffraction produced by a lipid
sample. Thus the La phase consists of a one-dimensional periodic lattice that is
composed of locally planar and parallel bilayers, which are separated by layers of
water of uniform thickness. The inverted hexagonal phase, on the other hand,
constitutes a two-dimensional phase, in which rod-like structures are laterally placed
on a two-dimensional lattice. Finally, cubic phases demonstrate three-dimensional
periodicity. Thus, by using X-ray diffraction, a phase diagram of a lipid system can be
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obtained. This is usually accomplished by observing the sequence of equilibrium
phases that the system adopts as the thermodynamic variables of the sample are
altered. In practice, the inherent disorder of the liquid crystalline state can often
restrict the number of observable diffraction orders significantly.
If lipid phase changes are physiologically relevant, they must take place on a
time scale which is comparable to that of changes occurring in vivo (Caffrey, 1989).
Traditional X-ray diffraction requires long exposure times, and any lipid phase
changes that occur during the fusion mechanism must occur very rapidly (on a
millisecond time scale). TRXRD is therefore the best option for the investigation of
the effects of a viral fusion peptide on lipid phase changes.
The first TRXRD study of lipid phase transitions in membranes and membrane
lipid extracts was described in 1972 (Dupont et al, 1972). TRXRD requires an
intense, monochromatic X-ray beam with a very high repetition rate, and a live-time
X-ray imaging device, which constantly monitors the diffracted X-rays that are
produced by the lipid sample. Thus a set of consecutive X-ray diffraction scans, which
have a set time interval between each scan, is obtained. By examining the positions of
the diffraction orders that are observed on each of the consecutive scans, it is possible
to determine the lattice types or packing symmetries of the lipid molecules in the
sample, and thus the lipid phases present. As an example, if the lipid in the specimen is
all present in the lamellar phase, the diffraction pattern will consist of a lamellar series
ofBragg peaks, but ifmore than one phase is present then the diffraction pattern will
consist ofmore than one series ofBragg reflections. The lattice parameters, or d-
spacings, can be calculated from the distance of the individual peaks from the centre
of the diffraction pattern. Absolute lattice spacing can be obtained by comparison with
that obtained for a known standard under the same experimental conditions. The
nature of any phase transitions, that is whether they are ordered, the time-span of any
co-existence of domains of the converting lipid phases, and the temperature ranges
over which any transitions occur can also be determined very easily. Any correlations
between the variable parameter, for example the temperature of the sample, and the
phase changes that occur within the sample can be determined. Furthermore, if the
areas under the individual diffraction peaks are measured, which is normally done by
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the fitting ofGaussians using the least squares method, then the relative amounts of
the different lipid phases can be ascertained throughout the lipid phase transitions.
4.3 Application of Time-Resolved X-ray Diffraction to Fusion Studies: Aims of
these Experiments
TRXRD data were obtained to confirm the identity of the phase transitions
that were measured by DSC (see Chapter 2). The same type of lipid and similar
peptide mole fractions were therefore used for the DSC and the TRXRD experiments.
There have been very few previous investigations using TRXRD of the effects of
fusogens on lipid phase transitions, and even conventional X-ray diffraction studies
are limited. The fusion peptides of SIV (Colotto et al, 1996) and Influenza virus
(Colotto and Epand, 1997) have been examined using X-ray diffraction methods.
Both of these fusion peptides were shown to have a bilayer destabilising effect. The
SIV peptide also increased the spontaneous curvature of the hexagonal phase lipid,
whilst the Influenza virus fusion peptide, which is activated at low pH, induced cubic
phase formation at pH 5.0. DAGs, which are fusion promotors, have been found, by
X-ray diffraction, to increase the spontaneous negative curvature ofMeDOPE (Ellens
et al, 1989). A second aim was, therefore, to determine any effects of the FeLV
fusion peptide on lipid structural parameters. In particular, any changes in the lattice
spacings, and thus in the spontaneous radius of curvature of the monolayers present,
were of great interest.
4.4 Materials and Methods
4.4a Sample Preparation
DiPoPE was purchased from Avanti Polar Lipids (Alabaster, AL, USA).
Preparation of lipid and lipid/peptide films was as described in Chapter 2. The buffer
used for the subsequent preparation of the lipid suspensions was 20mM PIPES, ImM
EDTA, 150mM NaCl and 0.002% NaN3, at pH 7.4. After addition of the required
amount ofbuffer, the suspensions were vortexed thoroughly several times and were
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then subjected to 3 freeze-thaw cycles, as described in Chapter 3, in order to obtain as
homogeneous a sample as possible. In practice this must potentially be one of the
main errors in the experimental proceedure, as it is extremely difficult to obtain good
homogeneity ofPE lipids in aqueous suspension. Samples were stored in the fridge at
4°C and re-vortexed just before use. All samples were used within 24 hours of
preparation. Ideally a check should be made for possible radiation damage and/or
oxidation of lipids at the end of the experiments using TLC. In practice, careful
preparation of the samples should minimise oxidative deterioration. Studies by several
groups have failed to reveal any radiation damage to samples, providing that the beam
is running as expected (K.R. Jeffrey, personal communication).
4.4b X-ray Diffraction
The X-ray diffraction experiments were performed at station 8.2 of the
synchotron radiation source at the Daresbury Laboratory, Daresbury, UK. By using a
subsidiary accelerator a synchotron increases the speed of the electrons so that it is
close to that of light. Accelerators work on the principle of synchronous acceleration.
The electrons then follow a circular path under the action of a magnetic field, and
their energy is increased by applying synchronous electrical pulses from a high-
frequency alternating potential difference that is connected to several cylindrical
electrodes arranged around the track. Whenever the electrons pass through the
bending magnets they lose energy in the form of electromagnetic radiation. The
electrons that reside in the storage ring do not form a continuous stream, but occur in
groups that are separated in time by 10"8 to 10"9 seconds. Thus the emitted radiation is
also pulsed at a similar frequency, which allows time-resolved experiments to be
performed on nanosecond timescales. Devices called wigglers are used to alter the
wavelength of the radiation produced, while undulators produce interference effects
and thus produce a spectrum of radiation that is a series of narrow harmonics. By
changing the settings within the undulators the wavelength that is produced can be
tuned, and thus the useful flux can be greatly increased. A monochromator is then
used to select the appropriate wavelength required; this is fixed at 1.54A for Station
8.2. The beam of electrons was collimated so that only the sample was irradiated.
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Beam instability and decay during any diffraction measurement are potential sources
of error, and so the intensity of the incident beam must be monitored continually
during the experiment in order to allow subsequent normalisation of the data. This is
achieved by the use of a separate small detector which intercepts a small part of the
incident beam.
A teflon-lined brass chamber with mica windows was used as the sample
holder. Since the samples were composed of lipid bilayers that were completely
disordered with respect to the direction of the incident beam, they could be held
stationary in the beam and still fulfill the required geometry of diffraction. An external
circulating water bath was used to control the sample temperature, which was
monitored continuously by a thermocouple. A major source of error in TRXRD
experiments is often a lack of rapid and uniform changes in the temperature of the
sample. Thus a liquid of high coefficient of heat transfer, namely ethylene glycol, was
used in place ofwater in the water bath, at a high circulation rate. Furthermore, the
sample size was the minimum that would produce good diffraction data. The
temperature of the sample cell was linearly increased from 30°C to 70°C, at a heating
rate of 90°C/hour. Each temperature scan consisted of 120 frames of diffraction data.
An INEL position-sensitive, curved detector, was used to detect the diffracted
radiation, which ionises argon gas within the detector, and an 'avalanche'
phenomenom is created. An inducted charge is produced at the impact point of the
avalanche on the cathode readout strips, and this position is determined by the delay-
line method, which depends upon the difference in the arrival times of this charge at
each end of the delay line. An electronic position-sensitive processor then processes
the data. Most of the incident radiation is transmitted without interacting with the
specimen and so a beam stop is placed just in front of the detector to intercept the
directly transmitted beam and thus help to reduce fogging of the entire detector.
The XOTOKO programme was used to correct the raw data. Corrections for
sample thickness, and variation in detector response were applied, and background
counts were subtracted. Detector response was determined by measuring a fixed
source, 59Fe, for several hours, at the start and the end of data collection. The
detector was calibrated for small angle scattering using rat tail collagen, mounted in a
152
cell and lightly stretched, as a standard. Under these conditions, collagen has a unit
cell size of676.08 A (Fraser and MacRae, 1981). The corrected data were then
plotted using this calibrated x-axis, in order to obtain absolute values for lattice
spacings. The areas under the diffraction peaks were determined using the commercial
programme Sigmaplot, version 2.01.
4.5 X-ray Diffraction Results and Discussion
The diffraction patterns that were obtained verify that the transitions which
occurred in the DSC experiments were from La to Hn; no other phases were observed
in the X-ray data. Figure 4.4 shows a three-dimensional plot of the series of
diffraction patterns obtained over the entire measured temperature range for DiPoPE
plus FeLV peptide, present at a peptide mole fraction of 3.1 x 10~3. Figure 4.5 shows
a typical dififractogram for the TH region of the scan: this was taken from the data for
DiPoPE with FeLV peptide, present at a peptide mole fraction of 1.6 x 1 (T3, and at
42°C. In the lamellar phase, the Bragg spacings, or <7-spacings, of all of the orders of
diffraction are the integrals ofone fundamental spacing. In the hexagonal phase, the
ratio ofBragg spacings of the reflections is 1 :v/3: v/4: v/7. Thus samples were assigned
the Hh phase if a minimum of three diffraction peaks were observed which indicated
spacings in the ratios 1:V3:V4:V7. The <f-spacings for all samples were calculated from
the distance ofpeaks from the origin. The d-spacings for the La and Hn phases for
pure DiPoPE and the peptide-containing samples are plotted in Figure 4.6. The d-
spacings found in the present work are in good agreement with those previously
reported (Colotto et al, 1996; Colotto and Epand, 1997). It should be noted that in
the values presented in the references the definition used for the repeat spacing was
that adopted by Gruner (1991) and others in which the <7-space corresponds to the
distance from the centre of one Hn cylinder to the next. This distance is related to the
lattice spacing reported in the present work by multiplying the lattice spacing by 2/V3.
The small differences between this data and the two previous sets of data may be the
result ofdifferent heating protocols, different batches ofDiPoPE and different
calibrations. The transition from the Lato the Hn phase is ordered, that is both
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Figure 4.4. Three-dimensional plot of the series of consecutive
diffraction patterns obtained on heating from 30°C to 70°C for DiPoPE
plus FeLV fusion peptide, peptide mole fraction 3.1 x 10~3. The heating
scan rate was 90°C/hour.The origin is on the left, and the right hand limit
represents channel 270 of the 512 recorded. Thus each trace is a plot of
diffracted intensity vs detector position, the scattering angle increasing
from left to right. The first two lamellar and first three hexagonal
diffraction orders are visible as well defined peaks. The transition from
the lamellar to the hexagonal phase can be seen. The presence of a third,




Figure 4.5. Typical small angle X-ray diffraction profile in the TH region
of the scan series for DiPoPE plus FeLV fusion peptide, peptide mole
fraction 1.6 x 10 3, at 42°C. Channel numbers 50-300 of the 512 recorded
are shown. Part of the data has been amplified by a factor of 10 (x 10) for
the sake of clarity. The inset, a, shows an enlargement of the Bragg peak
for the third diffraction order of the Hn phase, and the presence of a
smaller peak, of smaller d-spacing than the main Hnpeak (solid lines).
Gaussian analysis of the two peaks is shown above (dotted lines).
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FeLV peptide mole fraction (xl0~3)
Figure 4.6. Variation in ri-spacings (A) for the La and Hn phases of
DiPoPE with increasing FeLV peptide concentration. dH measured (•) at
49°C, (■) at 50°C, and (♦) at 52°C. dL measured (O) at 33°C, (□) at
40°C, (A) at 44°C, and (®) at 45°C.
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lamellar and hexagonal phase domains coexist in the transition temperature region.
This was seen for the pure lipid and the peptide-containing samples. The preservation
of long range order throughout a lipid phase transition suggests that the transition
may be co-operative, with long range order being established in the nascent phase
(Caffrey, 1989). The slow rate ofwater penetration into the nascent Hn phase seen
with multilamellar vesicle (MLV) samples may prolong the detection of co-existence
ofLa and Hh domains.
No cubic intermediates are seen. It is possible, however, that very transient
phases are not detected due to the high scan rate employed (disordered structures
would not be seen either). In simple kinetic models of a phase transition, the free
energy difference between the two phases drives the transition but the intermediate
structures are at a higher free energy and thus they present a rate-limiting activation
energy barrier (Tate et al, 1992). Many lipids have very low monomer solubilities in
water and so kinetic relaxation of a lipid assembly into a state of lower free energy
may be so severely hindered that the system may be unable to attain true equilibrium
in the time available to it during an experiment. Moreover, the absence of lattice
structure in the observed diffraction pattern simply means that there is no lattice with
long range order present within the sample. Furthermore, over 12 orders ofdiffraction
are required before a cubic phase can be definitively assigned (Franks and Lieb, 1979).
Thus some of the previous studies have detected putative, as opposed to definite,
cubic phases.
Figure 4.5a (inset) shows the Gaussian analysis of the Bragg peak of the third
order of diffraction of the hexagonal phase. It can be seen that, in the presence of the
FeLV peptide, a second and different lattice was observed, of slightly narrower d-
spacing than that of the main Hu phase. As one cannot assign a lamellar or hexagonal
phase on less than three diffraction orders, it is not possible to state definitively what
this novel, peptide-induced phase is: there are only two observable diffraction peaks
for this phase, which represent the second and third diffraction orders. The diffraction
amplitudes ofhigher orders were too small to detect, and the first orders of the two
hexagonal phases probably overlap due to the decrease in spatial resolution that was
seen at smaller diffraction angles. This may account for the observed slight increase in
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the mosaic spread of the first order of diffraction of the hexagonal phase in the
presence ofpeptide. However, the two observed novel peaks fitted to a d-spacing of
1: V3, and they occurred as a shoulder on the definitely identified main Hn phase.
Thus this may represent a novel Hn phase, which was most noticeable in the samples
containing 1.6 x 10~3 mole fraction ofFeLV peptide. A measure of the maximum
percentage ofDiPoPE present in this phase as a proportion of the total amount of
hexagonal phase lipid yielded the following data:
Table 4.1. The amount ofDiPoPE present in the novel, peptide-induced lipid phase as
a function of the concentration ofFeLV fusion peptide present in the sample.
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Evidence of the peptide-induced lattice disappeared completely as heating
continued well above TH, indicating that this phase was transient. No extra peaks were
seen in the pure lipid samples, and thus it is clear that this novel phase was due to the
presence ofpeptide. This novel phase may be due to the formation ofextremely
peptide-rich domains within the sample, which have a higher intrinsic negative
curvature than that of the pure lipid. Not all of the peptide was incorporated into
these domains, since the d-spacing of the main Hn phase (dH) was also decreased in
the presence of the FeLV peptide (see Figure 4.6): this also suggests that the FeLV
peptide is decreasing the spontaneous radius of curvature, Ro, of the system in this
range ofpeptide concentration.
A reduction in Ro will destabilise bilayer structures relative to inverted non-
bilayer phases. DAGs have been found to decrease Ro, that is to increase the
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spontaneous negative curvature, ofMeDOPE (Ellens et al, 1989). Physiological levels
ofDAGs are known to promote fusion. (Siegel et al, 1989a), and have also been
found to enhance a La to Qn transition (Basanez et al, 1996), to bicontinuous Q224
(Luzzati et al, 1993). This cubic phase is related to the putative fusion intermediate, in
the 'patch-the-puncture' fusion model (Nieva et al, 1995).
An interesting observation of these experiments is that ofmarked broadening
of the La diffraction peaks on heating in the presence of the FeLV peptide, and in a
manner that depends upon the peptide concentration. (The width of the peaks was
determined by fitting Gaussians and measuring the width at half height). This
represents disordering of the La phase, and may be consistent with the start of a
transition to an inverted cubic phase (Gruner et al, 1988). X-ray studies ofDiPoPE
with an SIV mutant fusion peptide at pH 7.4 (Colotto et al, 1996), and from Influenza
virus at pH 5.0 (Colotto and Epand, 1997) have indeed detected the formation of a
cubic phase. The heating scan rates used in these studies were considerably slower
than that used here, which may explain why no ordered cubic phase was detected in
our study. When rapid heating was used with the Influenza fusion peptide, no cubic
phase was observed (Colotto and Epand, 1997). It has also been observed that, even
with pure MeDOPE, the extent of cubic phase formation is very dependent upon scan
rate (Siegel and Banschbach, 1990; van Gorkom et al, 1992).
The FeLV peptide also produced broadening of the Hn peaks. Part of the peak
broadening may be due to vesiculation of the MLVs present in the samples, as
suggested for the SIV fusion peptide/MeDOPE system: the conversion ofMLVs to
smaller vesicles with fewer lamellae is thermodynamically favourable, but the fusion
peptide may greatly accelerate this process (Colotto et al, 1996).
The effect of the FeLV peptide on dH is seen to exhibit a biphasic trend with
peptide concentration, reminiscent of that seen for TH in our DSC measurements. The
fusion peptide had little effect on dL at temperatures well below TH, (see Figure 4.7),
but as TH is approached, dL decreases with increasing peptide concentration. It can be
seen from Figure 4.7 that the temperature-dependance of dH and dL is very similar for
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Figure 4.7. Change in J-spacings (A) of the La and Hn phases with
temperature as calculated from the X-ray diffraction patterns. DiPoPE alone
(O); DiPoPE plus FeLV peptide, at peptide mole fractions: of 1.6 x 10~3 (□),
3.1 x 10"3 (V) and 5.5 x 10~3 (©).
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lipid phase tend to decrease as the temperature rises, due to increased disorder of the
hydrocarbon chains at higher temperatures (Luzzati and Husson, 1962).
There are two aspects ofmembrane fusion mechanisms that can explain the
relationship between a peptide-induced increase in membrane fusion rates and the
effect of the peptide on lipid polymorphism. The first aspect is the formation of a stalk
or interlamellar attachment (ILA) intermediate which has overall negative curvature
(Siegel, 1993). Thus the formation of this first intermediate would be accelerated by
agents or conditions which favour the formation of inverted phases. The monolayers
involved in the formation of this stalk intermediate are the trans or contacting
monolayers (Chernomordik, 1996). The X-ray diffraction data shown here
demonstrate that the putative fusion peptide ofFeLV causes dH to decrease (Figure
4.6), indicating that the peptide does indeed promote negative monolayer curvature.
Another mechanism by which peptides can promote the rate of fusion is by
favouring the partitioning of the TMC intermediate toward the fusion pore/cubic
phase pathway (Siegel and Epand, 1997). This mechanism has been suggested for the
Influenza fusion peptide (Colotto and Epand, 1997). The relationship between
conditions leading to cubic phase formation and to increased rates ofmembrane
fusion has also been noted for fusion induced by DAG (Basanez et al, 1996; Basanez
et al, 1997). The possibility of such a phenomenon occurring with the FeLV peptide is
suggested by the fact that low concentrations ofpeptide promote the formation of
isotropic resonances in j1P NMR ofMeDOPE and DiPoPE (see Chapter 3, Figures
3.8 and 3.9). Although no cubic phases were observed for DiPoPE by X-ray
diffraction, this lipid forms cubic phases less readily. As a pure lipid, the cubic phase
has never been observed with DiPoPE and, in the presence of the Influenza peptide,
the cubic phase is only found with DiPoPE mixed with other phases and with a low
degree of order, presenting limited evidence for the formation of a cubic phase.
Moreover, disordering of the La phase in the presence of the FeLV peptide was seen,
which, as noted, may be consistent with the start of a transition to an inverted cubic
phase (Gruner et al, 1988). Thus this mechanism certainly cannot be ruled out for the
FeLV fusion peptide, and a further TRXRD study of the effects of the FeLV peptide
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on phase transitions of lipids using a lipid such as MeDOPE, which forms cubic
phases much more readily than DiPoPE, would be extremely beneficial.
The experiments that have been described in this chapter and the two chapters
preceeding this one have used pure lipid species. Biological membranes are much
more complex than this, consisting of a heterogeneous mixture of lipid types. It is,
however, quite possible that the interaction ofpeptides occurs with (a) particular lipid
species rather than with the membrane as a whole (see Chapter 7). Moreover, in lipid
mixtures where the possibility of lateral phase separation occurs, there might exist a
difference between the global and local monolayer curvature (Polozov et al, 1997).
As mentioned in Chapter 1, a large body of evidence indicates that biological
membranes are indeed laterally structured. Thus studies of the effects of a fusion
peptide on lipid phase parameters using single lipid species, which show a higher
degree of intrinsic negative curvature than that of a whole biological membrane, have
relevance to the effects that this peptide may produce in vivo.
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Chapter 5: Investigation of the effects of the FeLV Fusion Peptide on





The existence of the neutron was first predicted by Ernest Rutherford in 1920,
and it was first identified by Sir James Chadwick in 1932. In 1939. following some
work by Fermi in Italy and Hahn and Strassman in Germany, it was found that the
bombardment ofuranium by neutrons could split the uranium nucleus into two large
nuclei, for example barium and krypton, and that fission neutrons were emitted during
this process. This discovery formed the basis for the production of chain reactions
using uranium 235 in nuclear reactors, and hence a source ofhigh energy neutrons.
It is only relatively recently, since the early 1970's, that neutron beams have
been used to study biological membranes and their constituent molecules. The
theoretical background and practical applications of neutron diffraction are very
similar to those ofX-ray diffraction. Similarly, the main aim of this technique also is
to identify the conformations of the molecules that are being studied.
5.2 Theoretical Background to Neutron Diffraction
The basic theory of diffraction has been discussed, in part, in Chapter 4. As
mentioned previously, neutrons can be considered to possess wave properties, and
thus the diffraction of a beam ofneutrons obeys the same laws as those seen for X-ray
diffraction. However, neutrons being uncharged are not scattered by electron clouds,
but by the atomic nuclei present within a sample. One advantage ofneutron
diffraction, therefore, is that it is sensitive to the isotopes that exist in a sample, in
particular to the presence ofdeuterium. Substitution ofdeuterium for hydrogen in a
sample will thus alter the neutron scattering properties of that sample. This can be
used to locate individual atoms and to determine the phases of the diffracted
amplitudes (Hvoslef, 1958) (see below).
In the work reported in Chapter 4 a large amount of information was obtained
about the structure of the lipid phases that were present in samples, by the relatively
simple measurement of the positions of the observed diffraction peaks. The
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measurement of the existing lattice symmetry does not, however, describe the
structure fully, since many molecular arrangements are possible within a given unit
cell. Quantitative analysis of the relative intensities of the orders of diffraction
produced by a sample reveals much more detailed information about the structure of
the lipid bilayer. This is because the diffracted intensities describe the distribution of
the scattering matter within the lipid bilayer (Franks and Lieb, 1981); in other words,
the intensity of the radiation that is diffracted through a given angle depends both
upon the angle of diffraction and also upon the substructure of the diffracting object.
Thus by measuring the distribution of the intensity of radiation diffracted by a lipid
bilayer, the neutron scattering density profile, and hence the structure, of this bilayer
can be determined.
The strength of the scattering from an atom that is measured in diffraction is
called its coherent scattering amplitude. In X-ray diffraction the X-ray scattering
amplitudes ofatoms are directly proportional to their electron densities, and thus to
their atomic numbers. There is, however, no logical sequence to the coherent neutron
scattering amplitudes ofbiological molecules, as seen by examination of the atomic
numbers of atoms. Moreover, there is a phase change of 180° for the diffracted beam
relative to the incident beam upon interaction with all biological molecules except for
neutrons that are scattered by hydrogen atoms (Bacon, 1975); these do not exhibit a
phase change, and thus, by convention, hydrogen is given a negative scattering
amplitude.
The scattering amplitude density of a molecule can be described by the sum of
the coherent scattering amplitudes of its constituent atoms divided by the volume of
the molecule. Figure 5.1 shows the scattering amplitude densities for water and for
various regions of a phospholipid molecule, as shown in Franks and Lieb (1981).
Hydrogen and deuterium have vastly different neutron coherent scattering amplitude
densities: -3.7 and +6.7 Fermi units respectively (Zaccai et al, 1975), and so,
therefore, have water and 'heavy' water, or 2H20. Thus the introduction of2H20 into
the sample will change the scattering density of that region enormously. For an H20-
hydrated lipid bilayer, the main peaks of neutron diffraction occur at the fatty acid
















































Figure 5.1. X-ray and neutron coherent scattering amplitude densities for
water and different regions of a typical phospholipid molecule (Franks and
Lieb, 1981). The same absolute scale is used for both graphs.
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and oxygen atoms scatter neutrons strongly. The polar phosphates of the lipid
headgroup region also have a large neutron scattering amplitude, while the
hydrocarbon chains and the terminal methyl groups show poor neutron scattering.
The relative X-ray scattering densities for the different regions of a bilayer are
somewhat different, and thus these two techniques can be used in a complementary
fashion.
The diffraction pattern, which is composed of the observed orders of
diffraction, can be thought of as an analogue form of a spatial frequency analysis, or
Fourier analysis. Fourier's theorem states that any mathematical function can be
considered as the sum of a series of sinusoidal frequency components (Warren, 1987).
Thus a mathematical function can be used to describe the intensity of neutrons that
are diffracted by a grating, or indeed by stacked lipid bilayers. By adding together all
of the component cosine waveforms, which have different amplitudes and spatial
frequencies, a waveffont is produced which provides an exact waveform description
of the distribution of the diffracted neutrons, and thus the neutron density profile of
the lipid bilayer. The spatially varying cosine wave components are a mathematical
model; they do not describe real objects. The spatial frequencies will all be multiples
of the fundamental frequency, rather like the harmonics of a musical note. Thus the
part of the beam which is undiffracted and passes straight through the sample is not
measured, but each order of diffraction is measured in turn, with the sample
positioned at the appropriate Bragg angle relative to the incident beam. The first order
of diffraction is equivalent to the first musical harmonic, the second order to the
second harmonic and so on. The fine details of the unit cell are described by the high-
frequency cosine wave components, or the higher orders of diffraction.Thus if the
high spatial frequency components are unobtainable, an imperfect wavefront will
result, which thus gives a 'low-resolution' structure for the lipid bilayer. In practice,
the higher orders of diffraction can be very difficult to measure and to phase
unambiguously. This is particularly true ofneutron, as opposed to X-ray, diffraction
studies ofhydrated bilayers, as the hydrogen nucleus produces a large amount of
incoherent neutron scattering, due to the different spin orientations of the hydrogen
nuclei in the sample, which significantly lowers the signal-to-noise ratio.
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The distribution of the neutron scattering density in the unit cell, or hydrated
bilayer, can thus be calculated in practice from a Fourier series by using the measured
amplitudes of the observed diffraction peaks as the Fourier components. The
amplitudes are often referred to as the structure factors, which are the amplitudes
after they have been correctly 'phased' relative to one another (see below). The
structure factors of the diffraction pattern are transformed into wave functions, and
these cosine waves are then added together to produce the final neutron scattering
profile for the sample. This process is called a Fourier transform, or Fourier synthesis
if the sample is non-randomly distributed, and the scattering density distribution thus
produced can then be used to determine the structure of the bilayer. By comparing the
scattering density profiles of different samples, any changes in the structure of the
bilayer that may have occurred on addition of substances, such as fusion peptides, can
be determined.
The underlying diffraction from a stack ofN bilayers is similar to that for a
single bilayer, only it is N times larger and it is subject to the restrictions imposed by
the lattice. Thus the neutron density profile of a stack ofmembranes represents the
neutron density profile of a single bilayer that is repeated at regular intervals, and at
the Bragg angles of the lattice, the diffracted waves will interfere constructively. The
sum of the scattered amplitudes at each Bragg angle of a regular stack of bilayers is
proportional to the Fourier transform of the scattered density distribution for a single
bilayer. Thus the measurement of the scattered amplitude at these distinct points is
equivalent to the sampling of the Fourier transform or synthesis of a single bilayer unit
at the particular points in reciprocal space where :
R = n 5.1
d
R being the reciprocal space coordinate, n the order of diffraction and d the bilayer
repeat distance.
It is vital that the amplitudes of the cosine wave components are correct if the
Fourier function is to represent the bilayer structure accurately. In practice, various
corrections have to be applied to the observed values of the diffraction amplitudes in
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order to allow for errors that arise from the basic experimental proceedure of
diffraction and also from the particular conditions of each individual experiment (see
Results and Discussion section).
In addition to determining the moduli of the individual cosine wave
components, the signs of the different amplitudes must also be determined. This is
because the different component cosine waves must be 'phased' with respect to each
other; in other words, their positions along the x-axis relative to one another must be
calculated. The phasing ofdiffraction data represents the most difficult part of the
entire analytical proceedure. By using oriented multilayers the analysis required to
deduce the distribution of the scattering density across a bilayer is reduced, as the
bilayers are centrosymmetric and hence only one dimensional analysis is necessary.
This is because symmetrical structures produce diffracted beams which are always
either in phase or 180° out of phase. Artificial lipid bilayers are usually symmetrical,
and even if the membrane itself is asymmetric, for example by the insertion of a fusion
peptide, a pair ofmembranes will form a symmetric unit. Even so, the amplitudes of
the different components could have either a positive or a negative value, depending
upon where the maxima reside on the component cosine wave of interest.
It is the intensity of the diffracted wave that is recorded by an order of
diffraction. Since the intensity equals the square of the amplitude, the information on
the sign of the amplitude is unavailable. Moreover, there are no direct methods by
which this can be obtained, and so a variety of different techniques are used for the
determination of the signs of amplitudes. One method is based on model building.
This is only applicable to membranes for which there have been comprehensive
structural studies using other techniques, which enable the construction of a model
that describes the predicted structure of that membrane accurately. The Fourier
transform of this model may then be calculated and used as a reference for the
different combinations of the possible phases of the measured amplitudes of the
experimental diffraction data. The Fourier transform that agrees most closely with that
of the model may then be assumed to be the correct one, providing that the agreement
is acceptably high.
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As mentioned earlier, the neutron scattering amplitudes ofhydrogen and
deuterium are very different. This is utilised in the isomorphous replacement of
hydrogen by deuterium, another method used for the phasing of diffraction data.
Isomorphous replacement infers that the exchange of one atom for another does not
alter the structure of the component under study. This allows the subtraction of the
phased amplitudes of the same sample in the presence ofprecise and different relative
percentages ofH20 and 2H20 to produce the difference scattering profile for the 2H20
region between the bilayers. Franks and Lieb (1981) demonstrated that the scattering
density of the region between the lipid bilayers progressively increases with increasing
2H20 concentration. Weiner and co-workers (1991) showed that this 2H20
distribution can be represented with good accuracy by a pair ofGaussian curves. Thus
the location and distribution of the heavy atoms are known, and the phases of the
structure factors that produce the correct Fourier transform of these Gaussians can
then be used to phase the original experimental data. Other methods, such as the use
of a swelling series, can also be used to phase neutron data; these are not described as
they were not used in the current study.
Once the signs and values for the amplitudes have been obtained, computer
based programmes are usually used to calculate, using a Fourier synthesis, the
component frequencies of the bilayer structure present in the sample, and thus the
structure of the bilayer unit that is present in that sample.
5.3 Application ofNeutron Diffraction to Fusion studies: Aims of these Neutron
Diffraction Experiments
The results reported in the previous three chapters demonstrate that the fusion
peptide ofFeLV appears to increase the negative curvature of the lipid monolayers
present in certain hpid-water systems. Neutron diffraction studies were, therefore,
performed on stacked, hydrated phospholipid bilayers in order to determine the effects
of the FeLV fusion peptide on membrane structure. Ofparticular interest was the
determination ofany changes in the molecular organisation of the lipid bilayers, and
also in the distribution of the water molecules present in the samples, particularly
those closely associated with the bilayers.
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5.4 Materials and Methods
5.4a Sample Preparation
Lipid bilayers were composed ofpure DOPC, or DOPC with 50% (mol)
DOPG. Both lipids were purchased from Avanti Polar Lipids (Alabaster, AL, USA).
The deuterium oxide (2H20) was purchased from Sigma Chemical Company Ltd.
(Fancy Road, Poole, U.K.). 20mg of total lipid, or lipid plus 1% (mol) peptide, were
vortexed thoroughly in chloroform. The peptide-containing samples were then
sonicated until the peptide dissolved. Samples were applied to flat quartz microscope
slides using an airbrush spraying technique. A minimum of 12 hours was allowed for
sample drying time in vacuo, to remove any residual solvent molecules. The same time
period was also allowed for rehydration with H20, 50% 2H20 or 100% 2H20, which
were present as an atmosphere of 98% relative humidity, so that the lipid lattices
could swell to their limits ofhydration under these conditions. This method results in
a regularly stacked and virtually fully-hydrated conformation of alternating layers of
lipid and water (see Figure 4.3, Chapter 4). Incoherent neutron scattering by the
hydrogen atoms present in a sample produces a strong background count, and so it is
very important that the samples are well-oriented in order to detect the weaker, higher
orders of diffraction. A highly-reproducible technique for sample preparation is also
required, in order to permit comparisons to be drawn between individual samples.
Three different 2H20 concentrations were used for each sample, since this is the
minimum number that is required to determine whether or not the structure factors
change their signs; in other words, whether the linear plot ofneutron scattering
amplitude against 2H20 concentration passes through zero. When altering the relative
amount of2H20 present for a sample, the sample was dried out in a normal
atmosphere for about 30 minutes before it was placed in the newly required 2H20
concentration. The use of four 2H20 concentrations per sample is preferable, but the




Neutron diffraction measurements were performed on the D16 instrument at
the Institut Laue et Langevin (ILL) (Grenoble, France). Neutrons are produced in a
nuclear reactor by fission ofuranium 235. The fission energy appears mostly as kinetic
energy of the fission products, including the fission neutrons. These neutrons can start
a chain reaction by causing the splitting of further uranium 235 nuclei. This is
controlled by the moderator, which comprises rods ofboron steel that absorb
neutrons. The neutrons so produced have a continuous spectrum ofwavelengths,
which are usually mainly less than 0.1nm. A longer wavelength is required for
diffraction studies; this is achieved by causing collisions between the neutrons, and
thus the partial loss of energy, until the neutrons attain thermal equilibrium with their
surroundings. By employing diffraction from a crystal, the 'cold' neutron beam is then
collimated and monochromatised: neutrons diffracted from a single angle will have the
same wavelength. As mentioned above, neutron beams are much weaker than X-ray
beams, and so both the neutron beam and specimens must have a much larger cross-
sectional area than those used in X-ray studies.
A schematic diagram of the experimental set up for D16 is shown in Figure
5.2. A graphite monochromator is used to deflect the incident beam out of the guide.
A cooled berylium filter enables wavelengths of greater than 4A to be obtained. The
neutron wavelength that was used in these experiments was 4.516A. Variable slits
allow adjustment of the width of the incident neutron beam. The neutron
diflfractometer holds the sample and detector. Diffraction will only be observed when
a sample is located at the Bragg angles around an axis that is perpendicular to the
incoming beam of radiation (see Figure 4.3, Chapter 4). For an unoriented dispersion
ofmembranes, such as that used in Chapter 4, this condition will be fulfilled, because
all angles of bilayer orientation are equally probable. If, however, the sample is
composed of oriented multilayers, for example stacked, hydrated bilayers on a flat
glass support, then the sample must be rotated through the Bragg angles in order to
collect the different orders ofdiffraction. The neutron dififractometer is used to
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specimen is rotated through an angle of 0 radians, then the detector must be rotated
through 20 radians, since the scattering angle is twice that of the incident angle (see
Figure 4.3, Chapter 4). This is called a 0:20 scan, and has the advantage that the
scattering angle is determined directly. Thus when the sample is at angle 0, the first
order of diffraction is collected, at 20 the second diffraction order and so on. It can be
seen that the diffraction orders are thus collected sequentially, and not simultaneously.
A low efficiency detector (the monitor) monitored the incident neutron beam. The
duration of each scan was set at a certain number of counts of this monitor, rather
than a fixed time interval; this eliminates potential errors due to changes in the beam
flux during the experimental proceedure. The acquisition time for the higher, weaker
orders was increased compared to that for the lower orders in order to obtain
diffracted intensies that were of sufficient strength to permit subsequent analysis.
All samples were run at 25°C. Each sample slide was mounted on a
goniometer, and thus held vertically inside an aluminium sample can. Water from a
thermostatically-controlled water bath was used to control the temperature of the
sample environment, by circulating in the wall of the can. Two water baths containing
either H20 or the required percentage of2H20 were placed in the bottom of the can.
The sample was then left for 12 hours before measurements commenced, so that it
had time to re-equilibrate fully after exposure to the atmosphere during transfer. The
size of the interior of each sample can was quite considerable; one potential error lies
in the lack ofproduction of a fully humidified, homogeneous atmosphere within the
can itself. Even with two water baths present, the dead space in the cans was large.
This might cause the sample to shift during the course of each experiment. For each
sample, the diffraction experiment comprised a series of repeat 0:20 scans in which
the detector scanned the sample through a narrow range of angles centered on the
appropriate Bragg angle. The individual scans from each series were then added
together to give a final total for each order ofdiffraction. Virtually no change in the
positions or intensities of the individual diffraction orders was observed during the
course of the scan series. Thus it appears that the 12 hour period was sufficient to
allow full equilibration within the sample can, and also between the sample and the
atmosphere within the can.
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Neutrons do not cause ionising damage to specimens, which allows samples to
be exposed to neutron beams for long time periods ofup to several days. This is
essential, as the flux ofneutron beams is low: several orders ofmagnitude less than
the photon fluxes that are produced by common X-ray sources. The average exposure
neutrons are non-ionising, their detection requires reaction with certain nuclei, which
convert them into ionising radiation; a gas-filled (3He) area detector was used for this
purpose. A beam stop was used to block the direct beam. The sample-to-detector
distance was measured, which was 1 metre. This was used to calibrate the detector,
according to the relationship:
where 6s is the scattering angle, y is the distance of the diffraction order from the
centre of the diffraction pattern, and Y is the specimen-to-detector distance. Figure
5.3 illustrates this relationship diagramtically. Thus if the specimen-to-detector
distance and the scattering angle are known, then the absolute positions of the
diffraction peaks on the detector, and hence on the observed diffraction pattern can be
calculated.
Six orders of diffraction were recorded that were of sufficient strength to
permit their analysis. The raw data were initially analysed using the D16 software.
This software joined together the individual frames ofdata for the individual orders
such that the six Bragg peaks for each scan were contained in one continuous plot.
Corrections to allow for any variation in the response of the different regions of the
detector were also applied at this stage. The detector response was calibrated using
the scattering ofH20 in a 1mm thick quartz cell, which is constant throughout the
range ofangles that were measured in this experiment. The diffracted intensities were
also corrected for background radiation at this point.
Sigmaplot, version 2.01, was used to fit Gaussian distributions to the
diffraction peaks. Each Gaussian curve was allocated a position, width and amplitude.
A computer programme, lattice fit, was then used to calculate the fr-repeat of each
time used for a sample was 8 hours at each 2H20 concentration. Further, since
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scan. These values for all of the scans of the same sample were within 1A; these were
then averaged to give the final ^/-repeat value for each sample. The calculated d-
repeats were 55.25A ± 0.58A for DOPC/DOPG and 55.60A ± 0.51A for
DOPC/DOPG plus FeLV peptide.
The intensity of each order ofdiffraction was given by the area under the fitted
Gaussian peak. Various further corrections were then applied to the values for these
intensities, using a programme called datstore, which uses both the calculated af-repeat
value and the individual intensities for each scan.
Absorption in the specimen, which leads to the removal ofneutrons from the
diffracted beams, must be considered. This is largely due to the substantial incoherent
scattering of the hydrogen atoms in the sample. The amount of absorption depends
upon the path lengths of the incident and the diffracted beams within the sample. If a
radiation beam enters a sample tangentially, the radiation that gives rise to the lowest
angle of diffraction will be more heavily absorbed than the higher orders. This is
because the path length of the beam in a sample that is,for example, at an angle 0 to
the incident beam is longer than that for a beam with the same sample located at angle
20. Moreover, the amount of radiation that is absorbed by a sample is also affected by
the relative percentages ofH20 and 2H20 that are present in the sample, and this must
also be allowed for.
The Lorentz factor correction was applied to the data. Ewald (1921) produced
the Ewald construction, which allows the geometry of diffraction to be predicted, and
the Lorentz factor to be determined. This factor corrects for the spreading out of each
diffracted intensity in reciprocal space, and the fact that the detector only samples a
certain amount of reciprocal space and hence it does not record all of the diffracted
intensities. In particular, the higher order intensities tend to be less thoroughly
sampled.
The mosaic spread of each sample was also measured, by performing a
rocking curve; here the sample is rotated around the position of a Bragg peak and the
detector is fixed at the position required to detect the Bragg reflection. The mosaic
spread is a measure of the amount ofdisorder within the sample, or the angular
distribution of the planes of the bilayers with respect to the glass slide. If the bilayer
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stacking is irregular, it will result in the intensity of the diffraction describing an arc,
which has the same degree ofangular extent as the mosaic spread of the sample,
instead of a spot that is centred on the detector (Worcester, 1976). If this arc of
diffraction is greater than the size of the detector, part of the diffracted intensity will
be lost, and this loss must be reversed. The mosaic spread was then calculated for
each sample by measuring the full width at half-height of the Gaussian curve that
describes the distribution of the diffracted intensity around the third Bragg angle.
The samples used in this study had low mosaic spreads: 0.65° for
DOPC/DOPG and 0.6° for DOPC/DOPG plus FeLV fusion peptide. No correction
was thus required for the potential lack of recording by the detector ofpart of the
widths of the diffraction peaks, as the mosaic spreads of the samples were less than a
few degrees (Worcester, 1976). Unsaturated phospholipids characteristically show
low values for mosaic spreads, and the values obtained here correlate well with
preceding measurements on comparable systems (e.g. Duff et al, 1993; Bradshaw et
al, 1994). It can be seen that the presence of the FeLV fusion peptide had little effect
upon the mosaic spread of the lipid bilayers.
Extinction of the first order of diffraction for samples that contain 100% 2H20
can be a problem. It results in a false reduction of the size of the first order of
diffraction relative to the weaker orders. In practice it is hard to correct for extinction;
the use of lower 2H20 concentrations can reduce this effect. Extinction did not
produce any obvious errors in this data, as the straight line plot for the first order
amplitudes against 2H20 concentration did not show any underestimation of the value
for the structure factor for this 2H20 concentration (see below).
The result of this stage of the datstore programme was thus the production of
a corrected value for each intensity of diffraction. These were then converted into
amplitude values, which are the square root values of each observed diffraction
intensity.
The data sets that were obtained for an individual sample at the three different
H20 concentrations were then scaled to each other by a programme called
New_3D20. This programme scales the different amplitudes of each order of
diffraction at the different 2H20 concentrations to each other using a least squares
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fitting to determine the appropriate scale factors. Thus, for example, the amplitudes of
the first orders of diffraction at the three 2H20 concentrations are scaled to each other
to give the best fit. These should fit to a straight line. This is because, when
considering a unit cell that is centro-symmetric with scattering densities at each point
that are either constant or else change linearly with the isotopic composition of the
water vapour, it also holds that the structure factors change linearly (e.g. Perutz,
1954; Worcester and Franks, 1976), since the difference in the structure factors at the
different 2H20 concentrations should represent the 2H20 distribution. It follows that
simultaneous scaling of several of the observed orders of diffraction for the different
2H20 concentrations should be possible, as they should all be affected identically by
any differences in the samples at the different 2H20 concentrations. The use of the
straight line relationship for scaling only really holds for the first four orders of
diffraction, as the water distribution is a relatively broad function and it contains little
information about the high resolution orders. Figures 5.4 and 5.5 show the graphs
produced by the straight line fitting proceedure for the DOPC/DOPG data alone and
in the presence of lmol% FeLV fusion peptide.
Information on the phasing of the data may also be obtained by this technique,
which is routinely used for this purpose (e.g. Worcester and Franks, 1976; Biildt et al,
1979; Franks and Lieb, 1979; Jacobs and White, 1989). Any change in sign which is
required to produce a straight line fit for the values of the amplitudes ofan order of
diffraction can be determined. Thus, if, for example, the numerical values for the
amplitudes of the first order at 0, 50 and 100% 2H20 are 15, 15, 45, then, assuming
that the first order becomes more negative, the values at 50 and 100% 2H20 must be
negative in order to produce a straight line fit for these three points. Moreover, by
choosing the centre of the bilayer as the origin of the unit cell, the distribution of the
water present resembles a Gaussian distribution with its maximum at the centres of
symmetry, x = ± d/2 (Worcester and Franks, 1976). The phasing of the orders is then
fairly straightforward (Franks et al, 1978), as the general rule applies that states that
the phasing of a Gaussian curve, which describes the 2H20 distribution, causes the
amplitudes of the even-numbered orders ofdiffraction to increase algebraically with



























Figure 5.4. The 2H20 phasing method, as shown for the pure DOPC/DOPG
lipid data. The order numbers are noted. The structure factor amplitudes
change linearly with the percentage of 2H20 present. The symbols represent
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Figure 5.5. The 2H20 phasing method, as shown for the DOPC/DOPG plus
lmol% FeLV fusion peptide. Details as described for Figure 5.4.
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algebraically. This also is only accurate for the determination of the first four orders of
diffraction.
Once the appropriate scale factors have been determined, the amplitude values
that were calculated by the datstore programme were then multiplied by the scale
factor for that data set. These were then plotted in Sigmaplot, and a straight line fit
was applied to these scaled amplitude values. The plots for pure DOPC/DOPG and
DOPC/DOPG plus lmol% FeLV fusion peptide are shown in Figures 5.4 and 5.5. It
can be seen that, whilst the values for the first three orders fall on good straight lines,
the fourth, fifth and sixth order points show some deviation from the predicted
straight line fit. This is partly due to the difficulties in obtaining very accurate values
for weaker orders of diffraction. The amplitude values that were produced by the
fitted straight line were then used as the correct individual structure factors for each
2 .
H2O concentration.
Next the data were phased in a complementary manner, using a combination
of the modelling technique and the information from H20/2H20 exchange. A
computer programme was utilised that created bilayer profiles from the scaled,
corrected structure factors, by adding together these known structure factors and thus
calculating a Fourier synthesis. Various combinations of signs for the different
diffraction orders, in particular the fifth and sixth orders, were tested until a sensible,
best fit to a bilayer profile was obtained. The distribution of the heavy water in the
samples was thus also calculated by subtracting the Fourier profile for a sample when
it was hydrated with H20 from that for the same sample hydrated with 2H20. Ifboth
sets ofdata are correctly phased, this should describe two Gaussian distributions.
In order to compare bilayer profiles produced by different samples, these must
first be scaled relative to each other with respect to amplitude. The sizes of the
Gaussian distributions were then used to scale the data sets to each other. This places
the data on the 'relative absolute scale' ofWeiner el al (1991). This scale allows the
detailed examination and modelling ofdiffraction data without precise knowledge of
the lipid cross-sectional area. It scales the data absolutely with respect to the contents
of the unit cell; in other words, it utilises the known differences in mean scattering
density that are induced by the selective replacement ofhydrogen by deuterium to
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scale the data sets with respect to the unit cell contents. Thus the relative scaling of
each pair ofdata sets was altered until the total area under their difference transform
was equal to the difference in their total scattering lengths per unit cell, whilst
ensuring that the area under the transform for each individual data set was equal to
the total scattering length for its unit cell contents.
Different samples may well have different amounts ofwater present in their
unit cells, which will affect the scaling of the samples to each other. Thus it was
necessary to determine the water content of the samples. This was achieved by the use
of 14C-DOPC and 3H-water (both isotopes from Amersham International, Amersham,
U.K.) as constituents in the individual samples, which were made up exactly as before,
under identical experimental conditions, except for the isomorphous replacements that
were present. Thus 14C-labelled lipid was spread evenly over the 5mm surface of a
halved coverslip and the solvent was evaporated to produce a dry lipid film. The
samples were placed under vacuum overnight, in order to remove any residual solvent
molecules, and they were then placed in a chamber, which was at approximately 98%
relative humidity and which contained tritiated water. The samples were left in this
atmosphere, at 25°C, which was the temperature used for the experiments, for at least
12 hours. Each sample was then very rapidly transferred to a tube containing
scintillant fluid, and the amount of radiation, and thus of each isotope, present within
each sample was measured using a scintillation counter. For both of the isotopes of
interest, three standard samples were run that contained a known amount of that
isotope. This enabled any variation in sensitivity between the different 'lanes' in the
counter to be determined, and also allowed for any 'cross channel' interference. Blank
coverslips were counted too to give as accurate a background reading as possible.
Four identical labelled samples were measured for each type of sample used in the
diffraction studies, and the values for the four samples were averaged to give a final
ratio of the number ofwater molecules present per lipid molecule. Once this ratio had
been determined for each different type ofdiffraction sample, the size of the water
distribution peaks could then be used to scale the different samples to each other.
The scattering density of the FeLV fusion peptide was calculated by adding
together the different values for the scattering amplitude densities of this peptide's
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component amino acids, using the values quoted in Jacrot (1976). This total was then
subtracted from the scattering density profiles for the peptide-containing samples, so
that any changes in neutron scattering for these samples were due to changes in the
water and/or lipid molecular arrangements present. Finally, the neutron scattering
density profiles were calculated for 8.07% 2H20, which is the concentration of2H20
that has zero scattering density. Thus, at this 2H20 concentration, the scattering
density distribution is due to the phospholipid molecules alone, and hence any changes
in their molecular packing on addition of the FeLV fusion peptide can be determined.
5.5 Neutron Diffraction Results and Discussion
Table 5.1 lists the experimentally determined, corrected and scaled structure
factors that were used in the Fourier syntheses and subtractions for pure 50% (mol)
DOPC/DOPG and for 50% (mol) DOPC/DOPG with lmol% FeLV fusion peptide
present. The errors quoted were calculated using the straight line fits for each
diffraction order at the three different measured 2H20 concentrations. The difference
in amplitude between each individual data point and the corresponding value that lay
on the straight line fit were calculated, and these differences for the three 2H20
concentrations were averaged to produce a value for each individual order of
diffraction. The phasing of the fifth and sixth orders was performed, in the main, by
selecting the combination of signs for these two phases, from every possible
permutation, that, after performing Fourier syntheses, produced the most plausible
neutron scattering density profiles at the three different 2H20 concentrations, and also
the most plausible 2F120 distributions, whilst still fitting the straight line plots. It is
very difficult to ensure that these are corrrect in the absence of additional information,
such as the introduction of a localised label into the bilayer scattering profile. Happily,
these weaker orders ofdiffraction do not provide a vast amount of information on the
bilayer scattering profile. The structure factors for the samples ofDOPC/DOPG and
ofDOPC/DOPG plus FeLV fusion peptide were also calculated in the presence of
8.07% 2H20. These were obtained from the linear relationship between the final,
corrected and scaled structure factor amplitudes and 2H20 concentration for each
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Order of Structure factors for DOPC/DOPG at varying percentages
Diffraction of2H20:
0% 2H20 50% 2H20 100% 2H2O
1 -15.61 ±0.09 -96.29 ± 0.09 -176.98 ±0.09
2 -29.00 ± 0.02 6.98 ± 0.02 42.96 ± 0.02
3 17.65 ±0.27 6.56 ± 0.27 -4.53 ± 0.27
4 -4.46 ± 0.22 1.96 ±0.22 8.38 ± 0.22
5 4.95 ±0.13 4.44 ±0.13 3.93 ±0.13
6 2.78 ±0.18 2.65 ±0.18 2.53 ±0.18
Order of Structure factors for DOPC/DOPG plus lmol% FeLV fusion
Diffraction peptide at varying percentages of H20:
0% 2h2o 50% 2h20 100%2h20
1 -6.79 ± 0.02 -88.16 ±0.02 -169.52 ±0.02
2 -22.25 ±0.01 5.19 ± 0.01 32.64 ±0.01
3 -8.44 ±0.14 -8.24 ±0.14 -8.04 ±0.14
4 0.01 ±0.01 2.51 ±0.01 5.01 ±0.01
5 3.06 ±0.01 3.43 ±0.01 3.80 ±0.01
6 -4.25 ± 0.06 -0.41 ± 0.06 3.45 ±0.06
Table 5.1. Experimentally determined, corrected and scaled structure
factors, obtained at 25°C and 98% relative humidity, used in Fourier
transforms and subtractions for : 50 mol% DOPC/DOPG (top table) and
50 mol% DOPC/DOPG plus lmol% FeLV fusion peptide (lower table).
185
order ofdiffraction. 8.07% 2H20 has a scattering density of zero, and thus
examination of a bilayer profile at this 2H20 concentration allows the exclusive
observation of the scattering density of the other components that are present in the
sample, namely the lipid, or lipid plus peptide. Figure 5.6 shows the neutron scattering
density profiles at 8.07% 2H20 ofbilayers ofDOPC/DOPG alone and in the presence
of 1% (mol) FeLV fusion peptide. The difference profile, calculated by subtracting the
scattering density due to lipid alone from the profile for lipid with peptide present, is
also shown. Phospholipid molecules are shown above the profile to orientate the
relative densities seen. The origin of the profile is thus the centre of the lipid bilayer.
The neutron scattering density profile for the pure DOPC/DOPG bilayer contains two
outer troughs corresponding to the water regions, and two high peaks that are located
about ± 19A from the centre of the bilayer. These peaks correspond to a region of
strong scattering within the bilayer that contains the fatty acid ester groups and the
phosphorus molecules of the headgroups. A trough of low scattering density is seen in
the centre of the bilayer, due to the terminal methyl groups. These three features are
classic of a neutron scattering density profile of a lipid bilayer (e.g. Worcester and
Franks, 1976; Biildt et al, 1979; King and White, 1986). The introduction ofDOPG
to a DOPC bilayer has been shown to increase the neutron scattering of the
headgroup region (Bradshaw, 1997); this is thought to be due to the presence of
counterions that associate with the anionic DOPG.
The difference profile for the bilayer neutron scattering density (dotted line,
Figure 5.6) shows that the addition ofFeLV peptide to the bilayers causes an increase
in scattering density close to the bilayer centre, a reduction at the surface and an
increase in the water region. The scale of these perturbations is much too high for
them to represent simply the scattering density of the peptide: the amount ofpeptide
present is tiny, only 1% (mol). They must, therefore, be caused by alterations in the
phospholipid packing (changes in water distribution have been eliminated from the
figure by showing the 8.07% 2F120 profiles). The difference profile must, therefore, be
an increase in the packing density of the phospholipid fatty acids, and a decrease in
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Figure 5.6. Neutron scattering density profiles at 8.U /% H20 of pure
DOPC/DOPG bilayers (solid line) and DOPC/DOPG plus 1% (mol)
FeLV fusion peptide (broken line). The difference profile calculated
by subtracting structure factors for the lipid alone from those of lipid
plus 1 mol% FeLV peptide is also shown (blue, dotted line). Two
phospholipid molecules are shown for orientation. The headgroups
contain the red oxygen atoms.
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This interpretation is totally consistent with the emerging models for the mode
of action of a fusion peptide. It has been demonstrated that fusion peptides become
embedded in the target cell membrane before fusion occurs (e.g. Stegmann et al,
1991). Previous modelling work has suggested that viral fusion peptides insert
obliquely into lipid bilayers and thus cause some of the bilayer acyl chains that are in
close contact to the peptides to become tilted (Brasseur et al, 1988; 1990; 1997). This
oblique orientation of viral fusion peptides with respect to the bilayer plane has been
correlated with fusogenic activity (e.g. Martin et al, 1991, 1993. 1994, 1995;
Liineberg et al, 1995; Ishiguro et al, 1996). The tilting of the acyl chains could
precede a more dramatic change in lipid ordering, producing new lipid phases that are
thought to be associated with the initial events ofmembrane fusion. Martin and co¬
workers (1993) have also related the oblique insertion of a viral fusion peptide to the
promotion of the formation of inverted lipid phases. Furthermore, it has been
suggested that a possible mechanism by which obliquely inserted peptides may perturb
bilayer structures is by expanding the centre of the bilayer more than the bilayer
surface (Colotto et ah 1996). A suggested mode of action for this is precession by the
fusion peptide, that is the tracing out of an inverted cone-shape by its motion (Epand
et aL 1992). Figure 5.7 shows a model of this concept. This would greatly increase
the negative curvature of the target membrane's outer lipid monolayer. The increase
in negative curvature could cause the outer monolayer to bend towards the apposing
bilayer, and hence it would allow the closer approach of the two fusing membranes at
the stage when they are still initially distinct and also an increased area of contact
between the two membranes (Colotto et al, 1996). Further, it would facilitate the
formation of transient, highly bent lipid intermediates in the fusion pathway, such as
are described in the 'stalk hypothesis'. The concentration ofFeLV fusion peptide that
was used in these neutron studies (1 mol%) has been shown to promote the formation
of non-bilayer lipid phases significantly and to increase the negative curvature of lipid
monolayers (see Chapter 3). Since the lipid molecules in these neutron diffraction
samples were confined to a planar bilayer configuration, any changes in elastic
monolayer curvature forces would be expressed as effects on molecular packing. Thus
an increase in scattering density close to the bilayer centre and a
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reduction at the bilayer surface were observed. The results described here add support
to these hypotheses for the fusion mechanism. It must, however, be remembered that
the results produced by conventional diffraction techniques such as this one do not
distinguish between static and dynamic disorder: the observed effects of the fusion
peptide on lipid packing are the time-averaged effects. For the future, more detailed
information on the effects of this fusion peptide on lipid packing and molecular
configuration could be obtained by specific deuterium labelling of different regions of
the phospholipid molecules. This would map the lipid structure along the normal to
the bilayer plane, as the deuterated portion of the lipid would produce an intense peak
in the neutron density profile and hence it would be readily located in the membrane
(e.g. Zaccai et al, 1975: Worcester and Franks, 1976; Biildt et al, 1978), with a
potential accuracy ofgreater than ± lA (Biildt et ah 1978).
Figure 5.8 shows the distributions of'heavy' water within and between
bilayers of pure DOPC/DOPG and DOPC/DOPG plus peptide. These were obtained
by subtracting the neutron scattering density profile for each sample in 0% *TLO from
the scattering density profile for the same sample in 100% 2H20. The difference
profile for the 2Fl20 distribution due to the presence of the FeLV peptide is also
shown; this is calculated by subtraction of the 'heavy' water distribution for the pure
lipid sample from that for the lipid plus FeLV peptide. For clarity, the origin has been
shifted from the centre of the bilayer to the centre of the water distribution between
two adjacent bilayers. The 2H20 distributions should describe pairs of Gaussian
curves, with the maxima close to the centre of the region between adjacent lipid
bilayers This is indeed observed for both the pure lipid and the lipid plus peptide
samples. It can be seen, from a comparison of the pure lipid profile in Figure 5.6 and
the 2H20 distribution for the DOPC/DOPG profile in Figure 5.8, that water penetrates
some distance between the lipid polar headgroups, but that it is totally excluded from
the hydrophobic region of the lipid bilayer. This is consistent with previous findings
for pure lipid bilayers (e.g. Zaccai et ah 1975; Duff et ah 1993; Bradshaw et al,
1994).
The profiles in Figure 5.8 also show that the 2H20 distribution changes in the
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Figure 5.8. H20 distribution within and between bilayers
of DOPC/DOPG (solid line), and DOPC/DOPG with 1 mol%
FeLV peptide (broken line). The difference profile due to the
presence of the FeLV peptide is also shown (blue, dotted line).
Two phospholipid molecules are shown for orientation (the head
groups contain the red oxygen atoms).
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water distribution. This could be as a result of the occurrence ofbilayer thinning,
since adsorption of amphiphilic peptides to the headgroup region of a lipid bilayer can
cause membrane thinning (Heller et al, 1997). Adsorption of the peptides magainin 2
(Ludtke et al, 1995, 1996) and alamethicin (Wu et al, 1995) were shown to cause
lateral expansion of the headgroup region of a bilayer. The degree of bilayer thinning
is thought to depend upon the amount of lateral expansion that is caused by the
absorption of the peptide. The lipid chains are thought to adjust to this by trans-
gauche excitations. The lipid chain volume remains constant and thus the hydrocarbon
region of the bilayer thins.
Longo and co-workers (1997) have, very recently, developed a micropipette
aspiration assay by which they can measure the effects of the addition ofpeptides to
lipid vesicles. Their study, using the fusion peptide from Influenza virus, showed that
exposure of lipid vesicles to this fusion peptide resulted in a rapid expansion of the
area of the vesicles' lipid membranes. Furthermore, the rate of expansion of the area
of the lipid membranes by the Influenza virus fusion peptide was greater as the pH
was lowered to that at which Influenza-mediated fusion is optimal. This, therefore,
adds support to the concept of fusion peptides producing bilayer thinning.
A local thinning of the bilayer around an adsorbed fusion peptide might lower
the tension that is required for rupture of the TMC lipid intermediate in the fusion
pathway (Siegel and Epand, 1997). This would result in a more rapid formation of
fusion pores. TMCs are thought to be common lipid intermediates in two competing
pathways, namely the La-Hn and La-Qn transitions. The stability of the TMC may,
therefore, be central to the differential rate of formation of these two lipid phases. The
longer that TMCs exist, the more likely they are to aggregate and to form
quasihexagonal arrays ofHn precursors. On the other hand, if the TMCs are less
stable, they are more likely to rupture and form ILAs, or fusion pores. Bilayer
thinning by a fusion peptide might decrease the stability of the TMC by reducing the
cohesion of the lipid molecules locally.
In-plane neutron scattering work on magainin 2 has also suggested that the
lateral expansion of the headgroup region of a bilayer that is produced by this peptide
causes a bending of the lipid molecules, and the formation of a pore-like arrangement
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(Ludtke et al, 1996). This pore is very similar in structure to that of a fusion pore.
Thus some of the effects of the FeLV fusion peptide on bilayer packing could also be
explained by thinning of the bilayer. There is, however, no evidence for the formation
of an aqueous channel or pore in DOPC/DOPG bilayers by the FeLV fusion peptide at
the molar concentration ofpeptide used in these experiments. A channel or pore is
represented by a continuous band ofwater that spans the entire width of the lipid
bilayer, as seen, for example, with melittin (Bradshaw et al, 1994), Influenza virus M2
peptide (Duff et al, 1994) and salmon calcitonin (Bradshaw, 1997).
It is possible that pore formation might be seen at higher concentrations of
fusion peptide: work with other membrane-associating peptides, for example the 20
amino acid peptide alamethicin (Fie et al, 1995, 1996), has shown that the type of
membrane association adopted by the peptide depends upon the peptide
concentration. Thus, at low concentrations this peptide adsorbs to the surface of the
membrane, whilst at high concentrations the peptide inserts across the membrane and
hence forms pores. The proposed driving force for this transition is the energy cost of
membrane thinning (Huang, 1995). Similar findings have occurred for magainin
(Ludtke et al, 1995), and the authors suggest that the dependency of peptide-bilayer
interactions on the energetics of bilayer thinning should hold for a wide variety of
peptide/lipid systems. The length ofpeptide chain that is required to span a typical
lamellar bilayer, which has a thickness 30A, is ~20 amino acids, and so the 28-residue
FeLV fusion peptide is certainly of sufficient length to form pores in a bilayer. In view
of the possible involvement of this fusion peptide in the formation ofbiological fusion
pores, and the fact that oligomerisation of fusion proteins/peptides is thought to be
crucial to the formation of a stable fusion pore, it would be interesting to repeat this
study, using a range of lipid:peptide molar ratios, in order to determine if the FeLV
fusion peptide does indeed exhibit a biphasic type ofmembrane interaction. However,
the great tendency of this peptide to self-aggregate at high peptide concentrations
might well provide serious practical problems for this study. Further, self-aggregation
is likely to result in the formation of a population ofpeptide, which might not
associate with the membranes at all. The use of in-plane neutron scattering would also
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be very beneficial to determine whether membrane thinning and pore formation are
indeed effects of the FeLV fusion peptide.
Results obtained for samples ofpure DOPC with and without FeLV peptide
showed negligible effect for the fusion peptide on bilayer structure (data not shown).
All diffraction data are incomplete, due to the limitations of the instrumentation used.
Thus profiles that are calculated by Fourier transformation of this data show
termination errors which may show as a Fourier ripple (Duff et al, 1994). The DOPC
data did indeed show such ripples.
It is interesting to note that the fusion peptide had a significant effect upon
lipid packing in the DOPC/DOPG bilayers but not in pure DOPC bilayers. Circular
dichroism (CD) studies of the secondary structure of the FeLV fusion peptide showed
that it formed a very small amount ofa helix in the presence ofDOPC/DOPG
bilayers, and that its overall CD spectrum was of a more charcteristically P type. No
helical structure was seen for this peptide in the presence of pure DOPC bilayers, and
the overall CD spectrum was also less classically P in shape qualitatively (see Chapter
6). Whilst this difference is indeed very small, it might be significant in view of the
lack of reliability ofCD as a method of determination of peptide secondary structure,
other than that which is helix.
It would be of great interest to deuterate different amino acid residues of the
FeLV fusion peptide specifically and use these deuterated peptides for neutron
studies. It would thus be possible to locate the atomic coordinates of the deuterated
residues to a fairly high degree of accuracy, and hence to determine the depth of
penetration of the peptide into the lipid bilayer. The possible existence ofmore than
one population ofpeptide molecules within a sample, for example one population that
inserts into the lipid bilayer and another that lies along the bilayer surface, could also
be resolved.
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Chapter 6: Circular Dichroism studies to investigate the Possible
Secondary Structures and Structural Plasticity of the Feline




Proteins fold up into a remarkable variety ofwell-defined, three-dimensional
forms. The 'conformation' of a protein molecule is the specific three-dimensional
arrangement of atoms in such a structure, and it is this precise conformation which
bestows corresponding function. Thus, in the study ofproteins, a major aim is to
define their structure, and so discover how they work.
For most proteins, all of the information needed to define the conformation of
a protein molecule is contained within its amino acid sequence. It is possible,
therefore, to study the structure of an isolated, synthetic peptide that corresponds to a
peptide fragment within a protein molecule and, to a large extent, extrapolate from
these results to the structure of the native peptide fragment.
A peptide chain will fold in such a way as to minimise the free energy of the
system. The local spatial arrangement of the amino acid residues within a peptide is
known as its 'secondary structure', which involves recognised structural motifs.
Stability of secondary structure tends to arise from the simultaneous formation of
many intramolecular hydrogen bonds. The properties of the particular amino acid side
chains present and of the peptide bond also impose some restrictions upon the folding
of a peptide. Due to the sharing of electrons between its constituent carbon, nitrogen
and oxygen atoms, the peptide bond has tortional inflexibility. Thus it resists rotation
about its axis, and the peptide chain can only fold through rotations of the alpha-
carbon bonds (see Figure 6.1).
These factors lead to the potential for the formation of certain periodic
secondary structures by peptide chains. These are broadly classed as either a-helical
or p structures, the most extensive form of the latter being the p sheet (see Figure
6.2). The term 'random' structure is often used to describe non-regular peptide
structure.
As in the case of proteins, the determination of a peptide's secondary structure
is necessary in order to understand fully its biological mode ofaction. The use of
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Figure 6.2. Diagram of an alpha helix (a), and an antiparallel beta sheet
(b). Both of these secondary structures are stabilised by hydrogen
bonds, shown as dashed lines, in which a hydrogen serves as a bridge
between oxygen and nitrogen atoms. Adapted from Doolittle, 1985.
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of the different secondary structures adopted by a peptide in solution, and requires
only a small sample. For these reasons, it is an excellent technique for investigating
changes in the behaviour of a peptide in different solvents.
6.2 Theoretical Background
"Let not your left hand know what your right hand is doing"
Matthew 6:3
CD refers to the differential absorption of the left and right circularly polarised
components of plane, or linearly, polarised radiation, in the absence of a magnetic
field (Price, 1996).
As mentioned in Chapter 3, electromagnetic waves may be considered to
possess two wave motions that are at right angles to each other, namely an electric
component and a magnetic component (see Figure 3.3). In contrast to NMR, CD is
concerned, in the main, with the electrical properties of electromagnetic radiation.
The electric vector of electromagnetic radiation rotates about the direction of
propagation, executing one full revolution in one wavelength of the light wave. Plane,
or linearly, polarised radiation has an electric vector which is confined to a plane
perpendicular to the direction of propagation. Plane polarised radiation can also be
considered to be composed of a right and a left circularly polarised beam, which have
equal amplitude and are in phase. Conversely, a circularly polarised beam consists of
two perpendicular, plane polarised beams ofequal amplitude that are 90° out of phase
(see Figure 6.3). Thus the electric vector of a right circularly polarised beam (see
Figure 6.4a) will trace out a right handed helix along the direction of propagation (see
Figure 6.4b), and to an observer looking towards the light source, the electric vector
will rotate in a clockwise direction (see Figure 6.4c). Left circularly polarised light has
the opposite characteristics.
Dichroism ofcircularly polarised light results when the absorbance of a
medium varies with the direction of rotation of a circularly polarised beam (Warren,
1987). Ifplane polarised light is transmitted through such a material, then after the
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Figure 6.3. Circularly polarised radiation, produced by the electric vectors of










Figure 6.4. Right circularly polarised light, a) two electrical perpendicular
vectors 90° out of phase, b) the position of the resultant sum of the electrical
vectors along the direction of propagation, c) the sum of the electrical vectors
traces out a circular path when viewed along the axis of propagation towards
the light source.
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left and right beams have passed through the sample, their sum is no longer a plane
polarised beam but is elliptically polarised (see Figure 6.5). The difference in
absorption, AT, which is the parameter that is measured experimentally, is defined as:
AA=Al-Ar 6.1
where AL and AR are the absorbances of the left and right beams. CD results are
expressed either as the difference in molar absorbance, A^=£L -£r. (i.e. ctrf'.M"'), or
as the mean residue ellipticity [0]m™a- This latter parameter is defined by the
following:
[0]mnv,x = MRWe 6.2
10 dc
where MRW is the mean residue weight, that is the molecular weight divided by the
number of peptide bonds present (the peptide bond is the repeating unit of interest,
see later), 0 is the observed ellipticity, d is the path length in cm, and c is the
concentration (g/ml). Thus the units are deg.cm~.dmor1.
To exhibit differences in absorption of left and right circularly polarised light, a
molecule must be chiral. that is its mirror image cannot be superimposed upon it, and
thus it must lack any elements of reflection symmetry. Since left and right circularly
polarised light beams have helical symmetry themselves, an asymmetric molecule will
present a different polarisable medium to the two beams. These chiral groups are
termed intrinsic chromophores. an example being the peptide bond (see Figure 6.1).
The peptide bond absorbs light in the far ultraviolet (UV) region, in the range
of 180-240nm. The spectral properties of a peptide in the far UV mainly depend upon
the molecular environment and the mobility of the peptide bonds. Thus the different
principal types of secondary structure adopted by peptides give rise to characteristic
CD spectra in the far UV. CD can thus be used to determine the presence of these
different secondary structures within a peptide.
The origin of the CD absorption bands is explained as follows. In the far UV
region of the electromagnetic spectrum, the interaction of radiation with electrons of a
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peptide causes a redistribution of electron density and a reduction in the velocity of
the radiation. At certain frequencies v, the photon energy of the incident radiation will
satisfy the condition AE = hv. where AE is the energy difference between the ground
state and the electronic excited state, and the electron will undergo a transition into
the excited state. This transition is characterised by the frequency or wavelength at
which it occurs, and the magnitude of the electronic displacement involved. Thus the
electronic absorption spectra approximate to a collection ofdiscrete lines,
corresponding to such transitions. In solution the CD spectra are broadened by
interaction of the chromophore with the solvent, and smooth curves are obtained with
defined band shape. Each CD band is characterised by its wavelength or frequency at
which maximum light absorption occurs, by its intensity, which is the peak value for
the band and which may be positive or negative, and by its shape. CD spectra of
peptides in solution usually contain bands that represent sets of overlapping electronic
transitions.
Electronic transitions from the ground state to the excited state involve a
linear displacement of charge. To produce CD, a transition must involve both a linear
and a circular displacement of charge, with the two motions having a common vector
component. The circular displacement of charge generates a magnetic field and is thus
the magnetic component. This combination of linear motion along an axis with
circular motion about the same axis produces a helical charge displacement (see
Figure 6.6). The direction of rotation of the helix will be determined by the relative
signs of the electric and magnetic components. Thus, when this criterion is met, left
and right circularly polarised beams will interact differently with peptide molecules in
solution, and this will manifest as a difference in absorption. This helical charge
displacement only occurs for asymmetrical molecules.
The amide group has three n orbitals, as shown in Figure 6.7. With four n
electrons there will be two 7nr* transitions. The transition into the lowest n* orbital is
represented by the 190nm peptide band. Electronically this transition is mainly
accounted for by the displacement of n electron density from the region of the
nitrogen atom into the n* orbital, where it is located mainly on the carbon and oxygen
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Figure 6.7. The molecular orbitals of the amide group comprise 3tt orbitals
and two lone pairs. The 7t0 n* transition occurs near 190nm, and the nrc*
transition near 220nm. The other possible transitions have yet to be
definitively identified.
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oxygen. The highest energy lone pair (n orbital) is largely localised on the carbonyl
oxygen. The nn* peptide transition involves the transition of an n electron into an
orbital ofn* symmetry. Of the two non-bonding orbitals associated with C=0, it is
the axial n„ orbital which acts as hydrogen-acceptor, and the npr which contains the
optical electron (Bayley, 1973). The transition from Py symmetry to Pz symmetry
constitutes a rotation of charge about the C=0 bond (Bayley, 1973). The lack of
linear displacement means that this band is very weak in absorption. In peptides this is
seen as a CD band lying near 220nm.
A peptide bond is always optically active, regardless of the surrounding
chemical groups. The latter can, however, modify the optical properties of the peptide
bond. Thus, ifpeptide bonds are near each other in space, the transition dipole
moments can interact, which causes a splitting of the absorption bands (Campbell and
Divek, 1984). Any changes in the angle between adjacent groups will alter the
transition probability, the position of the absorption bands and also the rotational
strengths (Campbell and Divek, 1984). Thus for a given configuration, the optical
properties of two interacting peptide bonds will show marked dependence upon
conformation for both the nn* and rcrc* transitions. Hence it can be seen that the CD
spectrum is very sensitive to peptide secondary structure.
A major class ofpeptide secondary structure is the a helix (see Figure 6.2a).
The CD spectra for all a helices show negative bands at 222nm and 209nm, and a
positive band at 190nm (see Figure 6.8). These have been attributed to three major
effects: the mr* transition (222nm) (Schellman and Oriel, 1962; Woody and Tinoco,
1967) and two of the 7t7i* transitions (209nm and 190nm) (Rosenheck and Doty,
1961).
The p sheet has a different and characteristic spectrum (see Figure 6.8). The
negative band near 215nm is attributed to the nn* transition, whereas the nn*
transitions are thought to be responsible for the positive band near 198nm and the
negative band near 175nm. The CD spectra of p structures are, however, less well
defined than that of the a helix. They are weaker and, moreover, the p structure
shows strong reliance upon environmental conditions for its optical properties. In




















Figure 6.8. Characteristic CD spectra of the helix (H), p-form (p), P-turn (pt)
and unordered form (R). Reproduced from Chang et al, 1978.
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sheets are near enough to interact, and distinguishing properties are predicted for the
two structures (Woody, 1969). Thus, since both arrangements exist in biological
proteins, there is more variability in the optical properties of this secondary structure
group, and hence quantitative estimates are less reliable than for a helices. This is also
true for p turns.
The random coil peptide conformation displays, not surprisingly, optical
properties that are strongly non-conservative. There is still much debate as to the
precise origin of the CD bands seen for random coils, but the pronounced negative
band at 190nm (see Figure 6.8) is thought to represent the nn* transition, and the
weak positive band at 217nm is considered to represent the nn* transition (Bayley,
1973).
The CD spectrum of a peptide or protein molecule in the far UV region can be
represented as a linear combination of the different elements of secondary structure,
according to the equation:
[0(7.)] =fami)] +/p[0p(X)] +/[©,(>.)] +/n[0n(X)] 6.3
where [0//.)]. [0p(7,)],[0t(7,)] and [0n(7.)] are the basis spectra for a helix, p sheet,
turn and non-regular structures, and the/ are the respective fractions of these
structural elements (Schmid, 1989). The coefficients/ are obtained by solving this
equation simultaneously at a set of selected wavelengths. The major errors of this
procedure he in the choice of standard reference spectra. In the late 1960's, model
polypeptides were used to represent the different classes of secondary structure. The
structures of these model polypeptides were known from X-ray crystallography data,
and it was also assumed that each polypeptide only adopted a single conformation in
solution. The three forms ofpoly-Z-lysine were used, which show a helix, p sheet and
random coil conformations. Multicomponent analysis was then performed, in order to
calculate the secondary structure of the protein of interest. This analysis method
involved simulation of the sample protein's CD spectrum by suitable graphical
addition of the three standard curves. Thus:
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S = a[a] + 6[p] +r[R] 6.4
where a is the a helix, (3 the p sheet and R the random coil components.
The variation of a, p and R with wavelength is taken from suitable standards, and
then a, b and r varied so as to obtain a fit to the experimental curve over the entire
wavelength region.
The problem associated with this method is that real proteins and peptides
may not possess the exact geometrical configurations of those in the standard models.
CD properties depend upon the length of the secondary structural elements. The CD
spectrum of the peptide bond may also be influenced by the presence ofaromatic side
chains, disulphide bridges and prosthetic groups in the sample protein or peptide.
Furthermore, the peptide bond may exist in conformations other than the three forms
that are examined in the reference polypeptides.
More recent approaches are based on sophisticated fitting procedures that use
data sets comprising spectra ofwell-characterised proteins, whose secondary
structures are known. In order to improve accuracy, Chen and co-workers (Chen et
al, 1974) introduced an empirical factor that was dependent upon chain length for the
helix spectrum, and Chang et al (1978) added the |3 turn class. The CONTIN method
ofProvencher and Glockner (1981) avoids the problem of trying to define single
reference CD spectra that are supposed to characterise such broad and variable
classes as helix, sheet, turn and remainder, and thus permits a more flexible and
accurate analysis. Instead, it uses a linear combination of the CD spectra of 16
reference proteins for a direct analysis of the CD spectrum of a protein. (The
secondary structures of the 16 reference proteins have been determined to a high
resolution by X-ray crystallography.) Standard proteins range from highly a-helical
proteins, such as myoglobin (79% a helix, 0% [3 sheet by X-ray) to those such as
concanavilin A, which contain large amounts of P sheet (2% a helix, 51% (3 sheet by
X-ray). A thorough analysis of the CONTIN procedure showed that the a helix and p
sheet contents could be estimated fairly reliably when considering data over the range
of 190nm to 240nm; the percentages of p turns and remainder (random structure),
however, were much less well calculated. As a general rule, the accuracy of the results
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obtained is better for proteins which consist ofmainly a helix or mainly (3 sheet
conformations than for those which contain similar proportions of these two types of
structure. Also, the most reliable results are likely to be obtained when a related, well
characterised protein can be employed as a reference.
6.3 Practical considerations for CD
A diagram of a typical CD machine is shown in Figure 6.9. The light source is
usually a xenon arc lamp. The light is plane polarised by passage through prisms. The
phenomenon ofCD could be detected by a double beam instrument containing two
independent beams of left and right circularly polarised light. It is possible, however,
to split plane polarised radiation into its components using a crystal that can be made
to pass either right or left polarised light, depending upon the applied voltage of an
electric field. This electro-optic crystal, usually composed of ammonium dihydrogen
phosphate (Pockel's cell), comprises the high frequency modulator, which alternately
transmits each of the two circularly polarised light beams. A modulator was used in
the experiments described in this thesis. A double monochromator arrangement
reduces stray light. Nitrogen gas is used to flush the instrument both before switching
on the lamp and during measurements. This minimises the damage to the optical
system, and also removes as much oxygen as possible from the sample compartment,
which is important as oxygen absorbs strongly below 200nm.
Once the beam has passed through the sample, it is enhanced by a
photomultiplier. If a sample displays CD, the periodic variation in the polarisation of
the beam produced will lead to a periodic change in the extent of absorption and
hence in the light level reaching the photomultiplier. This leads to a small alternating
current in the photomultiplier output, which can be further amplified. This ac
component is proportional to the difference in absorption of the left- and right-
circularly polarised light. The detected signal can then be processed to give a CD
spectrum, which is a plot of AA or 9 as a function ofwavelength. Corrections for any
signals due to cuvettes and buffers are made by running the appropriate blanks, and
subtracting these signals from the sample signal.
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Proteins produce very small differences in absorption: usually around 10~4 to
10"6 absorbance units for a sample with a total absorbance of 1 unit (Schmid, 1989),
which means that less than 0.1% of the total absorbance signal must be measured with
a high degree ofaccuracy and reproducibility. Thus great care is needed in both the
control of experimental conditions and sample preparation.
The size of the CD signal depends upon the amount ofprotein or peptide
present, and therefore to optimise the signal-to-noise ratio, the protein or peptide
should provide as large a contribution as possible to the total optical density of the
sample. Thus the absorbance by the solvent should be as small as possible. The choice
of solvent is crucial, as some common buffers absorb strongly in the UV region. A
solvent blank should always be run first, to check that this is not a problem. Solutions
must be clarified by centrifugation or by passage through a ~0.2pm filter. Fused
quartz cuvettes are used to hold the sample; these are highly transparent below
200nm.
The total sample absorbance must be maintained at less than 1 absorbance
unit. This is usually achieved by using small sample cell lengths, often around 0.01 -
0.02cm. Numerous scans, usually 2 to 4, of a sample are performed, which improves
the signal-to-noise ratio. Scan rates must be kept fairly slow, at around lOnm/min, to
allow the use of a high time constant, and thus the accumulation ofmany
measurements. Finally, the spectral bandwidth used should be narrow, to allow good
resolution ofwavelength.
6.4 Application of CD to Fusion Studies: Aims of these CD Experiments
A viral fusion peptide, which comprises a span of relatively hydrophobic
amino acids, is thought to insert into the target membrane of its host cell and disrupt
bilayer stability, so initiating the fusion process (Brasseur et al, 1990). In the
preceding chapters, experimental work using the FeLV fusion peptide has provided
support for this membrane destabilising effect. Translocation from an aqueous
environment, such as extracellular fluid, to a lipid environment, such as a biological
membrane, is likely to involve substantial structural alterations of a peptide. Many
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proteins and peptides insert into membranes, and concomitantly alter their own
secondary structure, but they do not trigger extensive changes in the arrangements of
the lipid molecules in their target membranes. This poses a question; namely, what
features of the structure of a fusion peptide confer upon it these specific functional
properties?
There is much conflicting evidence on the active secondary structure of fusion
peptides. A modelling study of several viral fusion peptides assumed that they
completely formed a helices upon insertion into a membrane (Brasseur et al, 1990).
The resulting theoretical calculations suggested a favourable free energy for the
oblique insertion of'sided' helices at a shallow angle into the bilayer. Such 'sided'
helices have the majority of their more bulky, hydrophobic residues distributed on one
side of the a helix. Gallaher and co-workers (1992), however, have cautioned against
the earlier assumption that all fusion peptides are 'sided' helices in their active form.
Indeed, the Measles virus fusion peptide was found to adopt a conformation of 73% (3
sheet in one study (Epand et al, 1992) and, under different experimental conditions,
fusion peptides from different strains ofHIV have been shown to be mainly a-helical
(Rafalski et al, 1990), or conversely mainly (3 sheet (Nieva et al, 1994b), in then-
active forms. Hepatitis B virus fusion peptide favours a [3 sheet conformation in the
presence of lipid vesicles (Rodriguez-Crespo et al, 1996), as does PH-30, a sperm
fusion peptide involved in sperm-egg fusion (Muga et al, 1994). It thus appears
possible that viral fusion peptides may not all share a common active secondary
structure. One aim of the CD studies in this chapter, therefore, was to determine the
active secondary structure of the FeLV fusion peptide.
The conclusion drawn from the studies described above is that fusion peptides
change from one defined, inactive secondary structure to another different, and
equally well-defined, active secondary structure. None of these studies examined the
same viral fusion peptide in a whole range of different solvent systems. Since
membrane fusion is a dynamic process, involving large changes in the component
molecules, it is also possible that structural plasticity may be an essential property of
these initiators of fusion. The FeLV peptide contains significant numbers ofamino
acids that characteristically favour three different secondary structures, namely the a
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helix, the p sheet and a coiled conformation. It could be postulated that this would
lead to a large amount of dynamic structural flexibility for the FeLV fusion peptide.
Indeed, computer modelling work has suggested that this might be an important
factor for fusion peptides in general (Callebaut et al, 1994). Thus another aim of the
CD work reported in this thesis was to examine the secondary structure of the FeLV
fusion peptide in a variety of environments of differing hydrophobicity, and hence to
determine any changes in peptide secondary structure asscoiated with changes in
environment. The ultimate goal was to link peptide structure to function.
6.5 Materials and Methods
6.5a Sample Preparation
Samples for liposome studies
The far UV CD spectra ofproteins and peptides are much stronger than those
of lipid molecules. It is possible, therefore, to study the secondary structure of
peptides that have been reconstituted into membranes or LUVs.
Previous fusion studies have suggested that the type of lipid present in the
target membrane can affect the fusogenic capacity of certain viruses (e.g. Larsen et al,
1993; Novick and Hoekstra, 1988), and, more specifically, of certain viral fusion
peptides (Martin et al, 1991, 1993). Thus, in order to determine any effects of the
type of lipid on the secondary structure of the FeLV fusion peptide, several different
lipids were used to prepare the LUVs:
1) pure DOPC (a zwitterionic and thus neutral lipid, and the single most
physiologically representative lipid species).
2) DOPC present at a 50:50 molar ratio with one of the following:-
a) DOPE (PEs are fusion promoting lipids, and have been used for most of the
biophysical studies in this thesis; PE is necessary for HIV-induced fusion between
LUVs (Martin et al, 1993).
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b) DOPG (PGs are negatively charged lipids; a variety ofPGs have been used in
previous CD studies of fusion peptides and DOPC:DOPG bilayers were used in the
neutron studies described in Chapter 5 of this thesis).
c) dioleoylphosphatidylserine (DOPS) (PSs are also negatively charged and are
common constituents ofmammalian cell membranes).
Proteoliposomes containing the FeLV fusion peptide and a variety of different
pure lipid species were prepared in the following manner. Initially, a lipid:peptide
molar ratio of 50:1 was chosen, as this ratio is commonly used in fusion assays. The
50:1 ratio did not, however, yield a sufficiently strong signal-to-noise ratio, and so the
lipid molar fraction was progressively reduced until a good peptide signal was
produced. The final lipid:peptide molar ratio was thus 12:1, with a peptide
concentration of lmg/ml.
Dried lipid films were prepared using the required amounts of peptide and
chosen lipids, as described in Chapter 2. Detergent dialysis was then used to prepare
the proteoliposomes (New, 1990; Nordmeier et al, 1992). This method has the
disadvantage that it is virtually impossible to remove every detergent molecule from
the final preparation, and these may influence the interactions between the peptide and
the lipids. However, it was found to be impossible to use the 'cleaner' method of high
pressure extrusion through stacked polycarbonate filters (Hope et al, 1985) to
produce proteoliposomes containing the FeLV fusion peptide. This was because large,
uncertain quantities of the peptide became trapped in the filters, which led to very
poor peptide signals for samples of unknown peptide concentration. The detergent n-
octyl glucopyranoside (OG) was chosen to use for the dialysis regime as it does not
show strong light absorbance in the UV region. A solution ofOG at a final molar
concentration of four times that of the lipid (Sizer et al, 1987) was prepared in Tris-
HC1 buffer (lOmM Tris-HCl, 0.1mM EDTA, 0.001% sodium azide, pH 7.4). Low
molarity Tris-HCl buffer (<20mM) also has a relatively low absorbance above 190nm
in cells ofpath length 0.1cm or less.
The dried lipid films were dissolved in the detergent solution and sonicated
briefly to ensure thorough mixing and micelle formation. Next the samples were
dialysed at length against Tris-HCl buffer. Four consecutive 51 flasks ofpH 7.4 Tris
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buffer were used and were changed after 6, 12, 24 and 48 hours. After 24 hours of
dialysis, the dialysate was seen to become cloudy: this occurrence has been used to
ascertain the formation of liposomes using spectrophotometry (Huang, 1971). Finally,
after 90 hours of dialysis, the dialysate was transferred to centrifuge tubes and
centrifuged to remove any MLVs present. The resulting supernatant was used for the
CD measurements.
Samplesfor solvent studies
All chemicals were supplied by Sigma Chemical Co., UK. FeLV fusion peptide
was added to produce a concentration of lmg/ml to (a) 2M guanidine/50% ethanol, a
solvent often used in order to dissolve a fusion peptide for addition to fusion assays,
(b) trifluoroethanol (TFE), and (c) hexa-fluoroisopropanol (HFIP). TFE and HFIP
promote intramolecular hydrogen bonding at the expense ofhydrogen bonds with
water, and thus they promote formation of secondary structures in peptides. These
samples were then diluted 1:1 with distilled water, giving a final peptide concentration
of 0.5 mg/ml. Peptide was also added to sodium dodecylsulphate (SDS) at
concentrations of (c) 3mM and (d) 6mM in distilled water, to give a final peptide
concentration of 0.5mg/ml. SDS is a detergent, and thus forms micelles at
concentrations approaching and above its critical micellar concentration (CMC).
Lastly, the resulting suspensions were sonicated in a bath sonicator until the peptide
dissolved. TFE, HFIP and SDS all show little absorption in the UV region. Guanidine,
however, absorbs strongly below 205nm, and so the spectrum for this sample was set
at zero below this wavelength.
Negative staining transmission electron microscopy was used to examine the
peptide samples used in the solvent study to confirm the presence of (3 structure. The
peptide solutions were dried onto plastic-coated carbon grids, and then negatively
stained using 4% sodium phosphotungstate at pll 7.2. These stages of the sample
preparation for EM were performed by Mr. S. Mitchell, R.(D).S.V.S, University of
Edinburgh, EH9 1QH. A Philips 400 TEM was used to examine the samples, at
80kV, and x 60,000 magnification. Negative controls were performed by staining an
empty plastic-coated carbon grid, and also by staining the corresponding pure solvent.
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6.5b Circular Dichroism
CD spectra were recorded using a JASCO J-600 spectropolarimeter, over the
wavelength range 195-260nm, in a cell ofpath length 0.02cm, at 25°C. At least 4
spectra were averaged for each sample. A similar number of blank spectra were also
recorded for each sample in order to allow the subtraction of solvent and liposomal
contributions to the corresponding sample spectra. The blank samples contained the
same type and amount of solvent and, when appropriate, of liposomes, as were
present in the corresponding peptide sample. This produced difference spectra, which
were due purely to the FeLV peptide. Data points were recorded and plotted at 0.2nm
intervals. The raw data curves were smoothed and the data converted into molar
ellipticity units for analysis of secondary structural content. This analysis utilised the
CONTIN procedure of Provencher and Glockner (1981) to determine the amounts of
a helix and p sheet present. The method of Chang et al (1978) was used to verify the
overall trend in a helix contents. All CD measurements were performed at the CD
facility at Stirling University, Stirling, FK9 4LA, U.K. with expert technical assistance
from Dr. S.M. Kelly.
6.6 CD Results and Discussion
The far ultraviolet CD spectra of the FeLV fusion peptide in the various
liposomal preparations are shown in Figure 6.10. Satisfactory data could only be
obtained down to 195nm; below this wavelength the noise levels produced by vesicle-
induced light scattering prevented accurate determination ofellipticity. This
significantly reduces the reliability of estimates of secondary structures other than the
a helix.
Table 6.1 lists the percentages ofa helix, as determined by the two
independent analysis methods ofProvencher and Glockner, (1981) and Chang and co¬
workers (1978). The amount of p sheet is also quoted, as obtained by the analysis of
Provencher and Glockner, but, as mentioned above, the exact figures quoted for this
secondary structure should be viewed with caution. A further error may lie in the fact
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Table 6.1. Percentages ofFeLV peptide secondary structure in liposomal
suspensions of different phospholipids, as calculated by the methods of
Provencher and Glockner, (1981) and Chang et al, (1978).
Sample
FeLV peptide (lmg/ml) in
LUVs composed of:
% secondary structure as calculated by the methods of:
Provencher & Glockner Chang et al
(helix, sheet) (helix)
pure DOPC 0,71 0
DOPCDOPE 0, 79 0
DOPCDOPS 1, 66 3.1
DOPCDOPG 1, 73 22
Table 6.2. Percentages ofFeLV peptide secondary structure in a range of
solvent systems, as calculated by the methods ofProvencher and




% secondary structure as calculated by the methods of:
Provencher & Glockner Chang et al
(helix,sheet) (helix)
1M guanidine in
25% ethanol 0, nd* 0
50% TFE 20, 36 16
50% HFIP 30, 35 22
3mM SDS 2, 57 11
6mM SDS 12, 47 14
*The value for the sheet content of this sample could not be determined using the
method ofProvencher and Glockner without an unacceptably large error.
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that it may be inappropriate to apply to peptides methods of analysis that have been
derived for proteins. It is also possible that the amounts ofhelix present may be
underestimated, as up to two-fold reductions in ellipticity have been found in
membrane-bound proteins (Glaeser and Jap, 1985). Thus the amounts ofhelix quoted
here should be viewed as the minimum amounts ofhelix present in the various
samples.
It appears, from the results obtained in these experiments, that the FeLV
fusion peptide adopts a mainly p sheet structure in the presence of liposomes that are
composed of a range of different lipid species. No detectable a helix is formed in the
presence ofuncharged vesicles, even those containing 50 molar% PE. Very small
amounts ofhelical peptide are detectable in both types ofnegatively charged
proteoliposomes. Selection of distinct conformations, which depend upon the lipidic
environment, is characteristic ofmany membrane peptides and proteins (Surewicz et
al, 1992). It is well known that the surface pH in negatively charged vesicles is lower
than in bulk solution. This can affect the binding affinity ofpeptides and proteins to
lipid bilayers, and also the conformation adopted by the bound peptide or protein (e.g.
Spuhler et al, 1994; Leenhouts et al, 1995; Dunne et al, 1996; Pinheiro et al, 1997).
These four studies found that peptides, which contained negatively charged residues
at their interfacial regions, showed a marked prefence for binding to anionic vesicles.
This surprising discovery was explained by the creation of an increased proton
concentration at the anionic surface, which would result in protonation and charge
neutralisation of the negatively charged residues of the peptide, thus increasing the
hydrophobicity of the peptide. The differences noted here for the FeLV fusion peptide
are extremely small, however, and further studies are required to determine whether
this difference is significant. The estimate of helix content for the FeLV peptide in the
DOPC:DOPG sample as calculated by the method ofChang et al is at wide variance
with that ofProvencher and Glockner, and qualitatively seems unlikely on inspection
of the plotted spectrum for this sample. The DOPC:DOPG spectrum shows many
features that are classicallly (3 in character.
Previous studies of the HIV fusion peptide have suggested that the (3
conformation may be the active secondary structure for fusogenic activity. Thus Nieva
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et al (1994b) studied the fusion peptide ofHIV type-1, LAVia strain. They found that
the secondary structure of this peptide was an extended, antiparallel P structure under
the same experimental conditions that enabled it to promote fusion between negatively
charged LUVs. Moreover, when the HIV peptide induced leakage from vesicles
rather than fusion, an a-helical structure was observed. The a helix conformation has
been previously suggested to be associated with pore formation by peptides in vesicle
membranes (e.g. Lear et al, 1988; Degrado and Lear, 1990). Nieva and co-workers
thus proposed that it was the extended p structure that rendered the vesicles
susceptible to fusion, and that this peptide structure was likely to reside primarily at
the lipid-water interface, since in membrane proteins, transmembrane P structures
tend to be the exception rather than the rule (Unwin, 1993).
Rafalski and co-workers (1990) also studied the fusion peptide of the same
HIV strain. Using POPG vesicles, which do fuse in the presence of this peptide, and
fairly low lipkkpeptide ratios (30:1), their results demonstrated a P peptide
conformation for this peptide, but at higher lipkkpeptide ratios of about 200:1, the
peptide adopted an a-helical structure. Furthermore, in the presence ofPOPC
vesicles, which are not induced to undergo fusion by this peptide, the peptide adopted
a P conformation, regardless of the lipkkpeptide ratio.
Pereira and colleagues (1997) studied the interaction of the HIV LAVia strain
fusion peptide with neutral LUVs composed of a mixture ofDOPC, DOPE and
cholesterol. For this vesicle system, the fusion peptide adopted an extended p
structure under different experimental conditions that supported either peptide-
induced vesicle fusion or vesicle leakage. Moreover, the secondary structure of the
peptide was not affected by the peptide concentration, which is at variance with the
results of Rafalski et al (1990). One important difference in the experimental
protocols used by the two groups is that Rafalski and co-workers prepared
proteoliposomes, whereas Pereira et al added their peptide to prepared pure lipid
vesicles. The latter group suggest that it may be better to study the structure of a
peptide after partitioning of the peptide from the aqueous phase, in order to account
for any possible effects of the bilayer interface on the adopted peptide conformation.
However, when peptide is added to a LUV suspension, peptide-peptide interactions
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are favoured with respect to peptide-lipid interactions, and this may affect the
fiisogenic activity of the peptide (Martin et al, 1993), particularly that of very
hydrophobic fusion peptides, which have a very strong tendency to self-aggregate in
aqueous solutions. Self-aggregation has been noted previously by Slepushkin et al
(1992) and by Nieva et al (1994a). It appears that this self-aggregation is irreversible.
It has also been a serious problem when working with the FeLV fusion peptide.
Another important difference in the experimental protocols used is that Pereira et al
used a very low lipid:peptide ratio of 10:1, which further increases peptide-peptide
interactions.
Work on other fusion peptides has also demonstrated a possible role for the P
structure in fusion. Epand et al (1992) ascertained that the fusion peptide from
Measles virus displayed 73% P structure, but this was at a low lipid:peptide ratio
(6:1). As another example, the structure of the fusion peptide ofHepatitis B virus was
examined by Rodriguez-Crespo et al (1996) and found to be a highly stable P sheet in
the presence of negatively charged vesicles. Finally, the fusion peptide from PH-30,
which is the putative fusion protein ofmammalian sperm, adopted a P conformation
on binding to both neutral and negatively charged lipid vesicles (Muga et al, 1994).
Signal sequence peptides, like fusion peptides, must insert into membranes in
order to function. Reddy and Nagaraj (1989) studied certain of these sequences in a
variety of solvent systems. They found that increasing amounts of P structure were
seen on increasing the hydrophobicity of the peptide's environment. Moreover, a non¬
functional mutant peptide did not show P structure in a hydrophobic environment.
Further, relatively recent support for the ability ofpeptides that are in a P-type
conformation to destabilise membranes comes from work by White et al (1995) on
the interaction with vesicles of the antimicrobial peptides defensins. It thus appears
possible that peptides can function in a hydrophobic environment when present in a P
conformation.
Conversely, a correlation between a-helical secondary structure and fusion
activity has also been shown for several fusion peptides. Thus Lear and Degrado
(1987) studied a 16 and a 20 amino acid peptide which corresponded to regions of the
Influenza virus fusion peptide. The 20 amino acid peptide was fusogenic at low pH,
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and adopted an a-helical structure when bound to POPC vesicles. Furthermore, the
amount ofhelix formed increased at low pH. The 16 amino acid peptide neither
adopted a helical structure nor promoted vesicle fusion.
Takahashi (1990) studied various synthetic peptides which were closely
related to the Influenza virus fusion peptide. Each of the peptides that could promote
vesicle fusion adopted an a-helical conformation when bound to lipid membranes.
Luneberg et al (1995) also demonstrated that the Influenza virus fusion
peptide adopted an a-helical conformation upon insertion into lipid bilayers, as did
Gray and co-workers (1996). The latter group studied several fusogenic and non-
fusogenic mutants of this peptide as well. They found that the non-fusogenic mutants
had larger p/a ratios, with the non-fusogenic mutants having about 50-60% P
structure.
Rafalski et al (1991) investigated the secondary structure of the Influenza
virus fusion peptide and also the 2 mutant peptides, El and E4, which were studied in
whole virus work by Gething and co-workers (1986) (see Chapter 1). They correlated
the adoption of an a-helical structure with the promotion of fusion between LUVs by
these peptides.
Martin et al (1993, 1996) studied the fusion peptide ofHIV. In contrast to the
results ofNieva and co-workers (1994b) described above, an a-helical structure was
seen after interaction of the fusion peptide with LUV: the HIV peptide adopted 99%
P sheet and 0% a helix in dimethylsulphoxide (DMSO), but 25% a helix in the
presence ofLUVs. Similarly, Martin and co-workers demonstrated that the fusion
peptide of SIV also adopts an a-helical structure under experimental conditions which
enable it to promote fusion ofboth SUVs (1991) and LUVs (1994).
Clearly there is conflicting evidence as to the active secondary structure of
viral fusion peptides. Whilst it is quite possible that distinct viral fusion peptides adopt
different fusogenic conformations, due to differences in their primary structures, the
results of certain studies that were performed on the same fusion peptide by different
research groups provide opposing ideas on the active secondary structure of that
particular peptide. This may be due to a lack of a systematic approach. Thus
individual research groups use different experimental protocols: the types of lipids and
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vesicles, the lipid:peptide ratio, the presence or absence of cations and the lengths of
peptide fragments can all alter the dominant secondary structure of a fusion peptide.
Moreover, filtration, or density flotation and centrifugation, to remove the non-lipid
bound peptide is essential if the recorded spectrum is to be assigned purely to the
membrane-associated peptide.
The proteoliposomes that were used in this study of the FeLV peptide's
conformation were prepared by extensive dialysis. This should have removed any free
peptide molecules, unless they had aggregated into very large masses. In view of the
fact that proteoliposomes were prepared, and thus the peptide and lipid were dried
down together to form a film, it seems unlikely that large peptide aggregates would be
present. However, the lipid:peptide ratio was low, which does tend to increase
peptide-peptide interactions. In the absence of electron microcopy studies of the
samples, or re-examination of the same samples after filtration or centrifugation, it is
not possible to exclude fully the possibility that some of the peptide present was in the
form of peptide aggregates that were closely associated with the membrane surface.
Further studies are required in order to determine the active secondary structure for
this fusion peptide more definitively. Specifically, variation of the lipid:peptide ratio
would be useful, since an increase in this ratio will tend to favour partitioning of the
peptide into the membrane. This may alter the proportions of the different secondary
structures present in the peptide population. Examination of samples before and after
filtration, or density flotation and centrifugation, to determine any changes in the
relative amounts of the different secondary structures present would also be
necessary, and the use ofFourier transform infrared spectroscopy (FTIR) would be
very helpful, as this technique is much more accurate than CD at estimating the p
content of a sample, and, unlike CD, it is not affected by light scattering by vesicles.
The amino acid sequences ofmany fusion peptides suggest that these peptides
may show particular diversity in their range of possible secondary structures
(Callebaut el al. 1994). In order to examine this hypothesis, the secondary structure
of the FeLV fusion peptide was determined in a variety of solvent systems ofvarying
hydrophobicity.
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The far ultraviolet CD spectra of the FeLV fusion peptide in the various
solvents are shown in Figure 6.11. Once again, satisfactory data could only be
obtained down to 195nm. The CD spectra exhibit an increase in a-helical character on
changing from 1M guanidine/25% ethanol, through a selection of increasingly
hydrophobic solvents, to 50% HFIP. In the guanidine/ethanol sample, the peptide
produced a CD spectrum that was characteristic of random coil secondary structure.
This is to be expected for a hydrophobic peptide in a polar solvent that contains a
chaotropic agent. Short peptides are usually unordered in aqueous solution because of
strong water-peptide backbone interactions. To minimise these interactions, and to
mimic the environment within a lipid membrane, surfactants or organic solvents are
used.
SDS micelles provide a similar anisotropic environment to lipid vesicles
(Tanford and Reynolds, 1976). Wu and Yang (1978) studied the structure of a
number ofpeptide hormones in solutions of SDS micelles. Whilst this detergent
promoted secondary structure formation, it did not do so indiscriminately: the
secondary structure that was adopted by a peptide closely agreed with that predicted
from its amino acid sequence. SDS micelles are a system now widely used to study
peptide-lipid interactions (e.g. Hoyt and Gierasch, 1991; Li and Deber, 1994). The
critical micellar concentration (CMC) of SDS is 8mM at 20°C. In 3mM SDS, the
peptide's CD spectrum is typical of a p sheet, but as the SDS concentration increases
towards the CMC, the spectrum indicates that some a-helical structure is present.
It is generally accepted that TFE does not induce helical structure; rather it
stabilises helices in regions with an existing a-helical propensity (Segawa et al, 1991).
TFE also stabilises P structures (e.g. Lu et al, 1984). 50% TFE is quoted as the
concentration of TFE at which complete helicity of a peptide is obtained (Jasanoff and
Fersht, 1994). The CD spectrum of the FeLV fusion peptide in 50% TFE shows
considerably more a-helical character (-20% a helix) than that seen in SDS.
Slepushkin et al (1992) found that the HIV fusion peptide adopted approximately
32% a helix in pure TFE. The proportion of helix formed by the FeLV peptide is even
more pronounced in 50% HFIP, the most hydrophobic solvent system used in this
study. Analysis of the spectra gives the percentages ofa helix and p sheet in each
226
Wavelength(nm)
Figure6.11.CDspectraoftheLVfu ionpeptideinava i tyolvents,
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sample listed in Table 6.2. As mentioned for the liposomal samples, the exact values
of these estimates should be viewed with caution, particularly those of the p sheet.
However, an overall trend from random coil, through predominantly p sheet, to
significant amounts ofa helix can clearly be seen.
Figure 6.12 shows electron micrographs of (a) FeLV peptide in 3mM SDS (b)
FeLV peptide in 50% HFIP and (c) a negative control, namely a stained empty grid. P
fibrils are visible in the 3mM SDS sample, and these were only seen when there was
little evidence of a-helical content by CD spectroscopy (other data not shown). These
P fibrils appeared long and unbranched and were arranged in a meshwork.
FTIR has been used to study the secondary structures of the fusion peptides of
two other retroviruses: SIV (Martin et al, 1991, 1994) and HIV (Martin et al, 1993).
These peptides were found to show a partial conversion from a p sheet conformation
in an aqueous solvent to an a helix in a lipid environment. Moreover, the amount ofa
helix present was found to be proportional to the lipid:peptide ratio. In view of this
finding, and since the conversion from sheet to helix is incomplete, they suggested
that there might be two populations ofpeptide, one ofwhich penetrated the lipid
bilayer, whilst the other remained in the aqueous phase. (One serious drawback to CD
and FTIR is that they are incapable of distinguishing between a single population of
peptide, in which each individual peptide molecule has a varied secondary structure
along its length, and the presence of two distinct peptide populations, each with its
own distinct structure, the average of these yielding the same overall percentages for
the different secondary structure components as the single mixed population.) Martin
and co-workers (1991) argued that it was hard to believe that two well-defined
secondary structures could co-exist within the same short sequence. Consequently the
assumption from their SIV and HIV studies was that the a-helical form is the single,
fusion-active conformation. This view has, however, been questioned recently (Gray
et al, 1996; Chang et al, 1997).
Gray and co-workers found that the wild type fusion peptide of Influenza virus
contained about 40% a helix and about 30% P structure when bound to POPC SUV
at pH 5.0. They suggested that, whilst a minimum number of residues in an a-helical







Figure 6.12. Electron micrographs of a) FeLV peptide in 3 mM SDS, showing
P fibres, b) FeLV peptide in 50% HFIP and c) stained grid control.
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fusion peptide (e.g. Lear and Degrado, 1987), a certain amount of (3 structure may
also be required. Chang et al (1997) found that the HIV-1 fusion peptide inserted into
SDS micelles primarily as a helix (59%), but with substantial [3 structure present
concurrently (27%). They also used spin-label-attenuated 'H NMR to study peptide
insertion and structure, and showed that the N-terminal portion of the fusion peptide
formed a helix, whilst a flexible hinge region was present at positions 15 and 16. This
hinge region was located at the micelle surface. Furthermore, the amino acids present
at positions 15 and 16 (Ala and Gly) are absolutely conserved between all strains of
HIV-1 and HIV-2 (Myers et al, 1994). Possibly the peptide sequence following the
hinge region, which is on the micelle surface, may adopt a (3 conformation.
It is clear that a balance between a and p structure exists for many fusion
peptides, including the FeLV peptide, and this might allow these peptides to adopt
both a and p structures in different segments of the sequence. It also enables the
peptides to change their conformation in response to environmental changes.A
previous study has indeed demonstrated conformational flexibility for a synthetic, 21
amino acid peptide when it was inserted in a lipid bilayer (Vogel et al, 1988).
However, this flexibility was between a variety of different substructures, while the
conformation of the peptide as a whole remained predominantly helical.
Fusion is an extremely rapid, multi-step process, and so structural
measurements are obtained mainly lfom fusion end products. Thus only the final,
equilibrium conformations of the peptide are observed; none of the intermediate
structures and changes in conformation, which occur during the different stages of
fusion, are seen. It is possible that structural flexibility, rather than the rigid adoption
of a particular secondary structure, is a key property of fusion peptides. In other
words, since membrane fusion is a dynamic process which involves large structural
changes in the participating molecules, a critical feature of these catalytic peptides
may be their ability to 'flip' between different secondary structures extremely rapidly,
rather than, or as well as, the adoption ofany single, well-defined secondary structure.
The energy barriers between these different secondary conformations must be low: the
peptide must be able to adopt, at least transiently, these various structures, which
presumably represent local energy minima. Logically this leads to an examination of
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the amino acid sequence of a fusion peptide, in order to attempt to predict the most
likely secondary structure of that peptide.
Waterhous and Johnson (1994) suggested in 1994 that the current a priori
predictions of secondary structure from amino acid sequence were about 70%
accurate. Little has changed since then. Problems arise because it is still not possible
to identify and estimate definitively all of the different energetic factors in a system
that lead to the adoption of a particular secondary structure by a peptide or protein
molecule.
Wu and co-workers (1982) first suggested that peptides in lipid solutions
could adopt either an a or a P conformation, depending upon the secondary structure
forming potential of the peptide in aqueous solution. Thus Val and lie, which are p
branched residues, strongly favour p sheet formation in soluble proteins (Chou and
Fassman, 1987). Similarly Gly and Pro are helix-breaking residues in globular
proteins. Ala has a certain 'plasticity', so it can be easily fitted into various structural
contexts. Using the Chou-Fassman method of analysis, the FeLV fusion peptide is
predicted to form mainly P sheet (data not shown).
Many membrane-active peptides gain secondary structure on partitioning into
membrane interfaces. The membrane interface is about 15A thick, and comprises a
thermally disordered mixture ofwater and headgroups and methylenes from the edges
of the hydrocarbon core (Wiener and White, 1992). Work by Li and Deber (1994)
demonstrated that the factors affecting the propensity of a particular amino acid
residue to form an a helix may be different within a hydrophobic environment
compared to that seen under aqueous conditions. They identified that there was a
definite bias towards the residues Gly, Val, lie and Thr in membrane-spanning
regions. Thus, for example, the bacteriophage Ml 3 contains 3 Gly and 9 P-branched
residues (He, Val, Thr) in its 19 residue effective transmembrane segment (Deber et
al, 1993). Certainly many viral fusion peptides, including that ofFeLV, have an
abundance of these 3 types ofamino acid residue. Experiments described by Li and
Deber (1994) suggested that the flexibility ofGly may be greatly constrained within a
bilayer, and the amino acid sequence surrounding a Gly has a great influence on its
helix-forming potential. This may explain how fusion peptides such as the FeLV
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fusion peptide manage to have a large number ofGly residues and still form helical
structures. Richardson and Richardson (1989) noted that a Pro residue is preferred at
the N-cap + 1 position of an a helix, where it presumably acts as a helix initiator.
Despite the original supposition that Pro acts as a helix-breaking residue, Rodriguez-
Crespo and co-workers (1996) found that the fusion peptide ofHepatitis B virus
formed a significant amount ofa helix in TFE, and this peptide has a Pro residue
situated about two thirds of the way along the peptide. The FeLV fusion peptide also
has a Pro residue, at position 2. Charged groups may play a critical role in stabilising
the formation of helices by isolated peptides (Shoemaker et al, 1997). In particular,
interactions between the charged groups and the helix macrodipole influence the
stability of the helix. Acidic residues occur preferentially near the amino terminus but
not near the carboxy terminus. The FeLV fusion peptide has an acidic glutamate
residue at its N-terminal, and the first residue following its C-terminal is a basic lysine.
It seems that these various factors may well be important for the FeLV fusion peptide,
on examination of its sequence, and possibly the Chou-Fassman method is not the
most suitable one to use, although it is still quoted in many publications on viral fusion
peptides. Accordingly, a different and more recent computer programme, PHDsec,
was used to attempt to predict the secondary structure-forming potential of the FeLV
fusion peptide. The method ofPHDsec is described in Rost and Sander (1993). This
programme also predicted a mainly P structure for this peptide. Whilst both of these
programmes that have been used may not be ideal, it does seem as if the FeLV fusion
peptide has a certain propensity to form P structure, which agrees with the
experimental findings for this peptide in liposomal systems.
Figures 6.13 and 6.14 show the FeLV fusion peptide modelled as an a helix,
whilst Figure 6.14 also shows it adopting a p strand structure. It is clear, on
examination of the depicted a helices, that the FeLV fusion peptide does not adopt
the 'sided', amphipathic helical structure that has been suggested as being the crucial
peptide structure which confers fusogenic activity (e.g. Harter et al, 1989; Blobel et
al, 1992). [An amphipathic helix has opposing polar and non-polar faces along the
long axis of the helix (Segrest et al, 1974) ]. Gallaher and co-workers (1992) noted
previously that several putative retroviral fusion peptides only presented a completely
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Figure 6.13. FeLV fusion peptide modelled as an alpha helix. Hydrophobic
residues are shown in , polar residues in c\ an, acidic in red and basic
residues in blue. The top model shows the backbone structure, whilst the lower





Figure 6.14. FeLV peptide modelled as an alpha helix, with Pro and Gly, the
helix-breaking residues in the Chou-Fassman analysis, coloured green in the
top diagram. Using this scale of helix-forming potential for amino acid
residues, it can be seen that there is little scope for helix formation for the
FeLV fusion peptide. The lower diagram shows the FeLV fusion peptide
modelled as a beta strand. Modelling performed using Raswin.
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hydrophobic face over three turns of a helix. Murata et al (1993) have suggested that
the uneven distribution of side-chain bulkiness around the helix may be crucial to its
functional capacity, but Gallaher and co-workers pointed out that, for the same
retroviral fusion peptides, bulky, hydrophobic residues were located on the less
hydrophobic side of the helix. It is certainly unlikely that the acidic Glu residue of the
FeLV fusion peptide, which is negatively charged at pH 7.4, is inserted near to the
hydrophobic region of the target membrane. According to the interfacial
hydrophobicity scale ofWimley and White (1996), Glu shows a very low tendency to
partition into the bilayer. Much still remains to be elucidated as regards this peptide's
structure on interaction with a lipid membrane.
It is also important to remember that it is possible that the structures adopted
by any isolated peptide are not the same as those adopted by it when it is present in
the entire glycoprotein molecule. As an example, hydrophobic interactions between
the fusion peptide and other neighbouring domains of the fusion protein may be
important in stabilising a particular secondary structure of the fusion peptide after it is
activated and before it interacts with the target membrane. Oligomerisation of viral
fusion proteins is also believed to play an essential role in their mode of action. Such
specific cooperation is unlikely in a simple peptide model. A major practical problem
is the tendency for massive self-aggregation of these isolated hydrophobic peptides,
which would be restricted naturally when they formed part of a whole glycoprotein
molecule. Finally, other factors may also be equally as important as the secondary
structure of the peptide for the promotion of fusion. As mentioned in Chapter 5, the
orientations of fusion peptides with respect to the lipid bilayer have been studied (e.g.
Martin et al, 1991, 1993, 1994; Luneberg et al, 1995; Ishiguro et al, 1996) and these
results suggest a role for this factor in the fusion process, although, like the secondary
structural work, there are several conflicting results.
There is no doubt that the secondary structure is crucial to the functioning of
fusion peptides. As an example of this, Lear and Degrado (1987) observed that, whilst
the fusion peptide region of Influenza virus HA2 shows about 65% homology
between different Influenza strains, the nature of each residue, that is whether it is
hydrophobic, acidic or small, is absolutely conserved and occupies an invariant
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position in the aligned peptide sequences. Similarly, Bosch et al (1989) studied
various mutant fusion peptides from SIV, and found that mutations which increase the
overall hydrophobicity of the peptide enhance virus-induced cell fusion reactions,
whereas polar substitutions reduce or abolish the fusogenic activity of this peptide.
The importance of a specific sequence is well illustrated in the FeLV fusion peptide,
as this sequence is totally conserved for all known FeLV strains (see Chapter 1).
Nonetheless, despite an appreciation of the fundamental importance of secondary
structure, the precise conformational features of a fusion peptide that are required for
its fusion activity are still only partially understood.
In conclusion, the results of the CD studies described in this chapter provide
direct experimental proofof structural flexibility for the FeLV fusion peptide, which
had been previously suggested by a computer modelling study (Callebaut et al, 1994).
No definitive conclusion can be drawn as to the active secondary structure of this
fusion peptide, however; more experiments are required before this can be decided
with reasonable certainty.
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Chapter 7: Investigation of the ability of the Putative Fusion Peptide
of Feline Leukaemia Virus to promote Fusion
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Fusion Studies
7.1 Theoretical Background to Lipid Mixing as a Fusion Assay
Complete fusion between two cells or vesicles involves the merging of their
lipid membranes, followed by the mixing of their aqueous contents (see Chapter 1,
Figure 1.1). As mentioned in Chapter 1, liposomes are a useful model cell system, and
they are used extensively in fusion assays.
The fusion between lipid membranes can be followed using the principle of
resonance energy transfer (RET) (see Figure 7.1). RET depends upon the transfer of
fluorescent energy from a donor lipid molecule to a different acceptor lipid molecule.
A fluorescent molecule is excited by absorbing a photon of energy from
electromagnetic radiation of a precise wavelength, which is characteristic for that
fluorophore. A very short time later it then re-emits this energy, at a characteristic but
different wavelength. Thus if there are two chemically distinct fluorescent molecules
present in a lipid bilayer, and if the emission wavelength of the first fluorophore is the
same as the excitation wavelength of the second, then the first can act as a donor of
fluorescent energy to the second, acceptor molecule (Forster, 1949). It is then
possible to excite the donor with radiation of the appropriate wavelength and to
measure the transfer of fluorescent energy to the acceptor by monitoring the emission
of the latter, always provided that sufficient acceptor molecules are nearby in the
bilayer. The efficiency of energy transfer between two given fluorophores depends
upon their spatial separation (Fung and Stryer, 1978). If both donor and acceptor
molecules lie close together within a membrane, resonance energy transfer can be
almost 100%.
The incorporation of known percentages ofboth fluorophores into the same
lipid bilayers of a liposome population enables measurement of fusion with a
population of unlabelled liposomes. In the event of cell fusion occurring, the surface
density of the fluorescent lipids will be reduced, as a labelled bilayer merges with an
unlabelled bilayer. This method is called 'probe dilution'. The donor and acceptor
fluorophores will then be less close to each other, and less RET will occur, with a







Figure 7.1. The principle of resonance energy transfer (RET), which is
the transfer of fluorescent energy from a donor lipid molecule (shown in
pink) to an acceptor lipid molecule (shown in ). If both donor and
acceptor lipids lie close together within a membrane, RET can be almost
100%. If both are incorporated into one set of liposomes, and if fusion
occurs with unlabelled liposomes, the fluorescent lipids will be diluted.
The donor and acceptor will then be less close together, so less RET will
occur, and thus the emission by the acceptor lipid will decrease.
Concurrently, emission by the donor lipid will increase.
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molecules will increase, as less energy transfer has occurred. Usually the increase in
donor fluorescence is used as the measure of fusion of the lipid membranes. Control
experiments have shown that it is fusion which causes the observed changes in RET
and not non-specific processes, such as lipid exchange between bilayers (e.g.
Roseman and Thompson, 1980; Nichols and Pagano, 1981).
Struck et al (1981) developed an RET assay for liposome-liposome fusion,
using the fluorophores L-cx-A-(4-nitrobenzo-2-oxa-1,3-diazole) (NBD) as the
fluorescent energy donor and L-a-A-(Lissamine-Rhodamine B Sulfonyl) (Rh) as the
acceptor. These were attached to the free amino group of separate PE molecules to
produce fluorescent lipid analogues, which were then easily incorporated into lipid
bilayers of vesicles. The efficiency ofRET, E, was then shown to be calculated from
the emission ofNBD-PE at 530nm, using the equation:
F
E = 1-— 7.1
F o
where F is the fluorescence at 530nm in the presence ofRh-PE and F0 is the
fluorescence in the absence ofRh-PE and in the presence of 1% Triton-X, a detergent
which lyses the vesicles. It is vital to correct the value for the quantum yield for any
effect ofTriton-X on this parameter, and also for sample dilution. The effect ofTriton
X-100 on the quantum yield ofNBD-PE can be determined by incorporating NBD-
PE into vesicles at a concentration where essentially no self-quenching occurs, in the
absence ofRh-PE, and measuring fluorescence before and after the addition ofTriton
X-100. Rates of fusion between vesicles can thus be followed by measuring the
change in fluorescence at 530nm as a function of time.
This assay enables membrane mixing to be measured with high kinetic
resolution. There is a significant overlap between the emission band ofNBD-PE and
the excitation band ofRh-PE, so RET is relatively efficient, even when the probes are
present at low surface densities. Moreover, Rh-PE has a minimum in its excitation
spectrum at 450nm, which is close to the maximum excitation wavelength ofNBD-
PE. Thus there is very little direct excitation of the energy acceptor, Rh-PE. At low
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surface densities ofRh-PE, the efficiency of energy transfer was found to be nearly
proportional to the ratio ofRh-PE to total lipid in the vesicle bilayer. In this
concentration range, therefore, any decrease in the surface density of the energy
acceptor will result in a proportional decrease in measured transfer efficiency. The
efficiency ofenergy transfer was found to be independent of the surface density of the
energy donor, a situation which is similar to that found for other donor-acceptor pairs
(e.g. Vanderwerf and Ullman, 1980).
The RET assay of Struck and co-workers (1981) is widely used for
monitoring liposomal fusion. In addition to the points mentioned above, RET is a
fairly simple, very sensitive method, as it requires only low concentrations of lipid
probes. It enables lipid mixing to be monitored continuously, which allows kinetic
studies to be performed. Whilst some fluorescent probes perturb the packing
properties of the lipid bilayer, NBD-PE and Rh-PE do not per se cause perturbation
of the bilayer, since they protrude into the interface. Furthermore, head-group labelled
lipid analogues such as these are essentially non-exchangeable by spontaneous or
collision-mediated transfer between vesicles. Their quantum yields are also relatively
insensitive to their micro-environment. By performing a probe dilution type of lipid
mixing assay, any error due to RET occurring during vesicle aggregation, as opposed
to fusion, is avoided. Finally, lipid mixing assays in general are unaffected by leakage,
which usually does occur during vesicle fusion and which often interferes with assays
that are based on contents mixing.
Ideally, fusion should be studied by the measurement ofboth the lipid mixing
and the mixing of contents, which occur in complete fusion. This provides a more
detailed description of the molecular events that are occurring and also helps to
reduce possible artefacts. As an example, hemifusion, that is the fusion of only the
outer monolayers ofLUVs, will produce a decrease in RET. On the other hand,
fusion of liposomes is often leaky, and then contents mixing cannot be studied. Often,
therefore, lipid mixing alone has to be relied upon to monitor the fusion process, and
certainly lipid mixing assays are usually the initial types of fusion experiments to be
performed when studying a potential fusogen.
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Fusion activity can be confirmed either by demonstration of the fusion activity
in vitro from the purified candidate protein or peptide, or by expression of fusion
activity following transfection of the cloned gene(s) encoding the candidate fusion
protein or peptide (White, 1990).
Synthetic peptides corresponding to the N-terminal segment of the Influenza
virus HA2 were shown to interact with lipid bilayers and to promote fusion of lipid
vesicles (e.g. Lear and Degrado, 1987; Murata et al, 1987; Wharton et al, 1988;
Rafalski et al, 1991). Similar observations have since been made with the fusion
peptides from the retroviruses SIV, HIV-1, MuMLV and BLV (e.g. Rafalski et al,
1990, HIV-1; Martin et al, 1991, SIV; Defrise-Quertain et al, 1992, BLV; Nieva et
al, 1994b, HIV-1; Pereira et al, 1995, HIV-1; Martin et al, 1996, HIV-1; Pereira et
al, 1997, HIV-1; Zhu et al, 1998, MuMLV). Several mutational studies have also
implicated the amino terminus of retroviral TM proteins as being important in
catalysing the fusion of viral and cellular membranes (e.g. Bosch et al, 1989, SIV;
Schaal et al, 1995, HIV type-1; Delahunty et al, 1996, HIV type-1). Furthermore,
studies of the wild type and certain mutant fusion peptides from Influenza virus by
Gething and co-workers (1986), Diizgiines and Gambale (1988) and Wharton et al
(1988) and Rafalski and co-workers (1991), and from certain HIV strains by Martin et
al (1991) and Freed et al (1990) have correlated the fusogenic activity of the
synthetic fusion peptides in vitro with that of their corresponding parent glycoproteins
in vivo. Similarly, Diizgiines and Shavnin (1992) found an increase in membrane
destabilisation produced by the fusion peptide of Sendai virus at low pH, which
correlated with the enhanced fusion at low pH ofwhole Sendai virus with various
liposomes (e.g. Nir et al, 1986) and of one Sendai virus isolate with cultured cells
(Pedroso de Lima et al, 1991).
It can, therefore, be seen that synthetic fusion peptides are widely employed to
study the basic molecular mechanisms of virally-induced fusion, and that the results
obtained from these studies often show good correlation with the corresponding
biological fusion process. Synthetic peptides are particularly useful for the
determination of the minimum and precise molecular requirements of fusion. In
particular, the demonstration of fusion activity by the amino-terminal region of a TM
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protein from a virus requires that this be studied in isolation from the rest of the
protein molecule, as other regions of certain viral fusion proteins have been shown to
enhance fusion (e.g. Lear and Degrado, 1987, HA2).
7.2 Aim of the Fusion Assays
The sequence of the FeLV fusion peptide is recorded in the Swiss Protein
Data Bank (1996; release number 34.0). This sequence is, however, the putative
fusion peptide ofFeLV, since there is no experimental evidence for fusogenic activity
of this peptide. It does show marked homology to other known fusion peptides of
viruses, and it is an N-terminal segment that is released by proteolytic activation of the
fusion protein, which is also a feature shared with several other viral fusion peptides.
The aim of the fusion assay was thus to provide direct experimental evidence for the
fusogenic capacity of this peptide.
7.3 Materials and Methods
7.3a Materials
Previous fusion studies using synthetic peptides corresponding to the fusion
peptides from the retroviruses HIV (Martin et al, 1993), Bovine leukaemia virus
(BLV) (Defrise-Quertain et al, 1992) and SIV (Martin et al, 1994) have shown that
these peptides can induce lipid mixing between LUVs when the vesicles contain PE.
The lipid MeDOPE was chosen for the fusion assays of the FeLV peptide, since its
use in such assays has been well-documented (e.g. Ellens et al, 1984; Ellens et al,
1986). Furthermore, its use in the 31P NMR experiments described in Chapter 3 might
enable some comparisons to be drawn between certain membrane destabilising effects
and the fusion activity of the FeLV fusion peptide. Ideally, the use of similar types of
vesicles when comparing structural characteristics with fusion processes is preferred.
It is, however, often very difficult to obtain sufficiently large signals from LUV
preparations in a reasonable timespan to allow their use in structural studies. Thus it
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must always be borne in mind that there will be inherent differences in the lipid
preparations, which may influence the results obtained during these experiments.
MeDOPE was purchased from Avanti Polar Lipids (Alabaster, AL, USA).
Thin Layer Chromatography showed a single spot. The fluorescent lipids L-a-A-(4-
nitrobenzo-2-oxa-l,3-diazole)PE from egg (NBD-PE) and L-a-7V-(Lissamine-
Rhodamine B Sulfonyl)PE from egg (Rh-PE) were also purchased from Avanti.
DMSO was obtained from BDH Chemicals (Toronto, ON). The FeLV 28 amino acid
and SIV 12 amino acid peptides were synthesised by Albachem Ltd. (26 Craigleith
View, Edinburgh, ELM 3JZ, Scotland, UK) using solid phase synthesis. Their purities
were >95%, as determined by analytical HPLC, Maldi-TofMass spectrometry and
amino acid analysis. The FeLV fusion peptide sequence was as shown in Chapter 2
(section 2.4a). The SIV fusion peptide was chosen as a positive control since it is the
most homologous retroviral fusion peptide for which there is definite experimental
proof of fiisogenic activity.The SIV peptide sequence used in these experiments was
GVFVLGFLGFLA. This has been shown previously to promote lipid mixing, and
thus membrane fusion (Martin et al, 1994). The buffers used for the RET assays were
lOmM Glycine, O.lmM NaCl, O.lmM EDTA for the pH 9.5 buffer and lOmM Hepes,
0.15M NaCl, 1 mM EDTA for the pH 7.0 buffer.
7.3b Liposome Preparation
Lipid films were prepared as described in Chapter 2, using pure MeDOPE for
the unlabelled LUVs, and with 2 mol% ofboth NBD-PE and Rh-PE present for the
labelled LUVs. The dried lipid films were suspended initially in an iso-osmotic Glycine
buffer at pH 9.5, at a lipid concentration of20mg/ml. Liposomes were then prepared
from these suspensions.
It is difficult to prepare stable liposomes ofPE at the physiological pH of 7.4
in isotonic buffers (Papahadjopoulos and Miller, 1967). Pure PE liposomes can only
be made above pH 9.0, where the PE is negatively charged (Stollery and Vail, 1977).
The pKa of the amine group ofPE has been estimated to be about 9.5 (Tsui et al,
1986). Thus, injection ofPE liposomes into buffers of pH 6, where the PE is
protonated, leads to liposomal aggregation, leakage and lipid mixing (Kolber and
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Haynes, 1979; Pryor et al, 1983). By raising the pH, the amine group becomes
deprotonated and so the stability of the liposomal suspension is greatly improved.
Aggregation, and thus possible fusion or collapse, of the liposomes is prevented by
the liposomes carrying a sufficiently large net negative charge, which causes charge
repulsion between liposomes.
True 'model membrane' systems require that the vesicles present be closed,
unilamellar and reasonably large to avoid problems associated with small, highly
curved systems (Hope et al, 1985). The high degree of curvature ofSUV and their
intrinsic instability seem to facilitate peptide penetration and they may also provide a
driving force for fusion processes. Small vesicles may have phospholipid packing
defects that render them more susceptible to fusion (e.g. Wilschut et al, 1981;
Diizgiines, 1985; Parente et al, 1988; Stegmann et al, 1989). Thus, although fusion
reactions that are catalysed by viral fusion peptides in SUV systems do reveal peptide-
induced bilayer destabilisation, they do not necessarily reflect the intrinsic fusogenicity
of the particular peptide. It is generally thought to be essential to investigate the
fusion activity of fusion peptides using large, unilamellar vesicles.
On the other hand, Ott and Wunderli-Allenspach (1994) studied fusion
between Influenza virus and liposomes of varying size. They concluded that the
kinetics of fusion between virus and SUVs and between virus and LUVs were
identical. This agrees with data obtained by Van Meer et al (1985) on Influenza virus
and by Sarkar and Blumenthal (1987) on Sendai virus fusion. It is possible, therefore,
that the choice ofLUVs for fusion assays is less important than is currently widely
believed, but it is certainly less physiological to study fusion between SUVs. LUVs
were thus used in the assays described in this chapter, since the curvature of these
vesicles more closely resembles that of the plasma membrane.
After vigorous vortexing in the pH 9.5 glycine buffer on an orbital incubator,
the resulting lipid suspensions were subjected to five ffeeze-thaw cycles, in each of
which immersion in liquid nitrogen for two minutes was followed by plunging into a
water bath, at a temperature of 40°C to 60°C, until the samples thawed. Repeated
ffeeze-thaw cycles rupture and re-fuse any MLVs present, which results in the
production of some LUVs (New, 1990). A certain amount of fusion between
245
individual liposomes also occurs, so that the average size of the vesicles increases as
well as the proportion of unilamellar vesicles (Hope et al, 1985; New, 1990). Next the
samples were filtered under high pressures of~ 400 lb/in2 through two stacked
polycarbonate membrane filters, ofpore size 0.1pm, (Nucleopore Corp., Pleasanton,
CA, USA), using a high pressure extruder (Lipex Biomembranes Inc., Vancouver,
Canada) to yield LUVs. The samples were injected into the central chamber of the
extruder, above the stacked polycarbonate membranes, and nitrogen pressure was
applied from a standard gas cylinder that was fitted with a high pressure regulator.
The vesicles were collected and reinjected for extrusion for a total of 10 passes
through the filters. Once prepared, the liposomes were stored under refrigeration, in
air-tight glass containers, preferably under nitrogen. Deterioration of the preparation,
most commonly lipid oxidation and peroxidation, does occur with time, so that it is
recommended that liposomes be used within 2 days (Ellens et al, 1989; Allen and
Cleland, 1980 ). All of the LUVs were thus used within 48 hours of their preparation.
The extrusion method ofHope et al (1985) for the preparation ofLUVs has
many advantages. Extrusion does not require the presence of organic solvent or
detergent, whereas the dialysis method ofLUV production cannot completely remove
these contaminants. Dialysis is lengthy; for example, the detergent dialysis procedure
using octylglucoside that was discussed in Chapter 6 required days of dialysis, whilst
extrusion is a very rapid procedure. Extrusion also produces a population ofLUVs
that are of a fairly homogeneous size.
In order to ascertain the lamellarity of the extruded LUVs, negative staining
transmission EM and cryo-transmission EM were performed. The two-step drop
method was used for the negative staining proceedure (New, 1990). A drop of
bacitracin was placed on a coated EM grid, and removed 1 minute later using a piece
of filter paper, which was held just touching the edge of the grid and at 90° to its
plane. The grid was then covered with a drop of the liposome sample and left for 2
minutes to allow the vesicles to stick to the grid. Thereafter the remainder of the drop
was drawn offwith filter paper, as described previously for the removal of the
bacitracin and a drop of negative stain quickly placed on the grid, before the film had
time to dry. 1% ammonium molybdate at pH 7.0 in distilled water was used as the
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stain. One minute later, the drop of stain was drawn off and the grid was allowed to
dry completely. The samples were then examined, using a Philips 400 TEM that was
operated at an acceleration voltage of 80kV, and x 160,000 magnification.
Negative staining EM is much more readily available, but it is prone to
staining artefacts, so a range of samples were taken to Leeds University, where they
were subjected to cryo-EM. The cryo-EM was performed with initial help from Dr. S
Stoylova. The samples were observed in their ffozen-hydrated state. 5pi of the sample
suspension was deposited on a bare 1000-mesh copper grid, blotted with filter paper
and rapidly plunged into liquid nitrogen-cooled ethane, which was just above its
freezing point. The grids were next transferred into liquid nitrogen and then, by a
cryo-transfer workstation, they were inserted into a cryo-holder (Oxford Instruments,
Oxford, U.K.). The samples were thus kept in liquid nitrogen throughout the entire
transfer procedure. The samples were examined using a Philips CM10 EM, which was
operated at an acceleration voltage of lOOkV at temperatures that were below
-160°C. Images were recorded on Agfa Scientia 23 D 56 electron image sheet film
and also directly in digital format using a TVIPS (Tietz Video and Image Processing
Systems, Gauting, Germany) on-line image acquisition and analysis system, which is
based on a Photometries AT 200 Peltier-cooled slow-scan 512x512 CCD camera
controlled by Photometries PM3S software (Photometries, Tuscon, AZ, USA).
The size distribution of the LUVs was determined using photon correlation
spectroscopy (PCS). This technique is based upon quasi-elastic laser light scattering.
It measures the time dependence of light intensity fluctuations due to interference
created by the scattering of incident coherent laser light by particles in motion (New,
1990). LUVs in aqueous suspension undergo a Brownian type motion, which is size
dependent, small particles diffusing more rapidly than larger ones. Thus the
translational diffusion coefficient can be measured, which can then be used to
determine the mean hydrodynamic radius of the particles present, using the Stokes-
Einstein equation. The experimental set-up consisted of a Malvern Instrument
(Malvern Instruments, Malvern, U.K.) laser light source that was focused on a highly
polished square glass cuvette housed within a thermostatically-controlled goniometer
cell. (Accurate temperature control is essential in order to minimise random
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convection currents, which would superimpose on the Brownian motion present, and
lead to substantial errors in size measurements. Also fluid viscosity would vary, which
affects calculations.) The spectrometer was mounted on an air table to minimise
vibration and it was housed in a dark room to avoid problems produced by
neighbouring strong light sources. The samples were filtered several times before use
to remove any potential dust particles. Similarly, the cuvettes were soaked in strong
acid to clean them and then washed in filtered, distilled water before use. Scattered
light was detected by a photomultiplier assembly. This scattering was measured at
three different angles for each sample, and the resultant recorded photomultiplier
bursts were then 'correlated'. This was achieved by a computer programme, which
multiplied the amplitudes of the signal and the time-delayed copies together at
different times to give a correlation function. As the signals become more and more
out of phase with one another, their respective randomness increases, which causes an
exponential decay in the correlation function to a constant value. Mathematical
equations link the value of the correlation function at any given time separation to the
diffusion coefficient (D) of the particles present, and thence the particle radius can be
calculated from the Stokes-Einstein equation :
6/rr/R
where &=Boltzmann's constant, 7-absolute temperature, 77 =solvent viscosity, and R=
mean hydrodynamic radius. A standard sample, consisting of a uniform suspension of
90nm diameter beads, was used for calibration purposes. Thus the mean size of the
population ofLUVs that was present in each sample was determined.
7.3c LipidMixing Assay
Several attempts by myself to obtain positive proofof the fusogenic capacity
of the FeLV fusion peptide were unsuccessful. The main reason for this was the
insolubility of this peptide. I performed solubility tests on both the crude and the less
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pure (<75%) peptide fractions that were obtained from Albachem, since the pure
peptide was extremely expensive and also in very short supply. These peptide
fractions did not dissolve well in DMSO, which agreed with the reports from the
chemist who synthesised the FeLV peptide: she recorded that it would dissolve only
in >30% TFA, >50% ACN and other very hydrophobic solvents. None of these are
suitable for use in aqueous-based fusion assays. Surprisingly, the solubility of the
>95% pure peptide was eventually found to be quite reasonable in DMSO. The other
main problems were the lack of a reliable fluorimeter, and the numerous small
practical difficulties encountered when attempting to set up an assay on the basis of
reports in published papers. Many of these were overcome; for example the detection
of osmotically-induced liposomal lysis when using the concentrations of experimental
buffers for the internal and external liposomal solutions that were reported in a paper
by Kendall and Macdonald (1982). Ultimately, some direct proofof fusogenic activity
for the FeLV peptide was urgently required, in order to complement the DSC, NMR
and X-ray diffraction work and allow its publication. Thus, as part of our
collaboration, the successful fusion assays were performed by Dr. R.F. Epand,
McMaster University, Hamilton, Canada.
Lipid mixing was measured, using the probe dilution method of Struck et al
(1981). Thus the increase in NBD-PE fluorescence was measured as a function of
time. A SLM Aminco Bowman Series 2 Luminescence Spectrometer (Urbana, IL,
USA) with excitation and emission slits of 4nm was used. Peak absorbance of samples
was kept at <0.1 to reduce inner filter effects. Crossed polarisers were used to reduce
light scattering. Lowering the pH, and thus increasing the concentration ofhydrogen
ions (H) present, induces liposomal aggregation. Liposomes ofPE can be thought of
as existing in a state ofmetastable equilibrium, where small changes in pH, ionic
strength or divalent cation concentration can lead to substantial changes in
aggregation of the membranes (Allen et al, 1990). Aggregation is a prerequisite to
fusion and, moreover, it represents the rate-limiting step in the overall process of
fusion between two initially distinct membranes (e.g. Bentz et al, 1983; Bentz and
Ellens, 1988; Ott and Wunderli-Allenspach, 1994; Ott et al, 1994). Thus the 'pH-
jump' technique can be used to produce a potentially fusogenic liposomal population,
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which is not affected by the kinetics ofpre-aggregation. Similarly, an increase in the
concentration of sodium ions (Na+) present can induce liposomal aggregation. It is
critical to measure a baseline value for any parameter studied using pure PE liposomes
for the duration of the experiment in order to take any spontaneous liposomal fusion
into account.
The LUVs were initially premixed, at a ratio of 1:9 labelled:unlabelled, in a
fluorimeter cuvette containing Hepes buffer of pH 7.0 at 37°C. The residual
fluorescence was measured and this was set at zero. The pH at which the fusion assay
was performed was 7.0, as PE does not always aggregate well at pH 7.4 (e.g. Allen et
al, 1990 studied egg PE, and found that inhibition of liposomal aggregation was seen
in the pH range of 7.4- 8.0). The medium in the cuvettes was stirred continuously so
that mixing of the peptide and vesicles was as rapid as possible. The temperature of
the sample was monitored by a thermistor probe inserted into the cuvette. The LUVs
comprised 1% of the total volume in the cuvette. The final lipid concentration was
300pM. There was no detectable change in pEl upon addition of the LUVs, since the
volumes ofLUVs added were very small. The excitation wavelength used was
470nm, and the emission ofNBD was recorded at 530nm.
The FeLV and SIV peptides were dissolved separately in DMSO at a
concentration of lmg/ml. The peptide must partition from the aqueous phase into the
membrane to account for the possible effects of the bilayer interface on the adopted
peptide conformation (Deber and Goto, 1996). Thus the peptide was added externally
to the vesicles. The stock solutions ofpeptide were added to LUV preparations in the
fluorimeter cuvettes, to give a final peptide concentration of 10p.M. DMSO alone was
also used as a control. 100% lipid mixing was obtained by addition of 10% Triton X-
100 to the vesicle suspension to a final concentration of 0.1%. This eliminated RET
by lysing the vesicles, and this signal represented NBD fluorescence obtained at
infinite dilution. The effect ofTriton X-100 on the quantum yield ofNBD-PE was
also measured, and the appropriate corrections for this and sample dilution were
applied to obtain the final value for 100% lipid mixing.
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7.5 Fusion Assay Results and Discussion
Figure 7.2 shows a typical cryo-transmission EM that was obtained for a
sample of freeze-thaw extruded LUVs. The sample contained vesicles that were
composed of 50 mol% DOPC/50 mol% DOPE. No multilamellar vesicles are present,
and the two individual monolayers of the bilayer can be distinguished in some of the
vesicles. A total of 15 cryo-EMs were obtained on 7 liposome samples that contained
different types ofphospholipids. No MLVs were observed in any of these
micrographs, nor in any of the 12 negatively stained EMs, which were taken from 6
distinct liposome samples. A typical example of the micrographs that were obtained
using the negative staining technique is shown in Figure 7.3. This was taken from a
sample of 50 mol% DOPC/50 mol% DOPG LUVs. It is thus clear that this method
reliably produces unilamellar vesicles.
The distribution of the size of vesicles in a sample of 50 mol% DOPC/50
mol% DOPS liposomes is shown in Figure 7.4. The percentage of vesicles whose
diameter is within each range in nm is plotted. It can be seen that >70% have
diameters between 52.6nm and 101.69nm, whilst the range ofpossible diameters for
vesicles varies from 25nm to lOOOnm.
In conclusion, the method ofHope et al (1985) results in a good
homogeneous population of vesicles. Not surprisingly over the past few years this
method has become the standard method ofLUV preparation for fusion assays. No
EM or PCS studies were performed on the MeDOPE vesicle preparations that were
used in the fusion assays, due to geographical displacement from the required
equipment. However, the extensive nature of the tests that I had performed previously
in the U.K. on LUVs having a wide variety of different phospholipid compositions,
had unfailingly yielded the same qualitative results. These, together with previously
published studies, were regarded as sufficient proofof the nature of the vesicles used
in the fusion assays.
Figure 7.5 shows the percentages of lipid mixing which took place between
LUVs composed ofMeDOPE in the presence of the SIV and FeLV fusion peptides.
The SIV peptide promoted rapid lipid mixing, and thus membrane fusion, between the
labelled and unlabelled LUV populations, as seen by the increase in NBD-PE
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Figure 7.2. Cryo-transmission EM of freeze thaw extruded LUVs,
composed of 50 mol% DOPC/50 mol% DOPE. Some individual bilayers
are visible; for example, see arrow.
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Figure 73. Negatively stained transmission EM of freeze thaw extruded




















































































































Figure7.4.GraphofthesizdistributionDOPC/DOPSl p somes,wh cherpreparedbyfreez - thawingandhighpressureextru ion.
fluorescence upon probe dilution. These results agree very closely with previous
experiments performed using this peptide (Martin et al, 1994). The FeLV peptide also
produced membrane fusion, as shown by an increase in lipid mixing when compared
with that seen for an aliquot ofDMSO identical to that in which the peptide was
added to the liposomal preparation (top DMSO curve).
Using this particular lipid system, the SIV peptide showed greater
enhancement of fusion. This difference in potency may reflect the many differences
between these two peptides, viz their lengths, overall electrical charges, solubility
characteristics and probable miscibilities with different lipid species. Moreover,
different viral fusion peptides have been shown to require different specific
experimental conditions in order to promote maximum membrane fusion. The
retroviral Ebola virus fusion peptide requires the presence ofphosphatidylinositol (PI)
in the target membrane for fusion to occur (Ruiz-Argiiello et al, 1998). Calcium ions
might also be involved in this process. Similarly, SFV requires the presence of
ceramide (Nieva et al, 1994a; Corver et al, 1995; Wilschut et al, 1995). The presence
of only 1 -2 mol% of sphingolipid is sufficient to produce half-maximal fusion, and so
sphingolipids have been suggested as being co-factors for SFV fusion, possibly by
interacting directly with the fusion peptide and thus activating it (Wilschut et al,
1995). Cholesterol is also required for SFV fusion (e.g. White and Helenius, 1980),
with the 3j6 -hydroxyl group being the crucial factor (Phalen and Kielian, 1991). The
role of cholesterol appears to be in the binding of the peptide to the membrane, rather
than the actual fusion events (Wilschut et al, 1995). VSV requires PS (Eidelman et al,
1984), which has been proposed as the cellular receptor for this virus (Schlegel et al,
1983). Diizgiines and Shavnin (1992) studied synthetic peptides corresponding to the
fusion peptides of Influenza virus, VSV and Sendai virus. Whilst all three fusion
peptides were found to induce membrane destabilisation of lipid vesicles, the
occurrence and extent of destabilisation were dependent upon the phospholipid
composition of the LUVs. Finally, Larsen and co-workers (1993) showed that the
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It is certainly possible that interaction of peptides occurs with particular lipid
species rather than with the membrane as a whole (Polozov et al, 1997). Thus the
experimental conditions used here may not provide optimal fusogenic conditions for
the FeLV fusion peptide. Future experiments using LUVs ofdifferent lipid
compositions could determine the lipid requirements of this peptide in order to obtain
maximal fusion. In particular, it would be interesting to use liposomes of lipid
compositions that closely represented the target membranes ofFeLV in vivo, for
example the feline T cell and granulocyte plasma membranes. Pereira et al (1997)
studied the induction of fusion by the HIV-1 fusion peptide between LUVs that were
devoid of a net charge, using published information on the composition of the
membrane environment into which this peptide should partition in vivo (Aloia et al,
1993). Similarly, Ruiz-Argtiello and co-workers (1998) examined the fusogenic
capacity of the Ebola virus fusion peptide using LUVs of a lipid composition which is
close to that of the hepatocyte cell membrane, as the hepatocyte is one of the main
target cells of this virus. These fusion experiments, and indeed all other fusion assays
to characterise the FeLV fusion peptide, should be performed for a range ofpeptide
concentrations, to determine whether the rate of fusion is dependent upon the amount
ofpeptide present, and thus to demonstrate further that it is the fusion peptide that is
the active catalyst in this process.
It is possible that the biological fusion domain ofFeLV may be a different
length from the 27 amino acid peptide that is quoted in the literature. A study of the
N-terminal region of a B strain of Influenza virus showed that the peptide
corresponding to the N-terminal 20 amino acids was more fusogenic than shorter, 16
or less amino acid peptide fragments (Lear and Degrado, 1987). Similarly, Defrise-
Quertain and co-workers (1992) examined the fusion capacity of the N-terminal
region ofBLV, and found that the longest peptide fragment that was studied, which
was 24 amino acids in length, promoted the greatest amount of fusion between
vesicles. Conversely, Martin et al {1991) studied a variety of synthetic peptides which
corresponded to different lengths of the putative fusion peptide ofSIV. They found
that the most fusogenic of the peptides was the shortest, 12 amino acid peptide.
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Further fusion assays using FeLV fusion peptides of different lengths could determine
the length ofpeptide which produces maximal fusion.
Mutagenesis studies of the FeLV fusion peptide could provide further
evidence for the role of the precise amino acid sequence of this N-terminal region of
pl5E in fusion.
As mentioned earlier, it is advisable to perform assays of the mixing of
liposomal contents as well as lipid mixing assays, since lipid mixing may not correlate
purely with fusion. As an example of a potential error, Ellens et al (1989) found that
MeDOPE liposomes showed greatly increased fusion rates in the temperature range at
which isotropic 3IP NMR resonances were seen but true fusion, as measured by the
mixing of liposomal contents, dramatically decreased as TH was reached, due to
collapse of liposomes and the concurrent leakage of liposomal contents. Lipid mixing,
however, was observed to continue, since adjacent membranes were being
transformed into Hn structures. Rapid leakage of vesicle contents is, however, often
observed with isolated synthetic fusion peptides, which precludes the use of contents
mixing assays. Thus, Martin and co-workers (1993) found that the addition ofHIV-1
peptide to several different vesicle preparations induced such a rapid leakage that
contents mixing could not be observed. It has been suggested that fusion proteins may
serve to prevent the lysis of one or more of the membranes participating in fusion
(Hughson, 1995), and hence this effect will be lost when studying the isolated fusion
peptide. Shangguan and co-workers (1996), however, studied the fusion between
whole Influenza virus and liposomes, and discovered this process too was very leaky.
Attempts at assaying the mixing of vesicle contents would be worthwhile, since this
step represents the completion of fusion, and the precise role(s) of these viral fusion
peptides in the multi-step fusion process are still not known.
Work by Diizgiines and Shavnin (1992) (see above) found that none of the
fusion peptides from the three viruses studied induced complete fusion ofLUVs. They
noted that previous studies, which had reported the production of complete fusion by
viral fusion peptides (e.g. Lear and Degrado, 1987; Murata et al, 1987; Wharton et
al, 1988) had used SUVs in the main. It has been suggested that other sections of
viral fusion proteins may also be required for full fusion to occur (Wharton et al,
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1988; Duzgiines and Shavnin, 1992). The ultimate function of the fusion peptide may
therefore depend upon the remainder of the fusion protein, and LUV-synthetic
peptide systems do not allow for any effects caused by additional functionally relevant
domains in pi5E or gp70.
With this in mind, Pecheur et al (1997) studied the fusion induced by a small
11 amino acid peptide, which was anchored to a lipid membrane. Their aim was to
mimic more closely the normal membrane-anchored state ofviral fusion peptides,
since fusion peptides are always found in a polypeptide chain with a transmembrane
anchoring segment. The peptide did not induce fusion when in the free monomeric
form. Both lipid mixing and contents mixing were, however, readily observed using
the membrane-anchored peptide. They suggested that the free peptide could fold
along the vesicle surface, while the membrane-anchored peptide was restricted in this
action and hence showed increasing hydrophobic interactions with the target
membrane. Fusion studies of the FeLV fusion peptide in a membrane-anchored state
would thus be beneficial, since it is normally bound to the remainder ofpl5E, the
transmembrane protein segment of gp85.
Biological membranes are asymmetric in composition, and this asymmetry may
be important in fusion (Eastman et al, 1992; Devaux et al, 1993). Creating asymmetry
in model membranes is very difficult and such manipulations produce only crude
changes at best (Eastman et al, 1992). Similarly, transmembrane electrochemical
gradients could also affect the interaction of the FeLV fusion peptide with its target
membrane under physiological conditions and these are absent from the model
membrane systems described.
In Chapter 6 the apparent anomaly of the interaction of a negatively charged
peptide with a hydrophobic lipid membrane was mentioned. The peptide that was
studied by Pecheur and co-workers (1997) was negatively charged: it contained three
Glu residues at positions 3, 7 and 10. These fusion experiments were carried out at
neutral pH, and so neutralisation of the peptide's negative charge is not required for
fusion to proceed. The FeLV peptide has a glutamate residue at its amino terminus,
and this amino acid has been used in several previous mutagenesis studies of fusion
peptides. Diizgiines and Gambale (1988) found that a mutant of the Influenza virus
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fusion peptide, which had a glutamate residue inserted at the N-terminal position
showed a reduced membrane-penetrating activity compared to the wild type fusion
peptide. Rafalski et al (1991) found that this same mutant peptide bound less tightly
to lipid vesicles, showed a lower degree ofbilayer penetration and produced much
less leakage from vesicles than the wild type fusion peptide. The work by Ruiz-
Argiiello et al (1988) on the putative fusion peptide ofEbola virus showed that the
inclusion of the naturally-ocurring glutamate residue at the N-terminus severely
impaired peptide-vesicle interaction: only-12% ofpeptide bound to LUV when the
glutamate was present, whereas without it -33% of the peptide bound. Masking this
residue would, therefore, optimise the partitioning of this putative fusion peptide into
the target membrane. It is worth remembering, however, that the experiments
described here were all aimed at detecting maximal fusion. Possibly under
physiological conditions, the slight impairment of fusion could be beneficial to viral
replication; for example, by the avoidance of cell-cell fusion. Furthermore, FeLV is a
relatively slow viral infection, which can take years to produce a state of disease,
unlike the acute infections induced by agents such as Influenza virus.
It would be useful to have some method of determining the amount ofFeLV
fusion peptide that binds to vesicles under different experimental conditions. Previous
studies (e.g. Lear and Degrado, 1987; Ruiz-Argiiello et al, 1988) have used the
change in fluorescence of a tryptophan residue present in the fusion peptide, and the
decrease in the quenching of this tryptophan by the aqueous marker KI (Ruiz-
Argtiello et al, 1988) to confirm the interaction of the peptide with phospholipid
bilayers. Tryptophan shows a blue shift on interaction with a lipid membrane
(Dufourcq and Faucon, 1977), which is due to the indole group becoming partially
immersed in the membrane (Lakowicz, 1983). Unfortunately, the wild type FeLV
fusion peptide does not contain any tryptophan residues, nor is it quantitatively
detectable by any of the usual methods of determination ofprotein/peptide
concentration (e.g. Markwell et al, 1981). This problem has been encountered with
other fusion peptides, for example that ofSIV (R.M. Epand, personal
communication). One possibility would be to synthesise a mutant peptide that
contained a tryptophan residue, but this might alter the true nature and degree of the
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fusogenic capacity of the peptide. Quantitative amino acid analysis of samples
containing LUVs with bound peptide present could be performed after passage of the
vesicles down a filtration column or following density flotation and centrifugation to
remove any unbound peptide. This is, however, an extremely expensive technique to
use on a routine basis.
In conclusion, the major problems associated with the development of a
reliable, functional fusion assay to study the FeLV fusion peptide appear to have been
overcome. Evidence for ability of this peptide to promote fusion between lipid
membranes has been obtained, using a resonance energy transfer technique. A number
ofpotential experiments, which have been discussed, could now be performed in






At the outset of this thesis, August 1994, there were no published
experimental data on the putative fusion peptide ofFeLV. The work described herein
demonstrates membrane fusion activity for the FeLV peptide, in the form of lipid
mixing between liposomes. It also provides evidence that this peptide has effects on
lipid properties that are characteristic of viral fusion peptides. Thus, there are many
indications that fusion peptides do not act merely as aggregation agents for
neighbouring bilayers. The induction ofmembrane destabilisation by a fusion peptide
demonstrates the capacity of the peptide to play an active role in the actual molecular
changes that occur during the multistep fusion process. Structural studies of the
effects of the FeLV fusion peptide on lipid polymorphism confirmed this ability. Using
the technique ofDSC, this fusion peptide was, indeed, shown to destabilise the La
phase with respect to the Hn phase. Similarly, the X-ray diffraction results
demonstrated its capacity to increase the negative monolayer curvature of both the La
and Hn lipid phases, and also to promote the formation of a novel lipid phase, of
increased negative monolayer curvature compared to that of the other two phases. It
can be seen, therefore, that the FeLV fusion peptide promotes the destabilisation of
the bilayer phase relative to lipid phases ofhigher negative curvature. Moreover, the
NMR results showed that this peptide enhances the formation ofhighly curved,
isotropic lipid structures, which are thought to be involved in the rate-limiting stages
of the fusion pathway.
The molecular mechanism by which the FeLV fusion peptide promotes fusion
may depend upon the nature of the target membrane and also upon what the rate-
determining step is in that particular fusion pathway. The differences that were seen
for the interaction of the FeLV fusion peptide with bilayers of distinct lipid
composition (see Chapters 5 and 6) agree with the hypothesis that the interaction of
viral fusion peptides with a cell membrane will depend, at least in part, upon the
membrane environment into which the peptide partitions. The results of the DSC,
NMR and X-ray diffraction chapters suggested that the FeLV fusion peptide may
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accelerate both the rate of stalk formation, as well as the partitioning of the TMC
intermediate towards the formation of a fusion pore.
Exposure ofhydrophobic regions of viral fusion proteins, including the fusion
peptides, in the space between apposed membranes may help apposing bilayers to
bypass or overcome the strong repulsive hydration force that is present (Bentz et al,
1990). Perturbation of the target bilayer by the fusion peptide might have the same
effect if some of the lipid tails in the hydrophobic interior of the membrane became
exposed. Neutron diffraction studies revealed that the FeLV fusion peptide altered the
packing of certain lipid bilayers in a manner that agreed with the concept of
precession of a fusion peptide within a bilayer. Furthermore, the process of the
insertion of a peptide into a bilayer is likely to produce a certain amount ofexposure
of the hydrophobic lipid region, since even the interfacial region contains methylene
groups from the edges of the hydrocarbon core (Wiener and White, 1992).
The formation of fusion pores may be enhanced by fusion peptides. Thinning
of a bilayer, which was suggested by the observed change in the distribution of
'heavy' water in the presence of the FeLV fusion peptide (see Chapter 5), could
reduce the tension that is required to rupture that bilayer. Schoch and Blumenthal
(1993) showed that the fusion peptide of Influenza virus played an important role in
the widening of the fusion pore. It is possible that some of the fusion peptides stabilise
fusion protein oligomeric assemblies by interacting with the transmembrane portion of
the viral envelope protein or with neighbouring fusion peptides of adjacent monomers,
whilst other fusion peptides simultaneously interact with the target membrane. Thus
pore stabilisation and its widening may require specific peptide-peptide interactions.
Certainly, the FeLV fusion peptide demonstrated an extreme tendency towards self-
aggregation.
To my knowledge, this work provides the first published experimental
evidence of both fusogenic activity and the effects on lipid polymorphism of the FeLV
fusion peptide. It also demonstrates the phenomenon of structural plasticity for this
fusion peptide, a property which may be characteristic ofmany viral fusion peptides.
Whilst the precise role ofviral fusion peptides in the overall process of fusion
is still uncertain, major advances are being made in our understanding of these
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biological molecules. It is hoped that work with specific fusion proteins and peptides,
such as the FeLV fusion peptide, will continue to shed light upon the basic molecular
mechanisms which underlie this essential life process.
There are a number of further experiments that would be of interest to
conduct, in the light of the findings described in this thesis. Fusion assays performed
under a variety ofexperimental conditions could help to determine the factors
required for the optimal fusogenic activity of the FeLV fusion peptide. In particular,
the effects of the presence ofphysiological concentrations of calcium ions and also
different lipid species could be determined. The rates of fusion should also be
measured in the presence of several different peptide concentrations, in order to verify
that the fusion peptide is indeed the active catalyst. CD studies ofFeLV peptide-
containing proteoliposomes after filtration to remove any unbound peptide would
enable the determination of the secondary structure ofpurely membrane-bound
peptide, and the use ofFTIR as well would provide a more accurate estimation of the
P sheet content of these samples. A repetition of the TRXRD study using a slower
scan rate might enable definite identification of the novel, peptide-induced lipid phase
described in Chapter 4. Moreover, a similar study using MeDOPE might provide
further evidence of the ability of the FeLV fusion peptide to induce cubic phase
formation. Since the DSC results were based upon one set of data, it would also be
beneficial to repeat this study. Specific deuteration of the FeLV fusion peptide would
enable measurement, using neutron diffraction, of the exact position of the deuterated
amino acid residues with respect to the lipid bilayer, and thus the extent and depth to
which this peptide penetrates membranes. Determination of the effects ofnon-
conservative mutations in the sequence of the FeLV fusion peptide upon the ability of
this peptide to destabilise lipid bilayers, to promote the formation of negatively curved
non-bilayer structures and to promote fusion might identify amino acid residues that
are crucial to the functional ability of this peptide. Similarly, the use of fragments of
the fusion peptide sequence ofdiffering length could determine the minimum length of
peptide required to produce these various effects, and also the optimum peptide
length. Concurrent CD and FTIR studies of the secondary structures of these various
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abstract: The structural effects of the fusion peptide of feline leukemia virus (FeLV) on lipid
polymorphism were studied, using differential scanning calorimetry (DSC), 31P nuclear magnetic resonance
(NMR), and time-resolved X-ray diffraction. This peptide lowers the bilayer to inverted hexagonal phase
transition temperature, 7h, of dipalmitoleoylphosphatidylethanolamine (DiPoPE) at peptide mole fractions
of up to 1.5 x 10~3 at pH 5.0 and at pH 7.4. The temperature at which isotropic 31P NMR signals for
monomethyldioleoylphosphatidylethanolamine (MeDOPE) first occurred is lowered by the FeLV peptide.
The amount of isotropic signal seen at 40 °C is directly correlated to the peptidedipid molar ratio. In the
peptide-containing samples, more lipid remains in the isotropic state over the whole recorded temperature
range. Isotropic 31P NMR signals were observed for DiPoPE in the presence of the FcLV peptide for the
entire recorded temperature range of 35—50 °C, while pure DiPoPE showed no significant amount of
isotropic signal. X-ray studies of DiPoPE show the formation of a new lipid phase with peptide, which
is not seen in the pure lipid samples. Disordering of the La phase is evidenced by broadening of the
diffraction peaks, and the hexagonal cell parameter is decreased with peptide present. Our results suggest
that the FeLV peptide is increasing the negative curvature of the lipid system, which is thought to be
crucial to the formation of highly bent, high-energy structural fusion intermediates, such as the "stalk"
model. Fusion activity for this putative fusogenic peptide was also demonstrated, using a resonance energy
transfer (RET) lipid mixing assay. To our knowledge, this work provides the first published experimental
evidence of both fusogenic activity and effects on lipid polymorphism for the FeLV fusion peptide.
Membrane fusion plays a vital role in a large and diverse
number of essential biological processes. Despite this fact,
the precise molecular events which occur during fusion arc
still not known. Specific catalysts can promote fusion, and
these differ between individual fusion processes. Fusion
proteins from enveloped viruses, such as influenza virus
hemagglutinin (7, 2) and gpl60 from human immunodefi¬
ciency virus (3) arc among the most thoroughly studied
fusion catalysts. It has been proposed that, although the
initial triggers for the fusion pathway show great diversity,
the actual lipid changes which occur in the fusing membranes
may be very similar indeed for many fusion systems (4).
Thus, studies of one particular fusion pathway may have
wide-ranging implications for fusion in all eukaryotic cells
as well as for infective mechanisms of all intracellular
parasites.
In order for two initally distinct membranes to fuse, the
lipid molecules comprising the two bilayers must rearrange
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temporarily into highly curved intermediates at the fusion
site. It was first suggested that fusion intermediates were
formed during lipid transitions from the planar lamellar to
curved, nonbilayer phases (5). Studies by Ellens et al. (6)
revealed increased liposome fusion rates in the same tem¬
perature range in which Gagne et al. (7) observed isotropic
31P NMR1 resonances of the same lipid. Isotropic resonances
are due to lipid structures of high curvature in which lateral
diffusion of phospholipids can motionally average the
chemical shift anisotropy. They correlate with the presence
of lipidic particles, seen by electron microscopy (7, 8), and
with amorphous and inverted cubic phases, measured by
1 Abbreviations: FeLV, feline leukemia vims; DiPoPE, dipalmito-
leoylphosphatidylethanolamine; MeDOPE, monomethyldioleoylphos-
phatidylethanolamine; RET. resonance energy transfer; SIV, simian
immunodeficiency vims; La, liquid crystalline lamellar phase; Hn.
inverted hexagonal phase; TH, La—Hn phase transition temperature;
DSC, differential scanning calorimetry; 31P NMR, 31phosphorus nuclear
magnetic resonance; HPLC, high-performance liquid chromatography;
7S, lipid structures producing isotropic NMR signals; 7), temperature at
which isotropic signals are first detected; dL, lamellar phase unit cell
repeat distance (d spacing); dn, inverted hexagonal phase unit cell repeat
distance (d spacing); AA, amino acid; Ro, spontaneous radius of
curvature of the lipid monolayer; DG, diacylglycerol; MLV, multila¬
mellar vesicle; SUV, small unilamellar vesicle; TMC, transmonolayer
contact intermediate; NBD-PE, L-a-V-(4-nitrobenzo-2-oxa-l,3-diazole)-
PE from egg; Rh-PE, L-a-V-(lissamine-rhodaminc B sulfonyl)PE from
egg; ILA, interlamellar attachment; DMSO, dimethyl sulfoxide.
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X-ray diffraction (9). These highly curved isotropic lipid
arrangements may be fusion intermediates. Diacylglycerols
(DGs), which are fusion promoters, lowered the threshold
temperature at which isotropic structures occurred (70).
Isotropic structures were observed in the presence of DGs
(77). The fusion peptide of simian immunodeficiency virus
(SIV) promoted the formation of isotropic structures, while
a nonfusogenic mutant of this peptide did not (72). Similar
results were seen with the fusion peptide from influenza virus
hemagglutinin (13); the wild-type peptide increased isotropic
phase formation, but only at fusogenic pH, while the two
mutant nonfusogenic peptides studied did not. These
isotropic lipid mesophases occur on the pathway from the
lamellar phase to the inverted hexagonal (Hh) or ordered
cubic phases. Correlations have been found between the
inhibition of membrane fusion by certain compounds and
their ability to raise the lipid bilayer to inverted hexagonal
phase transition temperature (7)0 as measured by high-
sensitivity DSC (14). Similarly, fusion promoters have been
shown to lower 7h (75, 72, 13). While kinetically stable
lipid phases such as Hn and bicontinuous cubic phases may
not be involved in biological fusion, the first steps in their
transition pathways from the lamellar phase may be very
important, in particular the bilayer destabilization thus
produced.
A number of models have been proposed for the molecular
arrangements of the lipid in fusion intermediates. These are
based on a combination of experimental findings and
theoretical calculations of the energetics involved. The most
recent model (16) suggests the initial formation of a highly
bent modified stalk structure, composed of the outer lipid
monolayers of each bilayer, which then converts to a
transmonolayer contact intermediate (TMC). This interme¬
diate can then evolve into either a fusion pore/cubic phase
fomation or into Hn phases (77). There is much theoretical
(e.g., 18, 19) and experimental evidence (e.g., 77, 20—22)
to support this model. Recently, Lee and Lentz (23) have
identified distinct kinetic steps in the fusion pathway, which
support the stalk—pore hypothesis. The highly bent stalk
structure would be likely to give rise to isotropic NMR
signals. Fusion catalysts are thought to affect the kinetics
of the phase transitions, and not the thermodynamic stability
of the individual lipid phases themselves. Thus, a favoring
of the conversion of the lipid bilayer to nonlamellar phases
should enhance the rate of formation of the fusion stalk, while
an alternative mechanism would be a change of partitioning
of the TMC intermediate toward the fusion pore/cubic phase
pathway, as suggested for the influenza virus fusion peptide
(24).
Modeling studies have suggested that fusion peptides insert
obliquely into target lipid membranes and thus destabilize
lipid molecular packing (25). Longitudinal precession of the
obliquely oriented peptide would lead to greater disruption
of the bilayer center than of its surface, thereby increasing
the negative curvature pressure, and hence favoring the
formation of inverted lipid phases (26,13). We have studied
the effect of the fusion peptide from feline leukemia virus
(FeLV) on lipid polymorphism. FeLV is a pathogenic
exogenous retrovirus of cats (27) and the main cause of
nontraumatic death in adult domestic cats worldwide. The
proposed fusion peptide of FeLV is the hydrophobic amino
terminus ofpl5E, the transmembrane-like region of the viral
envelope glycoprotein spike gp85 (25). Its amino acid
sequence shows similarity to that of the known fusion peptide
of SIV (28), and also to those of other leukemia-producing
Retroviridae (Swiss Protein Data Bank). Using a resonance
energy transfer (RET) lipid mixing assay, we have also
demonstrated fusion activity for this peptide. To our
knowledge, this is the first published experimental work
using this fusion peptide. The results are discussed in the




were purchased from Avanti Polar Lipids (Alabaster, AL).
Thin-layer chromatography showed a single spot for each.
L-a-A-(4-nitrobenzo-2-oxa-l,3-diazole)PE from egg (NBD-
PE) and L-a-7V-(lissamine-rhodamine B sulfonyl)PE from
egg (Rh-PE) were also purchased from Avanti. Dimethyl
sulfoxide (DMSO) was obtained from BDH Chemicals
(Toronto, ON).
The FeLV 28 amino acid and SIV 12 amino acid peptides
were synthesized by Albachem Ltd. (26 Craigleith View,
Edinburgh, EH4 3JZ, Scotland, U.K.) using solid-phase
synthesis. Their purities were >95%, as determined by
analytical HPLC, Maldi—Tof mass spectrometry, and amino
acid analysis.
The FeLV peptide sequence, obtained from the Swiss
Protein Data Bank, was EPISLTVALMLGGLTVGGIA-
AGVGTGTK. The lysine was included on the carboxy
terminus to increase solubility. It is the next naturally
occurring residue on pl5E. The SIV peptide sequence was
GVFVLGFLGFLA, which has been shown previously to
promote lipid mixing and thus membrane fusion (29).
Preparation of Lipid and Lipid/Peptide Films. Weighed
amounts of the required lipid, or lipid plus peptide, were
vortexed thoroughly in chloroform. The peptide-containing
samples were then sonicated until the peptide dissolved. The
chloroform was evaporated using nitrogen gas, and the
samples were then placed under vacuum for 4 h, followed
by lyophilization overnight to remove any trace residual
solvent. The resulting films were then suspended in buffer
and vortexed vigorously at room temperature for 10 min.
The buffers used for the DSC, NMR, and X-ray diffraction
studies were 20 mM PIPES, 1 mM EDTA, 150 mM NaCl,
and 0.002% NaN3 for pH 7.4 samples, or 10 mM citrate,
0.15 M NaCl for pH 5.0 samples, and for the RET assays,
10 mM glycine, 0.1 mM NaCl, 0.1 mM EDTA for the pH
9.5 buffer, and 10 mM Hepes, 0.15 M NaCl, 1 mM EDTA
for the pH 7.0 buffer.
Differential Scanning Calorimetry. The samples were
made to a final DiPoPE concentration of 10 mg/mL,
including varying peptide concentrations as required, and
they and the reference buffer were degassed under vacuum
just prior to use. Thorough mixing was applied to ensure a
uniform sample suspension for injection into the sample
chamber. An MC-2 high-sensitivity scanning calorimeter
(Microcal Co., Amherst, MA) was employed, at a scan rate
of 45 K/h. The sample chamber held 1.4 mL. Continuous
heating scans were run from 25 through to 60 °C. A single
van't Hoff component was used to fit the recorded bilayer
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to hexagonal phase transition, and the reported transition
temperature is that for the fitted curve.
31 P NMR. A Bruker drx500 spectrometer, operating at a
frequency of 202.45 MHz with broad band proton decou¬
pling, was used to obtain the spectra. Three freeze—thaw
cycles were carried out prior to measurement to ensure that
all the lipid present was in the lamellar phase and also to
ensure full hydration of the dry MeDOPE and DiPoPE. The
suspensions were then vortexed vigorously to produce a lipid
paste and loaded into 5 mm diameter thin-walled NMR tubes.
The high lipid concentration of 50 mg/mL aids the formation
of nonbilayer phases. The lipid/peptide molar ratios were
100:1 or 200:1 for the peptide-containing samples. Samples
were heated in 5 or 10 °C steps. An equilibration time of
around 15 min was used after raising the sample temperature,
which was maintained to within ±0.1 °C by a Bruker B-VT
1000 variable temperature unit. A relaxation delay of 3 s
was used between scans. Prior to Fourier transformation,
exponential line-broadening of 100 Hz was applied.
X-ray Diffraction. The X-ray diffraction experiments were
performed at station 8.2 of the synchotron radiation source
at the Daresbury Laboratory. The radiation wavelength was
1.54 A. A Teflon-lined brass chamber with mica windows
was used as sample holder, and an external circulating water
bath was used to control the sample temperature, which was
continuously monitored via a thermocouple. The temperature
of the sample cell was linearly increased from 30 to 70 °C,
at a heating rate of 90 °C/h. All samples were at pH 7.4.
Each temperature scan consisted of 120 frames of diffraction
data. The XOTOKO program was used to correct the raw
data. Corrections for sample thickness and variation in
detector response were applied, and background counts were
subtracted. Detector response was determined by measuring
a fixed source, 59Fe, for several hours, at the start and the
end of data collection. The detector was calibrated for small
angle scattering using rat tail collagen, mounted in a cell
and lightly stretched, as a standard. Under these conditions,
collagen has a unit cell size of 676.08 A (30). The corrected
data were then plotted using this calibrated x-axis.
Liposome Preparation for Fusion Studies. Liposomes
were made from lipid films prepared as above, using pure
McDOPE for the unlabeled LUVs, and with 2 mol % of
both NBD-PE and Rh-PE present for the labeled LUVs. The
dried lipid films were suspended initially in an iso-osmotic
glycine buffer at pH 9.5, at a lipid concentration of 20 mg/
mL. After vigorous vortexing, the lipid suspensions were
subjected to five freeze—thaw cycles, by immersion in liquid
nitrogen for 2 min, followed by plunging into a water bath,
at a temperature of 40—60 °C, until the samples thawed.
Next the samples were filtered 10 times through two stacked
polycarbonate membranes, of pore size 0.1 pm, (Nucleopore
Corp., Plcasanton, CA), using a high-pressure extruder (Lipex
Biomembranes Inc., Vancouver, Canada) to yield LUVs.
Lipid Mixing Fusion Assay. Lipid mixing was measured
using the method of monitoring the change in the intensity
of fluorescence which results from fluorescence energy
transfer between the two bilayer-inserted probes, NBD-PE
and Rh-PE (31). A SLM Aminco Bowman Series 2
Luminescence Spectrometer with excitation and emission
slits of 4 nm was used. The LUVs were added, at a ratio of
1:9 labeled:unlabeled, into a continuously stirred fluorimeter
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Figure 1: Some representative thermograms obtained at pH 7.4.
Pure DiPoPE (a), DiPoPE with FeLV peptide present at a peptide
mole fraction of 0.5 x 10"3 (b), and 0.65 x 10~3 (c). TH is lowered
in the presence of the FeLV fusion peptide. DSC heating scan rate
was 45K/h.
LUVs comprised 1% of the total volume in the cuvette. The
final lipid concentration was 300 ^M. There was no
detectable change in pH on addition of LUVs, since the
volumes of LUVs added were very small. The excitation
wavelength used was 470 nm, and the emission of NBD was
recorded at 530 nm. A baseline fluorescence was measured
for these suspensions. The FeLV and SIV peptides were
dissolved separately in DMSO at a concentration of 1 mg/
mL. These stock solutions of peptide were added to LUV
preparations in the fluorimeter cuvettes to give a final peptide
concentration of 10 /tM. DMSO alone was also used as a
control. One hundred percent lipid mixing was obtained by
addition of 10% Triton X-100 to a final concentration of
0.1%.
RESULTS
Differential Scanning Calorimetry. Figure 1 shows three
representative thermograms, at pH 7.4, from which values
for 7h were obtained. It can be seen that TH is lowered in
the presence of both concentrations of FeLV fusion peptide
shown. Plots of change in TH with increasing peptide mole
fraction, at pH 7.4 and pH 5.0, are shown in Figure 2, parts
a and b, respectively. The resultant curves show an initial
decrease in 7h, followed by an increase in TH with consecu¬
tive rises in the peptide mole fraction. At peptide mole
fractions of > 1.5 x 10~3 a broadening of the enthalpy peaks
was observed, indicating a decrease in cooperativity for this
transition. The two pH curves are at least biphasic; obviously
the possibility exists that these curves are described by more
complex functions.
7h is a measure of the relative stability of the La and Hn
lipid phases. The reduction in 7ji observed initially with
increasing peptide concentration suggests that, at peptide
mole fractions below 1.5 x 10~3, this fusion peptide favors
the formation of the Hn phase over the La phase at both pH
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Table 1: Comparison of Effect of Viral Fusion Peptides on TH of
DiPoPE
slope of line slope of line
viral (°C/mole fraction peptide) (°C/mole fraction peptide)
fusion peptide atpH5.0 atpH7.4
influenza HA2 -453 ±112° 301 ± 49°
SIV not studied 360 ± 100fc
FeLV -2128 ±233 -1116 ±444
" From Epand and Epand (13). b From Epand et al. (12).
5.0 and pH 7.4. The FeLV virus fuses with biological cells
at pFI 7.4 (32), so a decrease in TH at both pFl values is to
be expected with this fusion peptide. Previous experiments
which studied the effect of the influenza virus fusion peptide
on 7h also found a difference with pH (13): the influenza
virus fusion peptide lowered TH at pH 5.0, but increased 7H
at pFI 7.4. These findings correlate with this peptide's pH-
dependent fusogenic ability. In the same study of the
influenza peptide, two nonfusogenic mutants were found to
raise Tu, at both pH 5.0 and pFI 7.4. DSC experiments
performed using the SIV fusion peptide at pH 7.4 showed a
decrease in Tu with the wild-type fusion peptide, and little
change in 7h with a nonfusogenic mutant (12). This suggests
that, at low peptide concentrations, a lowering of TH is a
fundamental property of viral fusion peptides. Table 1 shows
the values of the slopes for the dependence of 7h on the
mole fraction of fusion peptide for these three peptides: it
should be noted that the range of peptide concentrations
included here is not the same for FcLV as it is for the other
two peptides studied, as we are only comparing the FeLV
data which shows a reduction in 7'H, i.e., the first half of the
plotted results. This may explain in part why our gradients
are so much steeper for the FeLV data. However, some of
the quantitative differences between these values may be due
to the difference in the structures of the fusion peptides. The
FeLV peptide has an acidic residue on its amino terminus,
the influenza peptide has several acidic residues along its
length, and the SIV peptide has no polar residues. These
factors will affect the depth and angle of peptide penetration
into the lipid bilayer; alteration of the amino acid sequences
of fusion peptides changes the membrane orientation of these
peptides (25). Enhancement of Hn formation may be due
to disruption of lipid packing and/or effects on lipid
hydration, producing an increase in monolayer negative
curvature strain (55). X-ray studies of the Hn phase lattice
constant at constant temperature can determine whether
alteration of the spontaneous radius of curvature of the lipid/
water interface, Kq, occurs, and thus a change in monolayer
negative curvature strain. This is seen for DiPoPE samples
containing the FeLV peptide (see X-ray Diffraction Results).
7h is seen to increase at FeLV peptide mole fractions
above 1.5 x 10~3, at both pH 5.0 and pH 7.4. We propose
that this is due to increased self-aggregation of the extremely
hydrophobic FeLV peptide molecules at these higher con¬
centrations, thus preventing them, in part, from inserting into
the lipid bilayers. Grossly, the peptide does appear to self-
aggregate in these concentration ranges, as seen by the
formation of gel-like masses in these samples by the end of
the heating scans. A similar phenomenon has been observed
with Amphotericin B, which is also extremely hydrophobic
in nature (Epand, R. M., unpublished observation). 7h is
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Figure 2: Change in lamellar to inverted hexagonal phase transition
temperature of DiPoPE as a function of mole fraction of feline
leukemia vims fusion peptide at (a) pH 7.4 (■) and (b) pH 5.0
(•)■
seen to increase more in the presence of the FeLV peptide
at pH 5.0 than at pH 7.4; presumably there is more self-
aggregation of the peptide at this pH, possibly due to a
decrease in negative charge of the glutamate residues at
acidic pH. We suggest that the aggregated FeLV peptide
fraction may lie along the bilayer surface, rather than insert
into the membrane, and actually stabilize the La phase,
possibly by reducing its negative curvature strain.
3IP NMR Spectroscopy. Figure 3 shows the 31P NMR
powder patterns obtained for pure MeDOPE and for Me-
DOPE plus FeLV fusion peptide as a function of temperature.
The temperature at which isotropic resonances are first
detected, 7), drops with increasing peptide concentration.
There is also a direct correlation between the mole fraction
of peptide present and the amount of isotropic signal seen
at 40 °C. Moreover, in the presence of the FeLV fusion
peptide, a larger percentage of the lipid remains in this
isotropic state over the full range of recorded temperatures.
At 82 °C, a small amount of MeDOPE with FeLV peptide
has converted to the Hn phase, whereas by 75 °C, the pure
lipid already has a larger Hn signal. No significant differ¬
ences were found between the pH 7.4 and the pH 5.0
samples. Figure 4 shows the 31P NMR powder patterns
obtained for pure DiPoPE and for DiPoPE plus FeLV fusion
peptide as a function of temperature. The pure DiPoPE
samples show no significant isotropic peak at any of the
































Figure 3: 31P NMR spectra of pure MeDOPE, and samples containing different molar ratios of feline leukemia virus peptide, as a function
of temperature. Lipid concentration in all samples is 50 mg/mL. Only pH 7.4 data are shown, but the pH 5.0 results were qualitatively
similar.
recorded temperatures. However, in the presence of the
FeLV peptide, a substantial isotropic component is seen
throughout the entire recorded temperature range.
The shapes of 31P powder patterns are determined by the
extent of motional averaging, on the 31P NMR time scale,
of the chemical shift anisotropy of the 31P atom present in
the phospholipid headgroup. This, in turn, is directly
influenced by the types of motion possible within the
phospholipid dispersions. The amount of isotropic 31P NMR
resonance (7S) present in the NMR spectrum has been directly
correlated with the rate of membrane fusion between
MeDOPE vesicles (34). Furthermore, the initial appearance
of Is has coincided with the start of membrane fusion (35).
Similar findings have occurred with vesicles of different lipid
compositions (35). Phospholipid molecules in inverted cubic
phases generate isotropic 31P NMR spectra (36). It is
unlikely that ordered cubic phases are intermediates in fusion.
Fusion intermediates are isolated structures, not phases.
Furthermore, cubic phases have extreme kinetic stability (37).
This view is supported by our NMR data, which show
persistence of isotropic signals through a wide temperature
range, over a period of hours. However, it has been
suggested that fusion intermediates resemble intermediates
formed on the pathway to cubic phase formation (17). Work
with the fusion peptides from SIV (12) and influenza virus
(13) showed enhancement of /s in their presence. Our results
presented here for the putative fusion peptide from FeLV
suggest that it is indeed favoring the formation of lipid























Figure 4: 31P NMR spectra of DiPoPE alone and in the presence of a 100:1 molar ratio of lipid:FeLV peptide. Only pH 5.0 data are
shown, but the pH 7.4 results were qualitatively similar. Lipid concentration in all samples is 50 mg/mL.
structures which are likely to be involved in the rate-limiting
intermediate stages of the fusion pathway.
X-ray Diffraction Experiments. Time-resolved X-ray
diffraction data were obtained to confirm the phase transitions
measured by DSC and to determine any effects of the FeLV
peptide on lipid structural parameters. The diffraction
patterns verify that the transitions taking place in the DSC
experiments arc from La to Hn, no other phases being
observed in the X-ray data. However, it is possible that very
transient phases are not detected due to the high scan rate
employed (disordered structures would not be seen either).
Figure 5 shows a 3-dimensional plot of the series of
diffraction patterns obtained for DiPoPE plus EeLV peptide
present at a peptide mole fraction of 3.1 x 10~3 for the entire
measured temperature range. Figure 6 shows a typical
diffractogram for the TH region of the scan; this was taken
from the data for DiPoPE with FeLV peptide present at a
peptide mole fraction of 1.6 x 10"3 and at 42 °C. Samples
were assigned the Hh phase if a minimum of three diffraction
peaks were observed which indicated spacings in the ratios
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Figure 5: Three-dimensional plot of the series of consecutive
diffraction patterns obtained on heating from 30 °C to 70 °C for
DiPoPE plus FeLV fusion peptide, at a peptide mole fraction of 3
x 10~3. The heating scan rate was 90 °C/h. The origin is on the
left, and the right-hand limit represents channel 270 of the 512
recorded. The first two lamellar and first three hexagonal diffraction
orders are visible as well-defined peaks. The transition from the
lamellar to the hexagonal phase can be seen. The presence of a
third, peptidc-induced phase can be seen as a shoulder on the first
and second hexagonal phase peaks.
Channel number
Figure 6: Typical small-angle X-ray diffraction profile in the Tn
region of the scan series for DiPoPE plus FeLV fusion peptide at
a peptide mole fraction of 1.6 x 10~3, at 42 °C. Channel numbers
1—300 of the 512 recorded are shown. Part of the data has been
amplified by a factor of 10 (x 10) for the sake of clarity. The inset,
(a), shows an enlargement of the Bragg peak for the second
diffraction order of the Hn phase, and the presence of a smaller
peak, of smaller d spacing than the main Hn peak (solid lines).
Gaussian analysis of the two peaks is shown above (dotted lines).
1:V3:v'4:%/7. The d spacings for all samples were calcu¬
lated from the distance of peaks from the origin. The d
spacings for the La and Hn phases for pure DiPoPE and the
Davies et al.
0 1 2 3 4 5 6
FeLV peptide molar fraction (xlO 3)
Figure 7: Variation in d spacings (A) for the La and Hn phases
of DiPoPE with increasing FeLV peptide concentration. dH
measured (•) at 49 °C, (■) at 50 °C, and (♦) at 52 °C. dh measured
(O) at 33 °C, (□) at 40 °C, (A) at 44 °C, and (©) at 45 °C.
peptide-containing samples are plotted in Figure 7. The d
spacings found in the present work are in good agreement
with those previously reported (24, 38). It should be noted
that in the values presented in the references the definition
used for the repeat spacing was that adopted by Gruner and
others (39) in which the d space corresponds to the distance
from the center of one Hn cylinder to the next. This distance
is related to the lattice spacing reported in the present work
by multiplying the lattice spacing by 2/^/3. The small
differences between the two sets of data may be the result
of different heating protocols, different batches of DiPoPE,
and different calibrations. The transition from the La to the
Hn phase is ordered, i.e., both lamellar and hexagonal phase
domains coexist in the transition temperature region. This
was seen for the pure lipid and the pcptide-containing
samples. No cubic intermediates are seen. The slow rate
of water penetration into the nascent Hn phase seen with
multilamellar vesicle (MLV) samples may prolong the
detection of coexistence of La and Hn domains. Figure 6a
(inset) shows the Gaussian analysis of the Bragg peak of
the second diffraction order of the hexagonal phase. It can
be seen that, in the presence of the FeLV peptide, a second
and different lattice was observed, of slightly narrower d
spacing than that of the main Hn phase. As one cannot assign
a lipid phase on less than three diffraction orders, it is not
possible to state definitely what this novel, peptide-induced
phase is; there are only two observable diffraction peaks for
this phase, which represent the second and third diffraction
orders. The diffraction amplitudes of higher orders are too
small to detect, and the first orders of the two hexagonal
phases probably overlap due to the decrease in spatial
resolution seen at smaller diffraction angles. This may
account for the observed slight increase in mosaic spread of
the first order of diffraction of the hexagonal phase in the
presence of peptide. However, the two observed novel peaks
fit to a d spacing of 1: \/3, and they occur as a shoulder on
the definitely identified main Hn phase. Thus, this may
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represent a novel Hn phase, which was most noticeable in
the 1.6 x 10~3 FeLV peptide mole fraction samples. A
measure of the maximum percentage of DiPoPE present in
this phase as a proportion of total amount of hexagonal phase
lipid yielded the following data: 0% with no peptide present,
32%, 20%, and 21% at peptide mole fractions of 1.6 x 10~3,
3.1 x 10~3, and 5 .5 x 10 3, respectively. Evidence of the
peptide-induced lattice disappeared completely as heating
continued well above 7h, indicating that this phase is
transient. No extra peaks were seen in the pure lipid samples,
and thus it is clear that this novel phase is due to the presence
of peptide. Not all of the peptide is incorporated into these
domains, since the d spacing of the main Hn phase (dn) is
also decreased in the presence of the FeLV peptide (see
Figure 7); this also suggests that the FeLV peptide is
decreasing Rq of the system in this peptide concentration
range. A reduction in Rq will destabilize bilayer structures
relative to inverted nonbilayer phases. DGs have been found
to decrease Rq, i.e., to increase the spontaneous negative
curvature, of MeDOPE (35). Physiological levels of DGs
are known to promote fusion (40) and have also been found
to enhance a La to cubic phase transition (11), to bicontinu-
ous Q224 (41). This cubic phase is related to the putative
fusion intermediate, in the patch-thc-puncture fusion model
(42). An interesting observation in our experiments is that
of marked broadening of the La diffraction peaks on heating
in the presence of the FeLV peptide, and in a peptide
concentration-dependent manner. (The width of the peaks
was determined by fitting Gaussians and measuring the width
at half-height). This represents disordering of the La phase
and may be consistent with the start of a transition to an
inverted cubic phase (9). X-ray studies of DiPoPE with an
SIV mutant fusion peptide at pH 7.4 (38) and from influenza
virus at pH 5.0 (24) have indeed detected the formation of
a cubic phase. The heating scan rates used in these studies
were considerably slower than that used here, which may
explain why no ordered cubic phase was detected in our
study. When rapid heating was used with the influenza
fusion peptide, no cubic phase was observed (24). It has
also been observed that, even with pure MeDOPE, the extent
of cubic phase formation is very dependent on scan rate (10,
43). The FeLV peptide also produced broadening of the Hn
peaks. Part of the peak broadening may be due to vesicu-
lation of the multilamellar vesicles (MLVs) present in the
samples, as suggested for the SIV fusion peptide/MeDOPE
system; the conversion of MLVs to smaller vesicles with
fewer lamellae is thermodynamically favorable, but the fusion
peptide may greatly accelerate this process (38). The effect
of the FeLV peptide on dn is seen to exhibit a biphasic trend
with peptide concentration, reminiscent of that seen for 7'H
in our DSC measurements. The fusion peptide had little
effect on d\, at temperatures well below 7h, (see Figure 8),
but as T]i is approached, dL decreases with increasing peptide
concentration. It can be seen from Figure 8 that the
temperature-dependence of du and dL is very similar for both
pure lipid and the pcptide-containing samples.
Fusion Assay. Figure 9 shows the percentages of lipid
mixing between MeDOPE LUVs obtained in the presence
of the SIV and FeLV fusion peptides. MeDOPE was used,
since DiPoPE does not form stable liposomes. The SIV
peptide promotes rapid lipid mixing (and thus membrane
fusion) between the labeled and unlabeled LUV populations,
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Figure 8: Change in d spacings (A) of the La and Hn phases with
temperature as calculated from the X-ray diffraction patterns.
DiPoPE alone (O); DiPoPE plus FeLV peptide at a peptide mole




Figure 9: The percentages of lipid mixing between MeDOPE
LUVs induced by the SIV and FeLV fusion peptides. The peptides,
which were dissolved in DMSO, were added at time 0. Changes in
fluorescence due to equivalent aliquots of the pure DMSO solvent
are also shown. The top DMSO curve corresponds to 52 [iL of
added solvent as used for the FeLV peptide, and the bottom curve
to 24 fiL as used for the SIV peptide. Measurements were performed
at 37 °C, and at pH 7.0.
as seen by the change in NBD fluorescence on probe dilution.
Our results agree very closely with previous experiments
performed using this peptide (29). The FeLV peptide also
clearly produces membrane fusion, as shown by lipid mixing.
The SIV peptide shows greater enhancement of fusion using
this particular lipid system. This difference in potency may
reflect the many differences between these two peptides, for
example their lengths, overall electrical charges, solubility
characteristics, and probable miscibilities with different lipid
species. Moreover, different viral fusion peptides have been
shown to require different specific experimental conditions
in order to promote maximum membrane fusion (e.g., ref
44—46). Thus, the experimental conditions used here may
not provide optimal fusogenic conditions for the FeLV fusion
peptide. The SIV fusion peptide was chosen as a control
DMSO
DMSO
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since it is the most homologous retroviral fusion peptide for
which there is definite experimental proof of fusogenic
activity.
DISCUSSION
Two aspects of membrane fusion mechanisms can explain
the relationship between a pcptide-induced increase in
membrane fusion rates and the effect of the peptide on lipid
polymorphism. The first aspect is the formation of a stalk
or interlamellar attachment (ILA) intermediate which has
overall negative curvature (16). Thus the formation of this
first intermediate would be accelerated by agents or condi¬
tions which favor the formation of inverted phases. The
monolayers involved in the formation of this stalk intermedi¬
ate are the trans or contacting monolayers (22). There are
several examples of viral fusion peptides which lower Tu
and therefore favor the formation of inverted phases,
including both the SIV fusion peptide (72, 38) and the
influenza fusion peptide (13). In the present work we
demonstrate, by DSC and X-ray diffraction, that the putative
fusion peptide of FeLV can lower 7h of DiPoPE, at least at
low peptide mole fractions. This peptide also causes du to
decrease (Figure 7), indicating that the peptide promotes
negative monolayer curvature.
Another mechanism by which peptides can promote the
rate of fusion is by favoring the partitioning of the TMC
intermediate toward the fusion pore/cubic phase pathway
(17). This mechanism has been suggested for the influenza
fusion peptide (24). The possibility of such a phenomenon
occurring with the FeLV peptide is suggested by the fact
that low concentrations of peptide promote the formation of
isotropic resonances in 31P NMR of MeDOPE and DiPoPE
(Figures 3 and 4). Although no cubic phases were observed
for DiPoPE by X-ray diffraction, this lipid forms cubic
phases less readily. As a pure lipid, the cubic phase has
never been observed with DiPoPE and in the presence of
the influenza peptide the cubic phase is only found with
DiPoPE mixed with other phases and with a low degree of
order, presenting limited evidence for the formation of a
cubic phase. The relationship between conditions leading
to cubic phase formation and to increased rates of membrane
fusion has also been noted with DAG-induced fusion (77,
47).
The present work provides evidence that the N-terminus
of the fusion protein of FeLV has effects on lipid properties
which are characteristic of viral fusion peptides. It also
demonstrates membrane fusion activity for the FeLV peptide,
in the form of lipid mixing between liposomes. Furthermore,
this peptide is an N-terminal segment, released by proteolytic
activation of the fusion protein, which is also a feature shared
with several other viral fusion peptides. The molecular
mechanism by which it promotes fusion may depend on the
nature of the target membrane and also on what the rate-
determining step is in fusion. This peptide is suggested to
accelerate both the rate of stalk formation as well as the
partitioning of the TMC intermediate toward the formation
of a fusion pore.
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Abstract The secondary structure of the feline leukaemia virus
(FeLV) fusion peptide was investigated using circular dichroism
(CD). Our results show that this peptide can readily flip between
random, a-helical and (1-sheet conformations, depending upon its
environment. The CD spectrum changes from one characteristic
of random coil to predominantly p-sheet type, and finally to that
showing the characteristics of a-helical structure on moving from
an aqueous solvent, through several increasingly hydrophobic
systems, to a highly hydrophobic solvent. Electron microscopy
confirmed the presence of P structure. We propose that the
structural plasticity demonstrated here is crucial to the ability of
the fusion peptide to perturb lipid bilayers, and thus promote
membrane fusion.
© 1998 Federation of European Biochemical Societies.
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1. Introduction
Membrane fusion, the merging of two distinct lipid bilayers
to form one common bilayer, is essential to life, occurring
many times daily within every animal cell [1], Intercellular
fusion is also important, for example between sperm and
egg in the mammalian fertilisation process [2], In addition,
many intracellular parasites, including all enveloped animal
viruses, utilise fusion to gain entry to their target cells, and
thus cause disease [3]. However, despite the clear importance
of fusion, the precise mechanisms involved in this process are
still not known.
Enveloped viruses have specific envelope glycoprotein
'spikes', viral fusion proteins, which mediate fusion between
the virus and its target cell [4], Each fusion protein contains a
fusion peptide, a span of relatively hydrophobic amino acids,
which is thought to insert into the host cell target membrane
and disrupt bilayer stability, so initiating the fusion process
[5], The active participation of fusion peptides in the fusion
process, for example those of influenza virus and human im¬
munodeficiency virus (HIV), has been shown by a variety of
techniques including hydrophobic affinity labelling experi¬
ments [6] and site-directed mutagenesis studies [7,8]. Studies
using synthetic peptides, which correspond to the sequences of
viral fusion peptides, have helped to determine some of the
molecular mechanisms involved in viral-mediated fusion. In
particular, these synthetic peptides appear to be most useful
*Corresponding author. Fax: (44) (131) 650-6576.
E-mail: sdavies@labO.vet.ed.ac.uk
for studies on the minimum and precise molecular and struc¬
tural requirements for membrane destabilisation [9-11],
Translocation from an aqueous environment, such as ex¬
tracellular fluid, to a lipid environment is likely to involve
substantial structural alterations of a peptide. Many proteins
and peptides insert into membranes, and concomitantly alter
their own secondary structure, but they do not trigger huge
changes in the arrangements of the lipid molecules in their
target membranes.
There is much conflicting evidence on the active secondary
structure of fusion peptides. A modelling study of several viral
fusion peptides assumed that they completely formed a helices
on membrane insertion [5]. However, Gallaher et al. have
cautioned against the earlier assumption that all fusion pep¬
tides are 'sided' helices in their active form [12]. Indeed, the
measles virus fusion peptide was found to adopt a conforma¬
tion of 73% P sheet in one study [13], and, under different
experimental conditions, fusion peptides from different HIV
strains have been shown to be mainly a-helical [14] or con¬
versely mainly p-sheet [15] in their active forms. Hepatitis B
virus fusion peptide favours a P-sheet conformation in the
presence of lipid vesicles [16], as does PH-30, a sperm fusion
peptide involved in sperm-egg fusion [17]. However, none of
these studies examines the same fusion peptide in a whole
range of different solvent systems.
We wished to examine the secondary structure of the fusion
peptide from the retrovirus feline leukemia virus (FeLV) in a
variety of environments. The FeLV peptide contains signifi¬
cant numbers of amino acids that characteristically favour
three different secondary structures, namely the a helix, the
P sheet and a coiled conformation. The conclusion drawn
from the various studies mentioned above is that fusion pep¬
tides change from one defined, inactive secondary structure to
another different and equally well-defined active secondary
structure. We speculated that this might lead to a large
amount of dynamic structural flexibility for the FeLV fusion
peptide. Indeed, computer modelling work has hinted that this
might be an important factor for fusion peptides in general
[18]. Since membrane fusion is a dynamic process, involving
large changes in the component molecules, structural plastic¬
ity may be an essential property of these initiators of fusion.
2. Materials and methods
A 28-residue peptide (sequence EPISLTVALMLGGLTVG-
GIAAGVGTGTK), which corresponds to the common sequence of
the amino-terminal fusion peptide of all documented strains of FeLV
[19], was synthesised. A lysine (which is the next naturally occurring
carboxy-terminal residue in the fusion protein) was included on the
carboxy-terminus to increase peptide solubility. Peptide synthesis and
purification were performed by Albachem Ltd, 26 Craigleith View,
0014-5793/98/$ 19.00 © 1998 Federation of European Biochemical Societies. All rights reserved.
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Edinburgh EH4 3JZ, UK. The peptide was synthesised on an Applied
Biosystems 430A instrument, using Fmoc chemistry with the side
chain protecting groups selected as tBu (Ser, Thr) and OtBu (Glu).
The completed peptide was cleaved with a solution of TFA/H>0
(95:5) plus scavengers (ethanedithiol/thioanisole/triisopropanesilicane)
and the solution was evaporated under vacuum. The crude peptide
was dissolved in 50% TFA/FUO and purified by reverse phase HPLC,
using a RPC4 (lOx 100 mm) column, eluting with a linear gradient
from 10% acetonitrile in water (0.1% TFA) to 60% acetonitrile in
water (0.1% TFA) over 30 min. The peptide was characterised by
mass spectra (MALDI, PerSeptive Biosystem laserTec), amino acid
analysis (LKB 4150 alpha amino acid analyser) and analytical
HPLC using PRC4 (4.6X 100 mm), RPC8 (4.6x220 mm) and Vydac
C8 (4.6x250 mm) columns, running a linear gradient of 10% aceto¬
nitrile in water (0.1% TFA) to 90% acetonitrile in water (0.I'M. TFA)
over 30 min. The assembly of the peptide was reasonably efficient but
the purification process was found to be very difficult. The peptide
was found to be very insoluble; accordingly 50% TFA was added to
take it into solution. However, a very broad peak without any reso¬
lution was obtained under normal eluting conditions, unless a very
dilute solution was applied. Thus the purification could only be car¬
ried out batchwise on a small scale (0.5-1.0 mg per run).
The fusion peptide was added at a concentration of 1 mg/rnl to (a)
2 M guanidine/50% ethanol, a solvent often used for peptide addition
to fusion assays, (b) trifluoroelhanol (TFE), and (c) hexafluoroisopro-
panol (HFIP). These samples were then diluted 1:1 with distilled
water, giving a final peptide concentration of 0.5 mg/ml. Peptide
was also added to sodium dodecylsulphate (SDS) at concentrations
(c) 3 mM, (d) 6 mM in distilled water, to give a final peptide concen¬
tration of 0.5 mg/ml. The resulting suspensions were sonicated in a
bath sonicator until the peptide dissolved. All chemicals were supplied
by Sigma Chemical Co., UK.
CD spectra were recorded using a JASCO J-600 spectropolarimeter.
over the wavelength range 195-260 nm, in a cell of path length of 0.02
cm, at 25°C. At least four spectra were averaged for each sample.
Analysis of the spectra for secondary structure content utilised the
CONTIN procedure of Provencher and Glockner [20] to determine
the amounts of a helix and (3 sheet present, and the method of Chang
et al. [21] was used to verify the overall trend in a helix contents.
Negative staining transmission electron microscopy was used to
examine the peptide samples for the presence of |3 structure. The
peptide solutions were dried onto plastic-coated carbon grids, and
then negatively stained using 4% sodium phosphotungstate at pH
7.2. A Philips 400 TEM was used, at 80 kV, and x 60 000 magnifica¬
tion. Negative controls were performed by staining an empty plastic-
coated carbon grid, and also by staining the corresponding pure sol¬
vent.
3. Results
The far ultraviolet CD spectra of the FeLV fusion peptide
in the various solvents are shown in Fig. 1. Satisfactory data
could be obtained down to 195 nm; below this wavelength the
noise levels prevented accurate determination of ellipticity.
The CD spectra exhibit an increase in a-helical character on
moving from 1 M guanidine/25% ethanol, through a selection
E 5000 -
200 220 240 260
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Fig. I. CD spectra of the FeLV fusion peptide in a variety of sol¬
vents. Solid line: in I M guanidine/25% ethanol: short dash: in
50% TFE: dotted line: in 50% HFIP: long dash: in 3 mM SDS:
medium dash: in 6 mM SDS.
of increasingly hydrophobic solvents, to 50% HFIP. In the
guanidine/ethanol sample, the peptide shows a spectrum char¬
acteristic of random coil secondary structure, which is to be
expected for a hydrophobic peptide in a polar solvent con¬
taining a chaotropic agent. The critical micellar concentration
(CMC) of SDS is 8 mM at 20°C. In 3 mM SDS, the CD
spectrum is typical of a |3 sheet, but as the concentration of
SDS increases towards the CMC, the spectrum indicates that
some a-helical structure is present. The CD spectrum in 50%
TFE shows considerably more a-helical character and this is
even more pronounced in 50% HFIP. Analysis of the spectra
gives the percentages of a helix and (3 sheet in each sample
listed in Table 1. The exact values of these estimates should be
viewed with caution, since (a) ellipticity data could only be
collected down to 195 nm instead of 190 nm, which is the
preferred lower limit, and (b) it may be inappropriate to apply
the methods of analysis which have been derived for proteins
to oligopeptides. Moreover, the amounts of helix present may
well be underestimated, as up to twofold reductions in ellip¬
ticity have been found in membrane-bound proteins [22].
However, an overall trend from random coil through predom¬
inantly [3 sheet to significant amounts of a helix can clearly be
seen.
Fig. 2 shows electron micrographs of FeLV peptide in 3
mM SDS, FeLV peptide in 50"/. HFIP and negative control:
stained empty grid. Beta fibrils are visible in the 3 mM SDS
sample, and were only seen when there was little evidence of
a-helical content by CD spectroscopy (other data not shown).
Table 1
Percentages of FeLV peptide secondary structure, as calculated by the methods of Provencher and Glockner [20] and Chang et al. [21]
Sample FeLV peptide (0.5 mg/ml) in: % Secondary structure as calculated by the methods of:
Provencher and Glockner [20] (helix, sheet) Chang et al. [21] (helix)
1 M guanidine in 25% ethanol 0, nd" 0
50% TFE 20, 36 16
50% HFIP 30, 35 22
3 mM SDS 2, 57 11
6 mM SDS 12,47 14
"The value for the sheet content of this sample could not be determined using the method of Provencher and Glockner [20] without an unacceptably
large error.
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Fig. 2. Electron micrographs of (top) FeLV peptide in 3 mM SDS,
(middle) FeLV peptide in 50% HFIP and (bottom) stained grid con¬
trol.
These (3 fibrils appeared long and unbranched and were ar¬
ranged in a meshwork.
4. Discussion
A limited amount of Fourier transform infrared spectros¬
copy has been performed on the fusion peptides of two
retroviruses simian immunodeficiency virus (SIV) [23] and
HIV [24], These peptides were found to show a partial con¬
version from a [5-sheet conformation in an aqueous solvent to
an a helix in a lipid environment. Filtration to remove the
non-lipid bound peptide yielded an increase in the amount of
recorded a helix. Certainly the increase in the proportion of a
helix which we observed for the FeLV peptide on increasing
the solvent hydrophobicity agrees with these data. However,
the assumption from the SIV and HIV studies was that the a-
helical form is the single, fusion-active conformation. Work
on other fusion peptides [15,16] and a different study on the
HIV peptide [14] have all suggested that the (5 conformation
may be the fusion-active state.
Fusion is an extremely rapid, multi-step process, and so
structural measurements are obtained mainly on fusion end
products. Thus only the final peptide conformations are ob¬
served, but none of the intermediate changes in conformation,
which are adopted during the different stages of fusion, are
seen. We propose that structural flexibility, rather than the
rigid adoption of a particular secondary structure, may be a
key property of fusion peptides. Membrane fusion is a dynam¬
ic process involving large structural changes in the participat¬
ing molecules. We therefore suggest that it is possible that the
critical feature of these catalytic peptides is their ability to
'flip' between different secondary structures extremely rapidly,
rather than the adoption of any single, well-defined secondary
structure. The energy barriers between these different second¬
ary conformations must be low: the peptide must be able to
adopt, at least transiently, these various structures, which pre¬
sumably represent local energy minima. Clearly the secondary
structures adopted under certain conditions may vary between
individual fusion peptides, due to differences in their primary
structures. However, previous computer modelling has hinted
that structural flexibility may be a common property of fusion
peptides [18]. Here we provide direct experimental proof of
such flexibility for one fusion peptide. It is interesting to note
that there is an analogy with the structural plasticity previ¬
ously observed in a pathogenic prion peptide, PrP(106-126)
[25], which has been implicated in prion-related diseases.
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A neutron study of the feline leukaemia virus fusion peptide:
Implications for biological fusion?
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Abstract
Neutron diffraction studies were performed on stacked phospholipid bilayers to determine the effects of the feline
leukaemia virus (FeLV) fusion peptide on membrane structure. Bilayers were composed of dioleoylphosphatidylcholine
with 50% (mol) dioleoylphosphatidylglycerol. Neutron scattering profiles with peptide present showed an increase in
scattering density in the lipid-tails region, whilst scattering by the lipid headgroup region was decreased. This is
interpreted as a lowering of the packing density of the lipid headgroups and an increase in the packing density of the lipid
tails. Modelling studies and experimental evidence have suggested that fusion peptides catalyse fusion by increasing the
negative curvature of the target membrane's outer monolayer. Our results presented here add support to this hypothesis
for the fusion mechanism. The 2H20 scattering profile was also slightly perturbed in the lipid headgroup region with I %
(mol) FeLV fusion peptide present. The FeLV peptide had no significant effect on the organisation of bilayers containing
only dioleoylphosphatidylcholine. T) 1998 Elsevier Science B.V. All rights reserved.
Keywords: Viral fusion peptide; Neutron diffraction; Negative curvature
1. Introduction
Membrane fusion is essential to life, occurring
many times daily in every eukaryotic cell's homeo-
static processes. It also plays a key role in the in¬
fective mechanisms of many intracellular pathogens.
Despite its importance, the precise molecular struc¬
tures and the energetics involved in fusion are still
unknown. Fusion follows a multistep pathway,
through several uncertain, highly bent lipid inter¬
mediate conformations, resulting in fusion pore-
* Corresponding author: Fax: +44
sdavies@labO.vet.ed.ac.uk.
Ill 650 6142; e-mail:
formation. Viral fusion peptides, the fusogenic do¬
mains of specific viral envelope glycoprotein spikes,
operate as catalysts of fusion. The kinetics of fusion
have been characterised extensively [1,2]; less is
known about the structural changes involved. Sev¬
eral models have been devised for putative lipid
intermediates involved in fusion [3,4], It has been
suggested that fusion peptides catalyse fusion by
increasing the negative curvature of the target
membrane's outer monolayer [5,6], We wished to
investigate the effects of the feline leukaemia virus
(FeLV) fusion peptide on the structure of lipid
bilayers, to determine any changes produced in
molecular organisation.
092!-4526/97/$17.00 '<;> 1997 Elsevier Science B.V. All lights reserved
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2. Materials and methods
2.1. Materials
The FeLV peptide secpience, obtained from the
Swiss Protein Data Bank, was EPISLTVAL-
MLGGLTVGGIAAGVGTG'T'K. Lysine was in¬
cluded on the carboxy terminus to improve solubil¬
ity. It is the next naturally occurring residue. The 28-
amino acid peptide was synthesised hy Albachein
(University of Edinburgh, Scotland, UK) using
solid-phase synthesis. Its purity was > 95%, as deter¬
mined by analytical IIPLC, mass spectrometry and
ami no-acid analysis. Dioleoy [phosphatidylcholine
Fig. I. (a) Neutron scattering density profiles of pure DOPC/DOPG bilayers (solid line) and of DOPC/DOPG with 1% (niol) FeLV
peptide (broken line), and difference profile calculated by subtracting structure factors for DOPC/DOPCJ bilayers from structure factors
for DOPC/DOPG with 1% (mol) FcLV peptide (dotted line). Phospholipid molecules are shown above the profiles to orientate the
scattering densities, (b) 2H20 distribution within and between bilayers of DOPC/DOPG (solid line) and DOPC/DOPG with I % (mol)
FeLV peptide (broken line), and difference profile of JH20 distribution due to the presence of FeLV peptide (dotted line)
\
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(DOPC) and dioleoylphosphatidylglycerol (DOPG)
were purchased from Avanti Polar Lipids (Alabas¬
ter, AL, USA).
2.2. Neutron diffraction
Neutron diffraction measurements were per¬
formed on the DI6 instrument at the Institut Lane
et Langevin (Gtenoble, France). 20 mg of total
lipid, or lipid plus 1 % (mol) peptide, were vortexed
thoroughly in chloroform. The peptide-containing
samples were then sonicated until the peptide dis¬
solved. Thereafter, sample preparation, method de¬
tails and data processing were essentially as de¬
scribed previously [7], Samples were applied to
quartz slides using an airbrush spraying technique.
A minimum of 12 h was allowed for sample
drying time in vacuo, and also for rehydration with
H20, 50% 2H20 or 100% 2H20. All samples were
run at 25°C. The data were phased using the in¬
formation from H20/2H20 exchange, and put on
a 'relative absolute scale' using the method in Ref.
[8], 14C-phospholipids and 3II -water were used to
determine the water content of each sample. Six
orders of diffraction were recorded and analysed.
The calculated d-repeats were 55.25 A for IX) PC/
DOPG and 55.60 A for DOPC/DOPG plus FeLV
peptide.
3. Results
Fig. la shows the neutron scattering density pro¬
files at 8.1% 2H20 of bilayers of 50% (mol)
DOPC/DOPG alone and in the presence of 1%
(mol) FeLV peptide, and also the difference profile,
calculated by subtracting the scattering density due
to lipid alone from the profile for lipid with peptide
present. Phospholipid molecules are shown above
the profile to orientate the relative densities seen.
The profile produced with peptide present shows
decreased scattering density in the lipid headgroup
region, and an increase in scattering density in the
lipid tail region. Fig. lb shows the 2H20 distribu¬
tion within and between bilayers of pure DOPC/
DOPG and DOPC/DOPG plus peptide, and the
difference profile for 2H20 distribution due to the
icn R not) (199R) 000 000 ,1
presence of the FeLV peptide. Results obtained for
samples of pure DOPC with and without FeLV
peptide showed negligible effect for the fusion pept¬
ide on bilayer structure (data not shown).
4. Discussion
I he difference profile for the bilayer neutron
scattering density (dotted line, Fig. la) shows that
the addition of FeLV peptide to the bilayers causes
an increase in scattering density close to the bilayer
centre, a reduction at the surface and an increase in
the water region. The scale of these perturbations is
much too high for them to represent simply the
scattering density of the peptide: the amount of
peptide present is tiny, only 1% (mol). They must
therefore be caused by alterations in the phos¬
pholipid packing (changes in water distribution
have been eliminated from the figure by showing
the 8.1% 2112O profiles). We interpret the differ¬
ence profile, therefore, as an increase in the packing
density of the phospholipid fatty acids, and a de¬
crease in the packing density of their headgroups.
This interpretation is totally consistent with the
emerging model for the mode of action of a fusion
peptide: this suggests that the peptide inserts ob¬
liquely into lipid bilayers and precesses, i.e. it traces
out an inverted cone-shaped motion. Thus, it will
increase the negative curvature of the target lipid
monolayers. As our lipids are confined to a planar
bilayer configuration, changes in elastic monolayer
curvature forces will be expressed as effects on
molecular packing. Fig. 2 shows a model of this
concept. Ihe profiles in Fig. lb show that the
Fig. 2. Model of the FeFV peptide inserting into a lipid bilayer
and processing. This favours the bending of the lipid molecules
into a negatively curved, non-bilayer conformation.
PHYSB 2833 BRR GNS JAYASHREE
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2H20 distribution also changes, possibly as a result
of bilayer thinning. Our results add support to the
hypothesis that fusion peptides act by increasing
the negative curvature of the target cell's outer
monolayer, thus causing this to bend towards the
opposing bilayer. and allowing closer approach of
the two initially distinct membranes.
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Abstract
Tachykinins are a group ofpeptides which bind to G-protein coupled receptors. Receptor
affinity appears to depend on different secondary structures of tachykinin which share the same
hydrophobic carboxy-terminal sequence, FXGLM. Receptor activation is thought to be due to the
carboxy-terminal submerging into the bilayer and the amino-terminal binding on the surface.
Binding of tachykinins to phospholipid bilayers may take place both on the aqueous membrane
surface and in the hydrophobic region. The two-state equilibrium appears to depend on the surface
charge of the membrane. Deuterating substance P and neurokinin A at their carboxy-terminals, our
results show two populations of label for each peptide. One is very close to the water-hydrocarbon
interface, the other some 13A deeper. We report that the bilayer location of the two tachykinins is
remarkably similar, thereby inferring that receptor specificity must be controlled by finer levels of
structure.
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Substance P (SP) and neurokinin A (NKA) belong to the tachykinin family, a group of six
small amphipathic peptides which bind to G-protein coupled receptors. They are found in a wide
range of tissues including the central and peripheral nervous systems and gastro-intestinal tract.
Tachykinin receptor binding sites appear to involve both the extracellular loops and the
transmembrane domains [1]. An address-message model [2] has been proposed where the flexible
cationic N-terminal region, or "address domain", is responsible for receptor selectivity and the
structurally extended and conserved hydrophobic C-terminal delivers the message.
The binding of tachykinins to phospholipid bilayers appears to take place both on the
aqueous membrane surface and in the hydrophobic region. This two-state equilibrium may depend
on the surface charge of the membrane [3]. NMR (nuclear magnetic resonance), CD (circular
dichroism) and molecular modelling studies [4,5,6] have shown that SP has longer binding times
and a more complex structure in negatively charged lipid-based systems than zwitterionic ones. In
contrast, there is an argument against a membrane-mediated receptor mechanism, based on the
observation that a SP analogue with a charged C-terminus, may not insert into the hydrophobic core
ofmembranes, still shows SP agonist activity [4],
Our measurements test the hypothesis that different members of the tachykinin family
position their C-terminal message at different depths within the membrane. Neutron diffraction was
used to define the location of the specifically deuterated C-terminus of each peptide in synthetic
phospholipid bilayers.
Materials and Methods
Neutron diffraction measurements were carried out on the VI membrane diffractometer at
the Berlin Neutron Scattering Centre, Germany. Dioleoylphosphatidylcholine (DOPC) and
dioleoylphosphatidylglycerol (DOPG) were purchased from Avanti Polar Lipids (Alabama, USA)
and used without further purification. Peptide synthesis was carried out by Albachem (Edinburgh,
UK) to the following sequences: SP (RPKPQQFFGLM-NH2); NKA (HKTDSFVGLM-NH2). Both
2
peptides were synthesised in an undeuterated form and with leucine replaced by a deuterated
analogue which contained a total of 10 deuterons. Sample preparation, neutron data collection and
data analysis were as previously described [7], The experimental temperature was 25 ° C. Each
tachykinin was added singly at 10 mol% with respect to the lipid and the water baths contained pure
water, at one of three isotopic compositions: 0%, 50% or 100% 2H20 to assist with phase
assignment.
The data were placed on a 'relative absolute' scale [8] using the known neutron scattering
densities of 2H10-Leu and 2H20 as previously described [7], This method requires knowledge of the
molar percentage ofwater in the samples, which was determined as described in [9].
Results and Discussion
Figure 1 displays the neutron scattering density profdes across a DOPC:DOPG bilayer. The
inter-bilayer water compartment is at the outer region of the graph. A pair of phospholipid
molecules are also shown, to assist with interpretation of the profile.
Figure 2 shows difference profiles representing the distribution of deuterium label in
bilayers containing SP (b), and in bilayers containing NKA (c). The profiles were calculated by the
difference method. There are two distributions of label in each sample, one located close to the
water-hydrocarbon interface and another located approximately 8A from the bilayer centre. This is
summarised in Table 1. These findings are consistant with the two-state model. Membrane
insertion of SP and NKA allows water to penetrate deeper into the bilayer (data not shown).
Consistent with the monolayer area measurements of Seelig [3] these neutron data clearly
demonstrate bilayer penetration ofboth tachykinins into anionic lipid bilayers. However, the depth
ofpenetration of the two tachykinins studied is remarkably similar. Schwyzer [10] has proposed
that receptor binding and specificity of the tachykinins is a property of the membrane-bound
conformation of the peptides. Our evidence suggests that, in terms ofmembrane location, the
membrane bound forms of these two peptides is rather similar, implying that receptor specificity is
controlled by finer levels of structural detail.
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Table 1: Location of deuterium label on (2H10-Leu 10)-substance P and (2H10-Leu 9)-
neurokinin A. The centre , position and full width at half height (FWHH) of Gaussian distributions,
fitted by least-squares refinement in reciprocal space, are given.
Population Parameter Substance P Distribution Neurokinin A Distribution
1 Position (distance from 8.82 + 0.22 A 65.6 ± 5.5 % 7.48 ± 0.48 A 69.5 ± 7.5 %
centre of bilayer)
Width (FWHH) 6.99 ± 0.33 A 9.60 ± 0.97 A
2 Position (distance from 22.34 ± 0.83 A 34.3 ± 5.5 % 22.17 ± 0.65 A 30.5 ± 7.5 %
centre of bilayer)
Width (FWHH) 7.54 ± 0.66 A 6.73 ± 1.13 A
5
Figure Legends
Figure 1: Neutron scattering density profiles ofbilayers containing 50:50 (mol) DOPC and
DOPG. 5 orders of diffraction were measured on the VI instrument at the Berlin Neutron
Scattering Center. The sample conditions were 25°C, 100% relative humidity and the hydrated
solvent was 8.07% 2H20. At this concentration the solvent is effectively invisible to neutrons
making the phospholipid the sole contributer to the profile shown. Also shown are two
phospholipid molecules, to assist interpretation of the profile.
Figure 2: Difference neutron scattering density profiles calculated using 6 orders of
diffraction for SP and 5 for NKA. The profiles show the distribution of 2H10-leucine in 10% (mol)
SP (b) or NKA (c) in bilayers containing DOPC:DOPG 50:50. The exact location, width and peak
of each label was calculated by fitting Gaussians to the difference structure factor amplitudes in
diffraction space, thereby avoiding the termination error observed in Fourier subtractions. The
Fourier subtractions (solid line) fit well with the Gaussians (broken line), the poorer NKA fit is
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ABSTRACT: Neutron diffraction has been used to study the membrane-
bound structure of substance P (SP), a member of the tachykinin family of
neuropeptides. The depth of penetration of its C-terminus in zwitterionic and
anionic phospholipid bilayers was probed by specific deuteration of leucine
10, the penultimate amino acid residue. The results show that the interaction
of SP with bilayers, composed of either dioleoylphosphatidylcholine (DOPC),
or a 50:50 mixture of DOPC and the anionic phospholipid dioleoyl-
phosphatidylglycerol (DOPG), takes place at two locations. One requires
insertion of the peptide into the hydrophobic region of the bilayer, the other is
much more peripheral. The penetration of the peptide into the hydrophobic
region of the bilayer is reflected in a marked difference in the water
distribution profiles. SP is seen to insert into DOPC bilayers, but a larger
proportion of the peptide is found at the surface when compared to the
anionic bilayers. The positions of the two label populations show only minor
differences between the two types of bilayer.
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INTRODUCTION
Substance P (SP) belongs to the tachykinin family, a group of six small
amphipathic peptides that bind to G-protein coupled receptors. The receptors are
found in a wide range of tissues including the central and peripheral nervous systems
and the gastro-intestinal tract. The tachykinin family of peptides shares a common C-
terminus, FxGLM-NH2, where x is F or V in mammals.
The ligand-binding sites of tachykinin receptors appear to involve both the
extracellular loops and the transmembrane domains (Y. Yokota et al., 1992). An
address-message model (Schwyzer, 1987) has been proposed where the flexible
cationic N-terminal region of SP, or "address domain", is responsible for receptor
selectivity, whilst the structurally extended and conserved hydrophobic C-terminal
delivers the message. The proposed mechanism involves an interaction between
tachykinin and phospholipids which results in insertion of the C-terminal amino acids
into the lipid bilayer, followed by lateral diffusion of the peptide to reach the ligand-
binding site of a membrane-bound receptor. Seelig et al. (1996) have presented an
argument against the proposed membrane-mediated receptor mechanism, based on
their observation that a SP analogue with a charged C-terminus, which they suggest
would not insert into the hydrophobic core ofmembranes, still shows SP agonist
activity. However, the central role ofpeptide-lipid interactions in the proposed
scheme is supported by a number of observations that show that the conformation of
SP is determined by the nature of its local chemical environment (e.g. Chuen-Shang et
al., 1982; Chassaing et al., 1986; Woolley and Deber, 1987; Convert et al., 1991).
There have been several biophysical studies comparing the structure of SP in
zwitterionic and anionic lipid environments. Based on monolayer expansion
measurements, Seelig and MacDonald (1989) concluded that SP does insert into
monolayers containing negatively charged l-palmitoyl-2-oleoyl-phosphatidylglycerol
(POPG), but does not insert into zwitterionic monolayers composed of l-palmitoyl-2-
oleoyl-phosphatidylcholine (POPC).
Wu and Yang (1981) have proposed that polypeptides with a helix-forming
potential can only assume a helical conformation in hydrophobic environments, such
as the core ofbiological membranes, where the milieu enhances the intramolecular
hydrogen bonding necessary for the stabilisation of these structures. This argument
has been developed (Wu et al., 1982) with the demonstration that such helical
structures can only form by interaction with lipids when the peptide carries either no
charge or charges which are opposite to those of the polar head group of the lipid.
When this principle was applied to SP they showed that circular dichroism (CD)
spectra revealed an unordered structure in water or phosphatidylcholine, but a partial
helix in negatively-charged phosphatidylserine or sodium dodecylsulphate (SDS).
In contrast, Wooley and Deber (1987) have reported CD data from SP in the
presence of SDS, lysophosphatidylcholine and lysophosphatidylglycerol micelles that
show that the induced helical structure is independent of the lipid headgroup type.
Keire and Fletcher (1996) also concluded from CD and 'H-NMR studies that the
conformation of SP is independent of lipid head group type. They calculated SP
structures to 1-2 A resolution from NMR measurements of SP in three different
solution environments (SP/dodecylphosphocholine, SP/dodecylphosphocholine/NaCl
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and SP/SDS/NaCl) and found them all to be similar. The structure they determined
for SP is shown in Figure 1.
Against this background, the aim of the study described here was to test the
hypothesis that SP interacts with biological phospholipids in such a way that the
'message' portion of the peptide is delivered at a specific depth, or 'address' within a
bilayer. In order that the findings might also contribute to the debate on whether the
membrane interaction of SP is phospholipid-dependent, two different bilayer
compositions were used. In one system the bilayers were composed of the
zwitterionic phospholipid dioleoylphosphatidylcholine (DOPC); the other system




DOPC and DOPG were purchased from Avanti Polar Lipids (Alabama, USA)
and used without further purification. The 11 amino acid peptide (RPKPQQFFGLM-
NH2) was synthesised by Albachem Ltd. (26 Craigleith View, Edinburgh, EF14 3JZ,
Scotland, UK). The synthesis was carried out on an Applied Biosystems 430A
instrument, using Fmoc chemistry with the side chain protecting groups selected as
tBu (Ser, Thr) and OtBu (Glu). The completed peptide was cleaved with a solution of
TFA/H20 (95:5) plus scavengers (ethanedithiol/thioanisole/triisopropanesilicane) and
the solution was evaporated under vacuum. The peptide was purified by reverse phase
HPLC and characterised by mass spectra (MALDI, PerSeptive Biosystem laserTec),
amino acid analysis (LKB 4150 alpha amino acid analyser) and analytical HPLC.
Two batches ofpeptide were produced, one undeuterated and one containing
deuterated leucine (10 deuterons) at position 10. The purity of each peptide was
above 95%, as determined by analytical HPLC, mass spectrometry and amino acid
analysis. 20 mg samples of lipid, some ofwhich contained 3% (mol) peptide, were
deposited on quartz microscope slides (75 mm by 25 mm) using an artists' airbrush.
The spraying solvent was methanol. The slides were placed in a vacuum dessicator
for twelve hours to remove all traces of the solvent, before rehydration for 24 hours at
25°C in an atmosphere of 100% relative humidity.
Neutron data collection:
Neutron diffraction measurements were carried out on the VI membrane
difffactometer at the Berlin Neutron Scattering Centre, Germany. The sample
environment was a standard aluminium can, in which temperature control is achieved
by circulating water through an integral water jacket, and humidity control by
changing the solution in two Teflon water baths at the base of the can. These water
baths contained pure water, at one of three isotopic compositions: 0%, 50% or 100%
2H20. Using the 2H20/H20 exchange technique, every sample was measured at all
three 2H20 concentrations. At each change of solvent, the sample was first dried out
under vacuum, then rehydrated in an atmosphere saturated with water at the new
isotopic composition for at least 24 hours. All samples were run at 25°C. The
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scanning protocol consisted of sequential 9 scans around the predicted Bragg angle
for each order. Each scan covered the angular range (9n - 0.5°) to (9n + 0.5°), where 0n
is the Bragg angle for the rf order of lamellar diffraction.
Neutron data analysis:
The 2-dimensional array of detector counts for each frame of neutron
diffraction data was corrected for variations in pixel response by division by a
corresponding array of data recorded from water. The complete set of frames from
each scan was then collapsed into a linear spectrum and combined to generate a
pseudo 6- 29 scan. Up to this stage of the analysis, all calculations were carried out
using the VI instrument software.
The background around each peak was fitted and subtracted using SigmaPlot
v3.0 (Jandel Scientific Software GmbH), a commercial spreadsheet and graphs
package. Gaussian curves were then fitted to the Bragg reflections and the angular
position, width and area of each peak were recorded. Absorption and Lorentz
corrections were applied and the intensities square-rooted to produce structure factor
amplitudes. The relative scaling of the different data sets and the phases of each of
their orders were determined by least-squares fitting to straight line functions, as
shown in Figure 2.
The D-repeat of each sample was calculated by least-squares fitting of the
observed values of 2 <9 to the Bragg equation: nX = 2D.sin(6>1+J) where 5 is the angular
offset (misalignment) of the detector.
The data were placed on a 'relative absolute' scale (Wiener et al., 1991; Wiener
& White, 1991; Jacobs & White, 1989) using the known neutron scattering densities
of 2H and H to scale the [DOPC + 2H20] - [DOPC + H20] differences and the [DOPC
+ (2H10-Leu)-SP] - [DOPC + SP] differences. This method requires knowledge of the
molar percentage ofwater in the samples, which was determined as described below.
Gaussian distributions were fitted to the deuterated leucine sites by least-
squares methods. The process was carried out in reciprocal space, whereby each
Gaussian model is tested by comparing its calculated structure factors to the
differences between observed structure factors for deuterated and undeuterated
peptides.
Determination ofwater content:
The neutron diffraction sample preparation was repeated using 14C-labelled
DOPC and tritiated water so that scintillation counting could be used to determine the
waterrlipid molar ratio. Microscope coverslips (22 x 22 mm) were cut in half to
provide a suitable substrate which would fit into a standard scintillation counter tube.
In order to give the same sample thickness, approximately 5.0 mg of lipid was spread
on each half-coverslip. After vacuum dehydration and rehydration for 24 hours, in
small batches, at 25°C, the coverslips were quickly transferred to tubes of scintillant.
14C and 3H activity were measured using a Packard 1900CA Liquid Scintillation
Counter. Control samples containing tritiated water (1.2pl) or 14C-DOPC, equivalent
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to 5.0 mg of the experimental phospholipid were used to calibrate the scintillation
counter channel and cross-channel response. Clean coverslips served as controls for
the experiment, to ensure that the amount ofwater condensing on the reverse side was
negligible.
RESULTS
Table 1 shows the neutron structure factors ofDOPC bilayers with 3% (mol)
SP or (2H10-Leu)-SP and bilayers ofDOPC with 50% (mol) DOPG and 3% (mol) SP
or (2H10-Leu)-SP. Figure 2 shows an example of the structure factor data, scaled and
phased so that straight lines pass though each order of the structure factors from each
2H20/H20 exchange series. Neutron scattering density profiles, calculated by Fourier
transformation structure factors are shown in Figures 3 to 5.
The D-repeats of the various samples were 53.2 ± 0.4 A, 55.4 ± 1.0 A and 54.8
± 1.0 A for the pure DOPC, DOPC with 3% (mol) SP and 3% (mol) (2H10-Leu 10)-SP
and 52.6 ± 0.9 A, 55.0 ± 1.0 A and 55.4 ± 1.0 A for the corresponding DOPC/DOPG
samples. These differences in D-repeat, though well within the generally accepted
range (up to 1 A), are a potential source of error when the structure factors, or profiles
calculated from them, are subtracted from each other. This error is most marked in
the 100% 2FI20 structure factors, where even a small difference in the amount ofwater
present can represent a considerable change in the scattering density of that region of
the sample. The level of deuteration of the peptide in this study is relatively low when
compared to the 2F120-H20 differences so, in order to reduce the effect of these errors,
all profiles and subtractions were calculated at 8.07% 2H20, at which isotopic
composition water has a net scattering density of zero.
The mosaic spread of all samples used in the analysis was less than 0.5° (full
width at halfheight). There was no significant variation between the different
samples. The water content of the samples, measured by scintillation counting was
DOPC, 26.08 waters per lipid; DOPC + DOPG, 30.49; DOPC + SP, 26.35; DOPC +
DOPG + SP, 28.40. The maximum error in these measurements was estimated to be
±1.0 waters per lipid.
Two different model-fitting approaches were taken in order to interpret the
neutron data. The simpler of the two types ofmodel was two Gaussian distributions
(and their mirror images in the centrosymmetric unit cell). The Gaussian distributions
were fitted to the observed differences between deuterated and undeuterated SP, the
variables being height, width and position along the bilayer normal. The fitting
process was carried out in reciprocal (diffraction) space by comparing the calculated
structure factors of each model to the observed difference structure factors. The
results of this approach are summarised in Table 2.
The second approach was used to determine the location of the whole peptide
relative to the bilayer. It was essentially an elaboration of the Gaussian technique in
which the neutron scattering profile of SP was calculated by combining the molecular
co-ordinates of the peptide from a recent NMR structure determination (Keire &
Fletcher 1996) with the coherent scattering length of its component atoms. A
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Gaussian distribution, the integral ofwhich was equal to the scattering length of that
atom, represented each atom. In the case of the deuterium label distributions, the
scattering length of all atoms other than the deuteriums was set to zero. The scattering
length of the deuteriums was set at 1.041 x 10~12 cm, equivalent to the difference
between the scattering lengths of 'H and 2H. The best fit to the label distribution in
DOPC bilayers was found to be when the centre of the whole peptide was 12.0 A and
24.4 A from centre ofbilayer. The axis of the peptide was parallel to the bilayer
normal for the inserted peptide and perpendicular to the normal for the surface
peptide. In this calculation a smearing factor of 5.3 A was applied to each atom of the
inserted peptide and 4.4 A for the surface peptide. The corresponding figures for the
DOPC/DOPG bilayers were 14.2 A and 24.5 A from centre ofbilayer, with a 4.0 A
smearing factor for both populations ofpeptide. The results ofboth model-fitting
approaches are summarised in Figures 4 and 5. It should be noted that the figures
show a comparison of the calculated and observed scattering profiles in real space; the
actual model fitting was carried out in reciprocal space. Also shown is the calculated
scattering profile of SP, using the peptide locations and smearing factors determined
by the deuterium peak model fitting.
DISCUSSION
DOPC with DOPG bilayers:
Figures 4 and 5 and Table 2 clearly show that the interaction of SP with the
phospholipid membranes employed in this study takes place at two locations. One
involves insertion of the peptide into the hydrophobic region of the bilayer, the other
is much more peripheral. The penetration of the peptide into the hydrophobic region
of the bilayer is reflected in a marked difference in the water distribution profiles
(Figure 3) in the presence of peptide. These profiles which, more correctly, represent
not just the water, but also deuterium-exchanged sites on the peptide, each show a
large presence of deuterium right across the bilayer profile.
The difference profiles, showing the bilayer distribution of deuterated leucine
on SP clearly demonstrate two populations ofpeptide. In order to interpret these
findings in more detail, a model-fitting approach was employed, based on a recently
published NMR structure ofmicelle-bound SP (Keire and Fletcher, 1996), in which
the peptidedipid ratio was similar to that used in the neutron work. The NMR
structure was positioned on the bilayer normal, its exact location being determined by
fitting the calculated neutron scattering from the deuterium label sites to the observed
scattering in difference profiles. This approach is particularly appropriate for the
deeper location, as it positions the peptide relative to the surrounding phospholipids in
a very similar manner to that described in the NMR work. The conformation of SP in
the peripheral location is much less certain, but for want of a better alternative, we
have again used the Keire structure in our interpretation, but oriented with its long
axis parallel to the bilayer. In support of this, it should be noted that the work by
Keire and Fletcher only presents one structure for the peptide, whilst it is quite
feasible that their samples also contained two populations ofpeptide.
An alternative explanation for the two deuterium peaks would be to suggest
that the peptide aggregates in an anti-parallel manner. Three arguments refute this
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suggestion. Firstly, the relative sizes of the two populations of label are not
stoichiometric and differ between the two types of bilayer studied. Secondly, in order
to insert in the alternative (antiparallel) direction, the peptide would need to introduce
its N-terminus, together with its three positive charges, into the hydrophobic core of
the bilayer. Finally, the Fourier-transform infrared study ofChoo and co-workers
(1994) reported that SP aggregates in the presence of charged lipids, but not in an
anti-parallel manner.
Once the peptide structures had been located and oriented using the deuterium
label information, it was a straightforward matter to calculate the contribution of
scattering from all peptide atoms to the neutron scattering profiles. Figure 5(b)
illustrates the comparison of such a profile to the corresponding profile derived from
observed data, using the difference method. Reference to the figures shows that the
calculated scattering profile is relatively low and featureless. Thus any of a number of
surface peptide conformations could have been used in the calculation, without
seriously affecting the results. A comparison of the profiles shows that the majority
of the scattering difference comes from neither the peptide, nor the water, since the
profile corresponds to a bilayer with 8.07% 2H20, at which isotopic composition water
has a net coherent neutron scattering density of zero. The differences between the
profiles can only, therefore, represent rearrangements of the phospholipid. Wu and
coworkers (1995) have reported membrane thinning as a direct result ofpeptide
incorporation into phospholipid bilayers. It is quite possible that the insertion of SP
may have a similar effect on phospholipids.
DOPC bilayers
In order to contribute to the discussion on whether SP inserts into zwitterionic
membranes, neutron measurements were also performed on DOPC bilayers, some of
which contained SP at 3.0% (mol). The results, summarised in Table 2, show that SP
does indeed insert into DOPC bilayers, but it is interesting that more of the peptide is
found at the surface when compared to the anionic bilayers.
In comparison to the DOPC results, the positions of the two label populations
show only minor differences. Indeed, it is noticeable in Figure 3 that the water
distribution between adjacent bilayers is wider in those bilayers containing only
DOPC (a), indicating that the anionic bilayers are wider than the zwitterionic ones.
For practical reasons, the location of the label sites in Table 2 is expressed in terms of
distance from the centre of the bilayer. Were it possible to present the results as
distance from the bilayer surface, it is likely that the difference between the two lipids
would be even smaller.
Keire & Fletcher (1996) have reported that the conformation of SP, as
determined by 'H-NMR, does not differ significantly between anionic and
zwitterionic micelles. In both systems they observed a similar conformation for
association of the QQFFGLM residues with lipid micelles. The only variations in
structure were observed in the N-terminal residues, RPKP. This was interpreted as
indicating that the structure of SP at a micelle surface is determined largely by
hydrophobic forces, whilst the electrostatic interactions determine the amount of SP
7
that is bound. This interpretation is in close agreement with the neutron results
reported here.
However, the neutron data do not appear to agree with the monolayer
expansion measurements of Seelig and MacDonald (1988), who concluded that SP
does not insert into zwitterionic monolayers. It should be noted, however, that both
the lipids used (DOPC instead ofPOPC) and their arrangement (bilayers instead of
monolayers) differs between the two studies. It is arguable that monolayers do not
present an accurate representation of bilayers, especially when considering the
insertion ofmolecules into the bilayer centre, or beyond. Conversely, it is possible
that the nature of the neutron samples, in which adjacent bilayers are separated by a
narrow (15-20 A) water channel, artificially increases the concentration of peptide
close to the surface of the bilayers. This contrasts with the monolayer expansion
system, in which the peptide was introduced into the aqueous layer. The binding of
SP to the monolayer surface was reported to be dominated by electrostatic interaction.
Therefore an anionic surface would be predicted to attract the positively charged
peptide much more readily than would a zwitterionic surface.
The message-address model of Schwyzer (1987) requires that each tachykinin
interacts in a tightly controlled manner with phospholipid membranes. In order for
the message to be delivered at the correct address, the C-terminal portion of the
peptide must be located at a specific depth within the bilayer, irrespective of its
phospholipid composition. Whilst the neutron measurements reported here can
neither support or refute such a model, they clearly demonstrate that SP is able to
interact with both zwitterionic and anionic membranes in such a way that the C-
terminus of the peptide is positioned at a tightly controlled depth below the membrane
surface. Moreover, in agreement with other studies, the proportion ofpeptide that
penetrates the membrane is shown to be dependent upon the phospholipid
composition of the bilayer.
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Figure 1: The structure of substance P as determined by Keire and Fletcher (1996), as
used in the analysis of neutron diffraction data as described here. Both space-filling
(top) and wire-model (bottom) representations are shown. Leucine 10, the residue
that was deuterated in some of the peptide used in this study is indicated in black.
Figure 2: An example of the structure factors and their phase assignment using
FI20/2H20 exchange, in this instance DOPC with 50% (mol) DOPG and 3.0% (mol)
substance P. Each order has been fitted (least squares) to a straight line with negative
slope for odd numbered orders and positive slope for even numbered orders. This
relationship breaks down at higher order numbers, indicating that, at higher
resolution, the shape of the water distribution can no longer be described as a single
Gaussian distribution. For clarity, the eight orders are split between two plots; a)
shows the first four orders; b) shows orders 5 to 8 on an enlarged vertical scale. The
phasing of orders 7 and 8 is uncertain. All subsequent calculations only used the first
six orders.
Figure 3: The distribution of deuterium, introduced in the form of 50% 2H20, within
and between bilayers of: a) DOPC (solid line, left hand scale), DOPC with 3.0% (mol)
substance P (dashed line, right hand scale), and DOPC with 3.0% (mol) (2H10-Leu 10)-
substance P (dotted line, right hand scale); b) DOPC with 50% (mol) DOPG (solid
line, left hand scale), DOPC with 50% (mol) DOPG and 3.0% (mol) substance P
(dashed line, right hand scale), and DOPC with 50% (mol) DOPG and 3.0% (mol)
(2H10-Leu 10)-substance P (dotted line, right hand scale).
Figure 4: Model-fitting (1). Difference neutron scattering density profiles, calculated
from six orders of diffraction, showing the distribution of deuterium in 3% (mol)
(2H10-Leu 10)-substance P in (a) DOPC bilayers and (b) DOPC/DOPG bilayers
(50:50). The subtraction was carried out using structure factors representing 8.07%
2H20, to reduce the effect of slight differences in hydration level between the
samples. Each panel also shows (dashed line) the sum of two pairs ofGaussian
distributions, fitted to the difference data in reciprocal space (6 orders of diffraction).
Figure 5: Model-fitting (2). a) The distribution of deuterium in 3% (mol) (2H10-Leu
10)-substance P in DOPC/DOPG bilayers (50:50), shown as difference neutron
scattering density profiles calculated from six orders of diffraction. Also shown are
the calculated neutron scattering density distributions for deuterium in 3% (mol)
(2H10-Leu 10)-substance P, using the NMR structure for SP ofKeire and Fletcher
(1996). In Model 1 the peptide is arranged perpendicular to the bilayer and in Model
2 parallel to the bilayer, as indicated, b) Predicted neutron scattering profile of 3%
(mol) substance P (solid line) calculated using the whole Keire and Fletcher structure,
with the peptide arranged in two populations arranged as in (a). The dotted line is the
observed neutron scattering density profile at 8.07% 2H20, calculated by subtracting
the DOPC/DOPG profile from the (SP + DOPC/DOPG) profile. The two profiles
shown are very different, indicating that the dotted line includes scattering
contributions from sources other than the peptide alone. Since the dotted profile
represents a bilayer at 8.07% 2H20, at which isotopic composition water is effectively
invisible to neutrons, the difference between the predicted and observed profiles can
only be caused by rearrangements of the phospholipids.
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DOPC, 3% (mol) Substance P, 0% 2H20
(1) -0.68 -3.64 1.46 2.09 -0.86 -0.65 ±0.69 ±0.64
±0.05 ±0.11 ±0.11 ±0.11 ±0.05 ±0.05 ±0.05 ±0.05
DOPC, 3% (mol) Substance P, 100% 2H20
(2) -13.27 3.02 0.75 0.20 1.03 0.58 ±0.57 ±0.78
±0.25 ±0.10 ±0.05 ±0.05 ±0.08 ±0.05 ±0.05 ±0.05
DOPC, 3% (mol) (2H10-Leu 10)-Substance P, 0% 2H20
(3) -0.52 -2.85 0.98 0.80 -0.72 -0.85 ±0.93 ±0.82
±0.11 ±0.11 ±0.11 ±0.11 ±0.11 ±0.11 ±0.11 ±0.11
DOPC, 3% (mol) (2H10-Leu 10)-Substance P, 100% 2H20
(4) -13.14 3.55 0.75 -0.30 1.22 0.38 ±0.55 ±0.75
±0.25 ±0.10 ±0.05 ±0.05 ±0.08 ±0.05 ±0.05 ±0.05
DOPC+DOPG (50:50), 3% (mol) Substance P, 0% 2H20
(5) -0.90 -3.45 1.28 0.38 -0.71 0.39 ±0.06 ±0.69
±0.05 ±0.10 ±0.08 ±0.05 ±0.05 ±0.05 ±0.05 ±0.05
DOPC+DOPG (50:50), 3% (mol) Substance P, 100% 2H20
(6) -12.51 2.64 1.15 0.45 -0.47 -0.38 ±0.32 ±0.05
±0.25 ±0.10 ±0.08 ±0.05 ±0.05 ±0.05 ±0.05 ±0.05
DOPC+DOPG (50:50), 3% (mol) (2H10-Leu 10)-Substance P, 0% 2H20
(7) -0.43 -4.19 -0.68 -0.93 0.00 0.68 ±0.90 ±0.79
±0.05 ±0.15 ±0.05 ±0.05 ±0.05 ±0.05 ±0.05
DOPC+DOPG (50:50), 3% (mol) (2H10-Leu 10)-Substance P, 100% 2H20
(8) -12.05 3.03 -0.81 -0.56 0.00 -0.14 ±0.01 ±0.16
±0.25 ±0.10 ±0.05 ±0.05 ±0.05 ±0.05 ±0.05
DOPC, 0% 2HzO
(9) -8.14 -19.37 10.20 -3.63 -3.33 0.00 0.00 ±0.75
±0.20 ±0.26 ±0.20 ±0.15 ±0.15 ±0.05
DOPC, 100%2H20
(10) -161.48 28.29 5.58 8.51 -8.53 0.00 ±5.30 ±1.69
±1.00 ±0.30 ±0.15 ±0.20 ±0.20 ±0.15 ±0.08
DOPC+DOPG (50:50), 0% 2H20
(11) -14.67 -30.93 17.80 -2.45 2.95 -6.19 ±4.57 ±4.15
±0.25 ±0.30 ±0.26 ±0.10 ±0.10 ±0.18 ±0.15 ±0.15
DOPC+DOPG (50:50), 100%2H20
(12) -166.76 41.02 -12.91 5.99 4.06 -5.30 ±4.31 ±0.83
±1.00 ±0.35 ±0.25 ±0.15 ±0.15 ±0.15 ±0.15 ±0.06
Table 1: Experimentally determined, corrected and scaled neutron structure factors of
stacked bilayers ofDOPC, DOPC with 3% (mol) SP or (2H10-Leu)-SP, DOPC with
50% (mol) DOPG and DOPC with 50% (mol) DOPG and 3% (mol) SP or (2H10-Leu)-
SP. The measurements were made at 25°C and 100% relative humidity. The phasing
of orders 7 and 8 is uncertain. All subsequent calculations used only the first six
11
orders. The errors are related to the deviations of the observed points to straight lines
fitted through structure factors at three 2H20 concentrations, as in Figure 2.
Site Parameter DOPC Distribution DOPC+DOPG Distribution
1 Position* 6.61 ±0.22 A 57.5 ±5.5 % 8.82 ±0.22 A 65.6 ±5.5 %
Width* 9.18 ±0.88 A 6.99 ±0.33 A
2 Position* 22.04 ±0.22 A 42.5 ±5.5 % 22.34 ±0.83 A 34.3 ±5.5 %
Width* 8.27 ±0.83 A 7.54 ±0.66 A
Table 2: Gaussian models of deuterium label distribution of 3.0% (mol) (2Hi0-Leu
10)-Substance P in bilayers ofDOPC or DOPC+DOPG (50:50). The position, width
and size of Gaussian distributions were fitted, in reciprocal space, to difference
neutron structure factors. Six orders of diffraction were used in the fitting procedure.
* The position of each label site is expressed as distance from the centre of the
bilayer. # The width is the full width at half height.
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Improved accuracy and phasing of lamellar neutron diffraction data
by real-time swelling series method
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Abstract
The analytic continuation method has been widely used to phase Bragg reflections from lamellar samples of phos¬
pholipids. Here we describe its application to neutron diffraction data, collected from liquid-crystalline (L, phase)
samples of 1.2-dioleoyl-sn-glycero-phosphocholine (DOPC) under a state of shifting lamellar spacing. To provide
a comparison with the more normal neutron approach of isotopic substitution using 2H,G. data were collected from
similar samples, using the same experimental and optical conditions. We compare the two methods in terms of accuracy
of structure factor determination, unambiguitv of phase assignment and ease of use. 'C 1998 Elsevier Science B V. All
rights reserved.
Keywords: Neutron diffraction: Phospholipid; Phase assignment
1. Introduction
When performing neutron diffraction experi¬
ments on lamellar phospholipid samples, it is ne¬
cessary to ensure that each sample has reached
equilibrium with the humid atmosphere of the
sample can, before starting the data collection. It is
normal practice, upon loading a new multi-bilayer
lipid sample, to monitor the position of a strong
'Corresponding author; Present address: Department of
Preclinical Veterinary Sciences. Royal (Dick) School of Veterin¬
ary Sciences. University of Edinburgh. Surnmcrhall, Edinburgh
F.H9 IQH. Scotland. UK Fax: + 44 131 650 6576; e-mail:
j.bradshawffi ed.ac.uk
lamellar diffraction peak. As the bilayers take up
water from the atmosphere the lamellar distance
(D-repeat) increases, a process which is reflected in
a decreasing angle of diffraction. This is often pre¬
ceded by a period of reducing lamellar spacing as
the sample continues to dehydrate from its expo¬
sure to the, usually, dryer outside atmosphere. The
whole process may take several hours, depending
upon the size of the can. the surface area of the
water baths and the previous state of the sample.
Obviously, it helps if the disturbance to the
sample's hydration state is kept to a minimum by
transferring it as quickly as possible from its sealed
container to the experimental vessel.
The movements of diffraction peaks during sam¬
ple equilibration are accompanied by a rise or fall
0921-4526,98 SI 9 00 r 1998 Elsevier Science B V All rights reserved
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in diffracted intensity as the Bragg angles sample
difTerent spatial frequencies on the molecular
(hilayer) transform. "I his property has been used
to determine the structure factor phases in X-ray
experiments, when a pseudo-continuous transform
is mapped out using a number of samples, each
prepared to a difTerent lamellar spacing by con¬
trolling the humidity of the atmosphere or the
osmotic pressure of the solution [I J. Mere we
show that the oscillations of a Bragg peak in
a sample seeking equilibrium may be used both as
an aid to phasing the peak and to improve the
accuracy of its measurement. The method is pre¬
sented in a side-to-side comparison with the more
widely used 2H20/M,0 exchange approach to
phasing, in which the isotopic substitution of
hydrogen by deuterium is used in an adaptation
of the crystallographic method of isomorphous
derivatives.
2. Materials and methods
2.1. Sample preparation
1,2-dioleoyl-sn-glycero-phosphocholine (DO PC)
was purchased from Avanti Polar Lipids (Birming¬
ham. A I.) and used without further purification.
20 mg of the sample was deposited on quartz
microscope slides (75 mm x 25 mm) using an art¬
ist's airbrush. The spraying solvent was chloroform.
The slides were placed in a vacuum dessicator for
12 h to remove all traces of the solvent.
2.2. Neutron data collection
Neutron diffraction measurements were carried
out on the DI6 membrane difTractometer at the
Institut Lane et Langevin, Grenoble, F rance. The
sample environment was a standard aluminium
can, in which temperature control is achieved by
circulating water through an integral water jacket,
and humidity control by changing the solution in
two Teflon water baths at the base of the can. All
samples were run at 25 C. The water baths con¬
tained pure water, at one of three isotopic composi¬
tions: 0%. 50% or 100% 2U,0.
In the ll:() II,O exchanae experiments, each
sample was run at all three 311 ,C) concentrations.
Each sample was rehydrated at 25 C in an atmo¬
sphere of 100% relative humidity for at least 24 h
before being transferred to the D16 sample can At
each subsequent change of solvent, the sample was
first dried out. then rehydrated in an atmosphere
saturated with water at the new isotopic composi¬
tion for at least 24 h. The scanning protocol consis¬
ted of sequential 0 (sample angle) scans around the
predicted Bragg angle for each order. Each scan
covered the angle — 0.6' to + 0.6
The mosaic spread of the second order of diffrac¬
tion was determined for each sample, using stan¬
dard procedures.
For the swelling series measurements, the dry
DOPC sample, on its quartz slide, was quickly
transferred straight from its vacuum desiccator
into the IT 16 can together with two water troughs,
containing water. A series of continuous fl — 20
scans was immediately initiated. Each scan (from
0= 1.5" to 15.0 ) took approximately 3h to
complete.
2.3. Data analysis (/) 2H,0/H20 exchange
The two-dimensional array of detector counts for
each frame of data was corrected for variations in
pixel response by division by a corresponding array
of data recorded from water (FFO). The complete
set of frames from each scan were then collapsed
into a linear spectrum and combined to generate
a pseudo-(fl — 20) scan. Up to this stage, all of the
analysis was carried out by the DI6 instrument
software.
The background around each peak was fitted
and subtracted using Sigma Plot (Jandel Scientific
Software GmbFF), a commercial spreadsheet and
graphing package. Gaussian curves were then
fitted to the Bragg reflections and the angular
position, width and area of each peak recorded.
Absorption and Lorentz corrections were applied
and the intensities square-rooted to produce struc¬
ture factor amplitudes. The relative scaling of
the different data sets and the phases of each
of their orders were determined by least-squares
fitting to straight line functions, as shown in
/
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Fig. 1 Plot of structure factor amplitude versus "H.O concen¬
tration for stacked hilayers of DOPC in a saturated atmosphere
at 25 C The measurements were made on the DI ft instrument at
the Institut Laue et Langevin Least-squares fitting was used to
scale the three data sets to each other and to phase the indi¬
vidual orders of each set. The bottom panel shows orders 2- 5 on
an expanded scale.
Fig. 1. The whole procedure has been described
previously [2j.
The £>-repeat (lamellar repeat distance) was
calculated by least-squares fitting of the ob¬
served angles of diffraction (20) to the Bragg
equation: hA = 2D sin((?h + .x) where ). is the
wavelength of neutrons, h is the order of diffrac¬
tion and x is the angular offset (misalignment)
of the detector.
The data were placed on a relative absolute'
[3-5] scale using the known neutron scattering
densities of Ml,0 and M2Q to scale the (DOPC 4-
2H20) — (DOPC I- H20) difference. This method
requires knowledge of the molar percentage of
water in the samples, which was determined as
described below.
2.4 Determination of water content
T he neutron diffraction sample preparation was
repeated using ,JC-labelled DOPC and tritiated
water so that scintillation counting could be used
to determine the water : lipid molar ratio. Micro¬
scope coverslips (22 x 22 mm) were cut into half to
provide a suitable substrate which would fit into a
standard scintillation counter tube. In order to give
the same sample thickness, approximately 5.0 mg
of lipid was spread on each half-coverslip. After
vacuum dehydration and rehydration for 24 h,
in small batches, at 25"C, the coverslips were
quickly transferred to tubes of scintillant. I4C
and Ml activity were measured using a Packard
I900CA Liquid Scintillation Analyzer. Calibration
samples containing tritiated water (1.0 pi) or ,4C-
phosphoiipid equivalent to 5.0 mg of DOPC were
used to calibrate the scintillation counter channel
and cross-channel response. Clean coverslips ser¬
ved as controls for the experiment, to ensure that
the amount of water condensing on the reverse side
was negligible.
2.5. Data analysis (2) swelling series
Background subtraction and Gaussian-fitting
were carried out as for the 2H20/H20 exchange
data. After correction with absorption and Lorentz
factors the structure factors were calculated from
the intensities and plotted against their spatial fre¬
quencies. as shown in Fig. 2. Interpolation between
the points produced sets of structure factors, which
were then used to calculate [1] the continuous
transforms, also shown in the figure.
.3. Results and discussion
Figs. 1 and 2 show the structure factors deter¬
mined by each method. Neutron scattering density
profiles, calculated by Fourier transformation of
the 2H20/H20 exchange data are shown in Fig. 3.
Fig. 4 is a swelling series of bilayer profiles cal¬
culated from sets of structure factors determined
by interpolation between the observed points, as
shown in Fig. 2.
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Fig 2. Plot of structure factor amplitude versus spatial fre¬
quency of data points collected by real-time swelling series from
stacked bilayers of DOPC at 25 C The dry DOPC sample w as
placed in a Dl 6 sample can along with water troughs containing
100% il,0 Four consecutive 0 - 2t> scans were run over a total
period of 12 h. The three inset graphs are enlargements of the
regions corresponding to the third, fourth and fifth orders of
diffraction. Also shown are continuous transforms calculated
using the method of King and Worthington [I ]
The D-repeats of the 2I120/H20 exchange sam¬
ples were 53.5 + 0.5, 53.1 + 0.5 and 53.1 + 0.5 A
for the 0%, 50% and 100% 2H20 samples, respec¬
tively. The D-repeat of the swelling series sample
increased from 50.8 to 53.2 A over the 12 h of data
collection. The mosaic spreads (half-width at \/e
height) for the 2H20/H20 exchange samples were
0.38n. The mosaic spreads of the swelling series
sample was 0.34 , 0.38 , 0.38~ and 0.36 for the four
scans. The water content of pure DO PC bilayers at
25 C was determined to he 26.8 + 0.5 waters per
lipid. The tritium signal from the control coverslips
was less than l/200th of that from the sample
coverslips.
There was no noticeable increase or decrease in
the sample disorder throughout the swelling series
Z(A)
Fig f Neutron scattering density profiles of pure DOPC at
25 C and 100% relative humidity (a) 100% H.O. (b) 50% H,()
with 50% 2HO Profile (c) is a difference profile, showing the
distribution of :H.O calculated hv subtracting profile (at from
(h).
measurements, as determined by mosaic spread.
The low mosaic spread is typical for measurements
of (static) unsaturated phospholipids, such as
DOPC, but is perhaps not expected in dynamic
systems as reported here. We explain our findings
in terms of the sample quickly achieving equilib¬
rium with the atmosphere inside the sample can
compared to the very much slower equilibration
of the can atmosphere with the water at the base of
the can. The design of the water baths was such
that the surface area was relatively small (approx¬
imately 5 cm2) and positioned some 1.5 cm below
the rim.
Both of the methods used in this study give phase
information In the case of the 2IDO/H->0 ex¬
change approach, the phases are determined as
those which give the best fit to straight lines when
the structure factors of each order are plotted
against the percentage of 211,0 (see Fig. 1). Since
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Fig. 4. A swelling series of neutron scattering density profiles
calculated by Fourier transformation of structure factors deter¬
mined by interpolation between the observed points, as shown
in Fig. 2: (a) 0 « 50 A: (b) D = 51 A: [c) D - 52 A: <d) D = 53 A:
(e) D = 54 A
the distribution of^2^l20 approximates to a Gaus¬
sian peak centred at the origin, the phases are
predicted to alternate, with odd-numbered orders
negative and even ones positive. However, this
Gaussian approximation breaks down as the order
number increases because the width of the 2H20
peak is wide, and is actually better represented as
a pair of Gaussian distributions [2.4], In the case
of the swelling series approach, all possible phase
combinations are tried, the correct one being iden¬
tified as that which gives best agreement between
the observed points and the continuous transform
calculated from them [1], This is shown in Fig. 2.
Reference to the figure shows that the neutron
structure factors, determined at a range of spatial
frequencies, do not lie on the same continuous
transform. The explanation for this is discussed
below. However, it is clear from the figure that each
order traces out its own curve through the observed
points. This is even true for the first order reflec¬
tions. which show the largest change in spatial
frequency. The point at a spatial frequency of
0.0197 A"1 was the first point measured, from an
effectively dry sample; even though it lies well out¬
side the continuous transforms shown, it still fits
the curve plotted through the other first-order
points. T his curve may be interpolated to calculate
sets of structure factors of any intermediate /)-
repeat (since the hydration of the sample increased
steadily throughout the experiment, no two mens
ured points index to the same /)-repeat). Continu¬
ous transforms, calculated from these points, using
the method of King and Worthington show
a smooth variation in amplitude, reinforcing faith
in the phase assignments.
Interpolation between the measured values of
each structure factor allows determination of the
bilayer structure at any /7-repeat within the range
covered by the measurements. This feature compli¬
ments the standard neutron procedure of difference
calculation, which is most powerful when both data
sets in a subtraction have exactly the same D-re¬
peat. However, this is rarely the case; typically one
has to be content with a difference up to 2%
or so. Fig. 4 shows a series of bilayer scattering
profiles, calculated from points on the lines interpo¬
lated between the swelling series points. The differ¬
ence between profiles which differ by only 1.0 A is
apparent. Using the swelling series method, each
set of structure factors in a difference subtraction
can be calculated for the same D-repeat. thereby
removing ambiguity from the subtraction result.
It is apparent from Fig. 2 that the observed
points do not trace out a continuous transform.
One possible explanation is that the bilayer struc¬
ture changes during the hydraton process. This
point has been raised by Worcester [6], who has
suggested that the conformation of phosphatecon-
taining head group of dimyristoylphosphatidylcho-
line in the L, phase is dependent upon hydration
level. It is possible that our data demonstrate the
same phenomenon, though it is not certain that
the current resolution (h = 5) would be sufficient
to show this. However, unless any structural re¬
arrangement occurred over a very small change in
D-repeat (the smooth curves through each order in
Fig 2 do not show this to be the case) then calcu¬
lating an intermediate set of structure factors be¬
tween the observed points will simply result in an
intermediate structure.
An alternative (or complementary) explanation is
that increasing amounts of (negatively scattering)
water modify the unit-cell structure in such a way
that it is not valid to fit all of the swelling series to
the same continuous transform. This suggestion is
supported by Fig. 4 which compares the bilayer
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structure at different points on the swelling series. 11
is clear that water penetration into the head group
region reduces the height of the phosphate-ester
peaks, and shifts their centre of mass into the bi-
layer.
fig. 4 shows that the effect of increasing the
water content is to reduce the neutron-scattering
contrast of tfie system The reason for this is that
the region to which the negatively scattering water
is introduced is immediately adjacent to and. in¬
deed. totally overlaps (see Fig. 3). the region of
highest scattering density, namely the phosphates
and ester linkages. In order to avoid this effect, and
more-accurately mimic the X-ray technique, it
would be necessary to use 8.06% 2H,0; at this
isotopic composition, water has a net neutron scat¬
tering density of zero.
Despite the fact that the individual observed
points cannot be fitted to a single continuous trans¬
form. for the reasons explained above, it is our
assertion that it is still quite legitimate to interpo¬
late between the observed points in order to derive
sets of structure factors.
Table 1 compares the structure factors obtained
by the two methods. One distinct advantage of the
swelling series method is the potential increase in
the accuracy of intensity measurement. Any change
in D-repeat, caused by temperature or humidity
fluctuations, or incomplete equilibration, can result
in large differences in intensity of any given order
This effect is seen at its most extreme in tfie first
order, where a change in D-repeat of 2.5 A (from
50.8 to 53.2 A) causes a 280% change in amplitude
(which is equivalent to nearly 800% change in
intensity). These variations may occur within the
duration of the scanning of one sample (typically
12 h or so), or the same sample may equilibrate to
a slightly different D-repeat in any of the set of
measurements in a :M,0 TDO exchange series. In
stead of simply averaging out these differences, the
swelling series method, proposed here, provides
a much more systematic treatment of the data.
Each reflection is indexed individually to its spa¬
tial frequency. Moreover, with more than one point
for each order, it is possible to determine the pre¬
cise structure factor amplitude at any intermediate
point on the spatial frequency scale. When neutron
beam time is limited, the advantage of not needing
to wait for hours to be certain of complete equili¬
bration of a new sample is considerable.
Another weakness in the 2H20/H20 exchange
method which is overcome by the swelling series
approach is the requirement to scale the different
data sets to each other in the former. This require¬
ment is alleviated in the latter, since the entire series
of measurements is made on the same sample, with¬
out disturbing its alignment in the beam. No cor¬
rection is therefore necessary.
In practice, we do not see the swelling method
being used exactly in the way we have described
here. DO PC is a well-understood phospholipid, so
it was a reasonable choice for this study. However.
Table I
Relative absolute neutron structure factors /- *(/1) for oriented bilaver stacks of DOPC at 25 C' The D-repeat of each set is 5.1 2 A
/•♦(I) f*(2) F'O) F*(4) T*<5)
DOPC (2H20/T!20 exchange method)' -7 68 - 20.10 9.96 - 3.00 - 2 09
+ 0 10" ± 0 50 ± 0.34 +1.72 + 0 57
DOPC (swelling series methodf — 8 34 — 18 89 9.57 — I 57 — 4 13
'These data were calculated by least-squares fitting to measured structure factors at 0%. 50% and 100% 2IPO
bThe errors quoted are the maximum deviation of each order from the least-squares fitted straight line (as shown in Fig. I) and arc.
therefore, only an approximation. The two major contributions to the errors are likely to come from combining data from different
D-repeats and inaccuracies inherent in the measuring process itself. It is not easy to calculate meaningful error estimates for the swelling
series data, but they are expected to he no larger than those quoted for the 2H,0 IDO exchange data. Indeed, they are likely to be much
improved since the former of the two major contributors to the errors does not apply to these data.
'These data were calculated from curves fitted to structure factors measured from a sample as its D-repeat increased from 50 8 to 53.2 A.
over a period of 12 h.
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when applied to less well-studied lipids, unexpected
Isotropic phase transitions or phase separations
may well manifest themselves which, though easy
to identify in the neutron data, would detract from
the value of the technique. How we do see the
swelling method being applied is way of breaking
down each data collection run into several con¬
secutive scans. Each scan would be analysed in¬
dependently. A comparison of the position and
amplitude of each order from the consecutive scans
would then allow a more accurate estimation of
the amplitude, as well as reveal useful phase in¬
formation.
Taking all these advantages together, the im¬
proved accuracy, reduced equilibration time and
the ability to calculate structure factor sets at any
selected D-repeat (within a given range), the swell¬
ing series method has much to recommend its ad¬
option for neutron diffraction studies. We therefore
recommend the swelling method, not as a replace¬
ment for the more usual neutron approach of iso-
topic substitution, but rather as a complimentary
technique which can help to improve the accuracy
of structure factor determination, whilst also pro¬
viding an independent 'second opinion' for phase
determination. Its added advantage of reducing the
requirement for sample equilibration time at the
start of an experiment will assist in the optimal
utilisation of neutron beam time allocations For
maximum benefit, and closest parallel to the X-rav
method from which it is derived, the samples
should be run at 8.07% :H:0. though it will yield
increased information content at any :H,0 con¬
centration.
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Tu-AM-D4
Neutron diffraction studies of the interaction of tachykinins with
phospholipid bilayers ((Jeremy P. Bradshaw Maicoim J. M. Darkes Sarah M. A.
Davies.)) Department of Preciinical Veterinary Sciences. University of Edinburgh.
R. fD.i S. V. 5.. Summer'nall. Edinburgh. EH9 1QH. Scotland. UK.
The tachykinins are a group of peptides which bind to G-protein coupled receptors.
Receptor affinity appears to depend on different secondary structures of tachykinin
which share the same hydrophobic carboxy-terminal sequence. FXGLM. Receptor
activation is thoueht to be due to the carboxy-terminal submerging into the bilayer
and the amino-terminal binding on the surface. We have used neutron diffraction
measurements of specifically deuterated tachykinins to study the bilayer interaction
of these peptides and determine the depth of bilayer penetration of their carboxy-
termini. We report that the bilayer locations of two tachykinins, substance P and
neurokinin A. are remarkably similar, thereby inferring that finer levels of structure
must control receptor specificity. We present data relating the bilayer penetration
to the phospholipid composition of the membrane and present structural modeis
derived by using the location of deuterated peptides to position XMR structures of
the peptides relative to the bilayer normal.
